Methods to detect motor neuron disease comprising micro-RNAs

ABSTRACT

The present invention relates to compositions and methods for detecting motor neuron-specific miRNAs in a population of cells or subject. More particularly, the invention relates to detecting motor neuron-specific miRNAs to detect and treat motor neuron diseases associated with dysregulation of motor neuron-specific miRNAs, such as Amyotrophic Lateral Sclerosis (ALS).

CROSS REFERENCE TO RELATED APPLICATIONS

This application claims the benefit U.S. application Ser. No.15/553,922, filed Aug. 25, 2017, which claims the benefit of PCTApplication PCT/US2016/019602, filed Feb. 25, 2016, which claims thebenefit of U.S. Provisional Application No. 62/120,654, filed Feb. 25,2015, the disclosures of which are hereby incorporated by referencetheir entirety.

GOVERNMENTAL RIGHTS

This invention was made with government support under NS078398 awardedby the National Institutes of Health. The government has certain rightsin the invention.

FIELD OF THE INVENTION

The present invention relates to compositions and methods for detectingmotor neuron-specific miRNAs in a population of cells or subject. Moreparticularly, the invention relates to detecting motor neuron-specificmiRNAs to detect and treat motor neuron diseases associated withdysregulation of motor neuron-specific miRNAs, such as AmyotrophicLateral Sclerosis (ALS).

BACKGROUND OF THE INVENTION

MicroRNAs (miRNAs) are single-stranded, non-coding RNAs that regulatetranscription and translation of coding RNAs (mRNA). Since theirdiscovery in 1993, miRNAs have emerged as key regulators in numerousphysiological and pathological processes. miRNAs are highly conservedand are about 18-25 nucleotides in length. Typically, miRNAs directtranslational repression by binding to the 3′ untranslated region (UTR)of mRNAs. Because only partial complementarity is required formiRNA-mRNA interactions, a single miRNA can potentially regulatehundreds of mRNA transcripts.

Motor neuron diseases are those involving progressive loss of structureor function of motor neurons, including death of motor neurons. Suchdiseases include Amyotrophic Lateral Sclerosis (ALS), primary lateralsclerosis, progressive muscular atrophy, progressive bulbar palsy andpseudobulbar palsy. Most motor neuron diseases have no cure andavailable therapeutics are targeted at improving symptoms, relievingpain, and slowing degeneration. Motor neuron diseases, such as ALS, neednovel, innovative approaches to drug development since many traditionaltherapeutics have failed or only shown marginal benefits. Further, thereare no specific tests to diagnose motor neuron diseases. Early diagnosisor detection of motor neuron disease may facilitate earlier treatmentthus slowing degeneration. Thus, in addition to novel drugs, there is aneed for early, accurate detection of motor neuron disease.

While miRNAs are known regulators of physiological and pathologicalprocesses, little is known about their involvement in motor neuronconditions or diseases. Further, knowledge of motor neuron-specificmiRNAs may enhance the detection and treatment of motor neuron diseases.Compositions and methods exploiting motor neuron-specific miRNAregulation in motor neuron conditions or diseases are needed to furthermedical research and provide diagnostic and therapeutic resources forsuch conditions and diseases. The present invention providescompositions and methods for detecting and treating conditions anddiseases associated with aberrant motor neuron-specific miRNAregulation.

SUMMARY OF THE INVENTION

In an aspect, the disclosure provides a method to detect motor neurondisease. The method comprises measuring the amount of miR-218 in abiological sample obtained from a subject, and comparing the amount ofmiR-218 in the biological sample to a reference value, whereindysregulation of miR-218 relative to the reference value indicates motorneuron disease.

In another aspect, the disclosure provides a method to detect motorneuron disease. The method comprises measuring the amount of miR-218 andat least one additional miRNA selected from the group consisting ofmiR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and miR-379 ina biological sample obtained from a subject, and comparing the amount ofmiR-218 and at least one additional miRNA selected from the groupconsisting of miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380,and miR-379 in the biological sample to a reference value, whereindysregulation of miR-218 and at least one additional miRNA selected fromthe group consisting of miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, and miR-379 relative to the reference value indicates motorneuron disease.

In still another aspect, the disclosure provides a method to detect theefficacy of treatment or the progression of motor neuron disease. Themethod comprises: measuring the amount of miR-218 in a first biologicalsample obtained from a subject; then at a later time measuring theamount of miR-218 in a second biological sample obtained from a subject;and comparing the amount of miR-218 in the first biological sample tothe amount of miR-218 in the second biological sample, wherein a changein miR-218 indicates effectiveness of treatment or progression of motorneuron disease.

In still yet another aspect, the disclosure provides a method to detectthe efficacy of treatment or the progression of motor neuron disease.The method comprises: measuring the amount of miR-218 and at least oneadditional miRNA selected from the group consisting of miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and miR-379 in a firstbiological sample obtained from a subject; then at a later timemeasuring the amount of miR-218 and at least one additional miRNAselected from the group consisting of miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, and miR-379 in a second biological sampleobtained from a subject; and comparing the amount of miR-218 and atleast one additional miRNA selected from the group consisting ofmiR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and miR-379 inthe first biological sample to the amount of miR-218 and at least oneadditional miRNA selected from the group consisting of miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and miR-379 in thesecond biological sample, wherein a change in miR-218 and at least oneadditional miRNA selected from the group consisting of miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and miR-379 indicateseffectiveness of treatment or progression of motor neuron disease.

In a different aspect, the disclosure provides a method to improve motorneuron function in a subject diagnosed with a motor neuron disease,suspected of having a motor neuron disease or at risk for a motor neurondisease. The method comprises administering a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 composition,or combination thereof, to the subject.

In another different aspect, the disclosure provides a method oftreating a subject diagnosed with a motor neuron disease, suspected ofhaving a motor neuron disease or at risk for a motor neuron disease. Themethod comprises administering miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition, or combinationthereof, to the subject.

BRIEF DESCRIPTION OF THE DRAWINGS

The application file contains at least one photograph executed in color.Copies of this patent application publication with color photographswill be provided by the Office upon request and payment of the necessaryfee.

FIG. 1A, FIG. 1B, FIG. 1C, FIG. 1D, FIG. 1E and FIG. 1F depictschematics and images describing and validating the promoters used todrive cell type specific GFP-myc-Ago2 expression. (FIG. 1A, FIG. 1B)Mice were generated to express Cre recombinase under one of fourspecific cell type promoters: synapsin 1 (Syn) for all neurons; cholineacetyltransferase (ChAT) for motor neurons, glial acidic fibrillaryprotein (GFAP) for astrocytes or lysozyme M (Lyz2, LysM) for microglia.Cre recombinase drives expression of a tagged miRNA binding protein,Ago2, in the desired cell type. (FIG. 1C, FIG. 1D, FIG. 1E, FIG. 1F)Spinal cord sections from transgenic mice were stained for NeuN (red;neurons) or ChAT (red; MNs) or GFAP (red; astrocytes) or Iba1 (red;microglia) and GFP (green). Scale bars, 50 μm.

FIG. 2A and FIG. 2B depict a schematic and graph showing that miRNAAffinity Purification recapitulates cell type specific miRNA expression.(FIG. 2A) Schematic of miRAP demonstrating selective expression ofmyc-GFP-tagged Ago2 in motor neurons, which allows for IP of myc toisolate miRNAs from only motor neurons or IP of Ago2 to isolate miRNAfrom all spinal cord cell types. (FIG. 2B) miRAP from geneticallylabeled mice produces miRNA expression profiles that are expected of allneurons, motor neurons, astrocytes and microglia in the brainstem.Relative expression normalized to geomean of endogenous miRNA controls:miR-30c, 24, and 191. n=6/line. Values are expressed as mean±SEM.

FIG. 3A, FIG. 3B and FIG. 3C depicts a graph, a heatmap and a schematicshowing that CNS cell types cluster according to their miRNA expressionprofiles. (FIG. 3A) 3-Dimensional Principal Component Analysisillustrating the variation in our samples. The replicates of each spinalcord cell type cluster with each other moreso than any other cell type.miRNA expression from Ago2 IP from one of each of these four micecluster, indicating global miRNA signatures are comparable. (FIG. 3B)Hierarchical heatmap clustering demonstrates spinal cord CNS cell typescan be identified by their unique miRNA expression profiles and thatneuronal miRNA expression is distinct from astrocytes and microglia.(FIG. 3C) The top 3 miRNAs exhibiting cell type specificity in each CNScell type of the brainstem and spinal cord (CT<30 in both tissues). Thespecificity index (pSI) was calculated as described in the supplementalmethods.

FIG. 4A, FIG. 4B, FIG. 4C, FIG. 4D, FIG. 4E and FIG. 4F depict graphsshowing that MN-Enriched miRNAs are temporally depleted in ALS mousemodel and human patient spinal cord. (FIG. 4A, FIG. 4B) MN-enrichedmiRNAs, miR-218 and miR-138, are significantly depleted in ALS mousemodel spinal cord. This depletion occurs temporally and is maximized atend-stage. N=3-4. (FIG. 4C, FIG. 4D) Pan-Neuronal Enriched miRNAs arenot significantly depleted in ALS mouse model spinal cord, even atend-stage. N=3-4. (FIG. 4E, FIG. 4F) MN-enriched miRNAs, miR-218 andmiR-138, are significantly depleted in patient autopsy spinal cord ascompared to age-matched controls. N=4-10. Values are expressed asmean±SEM. **p≤0.01, ***p≤0.001, ****p≤0.0001. Student's two-tailed,unpaired t-test. Relative expression is normalized to RNA input andendogenous miRNA control, miR-24, (FIG. 4A, FIG. 4B, FIG. 4C, FIG. 4D)or U6 snRNA (FIG. 4E, FIG. 4F).

FIG. 5A, FIG. 5B, FIG. 5C, FIG. 5D, FIG. 5E and FIG. 5F depict graphsshowing that MN-enriched miRNAs are increased in ALS rat model CSF andare responsive to ALS therapy. (FIG. 5A) miR-218 expression istemporally increased in ALS rat model CSF. N=5-7/timepoint. 115d and130d timepoints included rats ranging from 112-119d and 126-134d,respectively. End-stage rats ranged from 160-242d; average=192±30d.(FIG. 5B, FIG. 5C) Neuronal miRNAs, miR-132 and miR-124, are notincreased in ALS rat model CSF. (FIG. 5D) miR-218 is reduced in ratstreated with SOD1-lowering ASO as compared to a CSF-treated controls.N=4/group. (FIG. 5E, FIG. 5F) miR-132 and miR-124 are not responsive toALS therapy. Relative expression is normalized to endogenous miRNAbiological fluid control, miR-103a-3p. Values are expressed at mean±SEM.*p≤0.05, **p 0.01. Student's unpaired t-test two-tailed (FIG. 5A) orone-tailed (FIG. 5D).

FIG. 6 depicts an immunoblot showing biochemical validation of cell typespecific tAgo2 expression. Myc immunoprecipitation and subsequentimmunoblot to confirm tagged-Ago2 expression in each transgenic mouse.GFP-myc-Ago2 (tAgo2; ˜130 kDa) is only expressed when LSL-tAgo2 mice arecrossed with mice expressing Cre recombinase under a cell type specificpromoter. One well was intentionally left blank between each mouse, withexception to LSL-tAgo2 only.

FIG. 7 depicts a graph showing putative endogenous miRNA controls forCNS cell types. Using global LoessM normalization of the miRNAmicroarray data, miR-191, 24 and 30c were found to be consistentlyexpressed across CNS cell types in both brainstem (bs) and spinal cord(sc). For the CNS cell types analyzed here, these miRNAs could serve ascontrols for normalizing miRNA RT-qPCR data.

FIG. 8 depicts a graph showing increased miR-218 levels in ALS rat modelCSF are not due solely to hSOD1 overexpression. miR-218 CSF levels arenot significantly increased at either 90 or 165 days in hSOD1 wildtypeoverexpressing rats. N=2-7/timepoint. Values are expressed at mean±SEM.Student's unpaired, two-tailed t-test.

DETAILED DESCRIPTION

In accordance with the present invention, motor neuron (MN)-specificmiRNAs selected from the group consisting of miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, and miR-379 have been discovered.In particular, the present invention provides compositions and methodsuseful in research, diagnostics, and therapeutics for conditions anddiseases associated with dysregulation of miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, and/or miR-379. The compositionsand methods are directed at modulating the activity of miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and/or miR-379.

Various aspects of the invention are described in further detail in thefollowing sections.

I. Compositions

(a) Nucleic Acid Molecules

One aspect of the invention pertains to isolated nucleic acid moleculesthat encode miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 or biologically active portions thereof, as well asnucleic acid molecules sufficient for use as hybridization probes toidentify miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379-encoding nucleic acids (e.g., miRNA, pri-miRNA,pre-mRNA) and fragments for use as PCR primers for the amplification ormutation of miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 nucleic acid molecules.

A nucleic acid molecule of the present invention, or a complement of anyof these nucleotide sequences, may be isolated using standard molecularbiology techniques. For instance, using all or a portion of the nucleicacid sequences of miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379, nucleic acid molecules may be isolatedusing standard hybridization and cloning techniques (e.g., as describedin Sambrook et al., eds., Molecular Cloning: A Laboratory Manual. 2nded., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press,Cold Spring Harbor, N.Y., 1989).

A nucleic acid of the invention may be amplified using cDNA, mRNA orgenomic DNA as a template and appropriate oligonucleotide primersaccording to standard PCR amplification techniques. The nucleic acid soamplified may be cloned into an appropriate vector and characterized byDNA sequence analysis. Furthermore, oligonucleotides corresponding tomiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 nucleotide sequences may be prepared by standard synthetictechniques known in the art, such as using an automated DNA synthesizer.

In another embodiment, an isolated nucleic acid molecule of theinvention comprises a nucleic acid molecule which is a complement of anucleotide sequence of miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379, or portion thereof. A nucleic acidmolecule which is complementary to a given nucleotide sequence is onewhich is sufficiently complementary to the given nucleotide sequencethat it can hybridize to the given nucleotide sequence, thereby forminga stable duplex.

Moreover, the nucleic acid molecule of the invention may comprise only aportion of a nucleic acid sequence encoding miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379. By way of example, afragment of the nucleic acid coding sequence may be used as a probe,primer, or a fragment encoding a biologically active portion of miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379. Thenucleotide sequence determined from the cloning of miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 allows forthe generation of probes and primers designed for use in identifyingand/or cloning miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 homologues in other cell types, as well as miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379homologues and orthologs from other species. The probe/primer typicallycomprises substantially purified oligonucleotides. The oligonucleotidestypically comprise a region of nucleotide sequence that hybridizes understringent conditions to at least about 6, 7, 8, 9, 10, 11, 12, 13, 14,15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30 or moreconsecutive nucleotides of the sense or antisense sequence of miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379, orof a naturally occurring mutant.

Probes based on the miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 nucleotide sequence may be used to detecttranscripts or genomic sequences encoding the same or similar miRNA. Theprobe comprises a label group attached thereto, such as a radioisotope,a fluorescent compound, an enzyme, or an enzyme co-factor. Such probesmay be used in diagnostic or screening assays.

A nucleic acid fragment encoding a “biologically active portion” ofmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 may be prepared by isolating a portion of a nucleotide sequencehaving miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380,or miR-379 biological activity, expressing the encoded portion ofmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 (e.g., by recombinant expression in vitro), and assessing theactivity of the encoded portion of miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379. For example, a nucleic acidfragment encoding a biologically active portion of miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 includes theseed region, or an RNA binding site.

The invention further encompasses nucleic acid molecules that differfrom the nucleotide sequence of the native miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379, due to degeneracy ofthe genetic code and thus encode the same miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 as that encoded by thenative nucleotide sequence.

In addition, it will be appreciated by those skilled in the art thatnucleotide sequence polymorphisms may exist within a population (e.g.,the human population). Such genetic polymorphism in the miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379coding sequence may exist among individuals within a population due tonatural allelic variation. Such natural allelic variations may result inas much as 15% variance in the nucleotide sequence. Any and all suchnucleotide variations and resulting polymorphisms in miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 that are theresult of natural allelic variation and that do not alter the functionalactivity of the miRNA are intended to be within the scope of theinvention. Thus, e.g., 1%, 2%, 3%, 4%, or 5% of the nucleotide bases inmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 (e.g., 1, 2, 3, 4, 5, 6, 8, 10, 15, 20, 25, 30, 35, 40, 45, 50,or 55) may be replaced by another nucleotide base.

Moreover, nucleic acid molecules encoding miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 from other species(miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 orthologs/homologues), which have a nucleotide sequence whichdiffers from that of a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 disclosed herein, are intended to be withinthe scope of the invention.

In addition to naturally occurring allelic variants of the miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379sequence that may exist in the population, the skilled artisan willfurther appreciate that changes may be introduced by mutation into thenative nucleotide sequence, thereby leading to changes in the sequenceof the encoded miRNA without altering the functional ability of themiRNA. For example, such mutations may include nucleotide substitutionsat “nonessential” nucleotide bases. A “nonessential” nucleotide base isone that may be altered from the wildtype sequence of miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 withoutaltering the biological activity, whereas an “essential” nucleotide baseis required for biological activity.

Accordingly, another aspect of the invention pertains to nucleic acidmolecules encoding miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 that contain changes in nucleotide basesthat may or may not be essential for activity. Such miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 sequencesdiffer from the native sequences. In specific embodiments, the isolatednucleic acid molecule includes a nucleotide sequence encoding miRNA thatis at least about 45% identical, 65%, 75%, 85%, 90%, 91%, 92%, 93%, 94%,95%, 96%, 97%, 98%, or more identical to the sequence of miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379. Anisolated nucleic acid molecule encoding miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 having a sequence whichdiffers from that of the naturally occurring sequence may be created byintroducing one or more nucleotide substitutions, additions or deletionsinto the native nucleotide sequence of miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 such that one or moresubstitutions, additions or deletions are introduced into the encodedmiRNA. Mutations may be introduced by standard techniques known in theart, such as site-directed mutagenesis and PCR-mediated mutagenesis.

As will be recognized by individuals skilled in the art, both arms of apre-miRNA hairpin encoding miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 may give rise to a maturemiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 miRNA. For instance, two mature miRNAs that may result from apre-miRNA encoding a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 miRNA may be miR-218-3p, miR-138-3p,miR-133a-3p, miR-133b-3p, miR-1193-3p, miR-34b-3p, miR-380-3p, ormiR-379-3p and miR-218-5p, miR-138-5p, miR-133a-5p, miR-133b-5p,miR-1193-5p, miR-34b-5p, miR-380-5p, or miR-379-5p, respectively.Specifically, a nucleic acid may be miR-218-3p, miR-218-5p, miR-138-5p,miR-138-3p, miR-133a-3p, miR-133b-3p, miR-34b-3p, miR-380-3p, ormiR-380-5p. As used herein, miR-218 refers to miR-218-1 and miR-218-2.

(b) miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 Agents

Another aspect of the invention pertains to miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 agents. As used herein,the term “miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 agent” refers to any molecule capable of modulatingone or more activities of miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379. A miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 agent may respectivelymodulate one or more activities of miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 by increasing or decreasingexpression of the respective miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 in a subject. In someembodiments, a miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 agent respectively modulates a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 activity byincreasing the respective expression of a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 in a subject. In otherembodiments, a miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 agent respectively modulates a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 activity bydecreasing expression of a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 in a subject. In a specificembodiment, a miR-218 agent modulates miR-218 activity by decreasingexpression of miR-218 in a subject. In another specific embodiment, amiR-138 agent modulates miR-138 activity by decreasing expression ofmiR-138 in a subject.

Exemplary miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 agents may include, without limitation, a compound,a drug, a small molecule, a peptide, a nucleic acid molecule, a protein,an antibody, and combinations thereof. miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 agents may be syntheticor naturally occurring.

In some embodiments, a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 agent is a compound. In another embodiment,a miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 agent is a drug. In yet another embodiment, a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 agent is asmall molecule. In another embodiment, a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 agent is a peptide. Inanother embodiment, a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 agent is a protein. In still anotherembodiment, a miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 agent is an antibody. In another embodiment, amiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 agent is a combination of miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 agents capable of respectivelymodulating miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 activity.

In preferred embodiments, a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 agent is a nucleic acid molecule.For instance, a miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 nucleic acid agent may be an antisenseoligonucleotide, a ribozyme, a small nuclear RNA (snRNA), a longnoncoding RNA (LncRNA), or a nucleic acid molecule which forms triplehelical structures.

In some embodiments, a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 agent is a ribozyme. Ribozymes arecatalytic RNA molecules with ribonuclease activity which are capable ofcleaving a single-stranded nucleic acid, such as miRNA, to which theyhave a complementary region. Thus, ribozymes (e.g., hammerhead ribozymes(described in Haselhoff and Gerlach (1988) Nature 334:585-591)) may beused to catalytically cleave miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 to thereby respectively inhibitactivity of miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379. A ribozyme having specificity for a miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379-encoding nucleic acid may be designed based upon the nucleotidesequence of a respective miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 cDNA. For example, miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 may be usedto select a catalytic RNA having a specific ribonuclease activity from apool of RNA molecules. See, e.g., Bartel and Szostak (1993) Science261:1411-1418; Suryawanshi, Scaria, and Maiti (2010) Mol Biosyst.6:1807-1809.

In other embodiments, a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 agent is a sn RNA. For instance, a miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379snRNA agent may be a snRNA capable of regulating transcription of anucleic acid sequence respectively encoding miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379. Alternatively, amiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 sn RNA agent may be a sn RNA capable of regulating splicing of amirtron encoding miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379.

In yet other embodiments, a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 agent is a LncRNA. A miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379LncRNA agent may be a LncRNA capable of regulating transcription of anucleic acid sequence respectively encoding miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379.

In other embodiments, a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 agent is a nucleic acid molecule whichforms triple helical structures. For example, miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 expressionmay be modulated by targeting nucleotide sequences complementary to theregulatory region of miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 (e.g., promoter and/or enhancers) to formtriple helical structures that respectively prevent transcription ofmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 in target cells. See generally, Helene (1991) Anticancer DrugDes. 6(6):569-84; Helene (1992) Ann. N.Y. Acad. Sci. 660:27-36; andMaher (1992) Bioassays 14(12):807-15.

In preferred embodiments, a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 agent is an antisenseoligonucleotide. Antisense molecules are oligonucleotides comprisingnucleic acid sequences complementary to a sense nucleic acid sequence. AmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 antisense oligonucleotide agent comprises nucleic acid sequencescomplementary to a miRNA encoding miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379, and may modulate the respectiveexpression of miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 by binding to a miRNA respectively encoding miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379. Theexpression of miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 may be modulated by blocking the respective activityof miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379, and respectively reducing the effective amount of miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 in acell.

An antisense oligonucleotide may bind through hydrogen bonds to a sensenucleic acid. As used herein, the term “sense nucleic acid sequence” isa nucleic acid sequence corresponding to an RNA sequence expressed in acell. For instance, a sense nucleic acid sequence may be an expressedmRNA nucleic acid sequence, or a DNA nucleic acid sequence correspondingto an expressed mRNA nucleic acid sequence. As such, an antisensemolecule of the invention comprises a nucleic acid sequencecomplementary to an expressed miRNA encoding miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379.

A miRNA encoding miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 may be a mature miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 or a miRNA processingintermediate encoding a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 miRNA. As such, an antisense nucleic acidmay comprise nucleic acid sequences complementary to a mature miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 orto a miRNA processing intermediate encoding a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 miRNA.Non-limiting examples of miRNA processing intermediates encoding amiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 miRNA include a pre-miRNA encoding miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379, a pri-miRNA encodingmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379, or a mirtron encoding miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379. In some embodiments, anantisense oligonucleotide comprises nucleic acid sequences complementaryto a pri-miRNA encoding miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379. In other embodiments, an antisenseoligonucleotide comprises nucleic acid sequences complementary to amirtron encoding miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379. In some embodiments, an antisenseoligonucleotide comprises nucleic acid sequences complementary to apre-miRNA encoding miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379. In yet other embodiments, an antisenseoligonucleotide comprises nucleic acid sequences complementary to amature miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380,or miR-379.

An antisense oligonucleotide may comprise nucleic acid sequencescomplementary to a noncoding region in a miRNA processing intermediateencoding a miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 miRNA. For instance, an antisense oligonucleotidemay comprise nucleic acid sequences complementary to a noncoding regionof a pri-miRNA, a pre-miRNA, or a mirtron encoding miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379. As usedherein, the term “noncoding region” is used to describe nucleic acidsequences that flank a mature miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 sequence in a miRNA processingintermediate encoding a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 miRNA.

In some embodiments, an antisense oligonucleotide comprises nucleic acidsequences complementary to a noncoding region of a pri-miRNA encodingmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379. In other embodiments, an antisense oligonucleotide comprisesnucleic acid sequences complementary to a noncoding region of a mirtronencoding miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379. In yet other embodiments, an antisenseoligonucleotide comprises nucleic acid sequences complementary to anoncoding region of a pre-miRNA encoding miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379.

In yet other embodiments, an antisense oligonucleotide comprises nucleicacid sequences complementary to coding and noncoding regions of a miRNAencoding miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379. In one alternative of the embodiments, an antisenseoligonucleotide comprises nucleic acid sequences complementary to thestem-loop of a pre-miRNA encoding miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379.

In preferred embodiments, an antisense oligonucleotide comprises nucleicacid sequences complementary to a coding region in a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 miRNA. Asused herein, the term “coding region” is used to describe a nucleic acidsequence present in a mature miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 miRNA. As will be recognized bythose of skill in the art, a nucleic acid sequence present in a maturemiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 is also present in a pri-miRNA encoding miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379, a pre-miRNAencoding miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379, and a mirtron encoding miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379. As such, an antisenseoligonucleotide comprising nucleic acid sequences complementary to anucleic acid sequence present in a mature miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379, may be complementaryto a mature miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379, as well as to a pri-miRNA encoding miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379, apre-miRNA encoding miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379, and a mirtron encoding miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379. In someembodiments, an antisense oligonucleotide comprises nucleic acidsequences complementary to a coding region of a pri-miRNA encodingmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379. In other embodiments, an antisense oligonucleotide comprisesnucleic acid sequences complementary to a coding region of a mirtronencoding miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379. In some embodiments, an antisense oligonucleotidecomprises nucleic acid sequences complementary to a coding region of apre-miRNA encoding miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379. In yet other embodiments, an antisenseoligonucleotide comprises nucleic acid sequences complementary to amature miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380,or miR-379.

An antisense oligonucleotide molecule may comprise nucleic acidsequences complementary to the entire coding region of a miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379miRNA. Alternatively, an antisense oligonucleotide molecule may comprisenucleic acid sequences complementary to only a portion of the coding ornoncoding region of a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 miRNA. As such, an antisenseoligonucleotide may comprise nucleic acid sequences complementary to 4,5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23,24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 55, 60, 65, 70, 80, 90, 100or more nucleotides of the coding or noncoding region of miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379. Insome embodiments, an antisense oligonucleotide comprises nucleic acidsequences complementary to 4, 5, 6, 7, 8, 9, or 10 nucleotides of thecoding or noncoding region of miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379. In other embodiments, anantisense oligonucleotide comprises nucleic acid sequences complementaryto 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 nucleotides of thecoding or noncoding region of miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379. In yet other embodiments, anantisense oligonucleotide comprises nucleic acid sequences complementaryto 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 nucleotides of thecoding or noncoding region of miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379. In yet other embodiments, anantisense oligonucleotide comprises nucleic acid sequences complementaryto 30, 35, 40, 45, 50, 55, 60, 65, 70, 80, 90, 100 or more nucleotidesof the coding or noncoding region of miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379. In preferredembodiments, an antisense oligonucleotide comprises nucleic acidsequences complementary to 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19,20, 21, 22, 23, 24, or 25 nucleotides of the coding or noncoding regionof miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379.

In particularly preferred embodiments, an antisense oligonucleotide ofthe invention comprises nucleic acid sequences complementary to a seedregion of a miRNA encoding miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379. In other particularly preferredembodiments, an antisense oligonucleotide consists of nucleic acidsequences complementary to a seed region of a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379. The seedregion is a 7-8 nucleotide motif in the miRNA that determinesspecificity of binding of an miRNA to a target mRNA regulated by themiRNA. In most miRNAs, the seed region is within nucleotides 1-9 of themature miRNA sequence. Antisense oligonucleotides comprising nucleicacid sequences complementary to the seed sequence of a miRNA have beenshown to inhibit activity of the miRNA. Such inhibitory activity isdescribed in PCT Publication No. WO 2009/043353, which is hereinincorporated by reference in its entirety for its description ofmodified oligonucleotides targeting miRNA seed sequences.

As will be recognized by individuals skilled in the art, both arms of apre-miRNA hairpin encoding miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 may give rise to a maturemiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 miRNA. For instance, two mature miRNAs that may result from apre-miRNA encoding a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 miRNA may be miR-218-3p, miR-138-3p,miR-133a-3p, miR-133b-3p, miR-1193-3p, miR-34b-3p, miR-380-3p, ormiR-379-3p and miR-218-5p, miR-138-5p, miR-133a-5p, miR-133b-5p,miR-1193-5p, miR-34b-5p, miR-380-5p, or miR-379-5p, respectively. Assuch, when an antisense nucleic acid comprises nucleic acid sequencescomplementary to a coding region of miR-380-3p, or miR-379-3p, anantisense nucleic acid may comprise nucleic acid sequences complementaryto a miR-218-3p, miR-138-3p, miR-133a-3p, miR-133b-3p, miR-1193-3p,miR-34b-3p, miR-380-3p, or miR-379-3p coding region of miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379,respectively, or to a miR-218-5p, miR-138-5p, miR-133a-5p, miR-133b-5p,miR-1193-5p, miR-34b-5p, miR-380-5p, or miR-379-5p coding region ofmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379, respectively. In some embodiments, an antisense nucleic acidcomprises nucleic acid sequences complementary to a miR-218-3p,miR-138-3p, miR-133a-3p, miR-133b-3p, miR-1193-3p, miR-34b-3p,miR-380-3p, or miR-379-3p coding region of miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379, respectively. In otherembodiments, an antisense nucleic acid comprises nucleic acid sequencescomplementary to a miR-218-5p, miR-138-5p, miR-133a-5p, miR-133b-5p,miR-1193-5p, miR-34b-5p, miR-380-5p, or miR-379-5p coding region ofmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379, respectively.

The size of a miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 antisense agent of the invention can and will varydepending on the target miRNA encoding a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379, the size of thenucleic acid sequence complementary to a region of miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379, and whetherthe antisense oligonucleotide comprises nucleic acid sequences inaddition to the sequences complementary to a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 miRNA. An antisenseoligonucleotide may be about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16,17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45 orabout 50 nucleotides in length. In some embodiments, an antisenseoligonucleotide is about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or about 15nucleotides in length. In other embodiments, an antisenseoligonucleotide is about 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, orabout 25 nucleotides in length. In yet other embodiments, an antisenseoligonucleotide is about 25, 26, 27, 28, 29, 30, 35, 40, 45, or about 50nucleotides in length. In some preferred embodiments, an antisenseoligonucleotide is about 5, 6, 7, 8, 9, or about 10 nucleotides inlength. In other preferred embodiments, an antisense oligonucleotide isabout 19, 20, 21, 22, 23, 24, or about 25 nucleotides in length. Inexemplary embodiments, an antisense oligonucleotide is 22 nucleotides inlength.

In certain embodiments, a nucleic acid sequence of an antisenseoligonucleotide comprising nucleic acid sequences complementary to amiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 miRNA may have one or more mismatched base pairs with respect toits target miRNA or precursor sequence, and remains capable ofhybridizing to its target sequence. For instance, a nucleic acidsequence of an antisense oligonucleotide comprising nucleic acidsequences complementary to a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 miRNA may have 1, 2, 3, 4, 5, 6,7, 8, 9, 10 or more mismatched base pairs with respect to its targetmiRNA or precursor sequence, and remains capable of hybridizing to itstarget sequence.

In certain embodiments, an antisense oligonucleotide comprises 8-25nucleotides at least 85% complementary to a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 miRNA. In otherembodiments, an antisense oligonucleotide consists of 8-25 nucleotidesat least 85% complementary to a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379. In still other embodiments, anantisense oligonucleotide consists of 8-25 nucleotides at least 85%complementary to a mature miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 miRNA.

In certain embodiments, an antisense oligonucleotide comprises 8-25nucleotides at least 90% complementary to a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 miRNA. In otherembodiments, an antisense oligonucleotide consists of 8-25 nucleotidesat least 90% complementary to a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 miRNA. In still otherembodiments, an antisense oligonucleotide consists of 8-25 nucleotidesat least 90% complementary to a mature miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 miRNA.

An antisense oligonucleotide of the invention may be synthesized usingchemical synthesis and enzymatic ligation reactions using proceduresknown in the art. For example, an oligonucleotide (e.g., an antisenseoligonucleotide) may be chemically synthesized using naturally occurringribonucleotides, deoxyribonucleotides, variously modified nucleotidesdesigned to increase the biological stability of the molecules or toincrease the physical stability of the duplex formed between theantisense and sense nucleic acids, or combinations thereof. For example,phosphorothioate derivatives and acridine substituted nucleotides may beused. Other examples of modified nucleotides which may be used togenerate an antisense nucleic acid include 5-fluorouracil,5-bromouracil, 5-chlorouracil, 5-iodouracil, hypoxanthine, xanthine,4-acetylcytosine, 5-(carboxyhydroxylmethyl) uracil,5-carboxymethylaminomethyl-2-thiouridine,5-carboxymethylaminomethyluracil, dihydrouracil,beta-D-galactosylqueosine, inosine, N6-isopentenyladenine,1-methylguanine, 1-methylinosine, 2,2-dimethylguanine, 2-methyladenine,2-methylguanine, 3-methylcytosine, 5-methylcytosine, N6-adenine,7-methylguanine, 5-methylaminomethyluracil,5-methoxyaminomethyl-2-thiouracil, beta-D-mannosylqueosine,5′-methoxycarboxymethyluracil, 5-methoxyuracil,2-methylthio-N6-isopentenyladenine, uracil-5-oxyacetic acid (v),wybutoxosine, pseudouracil, queosine, 2-thiocytosine,5-methyl-2-thiouracil, 2-thiouracil, 4-thiouracil, 5-methyluracil,uracil-5-oxyacetic acid methylester, uracil-5-oxyacetic acid (v),5-methyl-2-thiouracil, 3-(3-aino-3-N-2-carboxypropyl) uracil, (acp3)w,and 2,6-diaminopurine. Alternatively, the oligonucleotide may beproduced biologically using an expression vector into which a nucleicacid has been subcloned in an antisense orientation.

In certain embodiments, antisense oligonucleotides provided herein mayinclude one or more modifications to a nucleobase, sugar, and/orinternucleoside linkage, and as such is a modified oligonucleotide. Amodified nucleobase, sugar, or internucleoside linkage may be selectedover an unmodified form because of desirable properties such as, forexample, enhanced cellular uptake, enhanced affinity for otheroligonucleotides or nucleic acid targets, and increased stability in thepresence of nucleases. In certain embodiments, a modified nucleoside isa sugar-modified nucleoside. In certain such embodiments, sugar-modifiednucleosides may further comprise a natural or modified heterocyclic basemoiety or natural or modified internucleoside linkage and may includefurther modifications independent from the sugar modification. Incertain embodiments, a sugar modified nucleoside is a 2′-modifiednucleoside, wherein the sugar ring is modified at the 2′ carbon fromnatural ribose or 2′-deoxy-ribose. In certain embodiments, a 2′-modifiednucleoside comprises a 2′-substituent group selected from F, O—CH₃, andOCH₂CH₂OCH₃. In certain embodiments, a 2′-modified nucleoside has abicyclic sugar moiety. In certain embodiments, a bicyclic sugar moietycomprises a bridge group between the 2′ and the 4′ carbon atoms.

In certain embodiments, a modified oligonucleotide comprises one or moreinternucleoside modifications. In certain such embodiments, eachinternucleoside linkage of an oligonucleotide is a modifiedinternucleoside linkage. In certain embodiments, a modifiedinternucleoside linkage comprises a phosphorus atom.

In certain embodiments, a modified oligonucleotide comprises at leastone phosphorothioate internucleoside linkage. In preferred embodiments,each internucleoside linkage of a modified oligonucleotide is aphosphorothioate internucleoside linkage.

In certain embodiments, a modified oligonucleotide comprises one or moremodified nucleobases. In certain embodiments, a modified oligonucleotidecomprises one or more 5-methylcytosines. In certain embodiments, eachcytosine of a modified oligonucleotide comprises a 5-methylcytosine.

In certain embodiments, a modified nucleobase is selected from5-hydroxymethyl cytosine, 7-deazaguanine and 7-deazaadenine. In certainembodiments, a modified nucleobase is selected from 7-deaza-adenine,7-deazaguanosine, 2-aminopyridine and 2-pyridone.

In some embodiments, the antisense molecules of the invention may bemodified at the base moiety, sugar moiety or phosphate backbone toimprove, e.g., the stability, hybridization, or solubility of themolecule. By way of another example, the deoxyribose phosphate backboneof the nucleic acids may be modified to generate peptide nucleic acids(see Hyrup et al. (1996) Bioorganic & Medicinal Chemistry 4(I):5-23). Asused herein, the terms “peptide nucleic acids” or “PNAs” refer tonucleic acid mimics, e.g., DNA mimics, in which the deoxyribosephosphate backbone is replaced by a pseudopeptide backbone and only thefour natural nucleobases are retained. The neutral backbone of a PNA hasbeen shown to allow for specific hybridization to DNA and RNA underconditions of low ionic strength. The synthesis of PNA oligomers may beperformed using standard solid phase peptide synthesis protocols asdescribed in Hyrup et al. (1996) supra; Perry-O'Keefe et al. (1996)Proc. Natl. Acad. Sci. USA 93:14670-675.

PNAs of miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 may be used for therapeutic and diagnosticapplications. For example, PNAs may be used as antisense or miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379agents for sequence-specific modulation of expression by inducingtranscription arrest or inhibiting replication. PNAs of miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 mayalso be used in the analysis of single base pair mutations in a gene byPNA-directed PCR clamping; as artificial restriction enzymes when usedin combination with other enzymes, such as S1 nucleases (Hyrup (1996)supra); or as probes or primers for DNA sequence and hybridization(Hyrup (1996) supra; Perry-O′Keefe et al. (1996) Proc. Natl. Acad. Sci.USA 93: 14670-675).

In other embodiments, the oligonucleotides of the invention may includeother appended groups such as peptides (e.g., for targeting host cellreceptors in vivo), or agents facilitating transport across the cellmembrane (see, e.g., Letsinger et al. (1989) Proc. Natl. Acad. Sci. USA86:6553-6556; Lemaitre et al. (1987) Proc. Natl. Acad. Sci. USA84:648-652; PCT Publication No. WO 88/09810) or the blood-brain barrier(see, e.g., PCT Publication No. WO 89/10134). In addition,oligonucleotides may be modified with hybridization-triggered cleavageagents (see, e.g., Krol et al. (1988) Bio/Techniques 6:958-976) orintercalating agents (see, e.g., Zon (1988) Pharm. Res. 5:539-549). Tothis end, the oligonucleotide may be conjugated to another molecule,e.g., a peptide, hybridization triggered cross-linking agent, transportagent, hybridization-triggered cleavage agent, etc.

In certain embodiments, an antisense oligonucleotide of the invention issynthesized with a full phosphorothioate backbone with alternatingblocks of 2′-MOE and 2′fluoro sugar-modified nucleosides.

(c) Pharmaceutical Compositions

The miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 agents (also referred to herein as “active compounds”) of theinvention may be incorporated into pharmaceutical compositions suitablefor administration. Such compositions typically comprise the agent and apharmaceutically acceptable carrier. As used herein, the language“pharmaceutically acceptable carrier” is intended to include any and allsolvents, dispersion media, coatings, antibacterial and antifungalagents, isotonic and absorption delaying agents, and the like,compatible with pharmaceutical administration. The use of such media andagents for pharmaceutically active substances is well known in the art.Except insofar as any conventional media or agent is incompatible withthe active compound, use thereof in the compositions is contemplated.Supplementary active compounds may also be incorporated into thecompositions.

The invention includes methods for preparing pharmaceutical compositionsfor modulating the expression or activity of miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379. Such methods compriseformulating a pharmaceutically acceptable carrier with an agent whichmodulates expression or activity of miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379. Such compositions canfurther include additional active agents. Thus, the invention furtherincludes methods for preparing a pharmaceutical composition byformulating a pharmaceutically acceptable carrier with an agent whichmodulates expression or activity of miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 and one or moreadditional active compounds.

An agent which modulates expression or activity may, for example, be asmall molecule. For example, such small molecules include peptides,peptidomimetics, amino acids, amino acid analogs, polynucleotides,polynucleotide analogs, nucleotides, nucleotide analogs, organic orinorganic compounds (i.e., including heteroorganic and organometalliccompounds) having a molecular weight less than about 10,000 grams permole, organic or inorganic compounds having a molecular weight less thanabout 5,000 grams per mole, organic or inorganic compounds having amolecular weight less than about 1,000 grams per mole, organic orinorganic compounds having a molecular weight less than about 500 gramsper mole, and salts, esters, and other pharmaceutically acceptable formsof such compounds. It is understood that appropriate doses of smallmolecule agents depends upon a number of factors within the knowledge ofthe ordinarily skilled artisan. The dose(s) of the small molecule willvary, for example, depending upon the identity, size, and condition ofthe subject or sample being treated, further depending upon the route bywhich the composition is to be administered, if applicable, and theeffect which the practitioner desires the small molecule to have.Exemplary doses include milligram or microgram amounts of the smallmolecule per kilogram of subject or sample weight (e.g., about 1microgram per kilogram to about 500 milligrams per kilogram, about 100micrograms per kilogram to about 5 milligrams per kilogram, or about 1microgram per kilogram to about 50 micrograms per kilogram). It isfurthermore understood that appropriate doses of a small molecule dependupon the potency of the small molecule with respect to the expression oractivity to be modulated. Such appropriate doses may be determined usingthe assays described herein. When one or more of these small moleculesis to be administered to an animal (e.g., a human) in order to modulateexpression or activity of miR-155, a physician, veterinarian, orresearcher may, for example, prescribe a relatively low dose at first,subsequently increasing the dose until an appropriate response isobtained. In addition, it is understood that the specific dose level forany particular subject will depend upon a variety of factors includingthe activity of the specific compound employed, the age, body weight,general health, gender, and diet of the subject, the time ofadministration, the route of administration, the rate of excretion, anydrug combination, and the degree of expression or activity to bemodulated.

A pharmaceutical composition of the invention may be formulated to becompatible with its intended route of administration. Examples of routesof administration include parenteral, e.g., intravenous, intradermal,subcutaneous, oral (e.g., inhalation), transdermal (topical),transmucosal, and rectal administration. Solutions or suspensions usedfor parenteral, intradermal, or subcutaneous application can include thefollowing components: a sterile diluent such as water for injection,saline solution, fixed oils, polyethylene glycols, glycerine, propyleneglycol or other synthetic solvents; antibacterial agents such as benzylalcohol or methyl parabens; antioxidants such as ascorbic acid or sodiumbisulfite; chelating agents such as ethylenediaminetetraacetic acid;buffers such as acetates, citrates or phosphates, and agents for theadjustment of tonicity such as sodium chloride or dextrose. The pH canbe adjusted with acids or bases, such as hydrochloric acid or sodiumhydroxide. The parenteral preparation can be enclosed in ampoules,disposable syringes or multiple dose vials made of glass or plastic.

Pharmaceutical compositions suitable for injectable use may includesterile aqueous solutions (where water soluble) or dispersions andsterile powders for the extemporaneous preparation of sterile injectablesolutions or dispersion. For intravenous administration, suitablecarriers include physiological saline, bacteriostatic water, CremophorEL (BASF; Parsippany, N.J.), or phosphate buffered saline (PBS). In allcases, a composition may be sterile and may be fluid to the extent thateasy syringeability exists. A composition may be stable under theconditions of manufacture and storage and may be preserved against thecontaminating action of microorganisms such as bacteria and fungi. Thecarrier may be a solvent or dispersion medium containing, for example,water, ethanol, polyol (for example, glycerol, propylene glycol, andliquid polyetheylene glycol, and the like), and suitable mixturesthereof. The proper fluidity may be maintained, for example, by the useof a coating such as lecithin, by the maintenance of the requiredparticle size in the case of dispersion, and by the use of surfactants.Prevention of the action of microorganisms may be achieved by variousantibacterial and antifungal agents, for example, parabens,chlorobutanol, phenol, ascorbic acid, thimerosal, and the like. In manycases, it may be preferable to include isotonic agents, for example,sugars, polyalcohols such as mannitol, sorbitol, or sodium chloride, inthe composition. Prolonged absorption of the injectable compositions maybe brought about by including in the composition an agent which delaysabsorption, for example, aluminum monostearate and gelatin.

Sterile injectable solutions may be prepared by incorporating the activecompound in the required amount in an appropriate solvent with one or acombination of ingredients enumerated above, as required, followed byfiltered sterilization. Generally, dispersions are prepared byincorporating the active compound into a sterile vehicle which containsa basic dispersion medium and the required other ingredients from thoseenumerated above. In the case of sterile powders for the preparation ofsterile injectable solutions, the preferred methods of preparation arevacuum drying and freeze-drying, which yields a powder of the activeingredient plus any additional desired ingredient from a previouslysterile-filtered solution thereof.

Oral compositions generally may include an inert diluent or an ediblecarrier. Oral compositions may be enclosed in gelatin capsules orcompressed into tablets. For the purpose of oral therapeuticadministration, the active compound may be incorporated with excipientsand used in the form of tablets, troches, or capsules. Oral compositionsmay also be prepared using a fluid carrier for use as a mouthwash,wherein the compound in the fluid carrier is applied orally and swishedand expectorated or swallowed. Pharmaceutically compatible bindingagents and/or adjuvant materials may be included as part of thecomposition. The tablets, pills, capsules, troches, and the like, maycontain any of the following ingredients, or compounds of a similarnature: a binder such as microcrystalline cellulose, gum tragacanth orgelatin; an excipient such as starch or lactose; a disintegrating agentsuch as alginic acid, Primogel, or corn starch; a lubricant such asmagnesium stearate or Sterotes; a glidant such as colloidal silicondioxide; a sweetening agent such as sucrose or saccharin; or a flavoringagent such as peppermint, methyl salicylate, or orange flavoring. Foradministration by inhalation, the compounds are delivered in the form ofan aerosol spray from a pressured container or dispenser which containsa suitable propellant, e.g., a gas such as carbon dioxide, or anebulizer.

Systemic administration may also be by transmucosal or transdermalmeans. For transmucosal or transdermal administration, penetrantsappropriate to the barrier to be permeated are used in the formulation.Such penetrants are generally known in the art, and may include, forexample, for transmucosal administration, detergents, bile salts, andfusidic acid derivatives. Transmucosal administration may beaccomplished through the use of nasal sprays or suppositories. Fortransdermal administration, the active compounds are formulated intoointments, salves, gels, or creams as generally known in the art. Thecompounds may also be prepared in the form of suppositories (e.g., withconventional suppository bases such as cocoa butter and otherglycerides) or retention enemas for rectal delivery.

In one embodiment, the active compounds are prepared with carriers thatwill protect the compound against rapid elimination from the body, suchas a controlled release formulation, including implants andmicroencapsulated delivery systems. Biodegradable, biocompatiblepolymers may be used, such as ethylene vinyl acetate, polyanhydrides,polyglycolic acid, collagen, polyorthoesters, and polylactic acid.Methods for preparation of such formulations will be apparent to thoseskilled in the art. These may be prepared according to methods known tothose skilled in the art, for example, as described in U.S. Pat. No.4,522,811.

The nucleic acid molecules of the invention may be inserted into vectorsand used as gene therapy vectors. Gene therapy vectors may be deliveredto a subject by, for example, intravenous injection, localadministration (U.S. Pat. No. 5,328,470) or by stereotactic injection(see, e.g., Chen et al. (1994) Proc. Natl. Acad. Sci. USA 91:3054-3057).The pharmaceutical preparation of the gene therapy vector may includethe gene therapy vector in an acceptable diluent, or can comprise a slowrelease matrix in which the gene delivery vehicle is imbedded.

The gene therapy vectors of the invention may be either viral ornon-viral. Examples of plasmid-based, non-viral vectors are discussed inHuang et al. (1999) Nonviral Vectors for Gene Therapy. A modifiedplasmid is one example of a non-viral gene delivery system. Peptides,proteins (including antibodies), and oligonucleotides may be stablyconjugated to plasmid DNA by methods that do not interfere with thetranscriptional activity of the plasmid (Zelphati et al. (2000)BioTechniques 28:304-315). The attachment of proteins and/oroligonucleotides may influence the delivery and trafficking of theplasmid and thus render it a more effective pharmaceutical composition.

II. Methods

In an aspect, the present invention encompasses a method to detect amotor neuron disease. The method comprises measuring the amount ofmiR-218 in a biological sample obtained from a subject, and comparingthe amount of miR-218 in the biological sample to a reference value,wherein dysregulation of miR-218 relative to the reference valueindicates motor neuron disease. In a specific embodiment, miR-218 isincreased relative to a reference value. The method may further comprisetreatment of the subject if motor neuron disease is detected. In aspecific embodiment, the motor neuron disease is amyotrophic lateralsclerosis (ALS).

In another aspect, the present invention encompasses a method to detecta motor neuron disease. The method comprises measuring the amount ofmiR-218 and at least one additional miRNA selected from the groupconsisting of miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380,and miR-379 in a biological sample obtained from a subject, andcomparing the amount of miR-218 and at least one additional miRNAselected from the group consisting of miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, and miR-379 in the biological sample to areference value, wherein dysregulation of miR-218 and at least oneadditional miRNA selected from the group consisting of miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and miR-379 relative tothe reference value indicates motor neuron disease. In a specificembodiment, miR-218 is increased relative to a reference value. Inanother specific embodiment, method comprises measuring the amount ofmiR-218 and miR-138 in a biological sample obtained from a subject, andcomparing the amount of miR-218 and miR-138 in the biological sample toa reference value, wherein dysregulation of miR-218 and miR-138 relativeto the reference value indicates motor neuron disease. In a specificembodiment, miR-138 is increased relative to a reference value. Themethod may further comprise treatment of the subject if motor neurondisease is detected. In a specific embodiment, the motor neuron diseaseis ALS.

In still another aspect, the present invention encompasses a method todetect the efficacy of treatment or the progression of motor neurondisease. The method comprises measuring the amount of miR-218 in a firstbiological sample obtained from a subject; then at a later timemeasuring the amount of miR-218 in a second biological sample obtainedfrom a subject; and comparing the amount of miR-218 in the firstbiological sample to the amount of miR-218 in the second biologicalsample, wherein a change in miR-218 indicates effectiveness of treatmentor progression of motor neuron disease. For example, the secondbiological sample may be obtained days, weeks, months or years followingthe first biological sample. In a specific embodiment, ineffectivenessof treatment or progression of motor neuron disease is indicated ifmiR-218 is increased in the second biological sample relative to thefirst biological sample. The method may further comprise alteringtreatment modality if ineffectiveness of treatment or progression ofmotor neuron disease is detected. In a specific embodiment, the motorneuron disease is amyotrophic lateral sclerosis (ALS).

In yet still another aspect, the present invention encompasses a methodto detect the efficacy of treatment or the progression of motor neurondisease. The method comprises measuring the amount of miR-218 and atleast one additional miRNA selected from the group consisting ofmiR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and miR-379 ina first biological sample obtained from a subject; then at a later timemeasuring the amount of miR-218 and at least one additional miRNAselected from the group consisting of miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, and miR-379 in a second biological sampleobtained from a subject; and comparing the amount of miR-218 and atleast one additional miRNA selected from the group consisting ofmiR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and miR-379 inthe first biological sample to the amount of miR-218 and at least oneadditional miRNA selected from the group consisting of miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and miR-379 in thesecond biological sample, wherein a change in miR-218 and at least oneadditional miRNA selected from the group consisting of miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and miR-379 indicateseffectiveness of treatment or progression of motor neuron disease. In aspecific embodiment, ineffectiveness of treatment or progression ofmotor neuron disease is indicated if miR-218 in the second biologicalsample is increased relative to the first biological sample. In anotherspecific embodiment, method comprises measuring the amount of miR-218and miR-138 in a first biological sample obtained from a subject; thenat a later time measuring the amount of miR-218 and miR-138 in a secondbiological sample obtained from a subject; and comparing the amount ofmiR-218 and miR-138 in the first biological sample to the amount ofmiR-218 and miR-138 in the second biological sample, wherein a change inmiR-218 and miR-138 indicates effectiveness of treatment or progressionof motor neuron disease. For example, the second biological sample maybe obtained days, weeks, months or years following the first biologicalsample. In a specific embodiment, ineffectiveness of treatment orprogression of motor neuron disease is indicated if miR-138 is increasedin the second biological sample relative to the first biological sample.The method may further comprise altering treatment modality ifineffectiveness of treatment or progression of motor neuron disease isdetected. In a specific embodiment, the motor neuron disease is ALS.

In a different aspect, the present invention encompasses a method toimprove motor neuron function in a subject diagnosed with a motor neurondisease, suspected of having a motor neuron disease or at risk for amotor neuron disease. The method comprises administering a miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379composition, or combinations thereof. A miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 composition is asdescribed in Section I. In a specific embodiment, a miR-218 compositionis administered, wherein the composition decreases the amount orexpression of miR-218. In another specific embodiment, a miR-138composition is administered, wherein the composition decreases theamount or expression of miR-138. In still another specific embodiment,the motor neuron disease is ALS. Methods of diagnosing or determiningrisk of motor neuron disease are described in Section II(a).

In other aspects, the present invention encompasses a method of treatinga subject diagnosed with a motor neuron disease, suspected of having amotor neuron disease or at risk for a motor neuron disease. The methodcomprises administering a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition, or combinationsthereof. In a specific embodiment, a miR-218 composition isadministered, wherein the composition decreases the amount or expressionof miR-218. In another specific embodiment, a miR-138 composition isadministered, wherein the composition decreases the amount or expressionof miR-138. In still another specific embodiment, the motor neurondisease is ALS. As used herein, the terms “treating” or “treatment”include prevention, attenuation, reversal, or improvement in at leastone symptom or sign of symptoms associated with a motor neuron disease.Symptoms may be as described in Section 11(a).

In some embodiments, methods of the invention may be utilized to treat apopulation of cells that would benefit from a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 composition,or combinations thereof. Such cells include those in a subject as wellas those removed from a subject for therapeutic treatment, culturedcells, those used in gene therapy practices, and any other cell that maybenefit from a miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 composition, or combinations thereof.

(a) Motor Neuron Disease

Motor neuron-specific miRNAs have been identified. Accordingly, one ormore MN-specific miRNA may be used to detect or diagnose a motor neurondisease, improve the function of motor neurons, treat a symptomassociated with a motor neuron disease or prevent, delay progression ortreat a motor neuron disease. A motor neuron disease (MND) is aprogressive neurological disorder that destroys motor neurons, the cellsthat control essential voluntary muscle activity such as speaking,walking, breathing, and swallowing. Non-limiting examples of motorneuron diseases include amyotrophic lateral sclerosis (ALS), also calledLou Gehrig's disease or classical motor neuron disease, progressivebulbar palsy, also called progressive bulbar atrophy, pseudobulbarpalsy, primary lateral sclerosis (PLS), progressive muscular atrophy,spinal muscular atrophy (SMA), SMA type I, also called Werdnig-Hoffmanndisease, SMA type II, SMA type III (Kugelberg-Welander disease),congenital SMA with arthrogryposis, Kennedy's disease, also known asprogressive spinobulbar muscular atrophy, post-polio syndrome (PPS),spinal cord injury as well as others known in the art or yet to bediscovered. A motor neuron disease of the invention may result fromdysregulated miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379. A dysregulated miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 may result fromoverexpression or underexpression of miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379. In some embodiments, a motorneuron disease may result from overexpression of miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379. In aspecific embodiment, a motor neuron disease results from overexpressionof miR-218. In another specific embodiment, a motor neuron diseaseresults from overexpression of miR-218 and mIR-138. In a specificembodiment, the motor neuron disease is ALS.

A subject may or may not be having a symptom associated with motorneuron disease. Exemplary symptoms of motor neuron diseases includemuscle weakness including a weakened grip, weakness at the shoulder,tripping up over a foot, twitching of the muscles (fasciculations) ormuscle cramps. A skilled artisan will appreciate that specific diseasesare defined by specific symptoms. For example, ALS is recognized byweakness and wasting of the bulbar muscles (muscles that control speech,swallowing, and chewing), loss of strength and the ability to move armsand legs, and to hold the body upright, spasticity, spasms, musclecramps, fasciculations, slurred or nasal speech, loss of the ability tobreathe without mechanical support. Symptoms of progressive bulbar palsy(progressive bulbar atrophy) include pharyngeal muscle weakness(involved with swallowing), weak jaw and facial muscles, progressiveloss of speech, and tongue muscle atrophy, limb weakness with both lowerand upper motor neuron signs, outbursts of laughing or crying (calledemotional lability). Pseudobulbar palsy, which shares many symptoms ofprogressive bulbar palsy, is recognized by progressive loss of theability to speak, chew, and swallow, progressive weakness in facialmuscles leading to an expressionless face, a gravelly voice and anincreased gag reflex, an immobile tongue that may be unable to protrudefrom the mouth, outbursts of laughing or crying. Primary lateralsclerosis (PLS) shows symptoms of slow and effortful movements, slowedand slurred speech, stiff, clumsy, slow and weak legs and arms, leadingto an inability to walk or carry out tasks requiring fine handcoordination, difficulty with balance may lead to falls, overactivestartle response. Progressive muscular atrophy is marked by slow butprogressive degeneration of only the lower motor neurons, weakness inthe hands that spreads into the lower body, muscle wasting, clumsy handmovements, fasciculations, and muscle cramps. Spinal muscular atrophy(SMA) produces weakness and wasting of the skeletal muscles which ismore severe in the trunk and upper leg and arm muscles than in musclesof the hands and feet. Symptoms of SMA type I, also calledWerdnig-Hoffmann disease may include hypotonia (severely reduced muscletone), diminished limb movements, lack of tendon reflexes,fasciculations, tremors, swallowing and feeding difficulties, andimpaired breathing, scoliosis (curvature of the spine) or other skeletalabnormalities. Symptoms of SMA type II, the intermediate form, areinability to stand or walk unaided, and respiratory difficulties.Symptoms of SMA type Ill (Kugelberg-Welander disease) include abnormalgait; difficulty running, climbing steps, or rising from a chair; and afine tremor of the fingers, scoliosis and joint contractures—chronicshortening of muscles or tendons around joints, abnormal muscle tone andweakness. Congenital SMA with arthrogryposis (persistent contracture ofjoints with fixed abnormal posture of the limb) is associated withsevere contractures, scoliosis, chest deformity, respiratory problems,unusually small jaws, and drooping of the upper eyelids. Symptoms ofKennedy's disease, also known as progressive spinobulbar muscularatrophy, include weakness and atrophy of the facial, jaw, and tonguemuscles, leading to problems with chewing, swallowing, and changes inspeech, muscle pain and fatigue, weakness in arm and leg muscles closestto the trunk of the body, muscle atrophy and fasciculations, sensoryloss in the feet and hands, sensory neuropathy (pain from sensory nerveinflammation or degeneration), enlargement of the male breasts ordevelop noninsulin-dependent diabetes mellitus. Post-polio syndrome(PPS) symptoms include fatigue, slowly progressive muscle weakness,muscle atrophy, fasciculations, cold intolerance, and muscle and jointpain, difficulty breathing, swallowing, or sleeping.

A subject may or may not be diagnosed with motor neuron disease. Thereare no specific tests to diagnose most MNDs. However, MNDs may bediagnosed using a physical exam followed by a thorough neurologicalexam. The neurological exam may assess motor and sensory skills, nervefunction, hearing and speech, vision, coordination and balance, mentalstatus, and changes in mood or behavior. Additionally, tests may beconducted to rule out other muscle disorders such as electromyography(EMG), laboratory tests of blood, urine, or other substances, magneticresonance imaging (MRI), muscle or nerve biopsy, and transcranialmagnetic stimulation.

Some MNDs are inherited, but the causes of most MNDs are not known. Insporadic or noninherited MNDs, environmental, toxic, viral, or geneticfactors may be implicated. Accordingly, a subject may be at risk of orsuspected of having a motor neuron disease based on environmentalexposure or familial history. If the MND is inherited, it is alsoclassified according to the mode of inheritance which is associated withvarying risks. Autosomal dominant means that a person needs to inheritonly one copy of the defective gene from one affected parent to be atrisk of the disease. There is a 50 percent chance that each child of anaffected person will be affected. Autosomal recessive means theindividual must inherit a copy of the defective gene from both parents.These parents are likely to be asymptomatic (without symptoms of thedisease). Autosomal recessive diseases often affect more than one personin the same generation (siblings or cousins). In X-linked inheritance,the mother carries the defective gene on one of her X chromosomes andpasses the disorder along to her sons. Males inherit an X chromosomefrom their mother and a Y chromosome from their father, while femalesinherit an X chromosome from each parent. Daughters have a 50 percentchance of inheriting their mother's faulty X chromosome and a safe Xchromosome from their father, which would make them asymptomaticcarriers of the mutation.

(b) Biological Sample

In an aspect, the invention provides a method to detect dysregulation ofmiR-218 or miR-218 and at least one additional miRNA selected from thegroup consisting of miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, and miR-379 in a biological sample obtained from a subject.Further, miR-409 and miR-34c may be detected. The method generallycomprises (i) obtaining a biological sample from the subject, and (ii)measuring the amount of miR-218 or miR-218 and at least one additionalmiRNA selected from the group consisting of miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, and miR-379 in the biological sample.Further, miR-409 and/or miR-34c may be measured.

As used herein, the term “biological sample” refers to a sample obtainedfrom a subject. Any biological sample comprising a miRNA of theinvention is suitable. Non-limiting examples include blood, plasma,serum, urine, cerebrospinal fluid (CSF) and interstitial fluid (ISF). Ina specific embodiment, the biological sample is selected from the groupconsisting of CSF, serum and urine. In another specific embodiment, thebiological sample is CSF. In a specific embodiment, the biologicalsample comprises motor neurons. The sample may be used “as is”, thecellular components may be isolated from the sample, or a proteinfraction may be isolated from the sample using standard techniques.

As will be appreciated by a skilled artisan, the method of collecting abiological sample can and will vary depending upon the nature of thebiological sample and the type of analysis to be performed. Any of avariety of methods generally known in the art may be utilized to collecta biological sample. Generally speaking, the method preferably maintainsthe integrity of the sample such that the miRNA can be accuratelydetected and the amount measured according to the invention.

In some embodiments, a single sample is obtained from a subject todetect miRNAs in the sample. Alternatively, miRNAs may be detected insamples obtained over time from a subject. As such, more than one samplemay be collected from a subject over time. For instance, 2, 3, 4, 5, 6,7, 8, 9, 10, 11, 12, 13, 14, 15, 16 or more samples may be collectedfrom a subject over time. In some embodiments, 2, 3, 4, 5, or 6 samplesare collected from a subject over time. In other embodiments, 6, 7, 8,9, or 10 samples are collected from a subject over time. In yet otherembodiments, 10, 11, 12, 13, or 14 samples are collected from a subjectover time. In other embodiments, 14, 15, 16 or more samples arecollected from a subject over time.

When more than one sample is collected from a subject over time, samplesmay be collected every 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 ormore hours. In some embodiments, samples are collected every 0.5, 1, 2,3, or 4 hours. In other embodiments, samples are collected every 4, 5,6, or 7 hours. In yet other embodiments, samples are collected every 7,8, 9, or 10 hours. In other embodiments, samples are collected every 10,11, 12 or more hours. Additionally, samples may be collected every 1, 2,3, 4, 5, 6, 7, 8, 9, 10, 11, 12 or more days. In some embodiments, asample is collected about every 6 days. In some embodiments, samples arecollected every 1, 2, 3, 4, or 5 days. In other embodiments, samples arecollected every 5, 6, 7, 8, or 9 days. In yet other embodiments, samplesare collected every 9, 10, 11, 12 or more days.

(c) Detecting miRNAs

miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380,miR-379, miR-409 and miR-34c or a complement thereof, may be detectedusing standard molecular biology techniques. For instance, using all ora portion of the nucleic acid sequences of miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, miR-379, miR-409 and miR-34c,nucleic acid molecules may be detected using standard hybridization andcloning techniques (e.g., as described in Sambrook et al., eds.,Molecular Cloning: A Laboratory Manual. 2nd ed., Cold Spring HarborLaboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor,N.Y., 1989). As used herein, miR-218 refers to miR-218-1 and miR-218-2.Accordingly, miR-218-1 and/or miR-218-2 may be detected. As will berecognized by individuals skilled in the art, both arms of a pre-miRNAhairpin encoding miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, miR-379, miR-409, and miR-34c may give rise to amature miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380,miR-379, miR-409 or miR-34c miRNA. For instance, two mature miRNAs thatmay result from a pre-miRNA encoding a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, miR-379, miR-409, and miR-34cmiRNA may be miR-218-3p, miR-138-3p, miR-133a-3p, miR-133b-3p,miR-1193-3p, miR-34b-3p, miR-380-3p, miR-379-3p, miR-409-3p, andmiR-34c-3p and miR-218-5p, miR-138-5p, miR-133a-5p, miR-133b-5p,miR-1193-5p, miR-34b-5p, miR-380-5p, miR-379-5p, miR-409-5p, andmiR-34c-5p, respectively. Specifically, miR-218-3p, miR-218-5p,miR-138-5p, miR-138-3p, miR-133a-3p, miR-133b-3p, miR-34b-3p,miR-380-3p, miR-380-5p, miR-409-3p, miR-409-5p, miR-34c-3p, and/ormiR-34c-5p may be detected.

Methods for assessing an amount of nucleic acid expression in cells arewell known in the art, and all suitable methods for assessing an amountof nucleic acid expression known to one of skill in the art arecontemplated within the scope of the invention. The term “amount ofnucleic acid expression” or “level of nucleic acid expression” as usedherein refers to a measurable level of expression of the nucleic acids,such as, without limitation, the level of miRNA transcript expressed ora specific variant or other portion of the miRNA. The term “nucleicacid” includes DNA and RNA and can be either double stranded or singlestranded. Non-limiting examples of suitable methods to assess an amountof nucleic acid expression may include arrays, such as microarrays, PCR,such as RT-PCR (including quantitative RT-PCR), nuclease protectionassays and Northern blot analyses. In a specific embodiment, determiningthe amount of a miRNA comprises, in part, measuring the level of miRNAexpression.

In one embodiment, the amount of nucleic acid expression may bedetermined by using an array, such as a microarray. Methods of using anucleic acid microarray are well and widely known in the art. Forexample, a nucleic acid probe that is complementary or hybridizable toan expression product of a target gene may be used in the array. Theterm “hybridize” or “hybridizable” refers to the sequence specificnon-covalent binding interaction with a complementary nucleic acid. In apreferred embodiment, the hybridization is under high stringencyconditions. Appropriate stringency conditions which promotehybridization are known to those skilled in the art, or can be found inCurrent Protocols in Molecular Biology, John Wiley & Sons, N.Y. (1989),6.3.1 6.3.6. The term “probe” as used herein refers to a nucleic acidsequence that will hybridize to a nucleic acid target sequence. In oneexample, the probe hybridizes to an RNA product of the nucleic acid or anucleic acid sequence complementary thereof. The length of probe dependson the hybridization conditions and the sequences of the probe andnucleic acid target sequence. In one embodiment, the probe is at least8, 10, 15, 20, 25, 50, 75, 100, 150, 200, 250, 400, 500 or morenucleotides in length.

In another embodiment, the amount of nucleic acid expression may bedetermined using PCR. A nucleic acid may be amplified using cDNA, mRNAor genomic DNA as a template and appropriate oligonucleotide primersaccording to standard PCR amplification techniques. Methods of PCR arewell and widely known in the art, and may include quantitative PCR,semi-quantitative PCR, multiplex PCR, or any combination thereof.Specifically, the amount of nucleic expression may be determined usingquantitative RT-PCR. Methods of performing quantitative RT-PCR arecommon in the art. In such an embodiment, the primers used forquantitative RT-PCR may comprise a forward and reverse primer for atarget gene. The term “primer” as used herein refers to a nucleic acidsequence, whether occurring naturally as in a purified restrictiondigest or produced synthetically, which is capable of acting as a pointof synthesis when placed under conditions in which synthesis of a primerextension product, which is complementary to a nucleic acid strand isinduced (e.g. in the presence of nucleotides and an inducing agent suchas DNA polymerase and at a suitable temperature and pH). The primer mustbe sufficiently long to prime the synthesis of the desired extensionproduct in the presence of the inducing agent. The exact length of theprimer will depend upon factors, including temperature, sequences of theprimer and the methods used. A primer typically contains 15-25 or morenucleotides, although it can contain less or more. The factors involvedin determining the appropriate length of primer are readily known to oneof ordinary skill in the art.

The amount of nucleic acid expression may be measured by measuring anentire miRNA transcript for a nucleic acid sequence, or measuring aportion of the miRNA transcript for a nucleic acid sequence. Forinstance, if a nucleic acid array is utilized to measure the amount ofmiRNA expression, the array may comprise a probe for a portion of themiRNA of the nucleic acid sequence of interest, or the array maycomprise a probe for the full miRNA of the nucleic acid sequence ofinterest. Similarly, in a PCR reaction, the primers may be designed toamplify the entire cDNA sequence of the nucleic acid sequence ofinterest, or a portion of the cDNA sequence. One of skill in the artwill recognize that there is more than one set of primers that may beused to amplify either the entire cDNA or a portion of the cDNA for anucleic acid sequence of interest. Methods of designing primers areknown in the art. Methods of extracting RNA from a biological sample areknown in the art.

The level of expression may or may not be normalized to the level of acontrol nucleic acid. Such a control nucleic acid should notspecifically hybridize with an miRNA nucleotide sequence of theinvention. This allows comparisons between assays that are performed ondifferent occasions. In certain embodiments, the level of expression isnormalized to a control nucleic acid. In a specific embodiment, acontrol nucleic acid is selected from the group consisting of miR-191,miR-24 and miR-30c.

(d) Reference Level

According to the invention, a motor neuron disease may be detected basedon dysregulation of miR-218 or miR-218 and at least one additional miRNAselected from the group consisting of miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, and miR-379 relative to a reference value.Detecting dysregulation of miR-218 or miR-218 and at least oneadditional miRNA selected from the group consisting of miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and miR-379 relative toa reference value in the subject may be used to diagnose a motor neurondisease or determine the efficacy of treatment or determine theprogression of motor neuron disease. Additionally, at least one miRNAselected from the group consisting of miR-409 and miR-34c may bedetected.

Generally speaking, a miRNA disclosed herein may be classified asdysregulated when it has an increased or decreased amount relative to areference value. Any suitable reference value known in the art may beused. For example, a suitable reference value may be the amount of miRNAin a biological sample obtained from a subject, or group of subjects, ofthe same species that has no clinically detectable symptom of MND. Inanother example, a suitable reference value may be the amount of miRNAin a biological sample obtained from a subject, or group of subjects, ofthe same species that has no detectable MND pathology. In anotherexample, a suitable reference value may be the background signal of theassay as determined by methods known in the art. In another example, asuitable reference value may be a measurement of the amount of miRNA ina reference sample obtained from the same subject. The reference samplecomprises the same type of biological sample as the test sample, and maybe obtained from a subject when the subject had no clinically detectablesymptom of MND. A skilled artisan will appreciate that it is not alwayspossible or desirable to obtain a reference sample from a subject whenthe subject is otherwise healthy. For example, when monitoring theeffectiveness of a therapy or progression of disease, a reference samplemay be a sample obtained from a subject before therapy or at an earlierpoint in the disease. In such an example, a subject may have a risk ofMND (familial or environmental) but may not have other symptoms of MND(e.g. muscle weakness) or the subject may have one or more other symptomof MND. In an additional example, a suitable reference sample may be abiological sample from an individual or group of individuals that hasbeen shown not to have MND. In an embodiment, the reference value may bea sample of the same type of biological sample obtained from one or moreindividuals that has not been administered therapy but has a MND.

In certain embodiments, to classify the amount of miRNA as increased ina biological sample, the amount of miRNA in the biological samplecompared to the reference value is increased at least 2-fold. Forexample, the amount of miRNA in the sample compared to the referencevalue is increased at least 2-fold, at least 5-fold, at least 10-fold,at least 15-fold, at least 20-fold, at least 25-fold, at least 30-fold,at least 35-fold, at least 40-fold, at least 45-fold, at least 50-fold,at least 100-fold, at least 200-fold, at least 300-fold, at least400-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, orat least 10000-fold. In a specific embodiment, the amount of miR-218 inthe sample compared to the reference value is increased at least10-fold. In another specific embodiment, the amount of miR-138,miR-133a, miR-1193, and/or miR-34b in the sample compared to thereference value is increased at least 3-fold.

In certain embodiments, to classify the amount of miRNA as decreased ina biological sample, the amount of miRNA in the biological samplecompared to the reference value is decreased at least 2-fold. Forexample, the amount of miRNA in the sample compared to the referencevalue is decreased at least 2-fold, at least 5-fold, at least 10-fold,at least 15-fold, at least 20-fold, at least 25-fold, at least 30-fold,at least 35-fold, at least 40-fold, at least 45-fold, at least 50-fold,at least 100-fold, at least 200-fold, at least 300-fold, at least400-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, orat least 10000-fold.

In another embodiment, the increase or decrease in the amount of miRNAis measured using p-value. For instance, when using p-value, a miRNA isidentified as being differentially expressed between a a biologicalsample and a reference value when the p-value is less than 0.1,preferably less than 0.05, more preferably less than 0.01, even morepreferably less than 0.005, the most preferably less than 0.001.

(e) Treatment

According to the disclosure, the subject may be treated if motor neurondisease is detected. Additionally, the treatment modality may be alteredif ineffectiveness of treatment or progression of motor neuron diseaseis detected. The term “treatment” or “therapy” as used herein means anytreatment suitable for the treatment of MND. Treatment may consist ofstandard treatments for MND. Non-limiting examples of standard treatmentfor MND include Riluzole (Rilutek), Tizanidine (Zanaflex), Baclofen,quinine, hyoscine hydrobromide skin patch, NSAIDs, gabapentin, physicaltherapy, acupuncture, immunotherapy, gene transfer therapy, stem celland progenitor cell based cellular replacement therapy, antisenseoligonucleotide therapy, antioxidant therapy, antidepressant therapy,antibody therapy, autophagy control therapy, drug therapy(small-molecule inhibitor of kynurenine 3-monooxygenase JM6), and anytherapeutic agent known in the art or yet to be discovered. Stillfurther, treatment may be as described below or with an agent asdescribed in Section I.

(f) Administration

The present invention also provides for both prophylactic andtherapeutic methods of treating a subject at risk of, or susceptible toa MND. In a specific embodiment, the MND may be associated with aberrantmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and/ormiR-379 expression or activity. Generally, methods of the presentinvention include administering to a subject a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 compositionrespectively comprising at least miR-218 miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 agent. For instance, 1, 2, 3, 4,5, 6, 7, 8, 9, 10 or more miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 agents may be administered. Insome embodiments, 1, 2, 3, 4, or 5 miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 agents are administered. In otherembodiments, 5, 6, 7, 8, 9, 10 or more miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 agents areadministered. In one embodiment, one miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 agent is administered.In another embodiment, two miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 agents are administered. In yetanother embodiment, the miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 agent is delivered in combination withadditional therapeutic agents known in the art. miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 agents may beas described in Section 1(b).

In certain embodiments, a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition is administered incombination with at least one additional therapeutic agent. In certainembodiments, miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 composition is administered sequential to anadditional therapeutic agent. In other embodiments, a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 compositionis administered prior to the administration of an additional therapeuticagent. In certain embodiments, a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition is administered priorto and after the administration of an additional therapeutic agent. Inother embodiments, a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 composition is administered at the sametime as at least one therapeutic agent. In certain embodiments, amiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 composition may be administered without additional therapeuticagents.

Additional therapeutic agents may include those used in immunotherapy,gene transfer therapy, stem cell and progenitor cell based cellularreplacement therapy, antisense oligonucleotide therapy, antioxidanttherapy, antidepressant therapy, antibody therapy, autophagy controltherapy, drug therapy (small-molecule inhibitor of kynurenine3-monooxygenase JM6), and any therapeutic agent known in the art or yetto be discovered.

A miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 composition of the invention may be administered to a subject byseveral different means. For instance, compositions may generally beadministered in dosage unit formulations containing conventionalnontoxic pharmaceutically acceptable carriers, adjuvants, and vehiclesas desired.

Methods of administration include any method known in the art or yet tobe discovered. Exemplary administration methods include intravenous,intraocular, intratracheal, intratumoral, oral, rectal, topical,intramuscular, intraarterial, intrahepatic, intrathoracic, intrathecal,intracranial, intraperitoneal, intrapancreatic, intrapulmonary, orsubcutaneously. A composition of the invention may also be administereddirectly by infusion into central nervous system fluid. One skilled inthe art will appreciate that the route of administration and method ofadministration depend upon the intended use of the compositions, thelocation of the target area, and the condition being treated, inaddition to other factors known in the art such as subject health, age,and physiological status.

In a preferred embodiment, the oligonucleotide may be administeredparenterally. The term “parenteral” as used herein describesadministration into the body via a route other than the mouth,especially via infusion, injection, or implantation, and includesintradermal, subcutaneous, transdermal implant, intracavernous,intravitreal, intra-articular or intrasynovial injection, transscleral,intracerebral, intrathecal, epidural, intravenous, intracardiac,intramuscular, intraosseous, intraperitoneal, intravenous, intrasternalinjection, or nanocell injection. Formulation of pharmaceuticalcompositions is discussed in, for example, Hoover, John E., Remington'sPharmaceutical Sciences, Mack Publishing Co., Easton, Pa. (1975), andLiberman, H. A. and Lachman, L., Eds., Pharmaceutical Dosage Forms,Marcel Decker, New York, N.Y. (1980).

In some embodiments, a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 composition of the invention isadministered parenterally. When a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition is administeredparenterally, delivery methods are preferably those that are effectiveto circumvent the blood-brain barrier, and are effective to deliveragents to the central nervous system. For example, delivery methods mayinclude the use of nanoparticles. The particles may be of any suitablestructure, such as unilamellar or plurilamellar, so long as theantisense oligonucleotide is contained therein. Positively chargedlipids such asN-[1-(2,3-dioleoyloxi)propyl]-N,N,N-trimethyl-amoniummethylsulfate, or“DOTAP,” are particularly preferred for such particles and vesicles. Thepreparation of such lipid particles is well known in the art. See, e.g.,U.S. Pat. No. 4,880,635 to Janoff et al.; U.S. Pat. No. 4,906,477 toKurono et al.; U.S. Pat. No. 4,911,928 to Wallach; U.S. Pat. No.4,917,951 to Wallach; U.S. Pat. No. 4,920,016 to Allen et al.; U.S. Pat.No. 4,921,757 to Wheatley et al.; etc.

In preferred embodiments, a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition of the invention isadministered into the central nervous system. Methods of administering amiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 composition of the invention to the central nervous system areknown in the art. For instance, a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition of the invention maybe administered in a bolus directly into the central nervous system. AmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 composition may be administered to the subject in a bolus onceor multiple times. In some preferred embodiments, a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 compositionmay be administered in a bolus once. In other preferred embodiments, amiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 composition may be administered in a bolus multiple times. Whenadministered multiple times, a miR-218 miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition may be administeredat regular intervals or at intervals that may vary during the treatmentof a subject. In some embodiments, a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 composition isadministered multiple times at intervals that may vary during thetreatment of a subject. In other embodiments, a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 compositionis administered multiple times at regular intervals.

In another preferred embodiment, a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition is administered bycontinuous infusion into the central nervous system. Non-limitingexamples of methods that may be used to deliver a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 compositioninto the central nervous system by continuous infusion may includepumps, wafers, gels, foams and fibrin clots. In a preferred embodiment,a miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 composition is delivered into the central nervous system bycontinuous infusion using an osmotic pump. An osmotic minipump containsa high-osmolality chamber that surrounds a flexible, yet impermeable,reservoir filled with the targeted delivery composition-containingvehicle. Subsequent to the subcutaneous implantation of this minipump,extracellular fluid enters through an outer semi-permeable membrane intothe high-osmolality chamber, thereby compressing the reservoir torelease the targeted delivery composition at a controlled,pre-determined rate. The targeted delivery composition, released fromthe pump, may be directed via a catheter to a stereotaxically placedcannula for infusion into the cerebroventricular space.

Compositions of the invention are typically administered to a subject inan amount sufficient to provide a benefit to the subject. This amount isdefined as a “therapeutically effective amount.” A therapeuticallyeffective amount may be determined by the efficacy or potency of theparticular composition, the MND being treated, the duration or frequencyof administration, the method of administration, and the size andcondition of the subject, including that subject's particular treatmentresponse. A therapeutically effective amount may be determined usingmethods known in the art, and may be determined experimentally, derivedfrom therapeutically effective amounts determined in model animals suchas the mouse, or a combination thereof. Additionally, the route ofadministration may be considered when determining the therapeuticallyeffective amount. In determining the therapeutically effective amounts,one skilled in the art may also consider the existence, nature, andextent of any adverse effects that accompany the administration of aparticular compound in a particular subject.

In some embodiments, when a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition is administered in abolus into the central nervous system, the miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 composition may beadministered to the subject in an amount of about 0.1, 0.2, 0.3, 0.4,0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10,10.5, 11, 11.5, 12, 12.5, 13, 13.5, 14, 14.5, 15, 16, 17, 18, 19, 20,21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38,39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 60, 70, 80, 90, or about100 mg/kg or more. In one embodiment, when a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 composition isadministered in a bolus into the central nervous system, the miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379composition is administered to the subject in an amount of about 0.1,0.2, 0.3, 0.4, 0.5, or about 1 mg/kg. In another embodiment, when amiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 composition is administered in a bolus into the central nervoussystem, the miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 composition is administered to the subject in anamount of about 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 6.5, 7, 7.5, 8, 8.5,9, 9.5, or about 10 mg/kg. In yet another embodiment, when a miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379composition is administered in a bolus into the central nervous system,the miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 composition is administered to the subject in an amount of about10, 10.5, 11, 11.5, 12, 12.5, 13, 13.5, 14, 14.5, 15, 16, 17, 18, 19, orabout 20 mg/kg. In another embodiment, when miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 composition isadministered in a bolus into the central nervous system, the miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379composition is administered to the subject in an amount of about 20, 21,22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39,40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or about 50 mg/kg. In anadditional embodiment, when a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition is administered in abolus into the central nervous system, the miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 composition isadministered to the subject in an amount of about 50, 60, 70, 80, 90, orabout 100 mg/kg. In a preferred embodiment, when a miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 compositionis administered in a bolus into the central nervous system, miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379composition is administered to the subject in an amount of about 23, 24,25, 26, or about 27 mg/kg.

In some embodiments, when a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition is administered bycontinuous infusion into the central nervous system, the miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379composition may be administered to the subject in an amount of about0.1, 0.2, 0.3, 0.4, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 6.5, 7, 7.5,8, 8.5, 9, 9.5, 10, 10.5, 11, 11.5, 12, 12.5, 13, 13.5, 14, 14.5, 15,16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33,34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 60,70, 80, 90, or about 100 μg/day or more. In one embodiment, when amiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 composition is administered by continuous infusion into thecentral nervous system, the miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition is administered tothe subject in an amount of about 0.1, 0.2, 0.3, 0.4, 0.5, or about 1μg/day. In another embodiment, when a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 composition isadministered by continuous infusion into the central nervous system, themiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 composition is administered to the subject in an amount of about1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, or about10 μg/day. In yet another embodiment, when a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 composition isadministered by continuous infusion into the central nervous system, themiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 is administered to the subject in an amount of about 10, 10.5,11, 11.5, 12, 12.5, 13, 13.5, 14, 14.5, 15, 16, 17, 18, 19, or about 20μg/day. In another embodiment, when a miR-218, miR-miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 composition isadministered by continuous infusion into the central nervous system, themiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 composition is administered to the subject in an amount of about20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37,38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or about 50 μg/day. Inan additional embodiment, when a miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition is administered bycontinuous infusion into the central nervous system, the miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379composition is administered to the subject in an amount of about 50, 60,70, 80, 90, or about 100 μg/day. In a preferred embodiment, when amiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 composition is administered by continuous infusion into thecentral nervous system, the miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 composition is administered tothe subject in an amount of about 17, 18, 19, 20, 21, 22, or about 23μg/day.

One of skill in the art will also recognize that the duration of theadministration by continuous infusion can and will vary, and will dependin part on the subject, the MND, and the severity, progression andimprovement of the condition of the subject, and may be determinedexperimentally. In some embodiments, a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 composition isadministered by continuous infusion for 1, 2, 3, 4, 5, 6, 7, 8, 9, 10,11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28,29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46,47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64,65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82,83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100days or longer. In one embodiment, a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 composition isadministered by continuous infusion for 20, 21, 22, 23, 24, 25, 26, 27,28, 29, 30, 31, 32, 33, 34, 35 days or longer. In another embodiment, amiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 composition is administered by continuous infusion for 34, 35,36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53,54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65 days or longer. In yetanother embodiment, a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 composition is administered by continuousinfusion for 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78,79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95 daysor longer. Longer continuous infusions of the antisense oligonucleotidemay also be envisioned using existing pump technology as is known in theart.

When a miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380,or miR-379 composition of the invention is an antisense oligonucleotide,molecules of the invention are typically administered to a subject orgenerated in situ such that they hybridize with or bind to miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 orthe coding sequence of miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 inhibiting the respective biologicalactivity of miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379. The hybridization may be by conventional nucleotidecomplementarity to form a stable duplex, or, for example, in the case ofan antisense nucleic acid molecule which binds to DNA duplexes, throughspecific interactions in the major groove of the double helix. Anantisense nucleic acid molecule of the invention may be administered bydirect injection at a tissue site. Alternatively, antisense nucleic acidmolecules may be modified to target selected cells and then administeredsystemically. For example, for systemic administration, antisensemolecules may be modified such that they specifically bind to receptorsor antigens expressed on a selected cell surface, e.g., by linking theantisense nucleic acid molecules to peptides or antibodies which bind tocell surface receptors or antigens. The antisense nucleic acid moleculesmay also be delivered by direct infusion into a subject. The antisensenucleic acid molecules may also be delivered to cells using gene therapyvectors known in the art. To achieve sufficient intracellularconcentrations of the antisense molecules, vectors in which theantisense nucleic acid molecule is placed under the control of a strongpol II or pol III promoter are preferred.

(g) Restoring Motor Neuron Function and/or Treatment

A method of the invention comprises improving motor neuron function in asubject diagnosed with a motor neuron disease, suspected of having amotor neuron disease or at risk for a motor neuron disease byadministering a miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 composition to the subject. The miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 compositionmay decrease the amount or expression of miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379, respectively. In aspecific embodiment, a miR-218 composition may decrease the amount orexpression of miR-218. In another specific embodiment, a miR-138composition may decrease the amount or expression of miR-138.

An improvement in motor neuron function may be measured by severalmeans, including an increase in motor neurons, an improvement insymptoms associated with a motor neuron disease, and/or an improvementor restoration of miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 amount to that of a reference value,wherein the reference value is that of a subject without motor neurondisease.

A method of the invention also comprises treating a subject byadministering to the subject a therapeutically effective amount of acomposition comprising a miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 agent that decreases the expression ofmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379. In a specific embodiment, a method of the invention comprisestreating a subject by administering to the subject a therapeuticallyeffective amount of a composition comprising a miR-218 agent thatdecreases the expression of miR-218. In another specific embodiment, amethod of the invention comprises treating a subject by administering tothe subject a therapeutically effective amount of a compositioncomprising a miR-138 agent that decreases the expression of miR-138. Asused herein, “subject” may refer to a living organism having a centralnervous system. In particular, subjects may include, but are not limitedto, human subjects or patients and companion animals. Exemplarycompanion animals may include domesticated mammals (e.g., dogs, cats,horses), mammals with significant commercial value (e.g., dairy cows,beef cattle, sporting animals), mammals with significant scientificvalue (e.g., captive or free specimens of endangered species), ormammals which otherwise have value. Suitable subjects may also include:mice, rats, dogs, cats, ungulates such as cattle, swine, sheep, horses,and goats, lagomorphs such as rabbits and hares, other rodents, andprimates such as monkeys, chimps, and apes. In some preferredembodiments, a subject is a human. In other preferred embodiments, asubject is a rat. In yet other preferred embodiments, a subject is amouse. Subjects may be of any age including newborn, adolescent, adult,middle age, or elderly.

A subject may be at risk for developing a MND resulting fromdysregulation of miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379. In a specific embodiment, a subject may beat risk for developing a MND resulting from dysregulation of miR-218and/or miR-138. In another specific embodiment, a subject may be at riskfor developing a MND resulting from overexpression of miR-218. In stillanother specific embodiment, a subject may be at risk for developing aMND resulting from overrexpression of miR-138. As such, in someembodiments, treating a MND prevents a disorder from developing in asubject at risk of developing a MND resulting from dysregulation ofmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379. In other embodiments, treating a MND prevents a disorder fromdeveloping in a subject at risk of developing a MND resulting fromdysregulation of miR-218 and/or miR-138. In specific embodiments,treating a MND prevents a disorder from developing in a subject at riskof developing a MND resulting from overexpression of miR-218. In otherspecific embodiments, treating a MND prevents a disorder from developingin a subject at risk of developing a MND resulting from overexpressionof miR-138. Subjects at risk for a MND which is caused or contributed toby dysregulation of miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 activity may be identified by, for example,any or a combination of diagnostic or prognostic assays for detectingmiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 mutation or activity. A prophylactic agent may be administeredprior to the manifestation of symptoms characteristic of the miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379aberrancy, such that a disease or disorder is prevented, or delayed inits progression.

A subject may also be diagnosed as having a MND resulting fromdysregulation of miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379. In other embodiments, a subject may alsobe diagnosed as having a MND resulting from dysregulation of miR-218and/or miR-138. In a specific embodiment, a subject may also bediagnosed as having a MND resulting from overexpression of miR-218. Inanother specific embodiment, a subject may also be diagnosed as having aMND resulting from overexpression of miR-138. In some embodiments,treating a MND treats a disorder in a subject having a MND resultingfrom dysregulation of miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379. In other embodiments, treating a MNDtreats a disorder in a subject having a MND resulting from dysregulationof miR-218 and/or miR-138. In a specific, treating a MND treats adisorder in a subject having a MND resulting from overexpression ofmiR-218. In another specific embodiment, treating a MND treats adisorder in a subject having a MND resulting from overexpression ofmiR-138. As such, the present invention provides methods of treating anindividual afflicted with a disease or disorder characterized bydysregulation of miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379.

Treating a subject using a method of the invention may extend thesurvival of the subject. Alternatively, treating a subject using amethod of the invention may extend the disease duration of the subject.

In some embodiments, treating a subject extends the survival of thesubject. A method of the invention may extend the survival of a subjectby days, weeks, months, or years, when compared to the survival of asubject that was not treated using a method of the invention. As will berecognized by individuals skilled in the art, the number of days,months, or years that a method of the invention may extend the survivalof a subject can and will vary depending on the subject, the MND, andthe condition of the subject when treatment was initiated among otherfactors.

In other embodiments, treating a subject extends the disease duration ofa subject. As used herein, the term “disease duration” is used todescribe the length of time between onset of symptoms and death causedby the disease. A method of the invention may extend the diseaseduration of a subject by days, weeks, months, or years, when compared tothe survival of the subject that was not treated using a method of theinvention. The number of days, months, or years that a method of theinvention may extend the disease duration of a subject can and will varydepending on the subject, the MND, and the condition of the subject whentreatment was initiated among other factors.

III. Kits

In still other aspects, the present invention provides articles ofmanufacture and kits containing materials useful for treating theconditions described herein. The article of manufacture may include acontainer of a composition as described herein with a label. Suitablecontainers include, for example, bottles, vials, and test tubes. Thecontainers may be formed from a variety of materials such as glass orplastic. The container holds a composition having an active agent whichis effective for treating, for example, conditions that benefit frommiR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379 therapy. The active agent is at least one miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 agent of theinvention and may further include additional bioactive agents known inthe art for treating the specific condition. The label on the containermay indicate that the composition is useful for treating specificconditions and may also indicate directions for administration.

Definitions

Unless defined otherwise, all technical and scientific terms used hereinhave the same meaning as is commonly understood by one of ordinary skillin the art. All patents, applications, published applications and otherpublications are incorporated by reference in their entirety. In theevent that there is a plurality of definitions for a term herein, thosein this section prevail unless stated otherwise.

As used herein, “administering” is used in its broadest sense to meancontacting a subject with a composition of the invention.

As used herein, the term “hybridizes under stringent conditions” isintended to describe conditions for hybridization and washing underwhich nucleotide sequences at least 60% (65%, 70%, preferably 75%)identical to each other typically remain hybridized to each other. Suchstringent conditions are known to those skilled in the art and can befound in Current Protocols in Molecular Biology, John Wiley & Sons, N.Y.(1989), 6.3.1-6.3.6. A non-limiting example of stringent hybridizationconditions are hybridization in 6× sodium chloride/sodium citrate (SSC)at about 45° C., followed by one or more washes in 0.2.×SSC, 0.1% SDS at50-65° C. (e.g., 50° C. or 60° C. or 65° C.). Preferably, the isolatednucleic acid molecule of the invention that hybridizes under stringentconditions corresponds to a naturally-occurring nucleic acid molecule.As used herein, a “naturally-occurring” nucleic acid molecule refers toa RNA or DNA molecule having a nucleotide sequence that occurs in ahuman cell in nature (e.g., encodes a natural protein).

As used herein, the term “nucleic acid molecule” is intended to includeDNA molecules (e.g., cDNA or genomic DNA) and RNA molecules (e.g., mRNAor miRNA) and analogs of the DNA or RNA generated using nucleotideanalogs. The nucleic acid molecule may be single-stranded ordouble-stranded.

An “isolated nucleic acid molecule” means that the material is removedfrom its original environment (e.g., the natural environment if it isnaturally occurring). For example, a naturally occurring polynucleotidepresent in a living animal is not isolated, but the same polynucleotideor polypeptide, separated from some or all of the coexisting materialsin the natural system, is isolated, even if subsequently reintroducedinto the natural system. Such polynucleotides may be part of a vector orother composition and still be isolated in that such vector orcomposition is not part of its natural environment.

A “nucleic acid vector” is a nucleic acid sequence designed to bepropagated and or transcribed upon exposure to a cellular environment,such as a cell lysate or a whole cell. A “gene therapy vector” refers toa nucleic acid vector that also carries functional aspects fortransfection into whole cells, with the intent of increasing expressionof one or more genes or proteins. In each case, such vectors usuallycontain a “vector propagation sequence” which is commonly an origin ofreplication recognized by the cell to permit the propagation of thevector inside the cell. A wide range of nucleic acid vectors and genetherapy vectors are familiar to those skilled in the art.

A miRNA is a small non-coding RNA molecule which functions intranscriptional and post-transcriptional regulation of gene expression.A miRNA functions via base-pairing with complementary sequences withinmRNA molecules, usually resulting in gene silencing via translationalrepression or target degradation. A mature miRNA is processed through aseries of steps from a larger primary RNA transcript (pri-miRNA), orfrom an intron comprising a miRNA (mirtron), to generate a stem looppre-miRNA structure comprising the miRNA sequence. A pre-miRNA is thencleaved to generate the mature miRNA.

Primary miRNA transcripts are transcribed by RNA polymerase II and mayrange in size from hundreds to thousands of nucleotides in length(pri-mRNA). Pri-miRNAs may encode for a single miRNA but may alsocontain clusters of several miRNAs. The pri-miRNA is subsequentlyprocessed into an about 70 nucleotide hairpin (pre-miRNA) by the nuclearribonuclease III (RNase III) endonuclease, Drosha. Thus, isolatednucleic acid molecules of the invention have various preferred lengths,depending on their intended targets. When targeted to pri-miRNA,preferred lengths vary between 100 and 200 nucleotides, e.g., 100, 120,150, 180 or 200 nucleotides. In the cytoplasm, a second RNAse III,Dicer, together with its dsRBD protein partner, cuts the pre-miRNA inthe stem region of the hairpin thereby liberating an about 21 nucleotideRNA-duplex. Thus, isolated polynucleotides of about 80, 70, 60, 50, 40,30, 25, 21, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, or 6nucleotides in length are also considered in one embodiment of theinvention.

As used herein, the term “sufficiently identical” refers to a firstamino acid or nucleotide sequence which contains a sufficient or minimumnumber of identical or equivalent (e.g., an amino acid residue which hasa similar side chain) amino acid residues or nucleotides to a secondamino acid or nucleotide sequence such that the first and second aminoacid or nucleotide sequences have a common structural domain and/orcommon functional activity. For example, amino acid or nucleotidesequences which contain a common structural domain having about 65%identity, preferably 75% identity, more preferably 85%, 95%, or 98%identity are defined herein as sufficiently identical.

As used interchangeably herein, a “miR-218, miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, or miR-379 activity”, “biological activityof miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, ormiR-379” or “functional activity of miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379” refers to an activityexerted by a miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 respectively on a miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379 responsive cell, targetmRNA, or target protein as determined in vivo or in vitro, according tostandard techniques. A miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 activity may be a direct activity such asan association with a second protein or mRNA. A miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 activity maybe an indirect activity such as a cellular signaling activity mediatedby interaction of the miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 protein with a second protein or mRNA.

The term “sample” refers to a cell, a population of cells, biologicalsamples, and subjects, such as mammalian subjects. The term “biologicalsample” refers to tissues, cells and biological fluids isolated from asubject, as well as tissues, cells and fluids present within a subject.

As used herein, “subject” refers to a living organism having a centralnervous system. In particular, subjects may include, but are not limitedto, human subjects or patients and companion animals. Exemplarycompanion animals may include domesticated mammals (e.g., dogs, cats,horses), mammals with significant commercial value (e.g., dairy cows,beef cattle, sporting animals), mammals with significant scientificvalue (e.g., captive or free specimens of endangered species), ormammals which otherwise have value. Suitable subjects may also include:mice, rats, dogs, cats, ungulates such as cattle, swine, sheep, horses,and goats, lagomorphs such as rabbits and hares, other rodents, andprimates such as monkeys, chimps, and apes. In some embodiments,subjects may be diagnosed with a fibroblastic condition, may be at riskfor a fibroblastic condition, or may be experiencing a fibroblasticcondition. Subjects may be of any age including newborn, adolescent,adult, middle age, or elderly.

The term “miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 agent” refers to any molecule capable ofrespectively modulating miR-218, miR-138, miR-133a, miR-133b, miR-1193,miR-34b, miR-380, or miR-379 activity. Exemplary miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 agents mayinclude, without limitation, a compound, drug, small molecule, peptide,oligonucleotide, protein, antibody, and combinations thereof. miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379agents may be synthetic or naturally occurring. A miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379 agent may bea molecule identified in a screening assay as described herein.

The term “miR-218, miR-138, miR-133a, miR-133b, miR-1193, miR-34b,miR-380, or miR-379 indicator” refers to any molecule capable ofdetecting, respectively, the presence of miR-218, miR-138, miR-133a,miR-133b, miR-1193, miR-34b, miR-380, or miR-379. A suitable miR-218,miR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379indicator may be a compound, drug, small molecule, peptide,oligonucleotide, protein, antibody, and combinations thereof.

As used herein, the phrases “therapeutically effective amount” and“prophylactically effective amount” refer to an amount that provides atherapeutic benefit in the treatment, prevention, or management ofpathological processes mediated by dysregulation of miR-218, miR-138,miR-133a, miR-133b, miR-1193, miR-34b, miR-380, or miR-379. The specificamount that is therapeutically effective may be readily determined byordinary medical practitioners, and may vary depending on factors knownin the art, such as the type of disorder being treated, the subject'shistory and age, the stage of the disorder, and administration of otheragents in combination.

As used herein, a “pharmaceutical composition” includes apharmacologically effective amount of a therapeutic agent of theinvention and a pharmaceutically acceptable carrier. As used herein,“pharmacologically effective amount,” “therapeutically effective amount”or simply “effective amount” refers to that amount of an agent effectiveto produce the intended pharmacological, therapeutic or preventiveresult. For example, if a given clinical treatment is consideredeffective when there is at least a 15% reduction in a measurableparameter associated with a disease or disorder, a therapeuticallyeffective amount of an agent for the treatment of that disorder ordisease is the amount necessary to effect at least a 15% reduction inthat parameter.

The term “pharmaceutically acceptable carrier” refers to a carrier foradministration of a therapeutic agent. Such carriers may include, butare not limited to, saline, buffered saline, dextrose, water, glycerol,ethanol, and combinations thereof. The term specifically excludes cellculture medium. For drugs administered orally, pharmaceuticallyacceptable carriers may include, but are not limited to,pharmaceutically acceptable excipients such as inert diluents,disintegrating agents, binding agents, lubricating agents, sweeteningagents, flavoring agents, coloring agents and preservatives. Suitableinert diluents may include sodium and calcium carbonate, sodium andcalcium phosphate, and lactose, while corn starch and alginic acid aresuitable disintegrating agents. Binding agents may include starch andgelatin, while the lubricating agent, if present, may generally bemagnesium stearate, stearic acid or talc. If desired, the tablets may becoated with a material such as glyceryl monostearate or glyceryldistearate to delay absorption in the gastrointestinal tract.

As used herein, “percent complementarity” means the percentage ofnucleotides of a modified oligonucleotide that are complementary to amicroRNA. Percent complementarity may be calculated by dividing thenumber of nucleotides of the modified oligonucleotide that arecomplementary to nucleotides at corresponding positions in the microRNAby the total length of the modified oligonucleotide.

As used herein, “oligonucleotide” means a polymer of linked nucleosides,each of which may be modified or unmodified, independent from oneanother.

As used herein, “anti-miR” means an oligonucleotide having a nucleotidessequence complementary to a microRNA. In certain embodiments, ananti-miR is a modified oligonucleotide.

As used herein, “internucleoside linkage” means a covalent linkagebetween adjacent nucleosides.

As used herein, “linked nucleosides” means nucleosides joined by acovalent linkage.

As used herein, “nucleobase” means a heterocyclic moiety capable ofnon-covalently pairing with another nucleobase.

As used herein, “nucleoside” means a nucleobase linked to a sugar.

As used herein, “nucleotide” means a nucleoside having a phosphate groupor other internucleoside linkage forming group covalently linked to thesugar portion of a nucleoside.

As used herein, “modified oligonucleotide” means an oligonucleotidehaving one or more modifications relative to a naturally occurringterminus, sugar, nucleobase, and/or internucleoside linkage.

As used herein, “modified internucleoside linkage” means any change froma naturally occurring internucleoside linkage.

As used herein, “phosphorothioate internucleoside linkage” means alinkage between nucleosides where one of the non-bridging atoms is asulfur atom.

As used herein, “modified sugar” means substitution and/or any changefrom a natural sugar.

As used herein, “modified nucleobase” means any substitution and/orchange from a natural nucleobase.

As used herein, “5-methylcytosine” means a cytosine modified with amethyl group attached to the 5′ position.

As used herein, “2′fluoro sugar” means a sugar having a fluorinemodification at the 2′ position.

As used herein, “2′-O-methyl sugar” or “2′-OMe sugar” means a sugarhaving an O-methyl modification at the 2′ position.

As used herein, “2′-O-methoxyethyl sugar” or “2′-MOE sugar” means asugar having an O-methoxyethyl modification at the 2′ position.

As used herein, “2′-O-fluoro” or “2′-F” means a sugar having a fluoromodification at the 2′ position.

As used herein, “bicyclic sugar moiety” means a sugar modified by thebridging of two non-geminal ring atoms.

As used herein, “locked nucleic acid (LNA) sugar moiety” means asubstituted sugar moiety having a (CH₂)—O bridge between the 4′ and 2′furanose ring atoms.

In practicing the present invention, many conventional techniques inmolecular biology, microbiology, and recombinant DNA may be used. Thesetechniques are well known and are explained in, for example, CurrentProtocols in Molecular Biology, Volumes I, II, and III, 1997 (F. M.Ausubel ed.); Sambrook et al., 1989, Molecular Cloning: A LaboratoryManual, Second Edition, Cold Spring Harbor Laboratory Press, Cold SpringHarbor, N.Y.; DNA Cloning: A Practical Approach, Volumes I and II, 1985(D. N. Glover ed.); Oligonucleotide Synthesis, 1984 (M. L. Gait ed.);Nucleic Acid Hybridization, 1985, (Hames and Higgins eds.);Transcription and Translation, 1984 (Hames and Higgins eds.); AnimalCell Culture, 1986 (R. I. Freshney ed.); Immobilized Cells and Enzymes,1986 (IRL Press); Perbal, 1984, A Practical Guide to Molecular Cloning;the series, Methods in Enzymology (Academic Press, Inc.); Gene TransferVectors for Mammalian cells, 1987 (J. H. Miller and M. P. Calos eds.,Cold Spring Harbor Laboratory); and Methods in Enzymology, Vol. 154 andVol. 155 (Wu and Grossman, and Wu, eds., respectively).

EXAMPLES

The following examples are included to demonstrate preferred embodimentsof the invention. It should be appreciated by those of skill in the artthat the techniques disclosed in the examples that follow representtechniques discovered by the inventors to function well in the practiceof the invention, and thus can be considered to constitute preferredmodes for its practice. However, those of skill in the art should, inlight of the present disclosure, appreciate that many changes can bemade in the specific embodiments which are disclosed and still obtain alike or similar result without departing from the spirit and scope ofthe invention.

Introduction to the Examples.

Amyotrophic Lateral Sclerosis (ALS) is a fatal, adult-onsetneurodegenerative disease in which motor neurons (MNs) are selectivelylost. This progressive loss of MNs results in denervation and muscleatrophy, where most patients die within 3-5 years of symptom onset.Nearly 4 in 100,000 people in the US are affected by ALS. The majorityof ALS cases are sporadic with age being the highest risk factor fordisease. The remaining 10% of ALS cases are familial. Mutations insuperoxide dismutase 1 (SOD1) were the first identified genetic cause ofALS and are attributed to 20% of familial ALS; recently, ahexanucleotide repeat expansion in chromosome 9 open reading frame 72(C9orf72) is now associated with 20-40% of familial ALS cases. Currentlymouse and rat models containing mutated human SOD1 are still the mostwidely used and most faithfully recapitulate the disease pathology.

microRNAs (miRNAs) are small, regulatory RNAs that, canonically,regulate translation of protein-coding RNAs. miRNAs direct translationalrepression by partial binding to the 3′ UTR of mRNAs after first beingincorporated into a RNA-induced silencing complex (RISC), containingArgonaute-2 (Ago2). Because only partial complementarity is required formiRNA-mRNA interactions, a single miRNA can potentially regulatehundreds of mRNA transcripts. Emerging data demonstrate miRNAs arepowerful regulators of physiological and pathological cellularprocesses. Consequently, miRNA expression is often dysregulated indisease and miRNAs have been used as therapeutic and diagnostic targets.

miR-155, a glial-enriched miRNA, is upregulated in the spinal cords ofend-stage ALS model (SOD1^(G93A)) mice and human autopsy. InhibitingmiR-155 significantly delays disease progression in SOD1^(G93A) mice.Non-cell autonomous disease mechanisms are important and targeting animmunomodulatory miRNA may be an effective therapy for ALS. Despiteenthusiasm for this glial miRNA therapeutic approach, we hypothesizedthat MN miRNA changes in ALS may be equally or more important, as MNloss and pathology define the onset of disease and ultimately death.However, since MNs represent approximately 4% of the total mouse spinalcord volume, probing miRNA changes in MNs is challenging and must bedone utilizing a MN-targeted approach.

To date, most cell type enriched expression data have been generatedthough fluorescence activated cell sorting (FACS), laser capturemicrodissections (LCMs), and in situ histology. Each of these methodshas significant limitations, which can be overcome with the advent ofbiochemical purification systems such as, translating ribosome affinitypurification (TRAP) for mRNA, or miRNA tagging and affinity purification(miRAP) for miRNA.

To assess miRNA expression in CNS cell types, we employed miRAP, inwhich tagged-Argonaute2 (Ago2) is expressed in particular cell typesunder the control of the Cre-Lox system. Because catalyticallyfunctional miRNAs must first be loaded into the miRNA processing proteinAgo2, affinity purification via antibodies against Ago2 serves to alsoisolate active miRNAs from tissue lysates. Furthermore, by expressing aGFP-myc-tagged version of Ago2 only in particular cell types, miRNAsfrom distinct cell populations may be isolated via myc or GFPimmunoprecipitation (IP). To determine enriched miRNA expression in MNs,we crossed miRAP reporter mice (with a lox-stop-lox-GFP-myc-Ago2(LSL-tAgo2)) to mice expressing Cre under promoters targeting allneurons, MNs, astrocytes, and myeloid cells including microglia. Withthese experiments we were able to generate a physiologically relevantdatabase of well-validated miRNAs enriched in these CNS cell types and,via comparative analysis, discriminate MN-enriched miRNAs. We predictthese MN-enriched miRNA expression profiles will broadly inform onstudies of diseases and injuries specific to MNs. Here, we focused onALS disease mechanisms. By probing the expression of MN-enriched miRNAsin ALS rodent models, we have identified a new CSF, drug-responsivebiomarker of MN disease.

Example 1 Generation and Validation of Cell Specific Expression ofGFP-myc-Ago2 in CNS Tissues

We adapted the miRAP method developed by He, et al to expresstagged-Ago2 in specific cell populations relevant to ALS (He et al.Neuron 2012; 73(1): 35-48). Double transgenic mice carrying alleles ofCre recombinase under various promoters and lox-stop-lox-GFP-myc-Ago2(LSL-tAgo2) in the Rosa26 locus were generated (FIG. 1A). To target celltype specific expression of Cre recombinase, and thus cell type specificexpression of tAgo2, we used existing Cre lines with the followingpromoters: Synapsin 1 (Syn), choline acetyltransferase (ChAT), glialfibrillary acidic protein (GFAP), or lysozyme 2 (Lyz2, LysM) targeting apan neuronal, MN, astrocyte, or microglia cell population, respectively(FIG. 1B).

In order to validate tAgo2 expression in the desired cell types, weisolated brainstem or spinal cord and immunoprecipitated (IP'ed) withmyc antibodies from each transgenic mouse. As confirmed by Western blot,each double transgenic mouse expresses tAgo2 (˜130 kDa) in the brain andspinal cord, but LSL-tAgo2+, Cre-littermates do not (FIG. 6).Double-label immunofluorescence histology using a cell-specific antibodyand with an antibody against GFP indicated tAgo2 was being expressed inthe desired neuronal cell types. The Syn-Cre, LSL-tAgo2 mouse showedstrong expression of GFP in NeuN+ cells throughout the brain and spinalcord including in the brainstem (FIG. 1C). In ChAT-Cre double transgenicmice, tAgo2 expression was isolated to the ChAT+ brainstem motor nucleiand spinal MNs (FIG. 1D). For both of these lines, GFP expressionappeared cytoplasmic and not nuclear, in agreement with known Ago2localization. To visualize the cell types marked by GFAP- and Lyz2-Cre,we crossed these drivers with LSL-tdTomato/Ai9 mice. As anticipated, theLSL-tdTomato, GFAP-Cre mice showed robust Cre activity in astrocytes(labeled with anti-GFAP, FIG. 1E). And, as previously reported forGFAP-Cre drivers, there was sparse labeling of neurons, many of whichare likely late born neuronal progeny of GFAP+ neural stem cells. Asexpected LSL-tdTomato, Lyz2-Cre mice showed recombinase activity in somemicroglia (labeled with anti-Iba1, FIG. 1F). Unexpectedly, given theirwidespread use in targeting microglia for functional studies in the CNS,we also saw robust Cre activity in sparse subsets of neurons.Nonetheless, as the neuronal Cre lines both had high specificity, andonly the Lyz2 line showed any microglial Cre activity, we reasoned thatwe would still be able to identify miRNA enriched in each cell type viaa comparative strategy similar to that previously used to control forbackground in TRAP studies (Dougherty et al. Nucleic Acids Research2010; 38(13): 4218-4230).

Therefore, we harvested the brainstems and spinal cords from replicatetransgenic mice that carried both Cre-recombinase and LSL-tAgo2 alleles(experimental mice) or only LSL-tAgo2 (negative controls). Following BCAnormalization for protein input, miRAP was performed on these tissuesusing either myc or Ago2 antibodies (FIG. 2A). The resulting miRNAs wereisolated and assayed via TaqMan miRNA microarrays v3.0 (A+B cards). Toaccount for background miRNA expression associated with the myc-IP, weperformed Taqman miRNA microarrays on RNA from myc IP of both brainstemand spinal cord of littermate controls not expressing tAgo2. To thisend, we empirically determined background cycle threshold (CT) cut-offsfor each individual miRNA. We used these data to eliminate any miRNA notsignificantly enriched over background. Table 1 indicates the number ofmiRNAs in each cell type that were found to be expressed significantlyover noise in either brainstem or spinal cord.

TABLE 1 The number of miRNAs differentially expressed fromnon-transgenic in brainstem and spinal cord following miRAP. A total of672 miRNAs were queried. The criteria for a miRNA to be expressed abovebackground were 1) the miRNA must be expressed (CT < 40) in 2 of 3replicates (3 of 4 for Ago2); 2) the median expression for a miRNA ofthe triplicates must be CT < 35 (CT < 37 for Ago2); 3) the highest CT ofthe replicates must be 2 CT < the median of the non-transgenics. Thenumber of miRNAs expressed above background in an untagged Ago2immunoprecipiation represents an estimate of the number of all miRNAsexpressed above background in each tissue-type. Sample Brainstem SpinalCord ChAT 257 295 Syn 406 417 GFAP 325 295 Lyz2 123 56 Ago2 484 467

To confirm that miRAP from brainstem and spinal cord tissue wasaccurately recapitulating miRNA expression in each distinct cell type,we assessed the expression of miRNAs previously reported to exhibit celltype specificity or enrichment (FIG. 2B). miR-134, a miRNA involved incortical neuronal development, was robustly expressed in our Syn andChAT mice and greatly depleted in GFAP and Lyz2 mice. Expression ofmiR-219, which is known to act on NMDA receptors, was absent in MNs,consistent with lack of NMDA receptors. Only astrocytes exhibited highexpression of miR-204, a miRNA that has been extensively studied ingliomas. Finally, perfused Lyz2 tissue showed strong expression ofmiR-142-3p, a miRNA involved in hematopoetic cell differentiation,consistent with the lineage of microglia.

On a global level, the miRNA expression profiles for CNS cell types aredistinct. Following unsupervised 3D principal component analysis (PCA),we found that miRNA expression profiles were sufficient to clustersamples by their cell type of origin (FIG. 3A). Furthermore, the miRNAexpression profiles from IP of tagged and untagged Ago2 from eachtransgenic mouse clustered together in PCA, indicating global miRNAexpression in these mice is comparable (FIG. 3A). Hierarchical heatmapsalso demonstrate that these CNS cell types can be identified by theirunique miRNA expression profiles (FIG. 3B).

Using this global miRNA array data, we identified miRNAs that areconsistently expressed across CNS cell types: miR-24, 30c and 191 (FIG.7). The use of these miRNAs as putative endogenous controls fornormalizing RT-qPCR data will greatly aid in future studies of miRNAs inthe CNS. Furthermore, these results align well with previous reportsidentifying putative housekeeping miRNAs. Because U6 snRNA is nottypically loaded into Ago2, miRAP studies must employ endogenous miRNAcontrols for normalization of RT-qPCR data.

We have confirmed the validity of our approach by ensuring thetransgenic mice employed in these studies express tAgo2 in the desiredcell types and that miRAP produces a miRNA signature for these distinctCNS cell types that is consistent with previous reports.

Example 2 Identification of MN-Enriched miRNAs

To discriminate MN-enriched miRNA expression, we performed pairwisecomparisons with other CNS cell types. FIG. 3C indicates the top 3miRNAs in each cell type exhibiting enriched expression and theassociated specificity index for both brainstem and spinal cord. We thenvalidated the MN-enrichment of the top 8 miRNAs using the original 3samples from the arrays (technical replicate) and an additional 3samples (biological replicate) to confirm the array findings at a higherpower using individual RT-qPCR assays (Table 2). miR-218-5p and itslesser abundant 3p strand exhibited the strongest enrichment in MNs(Table 2). The MN-enrichment of miR-544 and miR-380-5p could not beconfirmed due to low expression (CT>35) and non-specificity of Taqmanprimers (repeated amplification in no-template control), respectively.All comparisons made using LoessM normalized array data are included inTable 3 (spinal cord) and Table 4 (brain stem).

TABLE 2 Confirmation of MN-enrichment of miRNAs in the spinal cord ascompared to all other neurons. The MN-enrichment of 6 of 8 miRNAs wasvalidated with individual RT-qPCR assays. Student's unpaired, two-tailedt-test, Bonferroni correction for multiple (6) comparisons. Values arenormalized to a geomean of endogenous miRNA controls, miR-30c, 24 and191, and expressed as the mean of N = 6. miRNA Fold-Change P-valuemiR-218 11.9 0.0002 miR-218-2 11.9 <0.0001 miR-138 3.2 <0.0001 miR-133a2.8 <0.0001 miR-1193 3.7 0.0008 miR-34b-3p 3.1 0.045

Example 3 Depletion of MN-Enriched miRNAs in Spinal Cord from ALS MouseModels and Patients

To determine whether MN-enriched miRNAs are relevant for MN disease, wecharacterized their expression in the spinal cords of an ALS mouse modeland human ALS patient autopsies. In our congenic ALS mouse model(B6.Cg-Tg(SOD1^(G93A))1Gur/J) colony, disease onset typically occurs at100-110 days, as marked by time to peak weight. We performed RT-qPCR onSOD1^(G93A) spinal cord harvested at 56, 84, 105, 126, and 147 days, aswell as end-stage (inability to right itself within 30 seconds). Therewas a robust and highly significant temporal depletion of MN-enrichedmiRNAs, miR-218 and miR-138, in SOD1^(G93A) spinal cord beginning at 126days (FIG. 4A, FIG. 4B). This depletion was maximized in end-stage ALSmouse model spinal cord. Following a similar trend, pan-neuronalenriched miRNAs, miR-382 and miR-672, are decreased, but notsignificantly depleted in ALS mouse model spinal cord, even at end-stage(FIG. 4C, FIG. 4D). Finally, miR-218 and miR-138 are also depleted inALS patient autopsy spinal cord as compared to non-diseased autopsyspinal cord controls (FIG. 4E, FIG. 4F).

Example 4 Dysregulation of MN-Enriched miRNAs as Biomarkers of MNDisease

Because MN-enriched miRNAs are depleted temporally in ALS mouse modeland patient autopsy spinal cord, we hypothesized these miRNAs might alsobe dysregulated in cerebrospinal fluid (CSF) as MNs are lost throughoutALS disease progression. Furthermore, as CSF bathes the brain and spinalcord, it might contain a detectable MN miRNA biomarker. Here, we usedALS SOD1^(G93A) rats for these CSF studies because of the larger volumeof CSF obtained from rats as compared to mice. Surprisingly, rather thandecreased, as in mouse and patient spinal cord tissues, miR-218increases throughout disease progression in ALS rat model CSF ascompared to non-transgenic rats (FIG. 5A). To ensure this effect was notsimply due to human SOD1 (hSOD1) overexpression, we measured miR-218levels in CSF from rats overexpressing wildtype hSOD1 at 95 and 165days. miR-218 CSF levels were not significantly different in hSOD1 WTrats as compared to non-transgenics at either timepoint (FIG. 8).However, there is a trend towards increased miR-218 CSF levels at 165days in hSOD1 WT rats, which could be reflective of the MN loss anddecreased survival that is associated hSOD1 WT mice. Furthermore,increased expression of miR-218 in ALS rat model CSF is not due toglobal increases in miRNA expression in CSF, as a neuronal miRNAs,miR-132 and miR-124, were decreased in rat SOD1^(G93A) CSF as comparedwith non-transgenic controls (FIG. 5B, FIG. 5C).

Because these data show that rats expressing human SOD1^(G93A) transgenehave increased levels of miR-218 in their CSF, we hypothesized thatdecreasing the levels of toxic transgene, SOD1^(G93A), would alsodecrease the miR-218 levels in CSF. Antisense oligonucleotides (ASOs)against SOD1 are well-tolerated, effectively and specifically lowerhuman SOD1^(G93A) and extend survival in this rat model. To this end, wetreated ALS SOD1^(G93A) rats with SOD1 ASO. As predicted, hSOD1 mRNA wassignificantly lowered in the lumbar spinal cord of these animals (asassessed 50 days post-treatment). Strikingly, miR-218 CSF levels werereduced in SOD1 ASO-treated rats as compared to artificial CSF(aCSF)-treated littermate controls (FIG. 5D), but the levels of neuronalmiR-132 and 124 were not (FIG. 5E, FIG. 5F). These data establishmiR-218 as the first MN-specific and drug-responsive biomarker of MNdisease.

Discussion for the Examples.

This study employs tools to assess in vivo miRNA expression in a celltype specific manner to discriminate MN-enriched miRNA expressionrelative to other CNS cell types. By focusing on MN-enriched miRNAexpression in models of MN disease, we defined the first drug-responsivebiomarker in an ALS disease model. In addition, we anticipate thisdataset of MN-enriched miRNAs will facilitate other insights into MNdisease mechanisms, risk factors and genetics underlying MNvulnerability.

In vivo cell type specific expression profiling techniques allowhigh-throughput access to key disease-relevant cell types, yet preservephysiological relevance as compared to ex vivo methods. This in vivoapproach is particularly relevant for MNs, which represent roughly 4% ofthe spinal cord volume and may not be easily isolated from neighboringcells. We adopted a comparative, systematic approach to defineMN-enriched miRNA expression relative to other CNS cell types. Inclusionof a pan-neuronal line allowed us to define which miRNAs distinguish MNsspecifically from neurons in general, while assessment of microglial andastrocyte profiles provided key controls and baseline data to facilitatefuture analyses with understanding the molecular correlates of thewell-known histological response of these cell types to diseasepathology. The ability to define in vivo, cell type-enriched expressionenables broad application of the concept of profiling the cell type mostaffected by a particular disease to understand disease mechanism andidentify biomarkers. For example, we hypothesize that understandingbrainstem dopaminergic miRNA profiles would reveal miRNA biomarkers forParkinson's disease. Likewise, miRNA profiles of pancreatic beta isletcells would reveal serum miRNA biomarkers for diabetes.

As a first application of MN-enriched miRNA data in MN disease, we havedefined a drug-responsive marker in CSF. Beyond this, we anticipatethese MN-enriched miRNAs may provide a window into understanding of MNdevelopment and disease. The dataset generated here could inform novelmiRNAs involved in cell fate specification, particularly thoseexhibiting enriched expression in a single CNS cell type. Furthermore,this study may provide insight into another emerging area of researchinterest: understanding the regulatory mechanisms that lead to cell typespecific expression. Oftentimes, miRNAs are embedded within introns ofgenes, and while their transcription is sometimes dictated by the hostgene promoter, there is increasing evidence that many miRNAs have theirown promoters. Our dataset also enables probing regional differences inmiRNA expression among the same cell type, which is of particularinterest in ALS as glia are the main drivers of disease progression.

Our data demonstrate miR-218 is a marker of MN loss and/or injury in ALSrat model CSF. miR-218 exists at two different genomic loci within theintrons of SLIT2 and SLIT3, which are important for axonal guidance. Ourwork highlights the importance of miR-218 and its relation to MN healthand disease.

Currently, the regulation of miR-218 deposition into the CSF throughoutALS disease progression is unknown. It is possible that deposition ofmiR-218 into the CSF may reflect a pathological disease mechanism beyondjust MN loss. While clearance of proteins and other molecules into theCSF can result from normal physiological processes, there is alsoincreasing evidence that deposition into the CSF can be pathological aswell. Disease-associated deposition could result from leakiness andpermeability of the blood brain barrier, pathological signaling inresponse to cellular stress or cellular damage that is incurred frommisfolded proteins and other neurological disease hallmarks. Futurestudies will help delineate whether the increased expression of miR-218in ALS rat CSF is due to MN loss and subsequent clearance or an activesignal or homeostatic attempt from diseased MNs. Understanding whethermiR-218 is also changed in spinal muscular atrophy, spinal cord injury,or other disease of the spinal cord may provide insights into themiR-218 CSF signal.

miRNAs have been increasingly used as biomarkers of disease because theyare measurable in biofluids, including CSF, serum and urine. Theirstability in biofluid likely arises from their extracellular associationwith Argonaute or presence exosomes, making them more resistant todegradation. However, the relatively low abundance of miRNA in biofluidshas made profiling miRNAs challenging. By defining miRNAs that wereenriched in our cell type of interest, that being the predominantlyaffected cell type in ALS, we were able to develop a miRNA biomarker whopresence in CSF reflected the progression of the disease.

Unlike multiple sclerosis with an imaging marker, muscles diseases withcreatine kinase, or HIV with viral load, ALS clinical trials arehampered by the lack of a disease responsive biomarker that may be usedas a proxy for MN health. Our data in animal models suggests thatmiR-218 in CSF may be such a marker. In clinical trials, if miR-218levels could be used as an early signal regarding efficacy of the drug,drugs could be assessed much more rapidly for their likelihood ofaffecting MNs, thus potentially selecting a more promising candidate fora much longer trial.

This study has identified the first MN-specific, drug-responsivebiomarker of MN disease. Our approach highlights a new pipeline forhypothesis-driven development of cell type specific miRNA biomarkers ofdiseases. miRNAs are ideal biomarkers because they are readilyquantifiable, stable in biofluids and report on physiological andpathological processes. A MN-specific, drug-responsive biomarker wouldrevolutionize the design and assessment of efficacy of MN diseasetherapies.

Methods for the Examples.

Animals. All mice were bred on a congenic C57BL/6J background. Togenerate cell-specific GFP-Ago2 expressing mice, a homozygous(ROSA)26Sortm1(CAG-GFP/EiF2c2)Zjh (LSL-tAgo2) mouse (Jax ID: 017626) wasbred to one of four Cre lines: Syn-Cre (Jax ID: 003966), ChAT-Cre (JaxID: 006410), GFAP-Cre (a gift from David H. Gutmann), Lyz2-Cre (Jax ID:004781). To visualize the cell types marked by GFAP and Lyz2, we usedLSL-tdTomato mice (JAX: 007905). Mice used in experiments wereheterozygous for LSL-tAgo2 and for a cell-specific Cre driver, whilecontrol mice were only positive for LSL-tAgo2. C57BI/6J SOD1^(G93A) micewere purchased from Jackson Laboratories (ID: 004435). For CSF studies,Sprague-Dawley non-transgenic, hSOD1 WT (provided by Pak Chan, StanfordUniversity) and the SOD1^(G93A) (Taconic model 2148) rat lines wereused.

At 9 weeks of age, mice were anesthetized with an overdose of inhaledisoflurane before being perfused with 20-30 mL of cold PBS. Perfusionwas critical for elimination of Lyz2-labeled monocytes in the blood.Following visual examination for complete exsanguination, whole spinalcords and whole brainstems were isolated and flash frozen in liquidnitrogen. Brainstem tissue included the pons and medulla with care toexclude any cortical, cerebellar, or spinal cord tissue. Tissues werestored at −80° C. until ready for miRNA isolation.

Histology: Double Label Cell Type Expression. Free-floating 50 μmsections of brain and spinal cord were washed in TBS and blocked in 5%normal horse serum, 0.1% triton, in TBS for one half hour.Goat-anti-ChAT (1:200, Millipore AB144) or rabbit anti-NeuN antibody(1:1000, Cell Signaling, 12943), both with chicken-anti-GFP (1:250,Ayes, GFP-1020) in blocking solution were applied to the tissuesovernight at 4oC. AlexaFluor 488-conjugated donkey anti-chicken (1:500,Jackson Immuno Research, 703-545-155) was added with DyLight 550 goatanti-rabbit (1:500, Thermo Scientific, 84541) or DyLight 550 donkeyanti-goat (1:500, Thermo Scientific, SA5-10087) in blocking buffer tothe tissue for one hour. Chicken anti-GFAP (1:1000, Abcam, ab4674) andrabbit anti-Ibal (1:250, Wako, 019-19741) were used to label Td tomatotissue. No antibody was necessary to visualize Td tomato expression.DyLight 488 goat anti-chicken 1:500, Thermo Scientific, SA5-10070) orDyLight 488 donkey anti-rabbit (1:500, Thermo Scientific, SA5-10038) inblocking buffer to the tissue for one hour. All sections were stainedwith DAPI. Slides were washed 3 times in TBS, mounted on superfrostslides, and coverslipped with Fluoromount (Southern Biotech, 0100-01).All slides were observed at 20× objectives using a Nikon A1Rsi Confocal.All images were taken at ambient temperature with a 405, 488 and 561 nmlasers. For image acquisition and formatting, ImageJ and Adobe PhotoshopCS6 Extended were used.

miRAP. Brainstem and spinal cords from perfused, 63 day-old mice wereharvested and flash frozen in liquid nitrogen and stored at −80° C. Forarray experiments, IPs were conducted on 3 double positive mice fromeach of the 4-cre driver lines and from an additional 4 negative controlmice at the same time for a given tissue type. Whole brainstem or spinalcord was homogenized using a hand blender in 1 ml of lysis buffer andmiRAP was conducted as previously described (He et al. Neuron 2012;73(1): 35-48). Briefly, Whole brainstem or spinal cord was lysed in 1 mLof ice-cold lysis buffer (10 mM HEPES [pH 7.4], 100 mM KCl, 5 mM MgCl₂,0.5% NP-40, 1 mM DTT, 100 U/mL RNasin Plus (Promega), and EDTA-freeprotease inhibitors (Roche)). Tissue was lysed using a hand blenderbefore centrifuging at +4° C. for 30 min at 13,000 g. 10 μg ofmouse-anti-Myc (sc-40; Santa Cruz Biotechnology) or 5 μg ofmouse-anti-Ago2 (2E12-1C9; Anova) in 350 μL of PBS-Tween was conjugatedto 50 μL of protein G Dynabeads (Invitrogen) for 45 min, rotating at RT.Antibody-conjugated beads were washed three times with 1 mL of PBS-Tweento remove any excess antibody. A BCA assay was performed on all tissuehomogenates to normalize input to the lowest protein concentration. 850μL of supernatant or supernatant diluted with lysis buffer were appliedto the antibody-conjugated beads and incubated at +4° C. for 4 hourswith end-over-end rotation. Beads were washed twice with low-salt buffer(50 mMTris-HCl [pH 7.5], 150 mM NaCl, 1 mM MgCl₂, 0.5% NP-40, 1 mM DTT,100 U/mL RNasin Plus) and twice with high-salt buffer (50 mMTris-HCl [pH7.5], 600 mM NaCl, 1 mM MgCl₂, 0.5% NP-40, 1 mM DTT, 100 U/ml RNasinPlus). 700 μL of Qiazol was added directly to the beads, and sampleswere vortexed for 30 sec and stored at −20° C.

miRNA Extraction and Quantification. RNA was isolated using miRNeasykits per manufacturer's instructions (Qiagen). miRNA microarrays wereperformed using 3 μL with pre-amplification using low density RodentMiRNA A+B cards sets 3.0 (Life Technologies) on a 7900HT qPCR machinefor 40 cycles. Analysis was conducted on SDSv2.2 software with automaticthresholding. Microarray miRNA targets were confirmed with individualTaqMan miRNA assays (Life Technologies) as per the manufacturer'sinstructions. qPCR samples were quantified in technical duplicates on anApplied Biosystems 7500 fast Real-Time PCR System.

Data Analysis and Statistics. Data are presented as mean±SEM. Allstatistical tests were conducted using R's Bioconductor toolkit, MSExcel, or with Graphpad Prism 6 Software. Array data was normalized byglobal LoessM in R studio as previously described (Risso et al.Bioinformatics 2009; 25(20): 2685-2691).

Differentially Expressed from Non-Transgenic: For a given sample, datawas excluded for a miRNA if it failed to be expressed at a significantlevel over the corresponding microarray data from three myc-IP miRNAextractions from negative control mice, matched by tissue type. Thecriteria for differential expression were 1) the miRNA must be expressedin at least two of three replicates (three of four for Ago2); 2) Themedian expression of the triplicates for a given miRNA must be CT<35(CT<37 for Ago2); 3) The highest CT of the triplicates for a given miRNAmust be 2 CT<the median CT of the non-transgenics.

Endogenous miRNA controls: To identify putative housekeeping miRNAs, weused the following criteria: 1) Using the LoessM normalized CTs, wesubsetted for miRNAs with a low standard deviation (<1) among thetriplicates; 2) The mean CT of the triplicates had to be <24 for allcell types. miR-24, 30c, and 191 were the top three miRNAs that metthese criteria.

Pairwise Comparisons: For the miRNAs that met these criteria, relativeexpression data was generated for all pairwise comparisons between celltypes in both tissues. Significant changes in miRNA expression profileswere determined by empirical Bayes given the low sample number, thelarge number of targets (672 miRNAs), and the inability to assume normaldistribution (Smyth et al. Stat Appl Genet Mol Biol 2004; 3: Article3).These data are included in completion in Table 3 (spinal cord) and Table4 (brain stem). Adjusted p values were calculated using theBenjamini-Hochberg correction (Klipper-Aurbach et al. Med Hypotheses1995; 45(5): 486-490).

Heatmap: miRNAs were included in the heatmap illustration (FIG. 3B) if agiven miRNA was found to have significant differential expression(Log2FC>2 and p<0.01) in at least one comparison.

Specificity Index. We used the R Package pSI (Xu et al. Journal ofNeuroscience 2014; 34(4): 1420-1431) to define which miRNAs wereenriched in each cell type when compared to all others, with minoradaptations to the input for use with qPCR microarrays. Briefly, weconverted CTs into a relative expression values, x, for each gene asx=2(40-CT), such that genes with lower CTs had higher relativeexpression and expression was in linear scale. This was then provided tothe function specificity.index as was a filter to remove those miRNAsnot expressed above background for each type, allowing calculation of ap-value for the enrichment of each miRNA in each cell type (pSI, inTable 1).

MN-enriched miRNAs: The top 8 miRNAs enriched in MNs were defined by thefollowing criteria: 1) The geomean of the ChAT triplicates from thearrays <30 CT; 2) Fold-change >1.75 in all spinal cord comparisons; 3)unadjusted p-value <0.01 in ChAT versus Syn comparison.

CSF Collection and miRNA Extraction and Quantification. CSF was obtainedfrom rats anesthetized with 5% isoflurane via puncture of the cisternamagna and spun at 16,000 g for 10 mins at +4° C. prior to freezing thesupernatant at −80° C. miRNA was extracted from CSF using the miRcuryRNA Isolation Kit-Biofluids (Exiqon). RT-qPCR was performed using themiRCURY LNA Universal RT and ExiLENT SYBR green kit (Exiqon). 6 μL ofundiluted RNA was used for RT using the miRCURY LNA Universal RT kit(Exiqon). The cDNA was diluted 1:20 in 17 μL of water and 2 μL of ROXreference dye (Invitrogen). 4 μL of diluted cDNA was used for each qPCRreaction using the ExiLENT SYBR Green kit (Exiqon). The data wasanalyzed using the 2{circumflex over ( )}(-ddCT) method and miR-103a-3pwas used as a normalization control (as per manufactuer's recommendationfor biological fluid). qPCR samples were quantified in technicalduplicates on an Applied Biosystems 7500 fast Real-Time PCR System.

SOD1 ASO Treatment. SOD1^(G93A) rats at 65 days of age were anesthetizedwith 5% isoflurane and given a 30 μL intrathecal bolus injection of 1000μg of ASO or artificial CSF (aCSF) within their lumbar spinal region.Cohorts were gender-and litter-matched. CSF and spinal cord wereharvested at 115 days of age. All surgeries and downstream analyses weredone by personnel blinded to the treatment groups.

TABLE 3 Spinal Cord miRNA data. detect_ detect_ detect_ detect_mean_sc.ChAT mean_sc.GFAP mean_sc.Lyz2 mean_sc.Syn pSI_sc.ChATpSI_sc.GFAP pSI_sc.Lyz2 pSI_sc.Syn SC.ChAT SC.GFAP SC.Lyz2 SC.Synhsa_let_7b_002404 30.879 35.020 31.267 36.072 0.152 0.811 0.263 0.927TRUE TRUE TRUE TRUE hsa_let_7e_002407 30.955 30.486 30.064 31.333 0.5880.574 0.377 0.703 TRUE TRUE TRUE TRUE hsa_let_7f_1_002417 36.988 36.52438.053 34.173 NA NA 0.913 0.050 FALSE FALSE TRUE TRUE hsa_let_7i_00217233.472 30.838 34.523 35.180 0.458 0.072 0.755 0.908 TRUE TRUE TRUE TRUEhsa_miR_106b_002380 30.817 27.576 29.987 27.067 0.909 0.326 0.809 0.089TRUE TRUE TRUE TRUE hsa_miR_10a_002288 35.055 35.056 37.102 36.059 0.3000.444 0.888 0.597 TRUE TRUE TRUE TRUE hsa_miR_1197_002810 32.465 35.96334.449 33.050 0.210 NA 0.721 0.370 TRUE FALSE TRUE TRUEhsa_miR_124_002197 35.423 35.842 35.382 37.266 NA NA 0.402 0.868 FALSEFALSE TRUE TRUE hsa_miR_127_5p_002229 31.428 35.136 34.115 32.536 0.117NA 0.798 0.403 TRUE FALSE TRUE TRUE hsa_miR_136_000592 29.264 33.33227.628 28.940 0.548 0.967 0.162 0.418 TRUE TRUE TRUE TRUEhsa_miR_136_00210 21.563 27.320 24.145 22.028 0.109 0.963 0.748 0.240TRUE TRUE TRUE TRUE hsa_miR_140_3p_002234 28.995 27.836 28.290 28.0650.769 0.539 0.561 0.399 TRUE TRUE TRUE TRUE hsa_miR_143_000466 27.61928.159 21.533 29.701 0.554 0.759 0.010 0.947 TRUE TRUE TRUE TRUEhsa_miR_144_002676 37.549 37.458 38.284 39.542 NA NA 0.589 NA FALSEFALSE TRUE FALSE hsa_miR_148a_002134 37.722 34.727 38.858 39.554 NA NA0.766 NA FALSE FALSE TRUE FALSE hsa_miR_149_002255 19.790 20.672 21.48119.353 0.447 0.688 0.872 0.239 TRUE TRUE TRUE TRUE hsa_miR_151_5P_00264230.948 27.369 26.408 29.995 0.953 0.292 0.164 0.719 TRUE TRUE TRUE TRUEhsa_miR_154_000478 25.101 29.523 26.728 26.622 0.138 0.914 0.571 0.542TRUE TRUE TRUE TRUE hsa_miR_15b_002173 36.618 36.061 35.342 40.824 NA NANA NA FALSE FALSE FALSE FALSE hsa_miR_183_002270 27.187 33.259 25.84226.869 0.471 NA 0.160 0.364 TRUE FALSE TRUE TRUE hsa_miR_189_00048834.202 33.163 31.920 30.879 NA 0.709 0.446 0.149 FALSE TRUE TRUE TRUEhsa_miR_190b_002263 28.285 27.710 26.596 30.132 0.527 0.480 0.242 0.944TRUE TRUE TRUE TRUE hsa_miR_196a_241070_mat 22.898 20.685 23.004 22.3430.740 0.233 0.740 0.510 TRUE TRUE TRUE TRUE hsa_miR_200a_001011 37.94237.898 39.681 39.675 NA 0.386 0.791 NA FALSE TRUE TRUE FALSEhsa_miR_200b_001800 32.621 32.764 31.536 35.312 NA NA NA NA FALSE FALSEFALSE FALSE hsa_miR_200b_002274 41.058 40.840 34.869 40.479 NA NA 0.022NA FALSE FALSE TRUE FALSE hsa_miR_200c_000505 29.521 28.937 24.55528.936 0.855 0.759 0.057 0.596 TRUE TRUE TRUE TRU hsa_miR_200c_00228639.357 39.448 39.774 39.626 NA NA 0.623 NA FALSE FALSE TRUE FALSEhsa_miR_206_000510 32.580 26.994 25.742 29.679 0.996 0.255 0.12 0.640TRUE TRUE TRUE TRUE hsa_miR_213_000516 28.312 26.353 27.318 27.441 0.8180.375 0.545 0.502 TRUE TRUE TRUE TRUE hsa_miR_214_000517 32.027 28.74529.776 31.372 0.897 0.202 0.398 0.696 TRUE TRUE TRUE TRUEhsa_miR_214_002293 36.503 34.840 37.066 38.480 NA 0.175 0.644 NA FALSETRUE TRUE FALSE hsa_miR_218_2_002294 25.488 35.935 30.916 29.525 0.002NA 0.674 0.418 TRUE FALSE TRUE TRUE hsa_miR_223_000526 24.678 28.61115.981 28.679 0.408 0.925 0.000 0.893 TRUE TRUE TRUE TRUEhsa_miR_22_000398 24.765 23.723 23.861 24.624 0.691 0.510 0.439 0.607TRUE TRUE TRUE TRUE hsa_miR_22_002301 28.491 28.403 28.568 29.796 0.4190.521 0.473 0.812 TRUE TRUE TRUE TRUE hsa_miR_23a_002439 35.070 32.07324.625 41.740 NA 0.370 0.000 NA FALSE TRUE TRUE FALSE hsa_miR_26b_00244433.164 30.729 29.582 34.928 0.690 0.302 0.155 0.982 TRUE TRUE TRUE TRUEhsa_miR_27a_002445 34.867 33.503 35.742 37.360 NA 0.180 0.656 0.956FALSE TRUE TRUE TRUE hsa_miR_27b_002174 35.044 33.956 34.215 34.349 NA0.539 0.503 0.466 FALSE TRUE TRUE TRUE hsa_miR_28_3p_002446 36.07237.158 37.479 36.676 NA NA NA NA FALSE FALSE FALSE FALSEhsa_miR_299_5p_000600 34.556 36.641 36.116 34.620 0.346 NA 0.748 0.327TRUE TRUE TRUE TRUE hsa_miR_29a_002447 28.575 27.217 29.270 26.827 0.7440.452 0.885 0.158 TRUE TRUE TRUE TRUE hsa_miR_29b_2_002166 28.849 30.24025.085 30.194 0.536 0.863 0.051 0.802 TRUE TRUE TRUE TRUEhsa_miR_30a_3p_000416 20.965 20.170 21.278 20.687 0.621 0.486 0.6990.465 TRUE TRUE TRUE TRUE hsa_miR_30c_1_002108 35.948 32.956 39.08939.727 NA 0.021 0.871 NA FALSE TRUE TRUE FALSE hsa_miR_30c_2_00211032.808 38.297 37.811 40.585 0.004 NA NA NA TRUE FALSE FALSE FALSEhsa_miR_30d_002305 24.046 27.665 28.018 30.140 0.029 0.556 0.653 0.952TRUE TRUE TRUE TRUE hsa_miR_30e_3p_000422 20.710 19.830 20.973 20.6390.597 0.457 0.677 0.531 TRUE TRUE TRUE TRUE hsa_miR_324_3p_000579 29.42724.147 26.753 25.193 0.981 0.161 0.682 0.239 TRUE TRUE TRUE TRUEhsa_miR_338_000548 26.821 23.285 24.875 25.198 0.932 0.200 0.522 0.520TRUE TRUE TRUE TRUE hsa_miR_338_5P_002658 26.074 23.052 23.289 24.2230.949 0.359 0.351 0.502 TRUE TRUE TRUE TRUE hsa_miR_33a_002136 31.91829.590 30.539 30.621 0.878 0.364 0.526 0.460 TRUE TRUE TRUE TRUEhsa_miR_340_000550 23.475 22.875 23.973 23.292 0.589 0.502 0.730 0.462TRUE TRUE TRUE TRUE hsa_miR_363_001283 39.170 40.277 38.929 35.354 NA NA0.650 0.013 FALSE FALSE TRUE TRUE hsa_miR_376a_001287 24.086 31.04826.324 25.302 0.071 0.986 0.611 0.386 TRUE TRUE TRUE TRUEhsa_miR_378_000567 25.843 25.735 22.340 27.387 NA NA NA NA FALSE FALSEFALSE FALSE hsa_miR_411_002238 24.845 31.212 26.382 25.055 0.196 0.9890.589 0.259 TRUE TRUE TRUE TRUE hsa_miR_412_001023 29.401 33.999 31.66030.565 0.114 NA 0.691 0.428 TRUE FALSE TRUE TRUE hsa_miR_421_00270022.275 22.096 23.281 23.044 0.414 0.484 0.738 0.638 TRUE TRUE TRUE TRUEhsa_miR_423_3P_002626 30.184 25.943 28.472 28.527 0.937 0.095 0.5980.532 TRUE TRUE TRUE TRUE hsa_miR_425_001104 31.256 27.795 28.489 30.5170.917 0.216 0.343 0.707 TRUE TRUE TRUE TRUE hsa_miR_431_002312 31.09436.118 34.404 31.738 0.104 NA 0.820 0.257 TRUE FALSE TRUE TRUEhsa_miR_455_001280 31.927 26.562 27.804 29.967 0.985 0.108 0.342 0.654TRUE TRUE TRUE TRUE hsa_miR_485_5p_001036 35.893 35.904 35.951 36.172 NANA 0.525 0.583 FALSE FALSE TRUE TRUE hsa_miR_493_3p_001282 38.550 29.48534.151 34.931 NA 0.004 0.499 0.587 FALSE TRUE TRUE TRUEhsa_miR_590_3P_002677 40.354 40.711 40.447 39.055 NA NA NA NA FALSEFALSE TRUE FALSE hsa_miR_653_002292 33.569 37.039 33.565 36.984 0.213 NA0.258 0.834 TRUE FALSE TRUE TRUE hsa_miR_671_5p_197646_mat 33.621 32.41427.096 34.593 NA NA 0.017 NA FALSE FALSE TRUE FALSE hsa_miR_708_00234240.439 40.391 40.302 39.815 NA NA NA NA FALSE FALSE TRUE FALSEhsa_miR_744_002325 30.577 30.629 30.064 30.735 0.560 0.666 0.430 0.592TRUE TRUE TRUE TRUE hsa_miR_875_5p_002203 25.517 28.405 20.202 35.6590.391 0.651 0.005 NA TRUE TRUE TRUE FALSE hsa_miR_935_002178 35.94734.504 35.791 34.312 NA NA 0.734 0.228 FALSE FALSE TRUE TRUEhsa_miR_93_002139 27.499 24.585 26.984 26.362 0.832 0.188 0.706 0.471TRUE TRUE TRUE TRUE hsa_miR_99b_002196 29.619 30.180 30.703 30.506 0.3530.629 NA 0.605 TRUE TRUE FALSE TRUE hsa_miR_9_002231 21.119 17.03319.942 19.886 0.900 0.077 0.637 0.568 TRUE TRUE TRUE TRUEmmu_let_7a_000377 26.605 22.901 29.543 23.721 0.710 0.144 0.999 0.144TRUE TRUE TRUE TRUE mmu_let_7a_002478 33.879 26.482 32.333 36.299 NA0.000 NA NA FALSE TRUE FALSE FALSE mmu_let_7b_000378 21.022 18.95220.591 21.083 0.683 0.252 0.588 0.702 TRUE TRUE TRUE TRUEmmu_let_7c_000379 20.247 18.747 20.629 20.101 0.641 0.321 0.743 0.544TRUE TRUE TRUE TRUE mmu_let_7c_1_002479 34.745 31.257 26.064 33.303 NA0.476 0.014 0.698 FALSE TRUE TRUE TRUE mmu_let_7d_001178 35.310 35.61732.794 32.821 NA NA 0.302 0.231 FALSE FALSE TRUE TRUE mmu_let_7d_00228321.114 20.892 22.375 21.161 0.481 0.520 0.835 0.439 TRUE TRUE TRUE TRUEmmu_let_7e_002406 18.883 18.865 20.928 19.214 0.365 0.495 0.927 0.441TRUE TRUE TRUE TRUE mmu_let_7f_000382 28.133 25.503 27.217 24.260 0.9000.424 NA 0.070 TRUE TRUE FALSE TRUE mmu_let_7g_002282 20.587 21.06721.987 21.300 0.340 0.608 0.776 0.546 TRUE TRUE TRUE TRUEmmu_let_7q_002492 30.813 35.502 33.242 33.315 0.059 NA 0.617 0.621 TRUEFALSE TRUE TRUE mmu_let_7i_002221 22.420 20.344 23.094 21.890 0.6910.234 0.848 0.461 TRUE TRUE TRUE TRUE mmu_miR_100_000437 21.277 18.53920.865 21.116 0.736 0.162 0.639 0.674 TRUE TRUE TRUE TRUEmmu_miR_101a_002253 21.391 22.078 22.549 22.492 0.316 0.630 0.687 0.647TRUE TRUE TRUE TRUE mmu_miR_101a_002507 35.607 35.338 35.313 34.185 NA0.666 0.611 0.240 FALSE TRUE TRUE TRUE mmu_miR_101b_002531 23.593 23.28424.919 23.229 0.536 0.522 0.877 0.321 TRUE TRUE TRUE TRUEmmu_miR_103_000439 23.842 23.307 25.438 23.785 0.478 0.450 0.905 0.406TRUE TRUE TRUE TRUE mmu_miR_105_002465 32.153 33.607 31.208 40.714 0.2950.506 0.157 NA TRUE TRUE TRUE FALSE mmu_miR_106a_002459 25.321 21.03926.750 22.667 0.806 0.081 0.980 0.216 TRUE TRUE TRUE TRUEmmu_miR_106b_000442 24.829 22.708 23.579 23.942 0.844 0.364 0.498 0.530TRUE TRUE TRUE TRUE mmu_miR_107_000443 25.595 25.491 21.860 25.747 0.7190.756 0.098 0.696 TRUE TRUE TRUE TRUE mmu_miR_10a_000387 22.311 20.70521.958 21.852 0.724 0.365 0.624 0.531 TRUE TRUE TRUE TRUEmmu_miR_10b_001181 24.756 23.502 24.193 23.460 0.787 0.531 0.622 0.318TRUE TRUE TRUE TRUE mmu_miR_10b_002218 19.724 19.901 22.288 18.429 0.4970.556 0.982 0.113 TRUE TRUE TRUE TRUE mmu_miR_10b_002572 30.867 31.25333.468 31.829 0.240 0.492 0.948 0.513 TRUE TRUE TRUE TRUEmmu_miR_1186_002825 35.674 34.292 35.448 37.548 NA NA 0.498 NA FALSEFALSE TRUE FALSE mmu_miR_1188_002866 34.066 36.573 36.296 35.675 0.152NA 0.737 0.568 TRUE FALSE TRUE TRUE mmu_miR_1191_002892 33.993 31.20626.053 32.943 NA 0.524 0.017 0.708 FALSE TRUE TRUE TRUEmmu_miR_1192_002806 39.297 39.488 39.624 39.611 NA NA 0.587 NA FALSEFALSE TRUE FALSE mmu_miR_1193_002794 29.446 31.092 31.622 32.179 0.1370.599 0.695 0.815 TRUE TRUE TRUE TRUE mmu_miR_1194_002793 38.551 38.75238.938 38.326 NA NA 0.645 NA FALSE FALSE TRUE FALSE mmu_miR_1195_00283936.882 36.650 36.988 39.681 NA NA 0.432 NA FALSE FALSE TRUE FALSEmmu_miR_1198_002780 28.387 26.877 29.951 26.235 0.705 0.393 0.967 0.102TRUE TRUE TRUE TRUE mmu_miR_1199_240984_mat 40.800 40.976 40.660 39.599NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_1224_240985_mat 40.588 40.83040.479 38.692 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_122_00224536.718 32.391 27.033 38.251 NA 0.313 0.005 NA FALSE TRUE TRUE FALSEmmu_miR_124_001182 22.915 27.716 24.414 22.536 0.326 0.953 0.672 0.149TRUE TRUE TRUE TRUE mmu_miR_125a_3p_002199 26.710 27.123 26.352 26.3390.602 0.736 0.486 0.431 TRUE TRUE TRUE TRUE mmu_miR_125a_5p_00219819.531 20.109 21.013 19.923 0.359 0.637 0.805 0.474 TRUE TRUE TRUE TRUEmmu_miR_125b_002508 28.814 28.271 30.011 29.716 0.409 0.383 NA 0.683TRUE TRUE FALSE TRUE mmu_miR_125b_3p_002378 31.665 29.295 28.707 32.2830.758 0.322 0.213 0.900 TRUE TRUE TRUE TRUE mmu_miR_125b_5p_00044919.134 18.277 17.962 19.210 0.673 0.541 0.362 0.667 TRUE TRUE TRUE TRUEmmu_miR_126_3p_002228 21.436 24.546 19.796 22.934 0.390 0.919 0.1380.724 TRUE TRUE TRUE TRUE mmu_miR_126_5p_000451 23.217 26.593 22.38624.760 0.324 NA 0.202 0.708 TRUE FALSE TRUE TRUEmmu_miR_1274a_121150_mat 32.404 33.863 28.270 35.143 0.477 0.794 0.0300.942 TRUE TRUE TRUE TRUE mmu_miR_127_000452 17.984 22.141 18.143 17.6270.433 0.953 0.446 0.283 TRUE TRUE TRUE TRUE mmu_miR_128a_002216 21.45923.311 21.623 20.888 0.535 0.848 0.541 0.292 TRUE TRUE TRUE TRUEmmu_miR_129_3p_001184 20.069 22.271 20.910 19.403 0.491 0.849 0.6700.206 TRUE TRUE TRUE TRUE mmu_miR_129_5p_000590 27.145 29.775 29.92527.053 0.266 0.789 0.896 0.209 TRUE TRUE TRUE TRUEmmu_miR_1306_121155_mat 33.892 35.991 35.909 34.131 NA NA 0.810 0.336FALSE FALSE TRUE TRUE mmu_miR_130a_000454 28.162 23.051 28.262 24.9550.894 0.062 0.910 0.229 TRUE TRUE TRUE TRUE mmu_miR_130b_000456 30.36227.283 28.242 29.307 0.907 0.251 0.425 0.607 TRUE TRUE TRUE TRUEmmu_miR_130b_002460 34.518 34.829 27.920 29.072 0.910 0.941 0.062 0.191TRUE TRUE TRUE TRUE mmu_miR_132_000457 18.750 22.630 18.745 17.460 0.5390.955 0.492 0.126 TRUE TRUE TRUE TRUE mmu_miR_133a_001637 37.169 39.18439.128 36.680 NA NA 0.835 0.183 FALSE FALSE TRUE TRUEmmu_miR_133a_002246 18.284 25.610 20.344 19.099 0.102 0.993 0.603 0.318TRUE TRUE TRUE TRUE mmu_miR_133b_002247 22.228 30.028 24.044 23.9310.069 0.995 0.488 0.477 TRUE TRUE TRUE TRUE mmu_miR_134_001186 24.45529.430 25.829 24.328 0.291 0.954 0.636 0.215 TRUE TRUE TRUE TRUEmmu_miR_135a_000460 23.965 20.438 22.637 21.522 0.929 0.228 0.682 0.317TRUE TRUE TRUE TRUE mmu_miR_135b_002261 25.636 22.688 26.516 23.6500.801 0.203 0.943 0.210 TRUE TRUE TRUE TRUE mmu_miR_136_002511 23.19831.431 25.603 23.459 0.123 NA 0.663 0.186 TRUE FALSE TRUE TRUEmmu_miR_136_002512 30.751 31.041 30.171 31.783 0.461 0.647 0.359 0.760TRUE TRUE TRUE TRUE mmu_miR_137_001129 21.829 26.038 21.266 22.713 0.3290.953 0.231 0.575 TRUE TRUE TRUE TRUE mmu_miR_138_002284 15.816 20.94018.263 16.941 0.087 0.935 0.705 0.398 TRUE TRUE TRUE TRUEmmu_miR_138_002554 24.601 28.346 26.566 25.101 0.212 0.890 0.714 0.344TRUE TRUE TRUE TRUE mmu_miR_139_3p_002546 34.023 33.445 31.486 29.2270.900 NA 0.489 0.035 TRUE FALSE TRUE TRUE mmu_miR_139_5p_002289 19.94822.750 19.943 19.486 0.507 0.896 0.471 0.301 TRUE TRUE TRUE TRUEmmu_miR_140_001187 22.521 21.960 24.091 22.526 0.479 0.437 0.901 0.422TRUE TRUE TRUE TRUE mmu_miR_141_000463 31.253 32.458 30.061 37.665 0.3370.522 0.156 1.000 TRUE TRUE TRUE TRUE mmu_miR_141_002513 28.856 30.45428.179 34.222 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_142_3p_00046427.484 26.708 20.479 32.121 0.596 0.521 0.005 NA TRUE TRUE TRUE FALSEmmu_miR_142_5p_002248 32.748 34.090 28.889 38.300 0.444 0.632 0.027 NATRUE TRUE TRUE FALSE mmu_miR_143_002249 30.354 27.693 27.746 33.9910.627 0.200 0.220 0.998 TRUE TRUE TRUE TRUE mmu_miR_145_002278 28.26725.943 25.032 32.452 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_145_002514 39.598 36.221 39.871 39.625 NA NA 0.764 NA FALSEFALSE TRUE FALSE mmu_miR_146a_000468 20.205 20.612 18.294 23.316 0.4400.570 0.167 0.978 TRUE TRUE TRUE TRUE mmu_miR_146b_001097 22.698 21.90321.670 22.024 0.759 0.599 0.431 0.468 TRUE TRUE TRUE TRUEmmu_miR_146b_002453 35.118 34.458 31.011 32.893 NA NA 0.136 0.387 FALSEFALSE TRUE TRUE mmu_miR_147_002262 28.214 30.341 34.695 39.546 0.033 NA0.765 NA TRUE FALSE TRUE FALSE mmu_miR_148a_000470 27.498 25.528 29.40826.749 0.628 0.224 0.973 0.316 TRUE TRUE TRUE TRUE mmu_miR_148b_00047126.707 26.805 25.776 26.507 0.642 0.708 0.381 0.522 TRUE TRUE TRUE TRUEmmu_miR_150_000473 23.612 24.661 20.531 26.976 0.455 NA 0.071 NA TRUEFALSE TRUE FALSE mmu_miR_150_002570 39.157 37.146 32.653 38.636 NA 0.5680.034 0.729 FALSE TRUE TRUE TRUE mmu_miR_151_3p_001190 29.393 24.39228.688 27.117 0.913 0.047 0.805 0.379 TRUE TRUE TRUE TRUEmmu_miR_152_000475 27.431 22.005 23.831 27.291 0.907 0.050 0.357 0.855TRUE TRUE TRUE TRUE mmu_miR_153_001191 29.827 33.226 27.820 30.060 0.5100.950 0.122 0.552 TRUE TRUE TRUE TRUE mmu_miR_154_000477 30.215 35.95231.332 29.029 0.389 NA 0.623 0.058 TRUE FALSE TRUE TRUEmmu_miR_155_002571 29.516 25.108 24.640 31.805 0.751 0.147 0.132 NA TRUETRUE TRUE FALSE mmu_miR_15a_000389 25.684 23.551 26.442 25.119 0.6930.221 0.864 0.452 TRUE TRUE TRUE TRUE mmu_miR_15a_002488 35.500 33.63632.562 35.057 NA 0.470 0.217 0.682 FALSE TRUE TRUE TRUEmmu_miR_15b_000390 24.047 22.118 22.240 24.231 0.739 0.361 0.339 0.786TRUE TRUE TRUE TRUE mmu_miR_16_000391 19.478 19.323 19.314 19.828 0.5270.604 0.486 0.635 TRUE TRUE TRUE TRUE mmu_miR_16_002489 34.399 30.66332.622 34.433 NA 0.097 0.464 0.820 FALSE TRUE TRUE TRUEmmu_miR_17_002308 24.571 21.219 23.448 22.552 0.913 0.210 0.677 0.369TRUE TRUE TRUE TRUE mmu_miR_17_002543 34.661 32.484 32.602 38.723 NA0.219 0.249 0.998 FALSE TRUE TRUE TRUE mmu_miR_181A_2_002687 40.45638.366 40.505 39.603 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_181a_000480 23.838 21.402 23.184 22.734 0.825 0.281 0.658 0.458TRUE TRUE TRUE TRUE mmu_miR_181c_000482 28.956 28.208 27.870 27.1910.821 0.655 0.511 0.254 TRUE TRUE TRUE TRUE mmu_miR_182_002599 22.93524.346 22.552 22.881 0.510 0.826 0.410 0.484 TRUE TRUE TRUE TRUEmmu_miR_1839_3p_12120_3_mat 24.704 24.328 27.016 25.038 0.367 0.4070.961 0.448 TRUE TRUE TRUE TRUE mmu_miR_1839_5p_12113_5_mat 26.72825.648 28.582 25.394 0.627 0.418 0.968 0.156 TRUE TRUE TRUE TRUEmmu_miR_183_002269 29.532 33.817 27.068 29.281 0.571 NA 0.093 0.456 TRUEFALSE TRUE TRUE mmu_miR_184_000485 27.527 32.548 27.199 30.752 0.1840.954 0.175 0.781 TRUE TRUE TRUE TRUE mmu_miR_185_002271 26.194 29.21829.561 25.105 0.343 0.813 0.929 0.067 TRUE TRUE TRUE TRUEmmu_miR_186_002285 22.785 21.581 21.943 22.370 0.733 0.489 0.484 0.547TRUE TRUE TRUE TRUE mmu_miR_186_002574 29.676 29.459 27.346 30.002 0.6650.677 0.192 0.720 TRUE TRUE TRUE TRUE mmu_miR_187_001193 31.217 25.65430.275 26.191 0.949 0.140 0.859 0.110 TRUE TRUE TRUE TRUEmmu_miR_188_3p_002106 38.923 38.713 39.440 39.453 NA NA 0.657 NA FALSEFALSE TRUE FALSE mmu_miR_188_5p_002320 25.421 23.733 19.030 25.431 NA NANA NA FALSE FALSE FALSE FALSE mmu_miR_1893_121170_mat 41.067 40.80740.667 39.923 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_1894_3p_24100_2_mat 27.754 27.636 24.011 33.056 0.513 0.4930.056 NA TRUE TRUE TRUE FALSE mmu_miR_1894_5p_12114_4_mat 38.132 37.62638.700 38.771 NA NA 0.680 NA FALSE FALSE TRUE FALSEmmu_miR_1896_121128_mat 23.931 22.339 20.892 30.141 0.571 0.306 0.114 NATRUE TRUE TRUE FALSE mmu_miR_1897_3p_12112_6_mat 40.727 40.894 40.61439.596 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_1897_5p_12119_9_mat20.325 19.912 15.717 23.724 NA NA 0.038 NA FALSE FALSE TRUE FALSEmmu_miR_1898_121195_mat 40.765 40.949 40.633 39.458 NA NA NA NA FALSEFALSE TRUE FALSE mmu_miR_1899_121198_mat 40.059 40.154 40.223 39.589 NANA NA NA FALSE FALSE TRUE FALSE mmu_miR_18a_002422 27.873 27.994 28.07627.983 0.520 0.650 0.572 0.522 TRUE TRUE TRUE TRUE mmu_miR_18a_00249034.460 32.829 32.514 33.417 NA 0.514 0.353 0.505 FALSE TRUE TRUE TRUEmmu_miR_18b_002466 34.967 40.959 40.289 39.992 0.005 NA NA NA TRUE FALSETRUE FALSE mmu_miR_1900_121143_mat 40.350 40.477 40.406 39.601 NA NA NANA FALSE FALSE TRUE FALSE mmu_miR_1901_121183_mat 36.706 36.929 35.81438.354 NA NA 0.301 0.875 FALSE FALSE TRUE TRUE mmu_miR_1902_121197_mat40.582 40.743 40.538 39.592 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_1903_121153_mat 37.136 37.793 39.222 37.513 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_1904_121162_mat 16.565 18.004 13.193 20.893 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_1905_121196_mat 27.519 30.77223.772 33.607 0.373 0.755 0.014 0.993 TRUE TRUE TRUE TRUEmmu_miR_1906_121169_ mat 38.551 40.095 39.687 NA NA NA NA FALSE FALSETRUE FALSE mmu_miR_190_000489 26.020 24.836 23.901 25.434 0.821 0.5680.283 0.572 TRUE TRUE TRUE TRUE mmu_miR_191_002299 20.171 19.761 20.10019.787 0.645 0.599 0.588 0.438 TRUE TRUE TRUE TRUE mmu_miR_191_00257630.096 30.591 30.703 31.638 0.333 0.591 0.543 0.788 TRUE TRUE TRUE TRUEmmu_miR_1927_121193_mat 37.263 36.434 37.663 37.542 NA NA 0.686 NA FALSEFALSE TRUE FALSE mmu_miR_1928_121164_mat 21.073 21.447 17.307 24.8840.505 0.605 0.049 NA TRUE TRUE TRUE FALSE mmu_miR_192_000491 25.82124.640 27.611 24.923 0.607 0.378 0.963 0.228 TRUE TRUE TRUE TRUEmmu_miR_1930_121201_mat 27.711 29.487 28.858 29.873 0.213 0.724 0.5360.775 TRUE TRUE TRUE TRUE mmu_miR_1931_121168_mat 40.049 40.269 40.12039.375 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_1932_121172_mat 34.48330.920 35.361 34.291 NA 0.055 0.884 0.593 FALSE TRUE TRUE TRUEmmu_miR_1933_3p_12114_5_mat 40.460 40.620 40.478 39.589 NA NA NA NAFALSE FALSE TRUE FALSE mmu_miR_1933_5p_12113_3_mat 36.958 31.287 33.44736.139 NA 0.046 0.385 0.762 FALSE TRUE TRUE TRUE mmu_miR_1934_121185_mat36.253 38.565 38.642 38.408 0.118 NA 0.735 NA TRUE FALSE TRUE FALSEmmu_miR_1935_121192_mat 40.374 40.629 40.327 39.848 NA NA NA NA FALSEFALSE TRUE FALSE mmu_miR_1936_121158_mat 38.865 38.937 39.344 39.702 NANA 0.594 NA FALSE FALSE TRUE FALSE mmu_miR_1937b_241023_mat 20.22320.471 17.105 24.382 0.492 0.541 0.081 NA TRUE TRUE TRUE FALSEmmu_miR_1937c_241011_mat 21.727 22.012 18.017 25.595 NA NA 0.055 NAFALSE FALSE TRUE FALSE mmu_miR_1938_121194_mat 38.639 38.671 39.20239.535 NA NA 0.620 NA FALSE FALSE TRUE FALSE mmu_miR_1939_121180_mat35.897 35.198 36.959 37.323 NA NA 0.712 0.816 FALSE FALSE TRUE TRUEmmu_miR_193_002250 35.129 33.877 33.044 36.199 0.637 0.434 0.243 0.894TRUE TRUE TRUE TRUE mmu_miR_193_002577 31.827 29.274 30.764 33.235 0.6150.160 0.451 0.945 TRUE TRUE TRUE TRUE mmu_miR_193b_002467 21.195 20.01723.182 22.324 0.359 0.222 0.907 0.705 TRUE TRUE TRUE TRUEmmu_miR_1940_121187_mat 37.494 38.721 39.788 37.955 0.268 0.663 0.9030.396 TRUE TRUE TRUE TRUE mmu_miR_1941_3p_12113_0_mat 38.707 38.73339.267 39.559 NA NA 0.623 NA FALSE FALSE TRUE FALSEmmu_miR_1941_5p_12114_0_mat 32.911 31.434 31.722 32.165 0.806 0.4860.450 0.506 TRUE TRUE TRUE TRUE mmu_miR_1942_121136_mat 37.383 35.68232.572 40.377 NA 0.393 0.058 NA FALSE TRUE TRUE FALSEmmu_miR_1943_121174_mat 34.219 31.433 33.667 34.136 NA 0.157 0.607 0.710FALSE TRUE TRUE TRUE mmu_miR_1944_121189_mat 40.038 38.885 40.224 36.979NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_1945_121166_mat 38.445 38.54338.984 39.087 NA NA 0.631 NA FALSE FALSE TRUE FALSEmmu_miR_1946a_121178_mat 41.375 40.616 40.439 40.411 NA NA NA NA FALSEFALSE TRUE FALSE mmu_miR_1947_121156_mat 37.774 35.276 38.705 39.625 NA0.079 0.726 NA FALSE TRUE TRUE FALSE mmu_miR_1948_121171_mat 35.09934.784 37.053 35.673 0.369 0.411 0.911 0.531 TRUE TRUE TRUE TRUEmmu_miR_1949_121182_mat 40.135 40.342 40.234 39.610 NA NA NA NA FALSEFALSE TRUE FALSE mmu_miR_194_000493 26.330 25.568 23.924 25.839 0.7990.655 0.231 0.571 TRUE TRUE TRUE TRUE mmu_miR_1950_121146_mat 40.52637.767 39.581 39.600 NA NA 0.604 NA FALSE FALSE TRUE FALSEmmu_miR_1951_121165_mat 35.079 35.529 36.820 40.704 NA NA 0.614 NA FALSEFALSE TRUE FALSE mmu_miR_1952_121167_mat 40.678 40.848 40.591 39.596 NANA NA NA FALSE FALSE TRUE FALSE mmu_miR_1953_121159_mat 39.401 39.47239.822 39.556 NA NA 0.639 NA FALSE FALSE TRUE FALSEmmu_miR_1954_121137_mat 29.035 29.632 26.449 36.272 0.422 0.504 0.083 NATRUE TRUE TRUE FALSE mmu_miR_1956_121129_mat 34.837 32.972 37.649 38.751NA 0.064 NA NA FALSE TRUE FALSE FALSE mmu_miR_1957_121163_mat 40.80040.976 40.660 39.599 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_1958_121181_mat 38.727 35.735 39.186 39.621 NA NA 0.723 NA FALSEFALSE TRUE FALSE mmu_miR_1959_121132_mat 27.370 28.292 25.195 34.8620.395 0.511 0.097 NA TRUE TRUE TRUE FALSE mmu_miR_195_000494 23.65120.103 23.001 22.685 0.850 0.107 0.691 0.542 TRUE TRUE TRUE TRUEmmu_miR_1960_121148_mat 36.303 34.907 37.184 37.489 NA NA 0.736 0.817FALSE FALSE TRUE TRUE mmu_miR_1961_197391_mat 25.571 26.372 21.89133.930 0.441 NA 0.035 NA TRUE FALSE TRUE FALSE mmu_miR_1962_121173_mat40.135 39.765 40.222 38.982 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_1963_121191_mat 40.800 40.976 40.660 39.599 NA NA NA NA FALSEFALSE TRUE FALSE mmu_miR_1964_121138_mat 37.371 36.401 38.090 38.242 NANA 0.711 NA FALSE FALSE TRUE FALSE mmu_miR_1965_121186_mat 40.817 40.94740.655 39.615 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_1966_121134_mat40.522 40.884 40.557 38.864 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_1967_121151_mat 40.791 40.969 40.662 39.651 NA NA NA NA FALSEFALSE TRUE FALSE mmu_miR_1968_121179_mat 38.202 33.226 38.270 40.336 NA0.005 0.626 NA FALSE TRUE TRUE FALSE mmu_miR_1969_121131_mat 22.67722.813 19.052 26.253 0.514 0.573 0.066 NA TRUE TRUE TRUE FALSEmmu_miR_196a_002477 23.463 23.683 26.769 28.784 0.123 0.212 NA NA TRUETRUE FALSE FALSE mmu_miR_196b_002215 26.664 24.959 29.268 26.734 0.4520.187 0.989 0.468 TRUE TRUE TRUE TRUE mmu_miR_1970_121202_mat 37.15840.486 37.291 35.218 0.588 NA 0.575 0.051 TRUE FALSE TRUE TRUEmmu_miR_1971_121161_mat 31.867 26.827 28.458 28.504 0.983 0.170 0.5050.433 TRUE TRUE TRUE TRUE mmu_miR_197_000497 25.970 31.605 25.145 36.0740.149 NA 0.073 NA TRUE FALSE TRUE FALSE mmu_miR_1981_121200_mat 28.86129.731 27.985 28.723 0.586 0.793 0.353 0.506 TRUE TRUE TRUE TRUEmmu_miR_1982.1_121157_mat 32.471 30.251 29.215 31.222 0.921 0.480 0.2270.563 TRUE TRUE TRUE TRUE mmu_miR_1982.2_121154_mat 31.162 32.098 28.47330.835 0.705 0.848 0.149 0.542 TRUE TRUE TRUE TRUEmmu_miR_199a_3p_00230_4 33.229 27.600 25.700 29.693 0.997 0.311 0.0950.604 TRUE TRUE TRUE TRUE mmu_miR_199a_5p_00049_8 34.977 35.802 35.68934.177 0.567 NA 0.717 0.227 TRUE FALSE TRUE TRUE mmu_miR_199b_00113134.903 34.917 36.895 36.159 NA NA 0.866 0.665 FALSE FALSE TRUE TRUEmmu_miR_19a_000395 26.653 23.770 23.913 26.348 0.866 0.283 0.288 0.759TRUE TRUE TRUE TRUE mmu_miR_19a_002544 39.970 40.091 40.183 39.587 NA NANA NA FALSE FALSE TRUE FALSE mmu_miR_19b_000396 23.455 20.176 21.77221.905 0.917 0.221 0.553 0.501 TRUE TRUE TRUE TRUE mmu_miR_1_00222220.609 24.439 22.001 21.881 0.177 0.892 0.569 0.541 TRUE TRUE TRUE TRUEmmu_miR_1_2_AS_002882 33.789 30.701 29.589 35.511 0.736 0.254 0.1330.984 TRUE TRUE TRUE TRUE mmu_miR_200a_000502 37.374 35.908 36.79740.028 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_200b_002251 34.15730.147 31.994 38.092 NA 0.053 NA NA FALSE TRUE FALSE FALSEmmu_miR_200c_002300 35.038 34.544 34.569 34.087 NA NA NA 0.347 FALSEFALSE FALSE TRUE mmu_miR_201_002578 39.119 38.981 39.419 39.702 NA NA0.582 NA FALSE FALSE TRUE FALSE mmu_miR_202_3p_001195 34.130 35.59829.818 38.508 NA NA 0.020 NA FALSE FALSE TRUE FALSEmmu_miR_202_5p_002579 36.557 36.487 36.622 38.051 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_203_000507 30.904 23.633 24.671 26.032 0.9990.141 0.323 0.532 TRUE TRUE TRUE TRUE mmu_miR_203_002580 38.162 33.98938.656 39.162 NA 0.019 0.742 NA FALSE TRUE TRUE FALSE mmu_miR_204_00050821.639 17.844 20.130 21.552 0.823 0.083 0.508 0.786 TRUE TRUE TRUE TRUEmmu_miR_205_000509 36.168 36.173 29.195 31.628 NA NA 0.034 0.274 FALSEFALSE TRUE TRUE mmu_miR_207_001198 39.609 39.847 39.859 38.772 NA NA0.645 NA FALSE FALSE TRUE FALSE mmu_miR_208_000511 36.655 39.691 32.83234.276 NA NA 0.079 0.252 FALSE FALSE TRUE TRUE mmu_miR_208b_00229037.345 36.626 34.475 40.825 NA NA 0.123 NA FALSE FALSE TRUE FALSEmmu_miR_20a_000580 23.510 20.560 20.501 22.040 0.941 0.360 0.288 0.574TRUE TRUE TRUE TRUE mmu_miR_20a_002491 33.464 33.864 31.505 33.131 NA0.783 NA 0.539 FALSE TRUE FALSE TRUE mmu_miR_20b_001014 26.251 22.32823.702 24.708 0.949 0.175 0.440 0.589 TRUE TRUE TRUE TRUEmmu_miR_20b_002524 36.450 39.946 39.831 39.368 NA NA 0.764 NA FALSEFALSE TRUE FALSE mmu_miR_210_000512 35.507 25.807 29.748 29.925 0.9990.012 0.513 0.519 TRUE TRUE TRUE TRUE mmu_miR_211_001199 23.729 22.21422.798 23.652 0.714 0.398 0.466 0.667 TRUE TRUE TRUE TRUEmmu_miR_212_002551 21.787 26.550 24.396 20.210 0.342 0.942 0.817 0.022TRUE TRUE TRUE TRUE mmu_miR_2134_241120_mat 25.220 26.216 21.255 30.2070.467 NA 0.030 NA TRUE FALSE TRUE FALSE mmu_miR_2135_241140_mat 38.82637.734 31.165 39.755 NA NA 0.006 NA FALSE FALSE TRUE FALSEmmu_miR_2136_241133_mat 39.360 37.795 37.095 38.837 NA NA 0.277 NA FALSEFALSE TRUE FALSE mmu_miR_2138_241080_mat 30.825 31.356 25.456 37.5110.486 0.585 0.009 NA TRUE TRUE TRUE FALSE mmu_miR_2139_241130_mat 38.02438.095 38.487 39.682 NA NA 0.539 NA FALSE FALSE TRUE FALSEmmu_miR_2146_241082_mat 27.401 26.323 23.305 30.057 0.613 0.456 0.080 NATRUE TRUE TRUE FALSE mmu_miR_214_002306 35.017 33.128 34.592 35.1140.665 0.285 0.572 0.706 TRUE TRUE TRUE TRUE mmu_miR_215_001200 34.22233.059 27.880 34.179 NA 0.662 0.026 0.772 FALSE TRUE TRUE TRUEmmu_miR_216a_002220 30.592 35.327 28.474 31.164 0.438 NA 0.092 0.579TRUE FALSE TRUE TRUE mmu_miR_216b_002326 25.938 36.270 26.110 26.5540.217 1.000 0.284 0.429 TRUE TRUE TRUE TRUE mmu_miR_217_001133 29.52435.038 33.026 32.032 0.023 NA 0.725 0.513 TRUE FALSE TRUE TRUEmmu_miR_217_002556 29.147 34.378 29.282 31.591 0.166 NA 0.236 0.715 TRUEFALSE TRUE TRUE mmu_miR_2182_241119_mat 31.894 32.813 34.424 37.603 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_2183_241095_mat 28.181 28.42424.513 34.224 0.485 0.524 0.049 NA TRUE TRUE TRUE FALSEmmu_miR_218_000521 15.157 22.592 18.977 17.487 0.016 0.971 0.719 0.411TRUE TRUE TRUE TRUE mmu_miR_218_1_002552 27.310 32.810 28.424 27.6090.232 0.980 0.542 0.323 TRUE TRUE TRUE TRUE mmu_miR_219_000522 28.76822.724 26.704 24.160 0.975 0.087 0.779 0.211 TRUE TRUE TRUE TRUEmmu_miR_21_000397 21.854 20.412 19.267 22.577 0.697 0.446 0.207 0.871TRUE TRUE TRUE TRUE mmu_miR_21_002493 36.703 36.669 37.067 38.292 NA NA0.524 NA FALSE FALSE TRUE FALSE mmu_miR_220_002468 40.664 40.854 40.56539.599 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_221_000524 24.56221.642 23.828 23.363 0.849 0.210 0.671 0.475 TRUE TRUE TRUE TRUEmmu_miR_222_002276 22.440 21.967 21.100 21.187 0.798 0.682 0.413 0.362TRUE TRUE TRUE TRUE mmu_miR_223_002295 29.696 29.533 19.004 34.351 0.5700.596 0.000 NA TRUE TRUE TRUE FALSE mmu_miR_224_002553 33.739 29.62230.948 30.549 0.975 0.265 0.536 0.347 TRUE TRUE TRUE TRUEmmu_miR_23a_000399 38.101 35.621 38.758 39.498 NA NA 0.715 NA FALSEFALSE TRUE FALSE mmu_miR_23b_000400 23.589 24.287 24.723 24.319 0.3500.658 0.708 0.564 TRUE TRUE TRUE TRUE mmu_miR_24_000402 19.249 19.33219.042 19.636 0.508 0.645 0.465 0.629 TRUE TRUE TRUE TRUEmmu_miR_24_2_002494 28.004 25.903 26.784 28.749 0.664 0.260 0.420 0.873TRUE TRUE TRUE TRUE mmu_miR_25_000403 24.910 23.155 28.754 26.164 0.3000.112 NA 0.632 TRUE TRUE FALSE TRUE mmu_miR_26a_000405 19.400 18.34919.799 18.864 0.661 0.453 0.750 0.406 TRUE TRUE TRUE TRUEmmu_miR_26b_000407 21.965 19.982 20.984 21.864 0.740 0.314 0.490 0.689TRUE TRUE TRUE TRUE mmu_miR_27a_000408 22.205 21.250 21.075 25.023 0.4860.357 0.296 0.984 TRUE TRUE TRUE TRUE mmu_miR_27b_000409 22.543 21.14221.638 21.953 0.768 0.469 0.505 0.516 TRUE TRUE TRUE TRUEmmu_miR_28_000411 23.530 23.280 19.520 26.346 0.565 0.557 0.063 0.988TRUE TRUE TRUE TRUE mmu_miR_28_002545 33.734 29.672 29.004 30.874 NA0.360 0.210 0.512 FALSE TRUE TRUE TRUE mmu_miR_290_000187 34.568 38.33232.703 37.070 0.329 NA 0.093 0.799 TRUE FALSE TRUE TRUEmmu_miR_290_3p_002591 40.715 40.888 40.610 39.599 NA NA NA NA FALSEFALSE TRUE FALSE mmu_miR_290_5p_002590 38.539 38.292 38.763 39.370 NA NA0.551 0.723 FALSE FALSE TRUE TRUE mmu_miR_291_3p_001135 39.716 40.91840.536 39.670 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_291_5p_00120240.679 40.889 40.559 38.886 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_291a_3p_002592 40.725 40.893 40.617 39.598 NA NA NA NA FALSEFALSE TRUE FALSE mmu_miR_291b_3p_002538 40.228 40.364 40.319 39.593 NANA NA NA FALSE FALSE TRUE FALSE mmu_miR_291b_5p_ 002537 40.827 40.97440.102 39.630 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_292_3p_00105436.543 40.991 40.487 39.557 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_292_3p_002593 37.337 37.261 31.933 38.244 NA NA 0.026 NA FALSEFALSE TRUE FALSE mmu_miR_292_5p_001055 32.090 39.133 38.466 35.412 NA NANA NA FALSE FALSE FALSE FALSE mmu_miR_293_001794 30.545 33.985 36.92737.689 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_293_002594 39.18539.336 39.466 39.619 NA NA 0.566 NA FALSE FALSE TRUE FALSEmmu_miR_294_001056 35.345 33.862 38.747 39.926 NA 0.074 0.844 NA FALSETRUE TRUE FALSE mmu_miR_294_002595 40.800 40.976 40.660 39.599 NA NA NANA FALSE FALSE TRUE FALSE mmu_miR_295_000189 38.865 38.753 37.345 39.773NA NA 0.258 NA FALSE FALSE TRUE FALSE mmu_miR_295_002596 41.230 40.88740.649 39.990 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_296_3p_00210134.506 35.537 36.603 36.656 NA NA 0.770 0.765 FALSE FALSE TRUE TRUEmmu_miR_296_5p_000527 23.767 22.719 27.116 25.004 0.274 0.201 0.9890.619 TRUE TRUE TRUE TRUE mmu_miR_297a_002454 32.589 27.503 31.14332.654 0.820 0.021 NA 0.832 TRUE TRUE FALSE TRUE mmu_miR_297b_5p_00162637.991 37.973 38.582 39.563 NA NA 0.584 NA FALSE FALSE TRUE FALSEmmu_miR_297c_002480 34.923 34.760 35.370 34.027 NA NA 0.738 0.267 FALSEFALSE TRUE TRUE mmu_miR_298_002598 30.511 34.138 29.386 28.972 0.6390.962 0.331 0.174 TRUE TRUE TRUE TRUE mmu_miR_299_002612 40.800 40.97640.660 39.599 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_29a_00211218.880 20.272 20.631 18.663 0.396 0.736 0.839 0.265 TRUE TRUE TRUE TRUEmmu_miR_29b_000413 22.096 23.254 19.985 23.180 0.508 0.814 0.161 0.749TRUE TRUE TRUE TRUE mmu_miR_29b_002497 25.948 25.957 22.206 29.062 NA NA0.067 NA FALSE FALSE TRUE FALSE mmu_miR_29c_000587 20.948 22.083 22.58521.339 0.325 0.695 0.803 0.439 TRUE TRUE TRUE TRUE mmu_miR_300_00019126.672 30.547 23.857 27.574 0.465 0.961 0.062 0.651 TRUE TRUE TRUE TRUEmmu_miR_300_002613 30.068 35.836 33.223 31.684 0.040 NA 0.741 0.400 TRUEFALSE TRUE TRUE mmu_miR_301a_000528 24.988 24.431 24.259 24.762 0.6670.598 0.447 0.543 TRUE TRUE TRUE TRUE mmu_miR_301b_002600 23.806 23.23324.592 23.643 0.566 0.492 0.784 0.440 TRUE TRUE TRUE TRUEmmu_miR_302a_000529 26.452 28.091 29.988 31.762 0.069 0.361 0.753 0.967TRUE TRUE TRUE TRUE mmu_miR_302a_002615 36.954 35.943 37.319 37.084 NANA 0.697 NA FALSE FALSE TRUE FALSE mmu_miR_302b_000531 36.591 34.48236.252 34.708 NA NA 0.752 0.228 FALSE FALSE TRUE TRUEmmu_miR_302b_001307 39.525 39.366 39.773 39.983 NA NA 0.576 NA FALSEFALSE TRUE FALSE mmu_miR_302c_002557 37.155 40.917 40.494 40.085 0.050NA NA NA TRUE FALSE TRUE FALSE mmu_miR_302c_002558 36.032 37.229 38.70037.763 NA NA 0.887 NA FALSE FALSE TRUE FALSE mmu_miR_302d_000535 34.90536.994 34.892 37.028 NA NA 0.327 0.794 FALSE FALSE TRUE TRUEmmu_miR_30a_000417 21.643 20.660 21.029 21.372 0.683 0.513 0.505 0.555TRUE TRUE TRUE TRUE mmu_miR_30b_000602 17.560 17.349 17.415 17.264 0.6190.638 0.553 0.455 TRUE TRUE TRUE TRUE mmu_miR_30b_002498 36.136 34.54236.464 37.099 NA NA 0.644 NA FALSE FALSE TRUE FALSE mmu_miR_30c_00041917.295 17.157 16.745 16.935 0.644 0.669 0.472 0.472 TRUE TRUE TRUE TRUEmmu_miR_30d_000420 24.417 22.754 23.617 24.391 0.698 0.361 0.500 0.685TRUE TRUE TRUE TRUE mmu_miR_30e_002223 21.865 20.533 21.461 21.738 0.6690.408 0.566 0.606 TRUE TRUE TRUE TRUE mmu_miR_31_000185 25.113 24.57825.846 26.116 NA 0.405 NA NA FALSE TRUE FALSE FALSE mmu_miR_31_00249526.718 27.680 28.770 27.077 0.308 0.645 0.891 0.398 TRUE TRUE TRUE TRUEmmu_miR_320_002277 21.617 19.602 22.107 21.161 0.687 0.243 0.811 0.493TRUE TRUE TRUE TRUE mmu_miR_322_001059 32.711 27.863 28.295 29.519 NA0.251 0.311 0.512 FALSE TRUE TRUE TRUE mmu_miR_322_001076 34.886 26.81629.866 27.636 NA 0.136 0.672 0.174 FALSE TRUE TRUE TRUEmmu_miR_322_002506 35.754 28.144 29.024 29.855 NA 0.188 0.334 0.470FALSE TRUE TRUE TRUE mmu_miR_323_3p_002227 25.679 34.949 28.564 24.9740.208 0.999 0.703 0.047 TRUE TRUE TRUE TRUE mmu_miR_324_3p_002509 28.00025.700 28.198 25.696 0.823 0.351 0.857 0.152 TRUE TRUE TRUE TRUEmmu_miR_324_5p_000539 26.356 24.861 25.898 25.099 0.789 0.473 0.6550.331 TRUE TRUE TRUE TRUE mmu_miR_325_001060 34.452 30.685 25.031 30.002NA 0.653 0.020 0.436 FALSE TRUE TRUE TRUE mmu_miR_325_002510 25.98327.615 27.307 25.724 0.423 0.783 0.754 0.274 TRUE TRUE TRUE TRUEmmu_miR_326_001061 36.939 28.374 35.872 35.442 NA 0.000 0.714 0.570FALSE TRUE TRUE TRUE mmu_miR_327_002481 39.083 40.737 40.499 39.740 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_328_000543 19.844 20.826 20.75220.004 0.422 0.730 0.681 0.440 TRUE TRUE TRUE TRUE mmu_miR_329_00019225.077 30.111 27.321 25.846 0.131 0.935 0.704 0.344 TRUE TRUE TRUE TRUEmmu_miR_32_002109 31.024 27.794 23.494 32.717 0.763 0.356 0.019 0.989TRUE TRUE TRUE TRUE mmu_miR_330_001062 32.387 34.544 31.881 34.615 NA NA0.262 0.817 FALSE FALSE TRUE TRUE mmu_miR_330_002230 33.769 35.68733.609 32.897 0.585 NA 0.502 0.254 TRUE FALSE TRUE TRUEmmu_miR_331_3p_000545 21.121 21.839 23.389 22.266 0.227 0.556 0.8880.567 TRUE TRUE TRUE TRUE mmu_miR_331_5p_002233 26.447 30.018 24.23528.002 0.401 0.942 0.085 0.730 TRUE TRUE TRUE TRUE mmu_miR_335_3p_00218524.204 32.080 29.145 24.623 0.065 NA NA 0.157 TRUE FALSE FALSE TRUEmmu_miR_335_5p_000546 20.019 24.151 22.165 21.066 0.146 0.896 0.6990.422 TRUE TRUE TRUE TRUE mmu_miR_337_000193 24.808 27.742 26.572 25.8660.200 0.840 0.679 0.494 TRUE TRUE TRUE TRUE mmu_miR_337_3p_002532 24.33529.317 26.350 25.540 0.115 0.933 0.642 0.444 TRUE TRUE TRUE TRUEmmu_miR_337_5p_002515 22.502 24.118 22.776 24.779 0.274 0.729 0.3890.833 TRUE TRUE TRUE TRUE mmu_miR_338_3p_002252 27.975 23.944 25.10025.953 0.968 0.201 0.422 0.539 TRUE TRUE TRUE TRUE mmu_miR_339_3p_00253328.323 27.527 26.418 30.378 0.542 0.439 0.226 0.966 TRUE TRUE TRUE TRUEmmu_miR_339_5p_002257 30.435 26.331 29.808 28.775 0.891 0.081 0.7520.440 TRUE TRUE TRUE TRUE mmu_miR_340_3p_002259 23.365 23.616 23.57723.956 0.448 0.644 0.520 0.637 TRUE TRUE TRUE TRUE mmu_miR_340_5p_00225822.205 21.848 22.815 22.211 0.536 0.534 0.727 0.491 TRUE TRUE TRUE TRUEmmu_miR_342_3p_002260 21.321 23.880 21.751 20.813 0.490 0.873 0.5710.264 TRUE TRUE TRUE TRUE mmu_miR_342_5p_002527 30.184 36.101 30.72431.060 0.207 NA NA 0.478 TRUE FALSE FALSE TRUE mmu_miR_343_002483 40.79740.943 39.789 39.404 NA NA 0.457 NA FALSE FALSE TRUE FALSEmmu_miR_344_001063 28.289 26.961 29.952 26.321 0.680 0.410 0.969 0.108TRUE TRUE TRUE TRUE mmu_miR_345_001137 26.501 25.026 26.910 26.797 0.5670.297 0.717 0.667 TRUE TRUE TRUE TRUE mmu_miR_345_3p_002529 30.62630.462 32.136 32.339 0.300 0.381 0.752 0.804 TRUE TRUE TRUE TRUEmmu_miR_345_5p_002528 29.401 26.673 30.028 28.619 0.744 0.158 0.8740.440 TRUE TRUE TRUE TRUE mmu_miR_346_001064 35.482 36.613 36.919 37.432NA NA 0.633 0.772 FALSE FALSE TRUE TRUE mmu_miR_34a_000426 18.255 23.34119.478 18.546 0.240 0.962 0.573 0.333 TRUE TRUE TRUE TRUEmmu_miR_34b_001065 30.158 32.933 33.550 32.506 0.078 0.716 0.860 0.586TRUE TRUE TRUE TRUE mmu_miR_34b_3p_002618 21.772 23.190 23.803 23.2800.200 0.668 0.783 0.610 TRUE TRUE TRUE TRUE mmu_miR_34b_5p_002617 29.44530.853 29.802 31.524 0.284 0.706 0.422 0.819 TRUE TRUE TRUE TRUEmmu_miR_34c_000428 24.217 26.464 28.795 25.613 0.108 0.618 NA 0.401 TRUETRUE FALSE TRUE mmu_miR_34c_002584 24.789 26.008 24.762 25.940 0.3720.762 0.395 0.698 TRUE TRUE TRUE TRUE mmu_miR_350_002530 27.855 24.20025.686 26.607 0.928 0.173 0.464 0.609 TRUE TRUE TRUE TRUEmmu_miR_351_001067 36.981 37.207 37.323 34.907 NA NA 0.735 0.094 FALSEFALSE TRUE TRUE mmu_miR_361_000554 22.743 23.747 26.542 23.436 0.2090.547 0.989 0.367 TRUE TRUE TRUE TRUE mmu_miR_362_3p_002616 26.20026.560 25.174 27.972 0.439 0.624 0.266 0.886 TRUE TRUE TRUE TRUEmmu_miR_362_5p_002614 27.713 26.227 29.748 27.733 0.493 0.239 0.9650.467 TRUE TRUE TRUE TRUE mmu_miR_363_001271 35.112 31.763 35.278 32.752NA 0.188 NA 0.216 FALSE TRUE FALSE TRUE mmu_miR_365_001020 26.691 21.52027.434 25.577 0.809 0.013 0.928 0.460 TRUE TRUE TRUE TRUEmmu_miR_367_000555 24.098 21.615 22.812 22.630 0.884 0.337 0.572 0.430TRUE TRUE TRUE TRUE mmu_miR_369_3p_000557 25.252 30.681 26.357 25.0510.309 0.979 0.575 0.211 TRUE TRUE TRUE TRUE mmu_miR_369_5p_001021 27.34633.699 27.481 29.284 0.158 0.986 0.229 0.638 TRUE TRUE TRUE TRUEmmu_miR_370_001068 36.845 36.916 37.275 38.519 NA NA 0.529 0.846 FALSEFALSE TRUE TRUE mmu_miR_370_002275 27.812 37.320 30.071 25.383 0.3221.000 NA 0.005 TRUE TRUE FALSE TRUE mmu_miR_374_002043 35.888 35.94931.764 38.675 NA NA 0.049 0.985 FALSE FALSE TRUE TRUEmmu_miR_374_5p_001319 28.990 24.221 24.822 25.278 0.990 0.286 0.3750.417 TRUE TRUE TRUE TRUE mmu_miR_375_000564 27.239 30.166 30.012 27.3780.228 NA NA 0.249 TRUE FALSE FALSE TRUE mmu_miR_376a_001069 20.51126.028 22.102 20.927 0.179 0.972 0.609 0.322 TRUE TRUE TRUE TRUEmmu_miR_376a_002482 26.417 32.304 28.456 26.618 0.170 0.976 0.682 0.222TRUE TRUE TRUE TRUE mmu_miR_376b_002451 22.440 26.856 27.602 22.3680.172 0.824 NA 0.136 TRUE TRUE FALSE TRUE mmu_miR_376b_002452 24.91433.500 27.221 25.424 0.103 0.998 0.632 0.238 TRUE TRUE TRUE TRUEmmu_miR_376c_002450 21.249 24.932 23.650 22.212 0.145 0.866 0.757 0.407TRUE TRUE TRUE TRUE mmu_miR_376c_002523 38.621 40.718 38.370 38.7320.459 NA 0.393 0.491 TRUE FALSE TRUE TRUE mmu_miR_377_000566 32.71034.245 34.053 33.271 0.315 NA 0.703 0.477 TRUE FALSE TRUE TRUEmmu_miR_379_001138 21.972 26.362 26.134 22.919 0.090 0.854 0.899 0.278TRUE TRUE TRUE TRUE mmu_miR_380_3p_001071 30.254 35.033 33.354 31.9180.064 NA 0.760 0.435 TRUE FALSE TRUE TRUE mmu_miR_380_5p_002601 23.58930.331 25.748 25.525 0.051 0.978 0.552 0.512 TRUE TRUE TRUE TRUEmmu_miR_381_000571 28.445 33.389 26.658 28.385 0.491 0.983 0.128 0.459TRUE TRUE TRUE TRUE mmu_miR_382_000572 20.937 29.384 24.871 19.561 0.2370.991 0.768 0.019 TRUE TRUE TRUE TRUE mmu_miR_383_001767 22.534 29.97525.067 23.078 0.094 NA 0.684 0.231 TRUE FALSE TRUE TRUEmmu_miR_384_3p_002603 23.280 25.392 24.325 23.128 0.417 0.826 0.6740.316 TRUE TRUE TRUE TRUE mmu_miR_384_5p_002602 18.262 21.020 19.03318.127 0.411 0.871 0.603 0.325 TRUE TRUE TRUE TRUE mmu_miR_409_3p_00233221.286 26.031 24.446 22.315 0.093 0.902 0.808 0.323 TRUE TRUE TRUE TRUEmmu_miR_409_5p_002331 26.908 35.390 30.555 28.663 0.022 NA 0.703 0.329TRUE FALSE TRUE TRUE mmu_miR_410_001274 19.898 25.075 22.390 19.9820.173 0.948 0.761 0.194 TRUE TRUE TRUE TRUE mmu_miR_411_001610 20.42924.068 22.266 20.705 0.250 0.893 0.717 0.298 TRUE TRUE TRUE TRUEmmu_miR_412_002575 25.523 34.189 25.255 25.460 0.332 0.999 0.273 0.333TRUE TRUE TRUE TRUE mmu_miR_423_5p_002340 30.360 27.126 28.185 29.6170.900 0.212 0.410 0.669 TRUE TRUE TRUE TRUE mmu_miR_425_001516 21.12322.834 16.568 25.320 0.453 0.737 0.016 0.986 TRUE TRUE TRUE TRUEmmu_miR_429_001077 33.809 36.377 34.473 36.700 0.205 NA 0.404 0.830 TRUEFALSE TRUE TRUE mmu_miR_431_001979 32.503 34.726 30.760 27.887 0.7600.951 0.473 0.006 TRUE TRUE TRUE TRUE mmu_miR_432_241135_mat 38.49037.084 35.029 36.021 NA NA 0.225 0.353 FALSE FALSE TRUE TRUEmmu_miR_433_001028 20.259 25.289 21.589 20.396 0.256 0.957 0.604 0.289TRUE TRUE TRUE TRUE mmu_miR_433_5p_001078 30.228 32.245 26.982 30.8850.553 0.911 0.070 0.686 TRUE TRUE TRUE TRUE mmu_miR_434_3p_002604 18.24323.286 19.240 18.182 0.308 0.969 0.559 0.264 TRUE TRUE TRUE TRUEmmu_miR_434_5p_002581 24.430 31.736 26.828 24.087 0.203 0.991 0.7030.096 TRUE TRUE TRUE TRUE mmu_miR_448_001029 28.223 36.293 30.417 27.6350.245 NA 0.669 0.070 TRUE FALSE TRUE TRUE mmu_miR_449a_001030 27.14230.045 25.134 28.069 0.461 0.924 0.121 0.668 TRUE TRUE TRUE TRUEmmu_miR_449b_001667 29.405 33.682 28.480 31.605 0.268 0.948 0.155 0.744TRUE TRUE TRUE TRUE mmu_miR_449b_002539 40.727 40.899 40.619 39.597 NANA NA NA FALSE FALSE TRUE FALSE mmu_miR_450B_3P_00263_2 35.959 33.05430.636 33.766 NA 0.522 0.113 0.523 FALSE TRUE TRUE TRUEmmu_miR_450a_3p_00252_5 40.800 40.976 40.660 39.599 NA NA NA NA FALSEFALSE TRUE FALSE mmu_miR_450a_5p_00230_3 35.187 32.418 33.647 32.204 NA0.415 0.655 0.188 FALSE TRUE TRUE TRUE mmu_miR_450b_5p_00196_2 40.52540.670 40.489 39.589 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_451_001141 37.033 32.191 30.809 37.857 NA 0.191 0.087 0.966FALSE TRUE TRUE TRUE mmu_miR_452_001032 36.411 37.134 37.605 40.297 NANA 0.550 NA FALSE FALSE TRUE FALSE mmu_miR_453_002484 39.483 39.59539.828 39.597 NA NA 0.613 NA FALSE FALSE TRUE FALSE mmu_miR_455_00245534.584 27.062 30.417 30.333 NA 0.035 0.550 0.486 FALSE TRUE TRUE TRUEmmu_miR_463_002582 26.304 26.350 22.867 31.467 0.498 0.505 0.069 NA TRUETRUE TRUE FALSE mmu_miR_463_002662 38.057 34.632 30.192 36.726 NA NA0.026 NA FALSE FALSE TRUE FALSE mmu_miR_464_001081 40.237 40.439 40.28038.634 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_465C_5P_002654 30.46432.392 25.806 35.592 0.439 0.716 0.012 NA TRUE TRUE TRUE FALSEmmu_miR_465a_3p_002040 34.515 36.175 34.166 34.299 NA NA 0.424 0.430FALSE FALSE TRUE TRUE mmu_miR_465a_5p_001082 34.974 26.714 32.320 31.671NA 0.004 NA 0.481 FALSE TRUE FALSE TRUE mmu_miR_465b_5p_002485 30.42035.363 34.766 32.266 0.039 NA 0.869 0.383 TRUE FALSE TRUE TRUEmmu_miR_466E_5P_002718 30.162 27.858 24.607 31.113 0.774 0.408 0.0580.946 TRUE TRUE TRUE TRUE mmu_miR_466J_002817 35.226 28.322 32.50431.986 NA 0.021 0.642 0.471 FALSE TRUE TRUE TRUE mmu_miR_466a_3p_00258630.538 26.507 30.484 29.971 0.800 0.049 0.759 0.594 TRUE TRUE TRUE TRUEmmu_miR_466b_3_3p_002500 31.942 27.874 30.752 31.264 0.876 0.072 0.5820.660 TRUE TRUE TRUE TRUE mmu_miR_466d_5p_002534 35.029 38.645 32.54139.543 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_466g_241015_mat34.038 31.760 37.315 38.056 NA 0.042 0.866 0.953 FALSE TRUE TRUE TRUEmmu_miR_466h_002516 36.735 35.344 36.958 38.103 NA 0.256 0.590 0.882FALSE TRUE TRUE TRUE mmu_miR_466k_240990_mat 35.911 31.450 34.810 37.035NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_467F_002886 33.166 27.24425.592 32.470 NA 0.185 0.074 NA FALSE TRUE TRUE FALSEmmu_miR_467H_002809 33.764 29.697 34.739 33.705 NA 0.028 0.889 0.636FALSE TRUE TRUE TRUE mmu_miR_467a_001826 30.022 24.813 25.330 29.4060.955 0.121 0.235 0.805 TRUE TRUE TRUE TRUE mmu_miR_467a_002587 27.60323.878 28.942 26.271 0.763 0.070 0.967 0.344 TRUE TRUE TRUE TRUEmmu_miR_467b_001671 32.002 26.872 30.360 29.231 0.954 0.070 0.714 0.384TRUE TRUE TRUE TRUE mmu_miR_467b_001684 31.650 27.444 23.596 34.258 NA0.262 0.020 NA FALSE TRUE TRUE FALSE mmu_miR_467c_002517 34.187 27.76332.178 32.692 0.953 0.010 0.582 0.636 TRUE TRUE TRUE TRUEmmu_miR_467d_002518 32.355 29.522 31.398 32.574 0.724 0.161 0.522 0.802TRUE TRUE TRUE TRUE mmu_miR_467e_002568 29.762 26.215 26.113 29.7400.870 0.228 0.220 0.851 TRUE TRUE TRUE TRUE mmu_miR_467e_002569 39.17437.658 39.443 36.066 NA 0.484 0.855 0.067 FALSE TRUE TRUE TRUEmmu_miR_468_001085 40.269 40.531 40.150 36.928 NA NA NA NA FALSE FALSETRUE FALSE mmu_miR_469_001086 39.224 39.642 39.042 36.826 NA NA 0.651 NAFALSE FALSE TRUE FALSE mmu_miR_470_002588 38.923 38.435 39.442 39.595 NANA 0.659 NA FALSE FALSE TRUE FALSE mmu_miR_470_002589 34.203 31.33926.021 40.506 0.673 0.356 0.006 NA TRUE TRUE TRUE TRUEmmu_miR_471_002605 40.344 40.523 40.377 39.598 NA NA NA NA FALSE FALSETRUE FALSE mmu_miR_483_001291 37.285 35.015 34.326 38.790 NA NA 0.1950.966 FALSE FALSE TRUE TRUE mmu_miR_483_002560 36.869 36.615 37.23739.476 NA NA 0.509 NA FALSE FALSE TRUE FALSE mmu_miR_484_001821 22.32220.136 21.311 21.207 0.843 0.348 0.576 0.465 TRUE TRUE TRUE TRUEmmu_miR_485_3p_001943 21.149 25.388 22.849 22.303 0.154 0.910 0.6170.478 TRUE TRUE TRUE TRUE mmu_miR_486_001278 31.827 25.420 30.227 24.4280.970 0.192 0.839 0.048 TRUE TRUE TRUE TRUE mmu_miR_487b_001285 21.62726.731 22.936 22.429 0.183 0.958 0.551 0.423 TRUE TRUE TRUE TRUEmmu_miR_487b_001306 23.180 30.278 26.332 23.456 0.108 0.984 0.752 0.165TRUE TRUE TRUE TRUE mmu_miR_488_001659 28.771 28.129 29.898 29.135 0.4700.411 0.812 0.568 TRUE TRUE TRUE TRUE mmu_miR_488_002014 32.195 34.73736.969 36.800 0.052 NA 0.890 0.829 TRUE FALSE TRUE TRUEmmu_miR_489_001302 27.089 33.366 27.996 25.652 0.415 NA 0.588 0.047 TRUEFALSE TRUE TRUE mmu_miR_490_001037 31.465 36.157 30.035 29.794 0.637 NANA 0.157 TRUE FALSE FALSE TRUE mmu_miR_491_001630 24.874 29.530 28.83525.402 0.115 0.879 0.881 0.233 TRUE TRUE TRUE TRUE mmu_miR_493_00251934.511 36.255 33.004 33.016 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_494_001293 34.753 36.588 36.252 33.580 NA NA 0.805 0.103 FALSEFALSE TRUE TRUE mmu_miR_494_002365 31.658 31.997 30.406 29.946 0.7780.790 0.434 0.242 TRUE TRUE TRUE TRUE mmu_miR_495_001663 18.622 23.71820.524 18.665 0.227 0.952 0.696 0.215 TRUE TRUE TRUE TRUEmmu_miR_496_001953 33.201 34.770 31.100 29.598 0.789 NA NA 0.051 TRUEFALSE FALSE TRUE mmu_miR_497_001346 29.107 23.568 29.597 27.202 0.8610.017 NA 0.373 TRUE TRUE FALSE TRUE mmu_miR_499_001352 33.880 35.63134.285 35.037 0.314 NA 0.462 0.660 TRUE FALSE TRUE TRUEmmu_miR_500_002606 29.012 29.215 29.250 27.924 0.645 0.700 NA 0.240 TRUETRUE FALSE TRUE mmu_miR_501_001356 37.050 37.050 37.450 37.737 NA NA0.591 NA FALSE FALSE TRUE FALSE mmu_miR_501_3p_001651 27.999 27.67629.219 26.327 0.655 0.569 0.908 0.112 TRUE TRUE TRUE TRUEmmu_miR_503_002456 35.674 35.308 35.416 35.057 NA NA 0.565 0.393 FALSEFALSE TRUE TRUE mmu_miR_503_002536 35.491 31.627 33.805 33.992 NA 0.1390.568 0.540 FALSE TRUE TRUE TRUE mmu_miR_504_002084 34.407 35.651 33.90831.961 NA NA 0.578 0.072 FALSE FALSE TRUE TRUE mmu_miR_505_001655 37.36438.370 38.988 39.577 NA NA 0.670 NA FALSE FALSE TRUE FALSEmmu_miR_509_3p_002521 36.861 37.575 34.121 36.583 NA NA 0.150 0.561FALSE FALSE TRUE TRUE mmu_miR_509_5p_002520 36.180 40.548 40.305 38.916NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_511_002549 37.004 37.84138.555 39.656 NA NA 0.641 NA FALSE FALSE TRUE FALSEmmu_miR_532_3p_002355 24.847 23.964 22.996 24.388 0.774 0.604 0.3040.569 TRUE TRUE TRUE TRUE mmu_miR_532_5p_001518 23.624 21.738 22.50122.843 0.816 0.396 0.503 0.527 TRUE TRUE TRUE TRUE mmu_miR_539_00128622.424 27.391 26.557 23.046 0.096 0.889 0.879 0.233 TRUE TRUE TRUE TRUEmmu_miR_540_3p_001310 32.548 35.708 33.102 33.145 0.315 NA 0.498 0.499TRUE FALSE TRUE TRUE mmu_miR_540_5p_002561 29.978 35.672 32.671 31.3830.054 NA 0.708 0.409 TRUE FALSE TRUE TRUE mmu_miR_541_002562 26.45731.737 25.784 25.739 0.488 0.991 0.299 0.246 TRUE TRUE TRUE TRUEmmu_miR_542_3p_001284 35.613 32.934 35.172 33.911 NA 0.273 0.746 0.322FALSE TRUE TRUE TRUE mmu_miR_542_5p_002563 35.612 37.261 36.674 33.012NA NA 0.788 0.027 FALSE FALSE TRUE TRUE mmu_miR_543_001298 21.458 26.58922.913 21.577 0.239 0.962 0.623 0.271 TRUE TRUE TRUE TRUEmmu_miR_543_002376 20.323 25.773 22.272 20.621 0.179 0.963 0.679 0.255TRUE TRUE TRUE TRUE mmu_miR_544_002550 21.890 28.591 26.732 23.829 0.017NA NA 0.331 TRUE FALSE FALSE TRUE mmu_miR_546_001312 31.935 34.19327.745 36.252 NA NA 0.018 NA FALSE FALSE TRUE FALSE mmu_miR_547_00256426.138 27.187 28.096 25.517 0.449 0.696 NA 0.182 TRUE TRUE FALSE TRUEmmu_miR_551b_001535 26.945 27.292 24.796 27.345 0.610 0.756 0.189 0.698TRUE TRUE TRUE TRUE mmu_miR_574_3p_002349 30.890 25.042 26.552 26.3170.995 0.188 0.497 0.368 TRUE TRUE TRUE TRUE mmu_miR_582_3p_002567 32.07630.934 33.779 33.073 0.390 0.246 0.876 0.698 TRUE TRUE TRUE TRUEmmu_miR_582_5p_002566 28.701 29.070 29.917 28.437 0.490 0.644 0.8130.333 TRUE TRUE TRUE TRUE mmu_miR_590_5p_001984 37.534 37.840 37.75536.904 NA NA 0.620 0.325 FALSE FALSE TRUE TRUE mmu_miR_592_002017 27.35430.566 28.369 27.732 0.309 0.882 0.591 0.419 TRUE TRUE TRUE TRUEmmu_miR_598_002476 24.686 27.608 27.022 24.559 0.287 0.832 0.835 0.210TRUE TRUE TRUE TRUE mmu_miR_599_241117_mat 37.161 34.690 37.474 35.386NA 0.283 0.861 0.232 FALSE TRUE TRUE TRUE mmu_miR_615_3p_001960 28.54729.223 32.805 28.065 0.359 0.527 0.998 0.175 TRUE TRUE TRUE TRUEmmu_miR_615_5p_002353 38.761 38.892 39.278 38.865 NA NA 0.662 NA FALSEFALSE TRUE FALSE mmu_miR_652_002352 27.051 23.635 27.536 24.383 0.8430.193 0.929 0.167 TRUE TRUE TRUE TRUE mmu_miR_654_3p_002239 40.15040.294 40.254 39.223 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_654_5p_002522 40.354 40.524 40.388 39.672 NA NA NA NA FALSEFALSE TRUE FALSE mmu_miR_665_002607 34.066 35.858 34.916 32.957 0.534 NA0.716 0.143 TRUE FALSE TRUE TRUE mmu_miR_666_3p_002448 36.520 37.13536.562 39.885 NA NA 0.365 NA FALSE FALSE TRUE FALSEmmu_miR_666_5p_001952 30.140 35.696 32.684 31.593 0.059 NA 0.688 0.435TRUE FALSE TRUE TRUE mmu_miR_667_001949 21.751 26.723 24.269 21.9170.175 0.934 0.767 0.213 TRUE TRUE TRUE TRUE mmu_miR_668_001947 27.66931.073 29.300 27.434 0.339 0.890 0.724 0.208 TRUE TRUE TRUE TRUEmmu_miR_669C_002646 34.778 29.582 32.826 32.985 NA 0.046 0.593 0.559FALSE TRUE TRUE TRUE mmu_miR_669D_002808 34.298 30.155 34.051 33.7950.806 0.043 0.732 0.624 TRUE TRUE TRUE TRUE mmu_miR_669E_002774 36.53633.561 36.941 37.575 NA 0.071 0.702 0.865 FALSE TRUE TRUE TRUEmmu_miR_669G_002813 40.400 40.565 40.423 39.587 NA NA NA NA FALSE FALSETRUE FALSE mmu_miR_669H_5P_002906 34.460 35.317 36.314 34.848 NA NA0.856 0.430 FALSE FALSE TRUE TRUE mmu_miR_669a_001683 29.042 28.04930.063 30.180 0.420 0.300 0.746 0.778 TRUE TRUE TRUE TRUEmmu_miR_669l_121149_mat 34.317 29.902 34.264 33.931 NA 0.025 0.752 0.643FALSE TRUE TRUE TRUE mmu_miR_669m_121190_mat 29.699 28.157 27.789 31.7500.586 0.337 0.254 0.974 TRUE TRUE TRUE TRUE mmu_miR_669n_197143_mat34.800 30.775 33.800 34.005 NA 0.073 0.625 0.623 FALSE TRUE TRUE TRUEmmu_miR_669o_121176_mat 32.436 29.443 33.191 32.963 0.586 0.077 0.8100.751 TRUE TRUE TRUE TRUE mmu_miR_670_002020 32.716 28.377 26.694 31.199NA 0.283 0.108 0.710 FALSE TRUE TRUE TRUE mmu_miR_671_3p_002322 28.74727.118 27.966 29.041 0.655 0.344 0.483 0.756 TRUE TRUE TRUE TRUEmmu_miR_672_002327 24.410 33.554 29.922 23.538 0.183 0.985 NA 0.030 TRUETRUE FALSE TRUE mmu_miR_673_001954 22.449 23.321 18.775 27.082 NA NA0.043 NA FALSE FALSE TRUE FALSE mmu_miR_673_3p_002449 26.805 35.82024.527 29.511 0.253 NA 0.053 0.684 TRUE FALSE TRUE TRUEmmu_miR_674_001956 28.166 25.112 27.887 27.705 0.776 0.126 0.695 0.606TRUE TRUE TRUE TRUE mmu_miR_674_002021 34.540 27.577 27.210 31.675 0.9970.151 0.143 0.693 TRUE TRUE TRUE TRUE mmu_miR_675_3p_001941 35.41332.390 28.177 35.510 NA 0.411 0.026 0.890 FALSE TRUE TRUE TRUEmmu_miR_675_5p_001940 37.050 35.095 33.268 36.332 NA NA 0.153 0.646FALSE FALSE TRUE TRUE mmu_miR_676_001958 28.640 28.417 29.646 29.7280.389 0.442 0.713 0.722 TRUE TRUE TRUE TRUE mmu_miR_676_001959 28.48324.952 30.121 26.862 0.749 0.095 0.981 0.281 TRUE TRUE TRUE TRUEmmu_miR_677_001660 37.303 37.402 37.637 35.148 NA NA 0.746 0.092 FALSEFALSE TRUE TRUE mmu_miR_679_001662 37.078 34.383 35.587 38.860 NA NA0.401 0.970 FALSE FALSE TRUE TRUE mmu_miR_680_001664 38.404 34.10933.469 34.865 NA 0.385 0.224 0.446 FALSE TRUE TRUE TRUEmmu_miR_682_001666 33.216 35.557 32.287 38.360 NA NA 0.172 0.988 FALSEFALSE TRUE TRUE mmu_miR_683_001668 38.963 37.814 39.189 37.954 NA NA0.748 NA FALSE FALSE TRUE FALSE mmu_miR_684_001669 40.800 40.976 40.66039.599 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_685_001670 32.87835.470 35.005 40.913 0.080 0.478 0.492 NA TRUE TRUE TRUE FALSEmmu_miR_686_001672 40.863 38.311 40.736 39.560 NA NA NA NA FALSE FALSETRUE FALSE mmu_miR_687_001674 39.989 39.280 40.194 39.568 NA NA NA NAFALSE FALSE FALSE FALSE mmu_miR_688_001675 38.490 40.710 36.581 39.679NA NA 0.145 NA FALSE FALSE TRUE FALSE mmu_miR_690_001677 38.523 38.41539.023 39.682 NA NA 0.591 NA FALSE FALSE TRUE FALSE mmu_miR_691_00167836.677 38.815 31.505 38.336 NA NA 0.015 NA FALSE FALSE TRUE FALSEmmu_miR_692_001679 40.794 40.381 36.138 37.213 NA NA 0.126 0.265 FALSEFALSE TRUE TRUE mmu_miR_693_001680 37.646 37.043 32.245 37.684 NA 0.7260.037 0.732 FALSE TRUE TRUE TRUE mmu_miR_693_3p_002036 40.395 39.66834.766 39.556 NA NA 0.041 NA FALSE FALSE TRUE FALSE mmu_miR_694_00168131.451 30.650 26.077 37.038 NA NA 0.020 NA FALSE FALSE TRUE FALSEmmu_miR_695_001627 38.256 39.781 35.674 38.668 NA NA 0.124 NA FALSEFALSE TRUE FALSE mmu_miR_696_001628 36.609 32.104 27.580 37.553 0.8430.290 0.012 0.973 TRUE TRUE TRUE TRUE mmu_miR_697_001631 36.200 35.92340.046 38.002 0.195 0.259 NA 0.646 TRUE TRUE TRUE TRUEmmu_miR_698_001632 40.328 40.366 40.363 39.643 NA NA NA NA FALSE FALSEFALSE FALSE mmu_miR_700_001634 26.172 25.761 28.528 25.500 0.503 0.4670.978 0.207 TRUE TRUE TRUE TRUE mmu_miR_701_001635 31.771 29.862 32.81833.616 0.417 0.129 0.729 0.914 TRUE TRUE TRUE TRUE mmu_miR_702_00163630.963 35.116 31.276 32.756 0.211 0.925 0.323 0.674 TRUE TRUE TRUE TRUEmmu_miR_704_001639 35.571 37.012 37.447 35.512 NA NA 0.849 0.298 FALSEFALSE TRUE TRUE mmu_miR_706_001641 32.189 33.896 32.173 40.404 0.2290.504 0.242 NA TRUE TRUE TRUE FALSE mmu_miR_707_001642 40.353 40.49640.419 39.590 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_708_00234124.115 22.834 24.270 23.436 0.711 0.429 0.714 0.401 TRUE TRUE TRUE TRUEmmu_miR_710_001645 33.815 35.216 36.312 38.961 0.103 0.400 0.665 NA TRUETRUE TRUE FALSE mmu_miR_711_001646 39.085 38.578 36.256 40.123 NA NA0.150 NA FALSE FALSE TRUE FALSE mmu_miR_712_001961 39.661 39.959 39.93137.770 NA NA 0.711 0.109 FALSE FALSE TRUE TRUE mmu_miR_712_002636 33.43132.443 25.894 34.968 0.681 0.609 0.005 0.961 TRUE TRUE TRUE TRUEmmu_miR_713_001648 39.497 39.231 38.729 40.164 NA NA 0.375 NA FALSEFALSE TRUE FALSE mmu_miR_715_001649 38.597 37.149 39.004 39.787 NA NA NANA FALSE FALSE FALSE FALSE mmu_miR_717_001652 41.436 34.738 35.05840.122 NA 0.105 0.179 NA FALSE TRUE TRUE FALSE mmu_miR_718_001656 35.00038.914 39.870 40.369 0.022 NA 0.774 NA TRUE FALSE TRUE FALSEmmu_miR_719_001673 39.496 39.436 39.653 37.089 NA NA 0.728 0.079 FALSEFALSE TRUE TRUE mmu_miR_720_001629 24.167 24.633 20.593 28.777 NA NA0.056 NA FALSE FALSE TRUE FALSE mmu_miR_721_001657 26.336 24.283 20.78131.059 0.648 0.346 0.034 1.000 TRUE TRUE TRUE TRUE mmu_miR_741_00245737.878 37.765 32.527 38.222 NA NA 0.033 0.761 FALSE FALSE TRUE TRUEmmu_miR_742_002038 38.576 36.894 39.163 39.500 NA NA 0.713 NA FALSEFALSE TRUE FALSE mmu_miR_742_002458 33.534 36.917 31.984 34.619 0.404 NA0.143 0.667 TRUE FALSE TRUE TRUE mmu_miR_743a_002469 29.264 32.39129.746 30.572 0.263 0.877 0.422 0.634 TRUE TRUE TRUE TRUEmmu_miR_743b_3p_002471 39.757 39.876 40.034 39.436 NA NA NA NA FALSEFALSE TRUE FALSE mmu_miR_743b_5p_002470 34.649 30.215 30.014 34.708 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_744_002324 24.023 25.380 24.18224.195 0.455 0.793 0.499 0.494 TRUE TRUE TRUE TRUE mmu_miR_758_00202535.957 36.206 35.942 32.714 NA NA 0.703 0.031 FALSE FALSE TRUE TRUEmmu_miR_759_002034 35.605 35.482 38.134 36.619 0.272 0.386 0.951 0.569TRUE TRUE TRUE TRUE mmu_miR_761_002030 37.353 36.994 33.659 38.451 NA NA0.098 0.881 FALSE FALSE TRUE TRUE mmu_miR_762_002028 35.244 35.63738.051 38.204 0.142 NA 0.852 NA TRUE FALSE TRUE FALSE mmu_miR_763_00203337.229 35.932 32.342 37.048 NA NA 0.075 NA FALSE FALSE TRUE FALSEmmu_miR_764_3p_002032 34.648 36.164 34.809 33.470 NA NA 0.593 0.191FALSE FALSE TRUE TRUE mmu_miR_764_5p_002031 32.356 34.427 33.719 30.8140.515 0.836 0.787 0.067 TRUE TRUE TRUE TRUE mmu_miR_767_241081_mat40.800 40.975 40.660 39.602 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_770_3p_002027 30.569 35.966 31.873 31.275 0.185 NA 0.546 0.400TRUE FALSE TRUE TRUE mmu_miR_770_5p_002608 32.645 35.829 34.391 32.8460.278 NA 0.725 0.308 TRUE FALSE TRUE TRUE mmu_miR_7a_000268 27.02730.847 23.932 25.453 0.722 NA 0.090 0.289 TRUE FALSE TRUE TRUEmmu_miR_7b_002555 27.123 32.566 24.728 26.755 0.545 0.995 0.093 0.405TRUE TRUE TRUE TRUE mmu_miR_802_002029 35.431 33.970 34.657 35.564 NA NA0.483 0.708 FALSE FALSE TRUE TRUE mmu_miR_804_002044 39.061 31.34832.156 36.554 NA 0.082 0.222 0.709 FALSE TRUE TRUE TRUEmmu_miR_805_002045 32.731 29.465 30.868 37.361 NA 0.088 0.348 NA FALSETRUE TRUE FALSE mmu_miR_871_002354 39.297 39.390 39.632 38.895 NA NA0.651 NA FALSE FALSE TRUE FALSE mmu_miR_872_002264 24.637 23.514 26.86524.808 0.438 0.288 0.967 0.470 TRUE TRUE TRUE TRUE mmu_miR_872_00254224.608 22.415 25.909 24.040 0.662 0.193 0.934 0.407 TRUE TRUE TRUE TRUEmmu_miR_873_002356 32.250 35.550 33.231 31.401 0.470 NA 0.663 0.141 TRUEFALSE TRUE TRUE mmu_miR_874_002268 38.004 37.796 38.534 39.585 NA NA0.582 NA FALSE FALSE TRUE FALSE mmu_miR_875_3p_002547 36.814 37.73334.232 39.656 NA NA 0.110 NA FALSE FALSE TRUE FALSEmmu_miR_876_3p_002464 36.338 38.484 37.176 38.533 NA NA 0.468 NA FALSEFALSE TRUE FALSE mmu_miR_876_5p_002463 36.405 38.658 38.726 36.765 0.238NA 0.846 0.336 TRUE FALSE TRUE TRUE mmu_miR_877_002548 23.304 19.70816.429 23.453 NA 0.323 0.046 NA FALSE TRUE TRUE FALSEmmu_miR_878_3p_002541 33.157 31.722 29.189 39.450 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_878_5p_002540 37.798 37.893 32.419 37.402 NANA 0.031 0.604 FALSE FALSE TRUE TRUE mmu_miR_879_002472 34.015 34.05534.827 34.343 NA NA 0.717 0.534 FALSE FALSE TRUE TRUE mmu_miR_879_00247328.646 28.606 27.363 27.211 0.780 0.746 0.423 0.310 TRUE TRUE TRUE TRUEmmu_miR_880_002665 35.770 29.151 33.468 38.671 NA 0.003 0.434 NA FALSETRUE TRUE FALSE mmu_miR_881_002475 38.590 38.635 33.232 39.302 NA NA0.027 0.808 FALSE FALSE TRUE TRUE mmu_miR_881_002609 34.675 37.06135.055 39.877 NA NA 0.317 NA FALSE FALSE TRUE FALSE mmu_miR_882_00261040.800 40.976 40.660 39.599 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_883B_5P_002669 34.843 35.469 32.374 38.205 0.454 0.598 0.1220.983 TRUE TRUE TRUE TRUE mmu_miR_883a_3p_002461 36.395 38.086 38.45737.598 NA NA 0.791 NA FALSE FALSE TRUE FALSE mmu_miR_883a_5p_00261140.646 40.806 40.576 39.599 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_883b_3p_002565 35.970 40.249 39.498 35.101 NA NA 0.883 0.057FALSE FALSE TRUE TRUE mmu_miR_92a_000430 19.851 20.028 17.119 22.1670.513 0.604 0.124 0.959 TRUE TRUE TRUE TRUE mmu_miR_92a_002496 40.48840.630 40.455 39.676 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_93_001090 23.262 21.456 24.556 22.792 0.633 0.245 0.922 0.407TRUE TRUE TRUE TRUE mmu_miR_96_000186 29.835 34.889 26.262 31.653 0.3670.980 0.034 0.727 TRUE TRUE TRUE TRUE mmu_miR_98_000577 28.720 31.65128.038 26.315 0.655 0.938 0.498 0.054 TRUE TRUE TRUE TRUEmmu_miR_99a_000435 21.378 18.906 19.610 21.071 0.822 0.290 0.405 0.710TRUE TRUE TRUE TRUE mmu_miR_99b_000436 23.084 21.118 23.632 23.366 0.5850.205 0.773 0.674 TRUE TRUE TRUE TRUE mmu_miR_9_000583 19.271 16.50018.698 18.273 0.825 0.213 0.676 0.496 TRUE TRUE TRUE TRUE log2FC_adj.p.value_ log2FC_ adj.p.value_ log2FC_ adj.p.value_ log2FC_adj.p.value_ log2FC_ adj.p.value_ log2FC_ adj.p.value_ ChATvs ChATvsChATvs ChATvs ChATvs ChATvs GFAPvs GFAPvs GFAPvs GFAPvs Lyz2vs Lyz2vsGFAP_sc GFAP_sc Lyz2_sc Lyz2_sc Syn_sc Syn_sc Lyz2_sc Lyz2_sc Syn_scSyn_sc Syn_sc Syn_sc hsa_let_7b_002404 4.141 0.299 0.388 0.957 5.1930.227 −3.753 0.324 1.052 0.794 4.805 0.184 hsa_let_7e_002407 −0.4700.836 −0.892 0.558 0.377 0.868 −0.422 0.810 0.847 0.501 1.269 0.318hsa_let_7f_1_002417 −0.464 0.945 1.065 0.767 −2.815 0.343 1.529 0.571−2.351 0.316 −3.880 0.095 hsa_let_7i_002172 −2.634 0.009 1.052 0.3631.708 0.159 3.686 0.000 4.342 0.000 0.656 0.563 hsa_miR_106b_002380−3.241 0.009 −0.830 0.616 −3.750 0.007 2.412 0.054 −0.509 0.714 −2.9200.022 hsa_miR_10a_002288 0.000 1.000 2.047 0.390 1.004 0.759 2.047 0.3671.004 0.659 −1.043 0.673 hsa_miR_1197_002810 3.498 0.031 1.984 0.2800.585 0.839 −1.514 0.401 −2.912 0.065 −1.399 0.434 hsa_miR_124_0021970.419 0.943 −0.041 0.986 1.842 0.501 −0.460 0.887 1.424 0.485 1.8830.366 hsa_miR_127_5p_002229 3.709 0.001 2.688 0.017 1.108 0.437 −1.0210.378 −2.600 0.011 −1.580 0.138 hsa_miR_136_000592 4.068 0.000 −1.6360.082 −0.325 0.836 −5.704 0.000 −4.393 0.000 1.312 0.138hsa_miR_136_002100 5.757 0.002 2.581 0.213 0.465 0.900 −3.175 0.093−5.292 0.004 −2.117 0.282 hsa_miR_140_3p_002234 −1.159 0.156 −0.7050.445 −0.930 0.360 0.454 0.639 0.229 0.794 −0.225 0.839hsa_miR_143_000466 0.540 0.961 −6.086 0.079 2.082 0.668 −6.626 0.0401.542 0.664 8.168 0.013 hsa_miR_144_002676 −0.092 0.975 0.735 0.3601.993 0.011 0.827 0.276 2.084 0.003 1.257 0.077 hsa_miR_148a_002134−2.995 0.190 1.136 0.728 1.832 0.548 4.131 0.056 4.827 0.022 0.696 0.814hsa_miR_149_002255 0.882 0.180 1.692 0.011 −0.436 0.633 0.810 0.216−1.318 0.029 −2.128 0.001 hsa_miR_151_5P_002642 −3.579 0.001 −4.5400.000 −0.953 0.517 −0.961 0.407 2.625 0.010 3.586 0.001hsa_miR_154_000478 4.422 0.000 1.627 0.192 1.520 0.279 −2.795 0.013−2.902 0.009 −0.107 0.948 hsa_miR_15b_002173 −0.557 0.969 −1.276 0.8554.206 0.437 −0.719 0.912 4.763 0.231 5.482 0.178 hsa_miR_183_0022706.072 0.003 −1.345 0.633 −0.318 0.927 −7.417 0.001 −6.390 0.002 1.0270.680 hsa_miR_189_000488 −1.039 0.907 −2.282 0.656 −3.323 0.521 −1.2430.813 −2.285 0.558 −1.041 0.841 hsa_miR_190b_002263 −0.575 0.835 −1.6890.298 1.847 0.309 −1.114 0.493 2.422 0.079 3.536 0.016hsa_miR_196a_241070_mat −2.212 0.054 0.106 0.968 −0.554 0.759 2.3190.042 1.658 0.136 −0.661 0.609 hsa_miR_200a_001011 −0.044 0.996 1.7390.298 1.733 0.367 1.783 0.258 1.777 0.229 −0.006 0.996hsa_miR_200b_001800 0.144 0.996 −1.084 0.815 2.691 0.478 −1.228 0.7462.548 0.373 3.776 0.183 hsa_miR_200b_002274 −0.219 0.996 −6.190 0.187−0.580 0.933 −5.971 0.173 −0.361 0.943 5.610 0.197 hsa_miR_200c_000505−0.584 0.853 −4.965 0.004 −0.585 0.836 −4.382 0.006 −0.001 0.999 4.3810.007 hsa_miR_200c_002286 0.090 0.994 0.417 0.860 0.268 0.914 0.3270.885 0.178 0.904 −0.149 0.937 hsa_miR_206_000510 −5.586 0.002 −6.8380.001 −2.901 0.182 −1.252 0.553 2.685 0.130 3.937 0.031hsa_miR_213_000516 −1.959 0.066 −0.994 0.420 −0.871 0.560 0.964 0.4081.087 0.313 0.123 0.934 hsa_miR_214_000517 −3.282 0.017 −2.251 0.141−0.656 0.768 1.031 0.517 2.626 0.052 1.595 0.275 hsa_miR_214_002293−1.663 0.239 0.563 0.787 1.978 0.205 2.226 0.089 3.641 0.004 1.415 0.303hsa_miR_218_2_002294 10.447 0.000 5.428 0.000 4.037 0.003 −5.019 0.000−6.410 0.000 −1.391 0.276 hsa_miR_223_000526 3.932 0.187 −8.698 0.0044.001 0.243 −12.630 0.000 0.068 0.986 12.698 0.000 hsa_miR_22_000398−1.043 0.774 −0.905 0.791 −0.141 0.974 0.138 0.968 0.902 0.707 0.7640.790 hsa_miR_22_002301 −0.088 0.987 0.078 0.968 1.305 0.205 0.165 0.9121.393 0.093 1.227 0.157 hsa_miR_23a_002439 −2.997 0.565 −10.445 0.0126.670 0.151 −7.449 0.054 9.667 0.011 17.115 0.000 hsa_miR_26b_002444−2.435 0.379 −3.583 0.174 1.764 0.610 −1.148 0.717 4.199 0.067 5.3470.026 hsa_miR_27a_002445 −1.365 0.647 0.874 0.788 2.493 0.346 2.2390.312 3.858 0.052 1.618 0.480 hsa_miR_27b_002174 −1.088 0.238 −0.8290.398 −0.695 0.561 0.259 0.840 0.393 0.676 0.134 0.913hsa_miR_28_3p_002446 1.086 0.716 1.407 0.558 0.604 0.868 0.321 0.918−0.482 0.822 −0.803 0.743 hsa_miR_299_5p_000600 2.085 0.534 1.561 0.6640.064 0.992 −0.524 0.911 −2.021 0.448 −1.497 0.608 hsa_miR_29a_002447−1.359 0.684 0.695 0.855 −1.749 0.568 2.054 0.392 −0.390 0.877 −2.4440.285 hsa_miR_29b_2_002166 1.391 0.736 −3.764 0.186 1.344 0.740 −5.1550.045 −0.046 0.988 5.109 0.048 hsa_miR_30a_3p_000416 −0.796 0.072 0.3130.578 −0.278 0.674 1.109 0.012 0.518 0.238 −0.591 0.187hsa_miR_30c_1_002108 −2.992 0.439 3.142 0.390 3.779 0.360 6.133 0.0546.771 0.028 0.637 0.895 hsa_miR_30c_2_002110 5.489 0.190 5.003 0.2627.777 0.095 −0.486 0.936 2.288 0.591 2.774 0.531 hsa_miR_30d_0023053.619 0.244 3.972 0.205 6.093 0.065 0.353 0.936 2.474 0.400 2.122 0.505hsa_miR_30e_3p_000422 −0.881 0.057 0.263 0.692 −0.071 0.927 1.144 0.0130.810 0.068 −0.334 0.513 hsa_miR_324__3p_000579 −5.280 0.010 −2.6730.254 −4.234 0.082 2.607 0.235 1.047 0.645 −1.560 0.505hsa_miR_338_000548 −3.535 0.055 −1.946 0.354 −1.623 0.529 1.590 0.4361.913 0.305 0.323 0.905 hsa_miR_338_5P_002658 −3.022 0.001 −2.785 0.004−1.851 0.074 0.236 0.873 1.171 0.183 0.935 0.323 hsa_miR_33a_002136−2.328 0.147 −1.379 0.445 −1.298 0.548 0.949 0.610 1.031 0.521 0.0810.971 hsa_miR_340_000550 −0.601 0.599 0.498 0.671 −0.183 0.912 1.0990.209 0.417 0.645 −0.681 0.462 hsa_miR_363_001283 1.107 0.841 −0.2410.970 −3.816 0.295 −1.348 0.728 −4.923 0.077 −3.575 0.233hsa_miR_376a_001287 6.962 0.000 2.238 0.072 1.216 0.441 −4.724 0.000−5.746 0.000 −1.022 0.421 hsa_miR_378_000567 −0.109 0.996 −3.504 0.0631.544 0.531 −3.395 0.054 1.652 0.361 5.047 0.005 hsa_miR_411_0022386.367 0.000 1.536 0.322 0.210 0.927 −4.830 0.001 −6.157 0.000 −1.3260.366 hsa_miR_412_001023 4.597 0.007 2.258 0.246 1.163 0.650 −2.3390.199 −3.434 0.042 −1.095 0.575 hsa_miR_421_002700 −0.179 0.889 1.0060.110 0.769 0.295 1.185 0.042 0.948 0.093 −0.236 0.752hsa_miR_423_3P_002626 −4.241 0.001 −1.713 0.232 −1.657 0.310 2.529 0.0502.584 0.039 0.055 0.976 hsa_miR_425_001104 −3.461 0.075 −2.767 0.192−0.739 0.830 0.694 0.799 2.722 0.146 2.028 0.318 hsa_miR_431_0023125.024 0.002 3.310 0.059 0.644 0.827 −1.714 0.333 −4.380 0.007 −2.6660.108 hsa_miR_455_001280 −5.364 0.001 −4.123 0.016 −1.960 0.340 1.2420.492 3.405 0.028 2.163 0.183 hsa_miR_485_5p_001036 0.011 0.998 0.0580.979 0.279 0.912 0.046 0.976 0.267 0.856 0.221 0.906hsa_miR_493_3p_001282 −9.065 0.046 −4.399 0.401 −3.619 0.571 4.666 0.3405.446 0.229 0.780 0.906 hsa_miR_590_3P_002677 0.357 0.690 0.092 0.939−1.300 0.061 −0.265 0.746 −1.657 0.005 −1.392 0.022 hsa_miR_653_0022923.470 0.318 −0.004 0.999 3.415 0.402 −3.475 0.296 −0.055 0.988 3.4200.289 hsa_miR_671_5p_197646_mat −1.207 0.889 −6.525 0.122 0.972 0.899−5.318 0.189 2.179 0.597 7.497 0.055 hsa_miR_708_002342 −0.048 0.996−0.137 0.972 −0.624 0.875 −0.089 0.974 −0.576 0.811 −0.487 0.874hsa_miR_744_002325 0.053 0.996 −0.512 0.728 0.158 0.924 −0.565 0.6400.106 0.926 0.670 0.539 hsa_miR_875_5p_002203 2.888 0.806 −5.315 0.48810.142 0.185 −8.203 0.220 7.254 0.259 15.457 0.017 hsa_miR_935_002178−1.443 0.572 −0.156 0.970 −1.636 0.539 1.287 0.562 −0.193 0.932 −1.4790.486 hsa_miR_93_002139 −2.914 0.003 −0.515 0.726 −1.137 0.367 2.3990.013 1.777 0.060 −0.622 0.570 hsa_miR_99b_002196 0.561 0.835 1.0840.542 0.887 0.679 0.524 0.796 0.327 0.838 −0.197 0.926 hsa_miR_9_002231−4.086 0.000 −1.177 0.011 −1.233 0.010 2.909 0.000 2.853 0.000 −0.0560.928 mmu_let_7a_000377 −3.703 0.011 2.938 0.063 −2.884 0.096 6.6420.000 0.819 0.600 −5.822 0.000 mmu_let_7a_002478 −7.397 0.169 −1.5460.871 2.421 0.768 5.851 0.289 9.818 0.048 3.966 0.488 mmu_let_7b_000378−2.070 0.000 −0.431 0.377 0.061 0.929 1.639 0.000 2.131 0.000 0.4920.271 mmu_let_7c_000379 −1.501 0.000 0.382 0.434 −0.146 0.842 1.8830.000 1.354 0.001 −0.529 0.218 mmu_let_7c_1002479 −3.489 0.299 −8.6810.007 −1.442 0.761 −5.193 0.085 2.046 0.512 7.239 0.017mmu_let_7d_001178 0.308 0.855 −2.515 0.006 −2.489 0.008 −2.823 0.001−2.797 0.001 0.026 0.983 mmu_let_7d_002283 −0.222 0.833 1.261 0.0280.047 0.963 1.483 0.007 0.269 0.650 −1.214 0.027 mmu_let_7e_002406−0.017 0.997 2.046 0.036 0.331 0.839 2.063 0.025 0.348 0.736 −1.7150.065 mmu_let_7f_000382 −2.629 0.459 −0.916 0.855 −3.873 0.279 1.7130.626 −1.244 0.696 −2.957 0.331 mmu_let_7g_002282 0.479 0.646 1.4000.067 0.712 0.462 0.920 0.219 0.233 0.777 −0.688 0.366 mmu_let_7g_0024924.689 0.002 2.429 0.141 2.502 0.163 −2.260 0.144 −2.187 0.136 0.0730.972 mmu_let_7i_002221 −2.076 0.000 0.674 0.248 −0.530 0.455 2.7500.000 1.546 0.003 −1.204 0.023 mmu_miR_100_000437 −2.738 0.000 −0.4120.654 −0.161 0.902 2.326 0.001 2.577 0.000 0.252 0.769mmu_miR_101a_002253 0.688 0.184 1.158 0.025 1.102 0.049 0.470 0.3830.414 0.412 −0.056 0.934 mmu_miR_101a_002507 −0.269 0.867 −0.294 0.823−1.421 0.117 −0.025 0.977 −1.152 0.129 −1.127 0.150 mmu_miR_101b_002531−0.309 0.757 1.326 0.036 −0.364 0.686 1.635 0.007 −0.055 0.940 −1.6900.006 mmu_miR_103_000439 −0.535 0.641 1.596 0.059 −0.057 0.971 2.1310.007 0.478 0.567 −1.653 0.038 mmu_miR_105_002465 1.454 0.907 −0.9450.924 8.561 0.162 −2.399 0.728 7.108 0.156 9.506 0.067mmu_miR_106a_002459 −4.282 0.062 1.429 0.651 −2.654 0.367 5.711 0.0121.627 0.493 −4.083 0.076 mmu_miR_106b_000442 −2.121 0.002 −1.250 0.084−0.887 0.301 0.871 0.220 1.234 0.061 0.363 0.646 mmu_miR_107_000443−0.104 0.994 −3.735 0.022 0.152 0.958 −3.631 0.018 0.256 0.883 3.8870.013 mmu_miR_10a_000387 −1.605 0.238 −0.353 0.882 −0.459 0.836 1.2520.359 1.146 0.373 −0.106 0.953 mmu_miR_10b_001181 −1.254 0.410 −0.5640.784 −1.296 0.456 0.690 0.669 −0.042 0.980 −0.732 0.614mmu_miR_10b_002218 0.177 0.983 2.564 0.146 −1.295 0.568 2.388 0.148−1.472 0.373 −3.859 0.018 mmu_miR_10b_002572 0.386 0.961 2.602 0.2980.962 0.795 2.215 0.359 0.576 0.818 −1.639 0.505 mmu_miR_1186_002825−1.382 0.813 −0.227 0.972 1.874 0.687 1.156 0.795 3.256 0.302 2.1000.544 mmu_miR_1188_002866 2.507 0.422 2.230 0.471 1.609 0.679 −0.2770.943 −0.898 0.759 −0.621 0.868 mmu_miR_1191_002892 −2.787 0.563 −7.9400.036 −1.050 0.875 −5.153 0.164 1.737 0.659 6.890 0.056mmu_miR_1192_002806 0.192 0.981 0.327 0.918 0.314 0.914 0.135 0.9570.122 0.950 −0.013 0.994 mmu_miR_1193_002794 1.645 0.017 2.175 0.0042.732 0.001 0.530 0.503 1.087 0.111 0.557 0.479 mmu_miR_1194_0027930.201 0.945 0.388 0.811 −0.225 0.906 0.187 0.912 −0.425 0.695 −0.6120.575 mmu_miR_1195_002839 −0.232 0.994 0.105 0.979 2.799 0.458 0.3370.936 3.031 0.285 2.694 0.366 mmu_miR_1198_002780 −1.510 0.063 1.5640.070 −2.152 0.016 3.074 0.000 −0.642 0.442 −3.716 0.000mmu_miR_1199_240984_mat 0.175 0.690 −0.141 0.754 −1.201 0.000 −0.3160.314 −1.377 0.000 −1.061 0.001 mmu_miR_1224_240985_mat 0.242 0.823−0.110 0.920 −1.896 0.003 −0.351 0.609 −2.138 0.000 −1.786 0.003mmu_miR_122_002245 −4.328 0.371 −9.685 0.027 1.533 0.836 −5.358 0.2165.860 0.145 11.218 0.008 mmu_miR_124_001182 4.801 0.000 1.499 0.172−0.379 0.830 −3.302 0.001 −5.180 0.000 −1.878 0.059mmu_miR_125a_3p_002199 0.413 0.890 −0.358 0.882 −0.371 0.884 −0.7710.653 −0.784 0.594 −0.013 0.994 mmu_miR_125a_5p_002198 0.578 0.262 1.4820.003 0.392 0.554 0.904 0.054 −0.186 0.726 −1.090 0.023mmu_miR_125b_002508 −0.543 0.690 1.197 0.238 0.902 0.464 1.740 0.0561.445 0.103 −0.295 0.813 mmu_miR_125b_3p_002378 −2.370 0.009 −2.9580.003 0.618 0.650 −0.588 0.598 2.988 0.001 3.576 0.000mmu_miR_125b_5p_000449 −0.857 0.077 −1.172 0.021 0.076 0.925 −0.3160.577 0.933 0.045 1.248 0.011 mmu_miR_126_3p_002228 3.110 0.000 −1.6400.002 1.498 0.005 −4.750 0.000 −1.612 0.001 3.138 0.000mmu_miR_126_5p_000451 3.376 0.000 −0.831 0.157 1.544 0.009 −4.207 0.000−1.833 0.001 2.374 0.000 mmu_miR_1274a_121150_mat 1.460 0.672 −4.1330.094 2.740 0.360 −5.593 0.015 1.280 0.600 6.873 0.004mmu_miR_127_000452 4.157 0.000 0.159 0.834 −0.357 0.561 −3.998 0.000−4.514 0.000 −0.516 0.255 mmu_miR_128a_002216 1.852 0.001 0.164 0.874−0.571 0.444 −1.687 0.003 −2.423 0.000 −0.735 0.192mmu_miR_129_3p_001184 2.203 0.000 0.841 0.184 −0.666 0.367 −1.362 0.017−2.868 0.000 −1.507 0.010 mmu_miR_129_5p_000590 2.630 0.017 2.780 0.020−0.093 0.963 0.150 0.936 −2.723 0.012 −2.873 0.012mmu_miR_1306_121155_mat 2.099 0.139 2.016 0.184 0.239 0.920 −0.082 0.968−1.860 0.162 −1.778 0.205 mmu_miR_130a_000454 −5.111 0.001 0.100 0.972−3.207 0.065 5.211 0.001 1.904 0.201 −3.307 0.029 mmu_miR_130b_000456−3.079 0.001 −2.119 0.024 −1.054 0.360 0.960 0.314 2.024 0.019 1.0650.252 mmu_miR_130b_002460 0.310 0.959 −6.598 0.001 −5.447 0.005 −6.9080.000 −5.757 0.001 1.152 0.551 mmu_miR_132_000457 3.880 0.000 −0.0050.994 −1.290 0.007 −3.885 0.000 −5.170 0.000 −1.285 0.004mmu_miR_133a_001637 2.015 0.273 1.958 0.298 −0.489 0.875 −0.057 0.976−2.504 0.126 −2.448 0.147 mmu_miR_133a_002246 7.326 0.000 2.060 0.0000.815 0.159 −5.266 0.000 −6.511 0.000 −1.245 0.012 mmu_miR_133b_0022477.800 0.000 1.816 0.184 1.703 0.256 −5.985 0.000 −6.097 0.000 −0.1130.948 mmu_miR_134_001186 4.975 0.000 1.373 0.138 −0.127 0.928 −3.6020.000 −5.102 0.000 −1.500 0.078 mmu_miR_135a_000460 −3.527 0.000 −1.3290.020 −2.443 0.000 2.199 0.000 1.084 0.038 −1.115 0.040mmu_miR_135b_002261 −2.949 0.003 0.879 0.454 −1.987 0.089 3.828 0.0000.962 0.347 −2.866 0.005 mmu_miR_136_002511 8.233 0.000 2.405 0.2380.261 0.929 −5.828 0.002 −7.972 0.000 −2.144 0.263 mmu_miR_136_0025120.290 0.975 −0.581 0.882 1.031 0.771 −0.871 0.780 0.741 0.769 1.6120.513 mmu_miR_137_001129 4.209 0.004 −0.562 0.826 0.884 0.699 −4.7720.002 −3.325 0.022 1.446 0.366 mmu_miR_138_002284 5.124 0.000 2.4470.000 1.125 0.099 −2.677 0.000 −3.998 0.000 −1.321 0.025mmu_miR_138_002554 3.745 0.001 1.965 0.084 0.500 0.768 −1.780 0.095−3.245 0.002 −1.465 0.176 mmu_miR_139_3p_002546 −0.578 0.952 −2.5370.487 −4.795 0.187 −1.959 0.589 −4.218 0.154 −2.258 0.505mmu_miR_139_5p_002289 2.803 0.000 −0.004 0.998 −0.462 0.699 −2.807 0.001−3.264 0.000 −0.457 0.608 mmu_miR_140_001187 −0.561 0.586 1.571 0.0510.005 0.995 2.132 0.005 0.566 0.474 −1.565 0.040 mmu_miR_141_0004631.205 0.867 −1.192 0.845 6.412 0.114 −2.397 0.553 5.207 0.126 7.6040.030 mmu_miR_141_002513 1.598 0.764 −0.677 0.918 5.367 0.159 −2.2750.538 3.768 0.238 6.044 0.060 mmu_miR_142_3p_000464 −0.776 0.823 −7.0050.001 4.637 0.025 −6.229 0.001 5.413 0.003 11.642 0.000mmu_miR_142_5p_002248 1.343 0.850 −3.859 0.353 5.552 0.202 −5.202 0.1634.210 0.244 9.412 0.011 mmu_miR_143_002249 −2.661 0.022 −2.608 0.0363.637 0.005 0.053 0.972 6.298 0.000 6.245 0.000 mmu_miR_145_002278−2.324 0.069 −3.235 0.017 4.184 0.003 −0.911 0.534 6.509 0.000 7.4200.000 mmu_miR_145_002514 −3.377 0.180 0.273 0.953 0.027 0.993 3.6500.134 3.404 0.143 −0.246 0.940 mmu_miR_146a_000468 0.407 0.469 −1.9110.000 3.111 0.000 −2.319 0.000 2.704 0.000 5.023 0.000mmu_miR_146b_001097 −0.796 0.084 −1.028 0.032 −0.675 0.217 −0.233 0.6910.121 0.814 0.354 0.486 mmu_miR_146b_002453 −0.660 0.936 −4.107 0.184−2.225 0.568 −3.446 0.238 −1.565 0.596 1.882 0.544 mmu_miR_147_0022622.127 0.617 6.481 0.043 11.332 0.001 4.353 0.163 9.205 0.002 4.852 0.113mmu_miR_148a_000470 −1.970 0.113 1.910 0.153 −0.749 0.679 3.880 0.0021.222 0.324 −2.659 0.029 mmu_miR_148b_000471 0.098 0.988 −0.931 0.415−0.200 0.914 −1.029 0.331 −0.298 0.790 0.730 0.505 mmu_miR_150_0004731.049 0.299 −3.081 0.002 3.363 0.001 −4.130 0.000 2.314 0.009 6.4450.000 mmu_miR_150_002570 −2.011 0.570 −6.503 0.020 −0.521 0.914 −4.4930.089 1.490 0.596 5.983 0.025 mmu_miR_151_3p_001190 −5.001 0.000 −0.7050.477 −2.276 0.014 4.296 0.000 2.725 0.001 −1.571 0.060mmu_miR_152_000475 −5.426 0.000 −3.600 0.000 −0.140 0.914 1.826 0.0095.286 0.000 3.460 0.000 mmu_miR_153_001191 3.399 0.007 −2.008 0.1530.232 0.917 −5.407 0.000 −3.167 0.011 2.240 0.082 mmu_miR_154_0004775.737 0.000 1.117 0.471 −1.186 0.517 −4.620 0.001 −6.923 0.000 −2.3030.080 mmu_miR_155_002571 −4.409 0.000 −4.876 0.000 2.289 0.027 −0.4680.695 6.697 0.000 7.165 0.000 mmu_miR_15a_000389 −2.134 0.087 0.7570.656 −0.566 0.771 2.891 0.018 1.568 0.195 −1.323 0.307mmu_miR_15a_002488 −1.864 0.017 −2.938 0.001 −0.443 0.721 −1.074 0.1971.421 0.065 2.495 0.003 mmu_miR_15b_000390 −1.930 0.000 −1.807 0.0010.184 0.826 0.122 0.873 2.114 0.000 1.991 0.000 mmu_miR_16_000391 −0.1550.855 −0.165 0.823 0.349 0.564 −0.009 0.983 0.505 0.241 0.514 0.253mmu_miR_16_002489 −3.736 0.002 −1.777 0.189 0.034 0.992 1.958 0.1143.770 0.002 1.811 0.143 mmu_miR_17_002308 −3.351 0.000 −1.123 0.190−2.019 0.020 2.228 0.004 1.332 0.075 −0.896 0.271 mmu_miR_17_002543−2.176 0.667 −2.059 0.664 4.063 0.360 0.117 0.976 6.239 0.059 6.1220.075 mmu_miR_181A_2_002687 −2.090 0.116 0.048 0.979 −0.853 0.657 2.1380.102 1.237 0.352 −0.902 0.533 mmu_miR_181a_000480 −2.436 0.000 −0.6540.316 −1.104 0.102 1.782 0.002 1.332 0.017 −0.450 0.486mmu_miR_181c_000482 −0.748 0.374 −1.086 0.174 −1.765 0.028 −0.338 0.726−1.018 0.145 −0.679 0.375 mmu_miR_182_002599 1.411 0.690 −0.383 0.933−0.055 0.992 −1.794 0.503 −1.466 0.558 0.328 0.926mmu_miR_1839_3p_1_2120_3_mat −0.375 0.835 2.313 0.021 0.335 0.841 2.6880.005 0.710 0.474 −1.978 0.038 mmu_miR_1839_5p_12113_5_mat −1.080 0.6411.854 0.302 −1.334 0.552 2.934 0.066 −0.254 0.887 −3.187 0.047mmu_miR_183_002269 4.285 0.013 −2.463 0.199 −0.251 0.929 −6.749 0.000−4.536 0.008 2.213 0.220 mmu_miR_184_000485 5.021 0.012 −0.328 0.9333.225 0.187 −5.349 0.009 −1.796 0.393 3.553 0.083 mmu_miR_185_0022713.024 0.003 3.368 0.003 −1.089 0.444 0.344 0.819 −4.112 0.000 −4.4560.000 mmu_miR_186_002285 −1.204 0.312 −0.842 0.511 −0.415 0.827 0.3620.812 0.789 0.474 0.428 0.752 mmu_miR_186_002574 −0.216 0.957 −2.3300.069 0.327 0.884 −2.114 0.079 0.543 0.682 2.657 0.027mmu_miR_187_001193 −5.563 0.000 −0.942 0.351 −5.026 0.000 4.621 0.0000.537 0.564 −4.084 0.000 mmu_miR_188_3p_002106 −0.210 0.941 0.518 0.6950.530 0.703 0.727 0.478 0.740 0.433 0.012 0.994 mmu_miR_188_5p_002320−1.688 0.357 −6.391 0.000 0.010 0.995 −4.703 0.003 1.698 0.288 6.4010.000 mmu_miR_1893_121170_mat −0.259 0.983 −0.400 0.932 −1.144 0.759−0.140 0.968 −0.885 0.737 −0.744 0.817 mmu_miR_1894_3p_241002_mat −0.1180.996 −3.743 0.293 5.302 0.159 −3.625 0.286 5.420 0.074 9.045 0.005mmu_miR_1894_5p_121144_mat −0.506 0.854 0.568 0.798 0.639 0.771 1.0740.493 1.145 0.424 0.071 0.971 mmu_miR_1896_121128_mat −1.592 0.823−3.039 0.508 6.210 0.167 −1.447 0.788 7.802 0.033 9.249 0.016mmu_miR_1897_3p_121126_mat 0.167 0.757 −0.113 0.844 −1.131 0.002 −0.2800.437 −1.298 0.000 −1.018 0.003 mmu_miR_1897_5p_121199_mat −0.413 0.945−4.607 0.035 3.400 0.167 −4.194 0.042 3.813 0.057 8.007 0.000mmu_miR_1898_121195_mat 0.184 0.748 −0.131 0.826 −1.307 0.001 −0.3150.415 −1.491 0.000 −1.176 0.002 mmu_miR_1899_121198_mat 0.095 0.9830.164 0.918 −0.470 0.717 0.069 0.958 −0.565 0.516 −0.634 0.496mmu_miR_18a_002422 0.121 0.988 0.203 0.933 0.110 0.963 0.082 0.968−0.011 0.995 −0.093 0.958 mmu_miR_18a_002490 −1.631 0.370 −1.945 0.267−1.043 0.650 −0.314 0.911 0.588 0.736 0.902 0.608 mmu_miR_18b_0024665.992 0.017 5.322 0.050 5.025 0.095 −0.670 0.873 −0.967 0.736 −0.2970.934 mmu_miR_1900_121143_mat 0.127 0.961 0.056 0.972 −0.749 0.487−0.071 0.952 −0.876 0.267 −0.805 0.330 mmu_miR_1901_121183_mat 0.2230.994 −0.892 0.882 1.648 0.743 −1.115 0.812 1.425 0.695 2.540 0.486mmu_miR_1902_121197_mat 0.161 0.820 −0.044 0.953 −0.990 0.016 −0.2050.658 −1.151 0.002 −0.946 0.012 mmu_miR_1903_121153_mat 0.657 0.9612.086 0.745 0.377 0.963 1.429 0.810 −0.280 0.955 −1.709 0.745mmu_miR_1904_121162_mat 1.439 0.040 −3.372 0.000 4.328 0.000 −4.8100.000 2.889 0.000 7.700 0.000 mmu_miR_1905_121196_mat 3.253 0.399 −3.7470.312 6.088 0.111 −7.000 0.033 2.835 0.400 9.835 0.004mmu_miR_1906_121169_mat −1.435 0.540 0.109 0.973 −0.298 0.924 1.5440.437 1.136 0.547 −0.408 0.874 mmu_miR_190_000489 −1.183 0.376 −2.1190.084 −0.586 0.742 −0.935 0.466 0.598 0.632 1.533 0.190mmu_miR_191_002299 −0.410 0.345 −0.071 0.922 −0.384 0.453 0.339 0.4140.026 0.955 −0.313 0.451 mmu_miR_191_002576 0.495 0.736 0.607 0.6161.543 0.159 0.112 0.936 1.047 0.255 0.936 0.334 mmu_miR_1927_121193_mat−0.829 0.823 0.400 0.918 0.279 0.929 1.229 0.605 1.108 0.596 −0.1220.964 mmu_miR_1928_121164_mat 0.373 0.961 −3.766 0.138 3.811 0.167−4.139 0.075 3.437 0.129 7.576 0.002 mmu_miR192_000491 −1.181 0.1691.790 0.038 −0.897 0.412 2.971 0.000 0.283 0.758 −2.688 0.002mmu_miR_1930_121201_mat 1.776 0.306 1.147 0.556 2.163 0.251 −0.629 0.7740.386 0.822 1.015 0.555 mmu_miR_1931_121168_mat 0.220 0.961 0.071 0.978−0.674 0.742 −0.149 0.939 −0.894 0.512 −0.745 0.615mmu_miR_1932_121172_mat −3.562 0.374 0.878 0.885 −0.191 0.978 4.4410.216 3.371 0.337 −1.069 0.817 mmu_miR_1933_3p_121145_mat 0.161 0.8900.019 0.979 −0.871 0.171 −0.142 0.873 −1.032 0.046 −0.889 0.099mmu_miR_1933_5p_121133_mat −5.671 0.385 −3.511 0.650 −0.819 0.929 2.1600.785 4.852 0.399 2.692 0.688 mmu_miR_1934_121185_mat 2.311 0.558 2.3890.506 2.155 0.619 0.077 0.982 −0.156 0.965 −0.234 0.956mmu_miR_1935_121192_mat 0.255 0.969 −0.047 0.985 −0.526 0.875 −0.3020.922 −0.781 0.703 −0.479 0.854 mmu_miR_1936_121158_mat 0.072 0.9960.479 0.840 0.837 0.677 0.407 0.840 0.765 0.595 0.358 0.850mmu_miR_937b_241023_mat 0.248 0.996 −3.117 0.792 4.159 0.721 −3.3660.740 3.911 0.631 7.277 0.362 mmu_miR_1937c_241011_mat 0.285 0.776−3.710 0.000 3.868 0.000 −3.995 0.000 3.583 0.000 7.578 0.000mmu_miR_1938_121194_mat 0.032 0.997 0.564 0.855 0.897 0.740 0.531 0.8370.864 0.643 0.333 0.898 mmu_miR_1939_121180_mat −0.699 0.936 1.062 0.8341.427 0.759 1.761 0.621 2.126 0.485 0.365 0.931 mmu_miR_193_002250−1.252 0.823 −2.085 0.579 1.070 0.836 −0.834 0.856 2.322 0.446 3.1550.307 mmu_miR193_002577 −2.553 0.001 −1.062 0.198 1.408 0.108 1.4900.046 3.961 0.000 2.471 0.002 mmu_miR193b_002467 −1.179 0.075 1.9860.005 1.129 0.151 3.165 0.000 2.307 0.001 −0.858 0.203mmu_miR_1940_121187_mat 1.227 0.767 2.295 0.426 0.461 0.916 1.067 0.754−0.766 0.788 −1.834 0.505 mmu_miR_1941_3p_121130_mat 0.026 0.996 0.5600.392 0.852 0.213 0.534 0.393 0.826 0.136 0.292 0.666mmu_miR_1941_5p_121140_mat −1.478 0.525 −1.189 0.616 −0.746 0.808 0.2880.924 0.732 0.714 0.443 0.861 mmu_miR_1942_121136_mat −1.701 0.885−4.811 0.440 2.994 0.716 −3.110 0.632 4.696 0.389 7.806 0.145mmu_miR_1943_121174_mat −2.786 0.004 −0.552 0.704 −0.083 0.963 2.2330.023 2.702 0.005 0.469 0.694 mmu_miR_1944_121189_mat −1.152 0.747 0.1870.970 −3.058 0.252 1.339 0.615 −1.906 0.399 −3.245 0.143mmu_miR_1945_121166_mat 0.098 0.979 0.540 0.600 0.642 0.561 0.442 0.6530.544 0.508 0.102 0.928 mmu_miR_1946a_121178_mat 0.759 0.941 0.936 0.8820.964 0.875 0.177 0.968 0.206 0.959 0.028 0.994 mmu_miR_1947_121156_mat−2.499 0.247 0.931 0.763 1.851 0.504 3.430 0.085 4.349 0.024 0.920 0.704mmu_miR_1948_121171_mat −0.315 0.964 1.954 0.406 0.573 0.876 2.269 0.3010.888 0.695 −1.381 0.542 mmu_miR_1949_121182_mat 0.207 0.907 0.099 0.948−0.525 0.626 −0.108 0.932 −0.733 0.327 −0.624 0.436 mmu_miR_194_000493−0.762 0.618 −2.406 0.036 −0.490 0.782 −1.644 0.140 0.272 0.822 1.9150.081 mmu_miR_1950_121146_mat −2.759 0.110 −0.945 0.703 −0.926 0.7261.815 0.314 1.833 0.283 0.019 0.994 mmu_miR_1951_121165_mat 0.450 0.9941.741 0.882 5.624 0.548 1.291 0.912 5.174 0.456 3.884 0.608mmu_miR_1952_121167_mat 0.170 0.764 −0.087 0.885 −1.082 0.004 −0.2560.502 −1.252 0.000 −0.995 0.004 mmu_miR_1953_121159_mat 0.071 0.9940.421 0.784 0.155 0.924 0.350 0.795 0.085 0.941 −0.266 0.842mmu_miR_1954_121137_mat 0.597 0.918 −2.586 0.314 7.237 0.004 −3.1840.174 6.640 0.003 9.823 0.000 mmu_miR_1956_121129_mat −1.865 0.806 2.8120.603 3.914 0.492 4.677 0.292 5.779 0.148 1.102 0.850mmu_miR_1957_121163_mat 0.175 0.690 −0.141 0.754 −1.201 0.000 −0.3160.314 −1.377 0.000 −1.061 0.001 mmu_miR_1958_121181_mat −2.992 0.1850.459 0.917 0.893 0.807 3.452 0.109 3.886 0.060 0.434 0.893mmu_miR_1959_121132_mat 0.923 0.690 −2.175 0.194 7.493 0.000 −3.0980.042 6.570 0.000 9.668 0.000 mmu_miR_195_000494 −3.548 0.000 −0.6500.354 −0.966 0.187 2.898 0.000 2.582 0.000 −0.317 0.663mmu_miR_1960_121148_mat −1.397 0.539 0.881 0.744 1.185 0.645 2.278 0.2112.582 0.128 0.305 0.905 mmu_miR_1961_197391_mat 0.801 0.945 −3.680 0.4348.359 0.071 −4.481 0.301 7.558 0.052 12.039 0.004mmu_miR_1962_121173_mat −0.370 0.886 0.087 0.972 −1.153 0.463 0.4580.780 −0.783 0.518 −1.240 0.310 mmu_miR_1963_121191_mat 0.175 0.690−0.141 0.754 −1.201 0.000 −0.316 0.314 −1.377 0.000 −1.061 0.001mmu_miR_1964_121138_mat −0.971 0.456 0.718 0.605 0.871 0.560 1.689 0.1141.841 0.071 0.152 0.923 mmu_miR_1965_121186_mat 0.130 0.846 −0.162 0.760−1.202 0.002 −0.292 0.443 −1.332 0.000 −1.040 0.004mmu_miR_1966_121134_mat 0.362 0.572 0.034 0.972 −1.658 0.002 −0.3270.553 −2.019 0.000 −1.692 0.001 mmu_miR_1967_121151_mat 0.178 0.835−0.129 0.882 −1.140 0.025 −0.307 0.560 −1.318 0.003 −1.011 0.027mmu_miR_1968_121179_mat −4.976 0.114 0.069 0.986 2.134 0.637 5.044 0.1047.110 0.017 2.065 0.547 mmu_miR_1969_121131_mat 0.136 0.994 −3.625 0.0713.576 0.105 −3.761 0.045 3.440 0.059 7.201 0.000 mmu_miR_196a_0024770.220 0.996 3.305 0.692 5.321 0.508 3.085 0.669 5.101 0.391 2.016 0.796mmu_miR_196b_002215 −1.705 0.456 2.604 0.199 0.070 0.984 4.309 0.0191.774 0.349 −2.535 0.181 mmu_miR_1970_121202_mat 3.328 0.270 0.134 0.979−1.939 0.629 −3.194 0.280 −5.268 0.048 −2.073 0.499mmu_miR_1971_121161_mat −5.039 0.129 −3.409 0.354 −3.363 0.442 1.6310.695 1.676 0.633 0.045 0.994 mmu_miR_197_000497 5.635 0.190 −0.8250.918 10.105 0.027 −6.459 0.118 4.470 0.280 10.929 0.009mmu_miR_1981_121200_mat 0.870 0.385 −0.876 0.369 −0.137 0.925 −1.7470.042 −1.008 0.240 0.739 0.431 mmu_miR_1982.1_121157_mat −2.220 0.106−3.256 0.022 −1.249 0.506 −1.036 0.495 0.970 0.487 2.007 0.139mmu_miR_1982.2_121154_mat 0.936 0.820 −2.690 0.265 −0.327 0.927 −3.6260.093 −1.263 0.579 2.363 0.294 mmu_miR_199a_3p_ 002304 −5.629 0.000−7.529 0.000 −3.536 0.027 −1.900 0.204 2.093 0.134 3.993 0.007mmu_miR_199a_5p_000498 0.824 0.835 0.712 0.845 −0.800 0.830 −0.113 0.968−1.624 0.448 −1.512 0.510 mmu_miR_199b_001131 0.014 0.998 1.992 0.3601.256 0.657 1.979 0.334 1.242 0.535 −0.737 0.766 mmu_miR_19a_000395−2.883 0.000 −2.740 0.000 −0.305 0.742 0.143 0.885 2.578 0.000 2.4350.000 mmu_miR_19a_002544 0.121 0.936 0.213 0.791 −0.383 0.603 0.0920.912 −0.504 0.329 −0.596 0.259 mmu_miR_19b_000396 −3.279 0.000 −1.6830.027 −1.550 0.063 1.596 0.026 1.729 0.013 0.133 0.903 mmu_miR_1_0022223.831 0.023 1.392 0.502 1.272 0.610 −2.438 0.167 −2.559 0.126 −0.1200.960 mmu_miR_1_2_AS_002882 −3.088 0.484 −4.200 0.293 1.722 0.759 −1.1120.834 4.810 0.162 5.922 0.098 mmu_miR_200a_000502 −1.466 0.715 −0.5770.911 2.654 0.444 0.889 0.810 4.120 0.098 3.231 0.221mmu_miR_200b_002251 −4.009 0.378 −2.162 0.706 3.936 0.456 1.847 0.7237.945 0.035 6.098 0.123 mmu_miR_200c_002300 −0.494 0.961 −0.469 0.933−0.951 0.855 0.025 0.992 −0.457 0.887 −0.482 0.906 mmu_miR_201_002578−0.139 0.994 0.300 0.943 0.583 0.875 0.438 0.905 0.721 0.754 0.283 0.926mmu_miR_202_3p_001195 1.468 0.774 −4.312 0.193 4.378 0.230 −5.780 0.0542.910 0.347 8.690 0.005 mmu_miR_202_5p_002579 −0.069 0.996 0.066 0.9791.495 0.519 0.135 0.959 1.564 0.355 1.429 0.429 mmu_miR_203_000507−7.272 0.002 −6.233 0.012 −4.873 0.067 1.039 0.741 2.399 0.307 1.3600.606 mmu_miR_203_002580 −4.173 0.153 0.494 0.927 1.000 0.839 4.6670.097 5.173 0.056 0.506 0.904 mmu_miR_204_000508 −3.795 0.000 −1.5090.008 −0.087 0.924 2.286 0.000 3.708 0.000 1.422 0.009mmu_miR_205_000509 0.005 1.000 −6.973 0.019 −4.539 0.171 −6.978 0.012−4.544 0.092 2.434 0.424 mmu_miR_207_001198 0.238 0.944 0.250 0.915−0.837 0.613 0.012 0.991 −1.075 0.356 −1.087 0.368 mmu_miR_208_0005113.037 0.649 −3.823 0.487 −2.379 0.741 −6.859 0.144 −5.415 0.237 1.4440.817 mmu_miR_208b_002290 −0.719 0.957 −2.870 0.558 3.480 0.521 −2.1510.661 4.199 0.288 6.351 0.107 mmu_miR_20a_000580 −2.949 0.000 −3.0090.000 −1.470 0.032 −0.059 0.948 1.479 0.013 1.539 0.013mmu_miR_20a_002491 0.400 0.943 −1.959 0.360 −0.333 0.920 −2.358 0.233−0.732 0.727 1.626 0.429 mmu_miR_20b_001014 −3.923 0.012 −2.550 0.141−1.544 0.473 1.374 0.435 2.380 0.125 1.006 0.571 mmu_miR_20b_0025243.495 0.088 3.380 0.123 2.918 0.233 −0.115 0.968 −0.577 0.799 −0.4620.874 mmu_miR_210_000512 −9.700 0.000 −5.759 0.000 −5.582 0.001 3.9400.005 4.117 0.003 0.177 0.931 mmu_miR_211_001199 −1.515 0.907 −0.9310.930 −0.077 0.993 0.584 0.941 1.438 0.814 0.854 0.913mmu_miR_212_002551 4.763 0.000 2.609 0.024 −1.577 0.236 −2.154 0.049−6.340 0.000 −4.186 0.000 mmu_miR_2134_241120_mat 0.996 0.687 −3.9640.020 4.988 0.005 −4.961 0.002 3.991 0.011 8.952 0.000mmu_miR_2135_241140_mat −1.092 0.961 −7.661 0.319 0.929 0.933 −6.5690.380 2.021 0.793 8.590 0.220 mmu_miR_2136_241133_mat −1.565 0.941−2.265 0.855 −0.523 0.970 −0.700 0.948 1.042 0.893 1.742 0.861mmu_miR_2138_241080_mat 0.531 0.961 −5.369 0.123 6.687 0.071 −5.9000.066 6.155 0.048 12.055 0.001 mmu_miR_2139_241130_mat 0.071 0.996 0.4630.882 1.657 0.464 0.392 0.887 1.586 0.355 1.194 0.523mmu_miR_2146_241082_mat −1.079 0.885 −4.096 0.279 2.655 0.579 −3.0170.415 3.734 0.271 6.751 0.046 mmu_miR_214_002306 −1.889 0.256 −0.4250.882 0.097 0.974 1.464 0.382 1.986 0.183 0.522 0.799 mmu_miR_215_001200−1.162 0.690 −6.341 0.003 −0.043 0.992 −5.179 0.008 1.120 0.592 6.2990.002 mmu_miR_216a_002220 4.735 0.001 −2.118 0.190 0.573 0.827 −6.8530.000 −4.162 0.004 2.691 0.068 mmu_miR_216b_002326 10.332 0.000 0.1720.955 0.616 0.822 −10.159 0.000 −9.716 0.000 0.443 0.838mmu_miR_217_001133 5.514 0.001 3.502 0.047 2.509 0.209 −2.012 0.254−3.006 0.061 −0.993 0.599 mmu_miR_217_002556 5.231 0.000 0.135 0.9612.444 0.110 −5.097 0.000 −2.787 0.028 2.310 0.080mmu_miR_2182_241119_mat 0.919 0.882 2.530 0.445 5.709 0.082 1.611 0.6454.791 0.077 3.179 0.281 mmu_miR_2183_241095_mat 0.244 0.983 −3.668 0.1216.044 0.013 −3.912 0.073 5.800 0.007 9.712 0.000 mmu_miR_218_0005217.436 0.000 3.821 0.000 2.330 0.000 −3.615 0.000 −5.105 0.000 −1.4900.003 mmu_miR_218_1_002552 5.499 0.000 1.113 0.401 0.299 0.891 −4.3860.000 −5.201 0.000 −0.815 0.525 mmu_miR_219_000522 −6.044 0.000 −2.0640.075 −4.608 0.000 3.980 0.000 1.437 0.175 −2.543 0.020mmu_miR_21_000397 −1.442 0.076 −2.587 0.003 0.723 0.521 −1.145 0.1692.165 0.006 3.310 0.000 mmu_miR_21_002493 −0.033 0.996 0.365 0.882 1.5890.355 0.398 0.840 1.622 0.216 1.224 0.387 mmu_miR_220_002468 0.190 0.736−0.100 0.882 −1.065 0.006 −0.289 0.460 −1.255 0.000 −0.965 0.007mmu_miR_221_000524 −2.920 0.000 −0.734 0.112 −1.199 0.012 2.186 0.0001.721 0.000 −0.465 0.303 mmu_miR_222_002276 −0.473 0.156 −1.340 0.000−1.253 0.001 −0.867 0.007 −0.780 0.012 0.087 0.848 mmu_miR_223_002295−0.163 0.945 −10.692 0.000 4.655 0.000 −10.529 0.000 4.818 0.000 15.3470.000 mmu_miR_224_002553 −4.117 0.000 −2.791 0.014 −3.191 0.007 1.3260.235 0.926 0.399 −0.400 0.771 mmu_miR_23a_000399 −2.479 0.110 0.6580.786 1.397 0.508 3.137 0.038 3.876 0.009 0.739 0.682 mmu_miR_23b_0004000.698 0.599 1.135 0.298 0.730 0.603 0.437 0.740 0.032 0.980 −0.404 0.744mmu_miR_24_000402 0.083 0.889 −0.207 0.538 0.387 0.239 −0.290 0.3170.304 0.267 0.594 0.029 mmu_miR_24_2_002494 −2.101 0.010 −1.220 0.1840.744 0.521 0.882 0.322 2.846 0.001 1.964 0.020 mmu_miR_25_000403 −1.7540.157 3.844 0.003 1.255 0.437 5.598 0.000 3.009 0.009 −2.589 0.030mmu_miR_26a_000405 −1.051 0.003 0.399 0.329 −0.536 0.215 1.450 0.0000.515 0.143 −0.935 0.011 mmu_miR_26b_000407 −1.983 0.000 −0.981 0.030−0.101 0.903 1.001 0.019 1.881 0.000 0.880 0.042 mmu_miR_27a_000408−0.955 0.489 −1.130 0.369 2.818 0.024 −0.175 0.926 3.773 0.001 3.9480.001 mmu_miR_27b_000409 −1.401 0.009 −0.905 0.125 −0.590 0.417 0.4960.407 0.811 0.126 0.315 0.608 mmu_miR_28_000411 −0.251 0.967 −4.0110.027 2.816 0.170 −3.760 0.028 3.066 0.065 6.826 0.000 mmu_miR_28_002545−4.062 0.019 −4.730 0.012 −2.860 0.173 −0.668 0.790 1.202 0.512 1.8700.313 mmu_miR_290_000187 3.765 0.346 −1.864 0.715 2.503 0.621 −5.6290.107 −1.262 0.746 4.367 0.221 mmu_miR_290_3p_002591 0.172 0.732 −0.1050.850 −1.116 0.002 −0.278 0.426 −1.289 0.000 −1.011 0.002mmu_miR_290_5p_002590 −0.247 0.994 0.225 0.972 0.832 0.901 0.471 0.9351.079 0.785 0.607 0.905 mmu_miR_291_3p_001135 1.202 0.108 0.82' 0.321−0.046 0.974 −0.381 0.681 −1.248 0.076 −0.866 0.255mmu_miR_291_5p_001202 0.210 0.790 −0.119 0.882 −1.793 0.001 −0.330 0.520−2.003 0.000 −1.673 0.001 mmu_miR_291a_3p_002592 0.168 0.730 −0.1080.841 −1.127 0.001 −0.276 0.414 −1.295 0.000 −1.019 0.002mmu_miR_291b_3p_002538 0.136 0.935 0.091 0.933 −0.635 0.391 −0.045 0.959−0.771 0.158 −0.726 0.208 mmu_miR_291b_5p_002537 0.148 0.877 −0.7250.133 −1.196 0.015 −0.873 0.047 −1.344 0.002 −0.471 0.310mmu_miR_292_3p_001054 4.448 0.063 3.944 0.128 3.014 0.318 −0.505 0.906−1.435 0.568 −0.930 0.766 mmu_miR_292_3p_002593 −0.076 0.997 −5.4040.299 0.907 0.914 −5.329 0.284 0.983 0.851 6.312 0.182mmu_miR_292_5p_001055 7.043 0.122 6.376 0.192 3.322 0.608 −0.667 0.932−3.721 0.416 −3.054 0.537 mmu_miR_293_001794 3.441 0.586 6.383 0.2147.145 0.203 2.942 0.600 3.704 0.444 0.762 0.910 mmu_miR_293_002594 0.1510.991 0.282 0.932 0.434 0.891 0.130 0.960 0.282 0.881 0.152 0.948mmu_miR_294_001056 −1.483 0.828 3.402 0.415 4.580 0.313 4.885 0.1926.063 0.079 1.178 0.809 mmu_miR_294_002595 0.175 0.690 −0.141 0.754−1.201 0.000 −0.316 0.314 −1.377 0.000 −1.061 0.001 mmu_miR_295_000189−0.112 0.994 −1.520 0.365 0.908 0.679 −1.408 0.388 1.020 0.509 2.4280.105 mmu_miR_295__002596 −0.343 0.961 −0.581 0.882 −1.239 0.679 −0.2380.936 −0.897 0.689 −0.659 0.810 mmu_miR_296_3p_002101 1.031 0.690 2.0970.270 2.149 0.316 1.066 0.600 1.119 0.527 0.053 0.983mmu_miR_296_5p_000527 −1.047 0.461 3.350 0.006 1.237 0.421 4.397 0.0002.284 0.041 −2.113 0.068 mmu_miR_297a_002454 −5.086 0.000 −1.446 0.1570.065 0.971 3.640 0.000 5.151 0.000 1.511 0.107 mmu_miR_297b_5p_001626−0.017 0.997 0.592 0.767 1.573 0.339 0.609 0.721 1.590 0.208 0.981 0.491mmu_miR_297c_002480 −0.163 0.988 0.447 0.882 −0.896 0.737 0.610 0.799−0.733 0.695 −1.343 0.479 mmu_miR_298_002598 3.627 0.016 −1.125 0.558−1.539 0.458 −4.752 0.002 −5.165 0.001 −0.414 0.848 mmu_miR_299_0026120.175 0.690 −0.141 0.754 −1.201 0.000 −0.316 0.314 −1.377 0.000 −1.0610.001 mmu_miR_29a_002112 1.393 0.002 1.752 0.001 −0.217 0.767 0.3590.487 −1.609 0.001 −1.969 0.000 mmu_miR_29b_000413 1.158 0.306 −2.1120.048 1.083 0.421 −3.269 0.001 −0.074 0.953 3.195 0.002mmu_miR_29b_002497 0.008 0.998 −3.742 0.001 3.114 0.007 −3.751 0.0003.105 0.002 6.856 0.000 mmu_miR_29c_000587 1.135 0.004 1.636 0.000 0.3910.468 0.501 0.231 −0.744 0.054 −1.245 0.003 mmu_miR_300_000191 3.8750.118 −2.815 0.301 0.902 0.836 −6.690 0.006 −2.973 0.216 3.717 0.128mmu_miR_300_002613 5.768 0.000 3.155 0.019 1.616 0.309 −2.614 0.037−4.152 0.001 −1.538 0.235 mmu_miR_301a_000528 −0.556 0.353 −0.729 0.199−0.225 0.793 −0.172 0.815 0.331 0.543 0.503 0.362 mmu_miR_301b_002600−0.573 0.468 0.785 0.274 −0.163 0.895 1.359 0.033 0.410 0.542 −0.9490.141 mmu_miR_302a_000529 1.639 0.857 3.536 0.531 5.310 0.369 1.8970.769 3.671 0.439 1.774 0.766 mmu_miR_302a_002615 −1.010 0.835 0.3650.945 0.130 0.978 1.376 0.669 1.140 0.689 −0.236 0.948mmu_miR_302b_000531 −2.108 0.462 −0.339 0.943 −1.883 0.564 1.770 0.5020.226 0.935 −1.544 0.551 mmu_miR_302b_001307 −0.158 0.996 0.249 0.9710.458 0.929 0.407 0.936 0.616 0.859 0.209 0.961 mmu_miR_302c_0025573.762 0.100 3.339 0.182 2.930 0.301 −0.424 0.912 −0.832 0.739 −0.4090.904 mmu_miR_302c_002558 1.198 0.882 2.668 0.558 1.731 0.767 1.4700.774 0.533 0.893 −0.937 0.856 mmu_miR_302d_000535 2.089 0.588 −0.0130.998 2.123 0.608 −2.102 0.517 0.033 0.993 2.136 0.500mmu_miR_30a_000417 −0.982 0.009 −0.613 0.141 −0.270 0.628 0.369 0.3780.712 0.053 0.343 0.403 mmu_miR_30b_000602 −0.211 0.690 −0.145 0.791−0.297 0.539 0.065 0.912 −0.086 0.822 −0.151 0.724 mmu_miR_30b_002498−1.594 0.418 0.328 0.918 0.962 0.702 1.922 0.279 2.556 0.111 0.634 0.766mmu_miR_30c_000419 −0.138 0.797 −0.551 0.084 −0.360 0.352 −0.413 0.182−0.222 0.474 0.191 0.568 mmu_miR_30d_000420 −1.663 0.006 −0.800 0.238−0.026 0.983 0.863 0.171 1.637 0.006 0.775 0.218 mmu_miR_30e_002223−1.332 0.000 −0.403 0.197 −0.126 0.787 0.928 0.001 1.205 0.000 0.2770.362 mmu_miR_31_000185 −0.535 0.570 0.732 0.359 1.002 0.236 1.267 0.0701.537 0.023 0.270 0.766 mmu_miR_31_002495 0.961 0.764 2.051 0.353 0.3590.916 1.090 0.649 −0.602 0.786 −1.693 0.420 mmu_miR_320_002277 −2.0150.000 0.490 0.259 −0.456 0.361 2.505 0.000 1.559 0.000 −0.946 0.016mmu_miR_322_001059 −4.848 0.209 −4.416 0.279 −3.192 0.529 0.432 0.9361.656 0.680 1.224 0.804 mmu_miR_322_001076 −8.070 0.000 −5.020 0.003−7.250 0.000 3.051 0.054 0.820 0.635 −2.231 0.168 mmu_miR_322_002506−7.610 0.000 −6.730 0.000 −5.900 0.001 0.880 0.667 1.711 0.300 0.8310.667 mmu_miR_323_3p_002227 9.271 0.000 2.885 0.001 −0.704 0.544 −6.3850.000 −9.975 0.000 −3.590 0.000 mmu_miR_324_3p_002509 −2.299 0.017 0.1990.918 −2.304 0.037 2.498 0.010 −0.004 0.998 −2.502 0.012mmu_miR_324_5p_000539 −1.495 0.194 −0.458 0.791 −1.257 0.373 1.037 0.3880.237 0.846 −0.800 0.510 mmu_miR_325_001060 −3.766 0.345 −9.421 0.011−4.450 0.309 −5.655 0.104 −0.683 0.859 4.971 0.154 mmu_miR_325_0025101.632 0.075 1.324 0.187 −0.258 0.875 −0.308 0.813 −1.891 0.032 −1.5820.083 mmu_miR_326_001061 −8.565 0.088 −1.067 0.917 −1.497 0.871 7.4980.140 7.069 0.143 −0.430 0.952 mmu_miR_327_002481 1.654 0.154 1.4170.256 0.657 0.699 −0.238 0.905 −0.997 0.385 −0.759 0.541mmu_miR_328_000543 0.982 0.013 0.909 0.033 0.160 0.826 −0.073 0.912−0.822 0.035 −0.749 0.065 mmu_miR_329_000192 5.034 0.000 2.245 0.0340.769 0.599 −2.789 0.006 −4.265 0.000 −1.475 0.145 mmu_miR_32_002109−3.230 0.216 −7.530 0.004 1.693 0.637 −4.301 0.079 4.923 0.037 9.2230.001 mmu_miR_330_001062 2.157 0.721 −0.505 0.948 2.228 0.706 −2.6630.553 0.071 0.988 2.733 0.525 mmu_miR_330_002230 1.918 0.120 −0.1600.948 −0.872 0.620 −2.078 0.086 −2.790 0.017 −0.712 0.603mmu_miR_331_3p_000545 0.717 0.218 2.268 0.000 1.145 0.067 1.551 0.0050.427 0.448 −1.123 0.040 mmu_miR_331_5p_002233 3.571 0.152 −2.213 0.4261.555 0.661 −5.784 0.015 −2.017 0.412 3.767 0.119 mmu_miR_335_3p_0021857.875 0.000 4.941 0.000 0.419 0.851 −2.935 0.017 −7.457 0.000 −4.5220.001 mmu_miR_335_5p_000546 4.132 0.000 2.146 0.001 1.047 0.108 −1.9870.001 −3.085 0.000 −1.098 0.049 mmu_miR_337_000193 2.934 0.017 1.7630.199 1.057 0.548 −1.171 0.393 −1.876 0.125 −0.706 0.616mmu_miR_337_3p_002532 4.982 0.000 2.015 0.084 1.205 0.411 −2.967 0.007−3.778 0.001 −0.811 0.505 mmu_miR_337_5p_002515 1.616 0.492 0.274 0.9432.277 0.350 −1.343 0.538 0.661 0.755 2.003 0.311 mmu_miR_338_3p_002252−4.032 0.000 −2.876 0.013 −2.023 0.110 1.156 0.318 2.009 0.056 0.8530.482 mmu_miR_339_3p_002533 −0.796 0.822 −1.905 0.365 2.055 0.402 −1.1090.622 2.851 0.114 3.960 0.033 mmu_miR_339_5p_002257 −4.104 0.000 −0.6270.706 −1.661 0.229 3.477 0.003 2.444 0.027 −1.034 0.401mmu_miR_340_3p_002259 0.251 0.652 0.212 0.706 0.591 0.200 −0.040 0.9440.340 0.389 0.380 0.353 mmu_miR_340_5p_002258 −0.357 0.462 0.609 0.1580.006 0.993 0.966 0.013 0.363 0.370 −0.604 0.129 mmu_miR_342_3p_0022602.559 0.000 0.430 0.321 −0.507 0.293 −2.129 0.000 −3.066 0.000 −0.9370.016 mmu_miR_342_5p_002527 5.917 0.000 0.540 0.803 0.876 0.657 −5.3770.000 −5.041 0.000 0.336 0.861 mmu_miR_343_002483 0.146 0.924 −1.0080.101 −1.393 0.030 −1.154 0.043 −1.538 0.006 −0.385 0.546mmu_miR_344_001063 −1.328 0.239 1.663 0.145 −1.968 0.107 2.991 0.004−0.640 0.561 −3.631 0.001 mmu_miR_345_001137 −1.476 0.125 0.409 0.7840.296 0.868 1.884 0.043 1.772 0.051 −0.113 0.932 mmu_miR_345_3p_002529−0.164 0.967 1.510 0.225 1.713 0.204 1.674 0.146 1.877 0.083 0.203 0.904mmu_miR_345_5p_002528 −2.728 0.000 0.627 0.449 −0.782 0.402 3.355 0.0001.946 0.005 −1.409 0.046 mmu_miR_346_001064 1.131 0.513 1.437 0.3541.950 0.236 0.306 0.896 0.819 0.567 0.513 0.769 mmu_miR_34a_000426 5.0860.000 1.223 0.044 0.291 0.742 −3.863 0.000 −4.795 0.000 −0.931 0.108mmu_miR_34b_001065 2.775 0.041 3.392 0.020 2.348 0.151 0.617 0.740−0.427 0.786 −1.044 0.493 mmu_miR_34b_3p_002618 1.417 0.002 2.030 0.0001.508 0.004 0.613 0.212 0.091 0.862 −0.523 0.288 mmu_miR_34b_5p_0026171.409 0.345 0.357 0.882 2.079 0.177 −1.052 0.466 0.670 0.633 1.722 0.192mmu_miR_34c_000428 2.246 0.004 4.578 0.000 1.396 0.139 2.331 0.003−0.851 0.288 −3.182 0.000 mmu_miR_34c_002584 1.218 0.037 −0.027 0.9791.151 0.095 −1.245 0.034 −0.067 0.922 1.178 0.046 mmu_miR_350_002530−3.655 0.000 −2.169 0.000 −1.249 0.036 1.486 0.005 2.406 0.000 0.9200.083 mmu_miR_351_001067 0.225 0.944 0.342 0.855 −2.075 0.098 0.1170.941 −2.300 0.027 −2.417 0.025 mmu_miR_361_000554 1.003 0.583 3.7990.009 0.693 0.742 2.795 0.038 −0.311 0.837 −3.106 0.023mmu_miR_362_3p_002616 0.360 0.840 −1.026 0.336 1.773 0.107 −1.386 0.1481.412 0.124 2.799 0.004 mmu_miR_362_5p_002614 −1.486 0.070 2.035 0.0190.021 0.992 3.521 0.000 1.507 0.056 −2.015 0.015 mmu_miR_363_001271−3.349 0.190 0.166 0.972 −2.360 0.473 3.515 0.159 0.989 0.714 −2.5260.323 mmu_miR_365_001020 −5.171 0.000 0.743 0.441 −1.114 0.273 5.9140.000 4.057 0.000 −1.857 0.025 mmu_miR_367_000555 −2.483 0.737 −1.2870.882 −1.469 0.868 1.197 0.874 1.015 0.845 −0.182 0.977mmu_miR_369_3p_000557 5.429 0.000 1.105 0.299 −0.201 0.912 −4.324 0.000−5.631 0.000 −1.307 0.176 mmu_miR_369_5p_001021 6.353 0.000 0.135 0.9481.938 0.095 −6.219 0.000 −4.415 0.000 1.803 0.071 mmu_miR_370_0010680.071 0.996 0.430 0.899 1.674 0.504 0.359 0.911 1.603 0.385 1.244 0.533mmu_miR_370_002275 9.508 0.000 2.260 0.002 −2.429 0.001 −7.248 0.000−11.937 0.000 −4.689 0.000 mmu_miR_374_002043 0.061 0.997 −4.124 0.4722.787 0.707 −4.185 0.436 2.726 0.596 6.911 0.158 mmu_miR_374_5p_001319−4.769 0.187 −4.168 0.279 −3.711 0.418 0.601 0.912 1.057 0.788 0.4560.928 mmu_miR_375_000564 2.926 0.011 2.773 0.024 0.139 0.946 −0.1530.936 −2.788 0.014 −2.634 0.025 mmu_miR_376a_001069 5.517 0.000 1.5920.003 0.416 0.548 −3.926 0.000 −5.101 0.000 −1.175 0.019mmu_miR_376a_002482 5.887 0.001 2.039 0.334 0.201 0.951 −3.847 0.038−5.686 0.002 −1.838 0.353 mmu_miR_376b_002451 4.416 0.306 5.162 0.225−0.071 0.992 0.745 0.912 −4.488 0.242 −5.233 0.182 mmu_miR_376b_0024528.585 0.000 2.307 0.028 0.510 0.742 −6.279 0.000 −8.075 0.000 −1.7970.074 mmu_miR_376c_002450 3.682 0.000 2.401 0.000 0.963 0.053 −1.2810.003 −2.719 0.000 −1.438 0.002 mmu_miR_376c_002523 2.097 0.395 −0.2500.953 0.111 0.978 −2.348 0.301 −1.986 0.355 0.361 0.906mmu_miR_377_000566 1.534 0.471 1.343 0.525 0.561 0.863 −0.191 0.941−0.974 0.596 −0.782 0.711 mmu_miR_379_001138 4.389 0.000 4.162 0.0010.947 0.531 −0.228 0.906 −3.442 0.001 −3.215 0.004 mmu_miR_380_3p_0010714.779 0.000 3.099 0.003 1.664 0.146 −1.680 0.079 −3.116 0.001 −1.4360.138 mmu_miR_380_5p_002601 6.742 0.000 2.159 0.002 1.936 0.007 −4.5830.000 −4.806 0.000 −0.223 0.796 mmu_miR_381_000571 4.944 0.001 −1.7870.289 −0.060 0.983 −6.732 0.000 −5.004 0.001 1.728 0.270mmu_miR_382_000572 8.447 0.000 3.934 0.005 −1.376 0.441 −4.513 0.001−9.823 0.000 −5.310 0.000 mmu_miR_383_001767 7.441 0.000 2.533 0.0000.544 0.539 −4.909 0.000 −6.897 0.000 −1.988 0.003 mmu_miR_384_3p_0026032.112 0.000 1.046 0.084 −0.152 0.884 −1.066 0.058 −2.264 0.000 −1.1970.036 mmu_miR_384_5p_002602 2.758 0.000 0.771 0.050 −0.135 0.836 −1.9870.000 −2.893 0.000 −0.906 0.016 mmu_miR_409_3p_002332 4.745 0.000 3.1600.004 1.029 0.458 −1.585 0.130 −3.716 0.000 −2.131 0.039mmu_miR_409_5p_002331 8.482 0.000 3.647 0.001 1.755 0.111 −4.835 0.000−6.727 0.000 −1.892 0.046 mmu_miR_410_001274 5.178 0.000 2.492 0.0000.084 0.916 −2.686 0.000 −5.093 0.000 −2.408 0.000 mmu_miR_411_0016103.639 0.000 1.837 0.009 0.275 0.807 −1.802 0.007 −3.363 0.000 −1.5620.020 mmu_miR_412_002575 8.665 0.000 −0.268 0.882 −0.063 0.973 −8.9340.000 −8.729 0.000 0.205 0.881 mmu_miR_423_5p_002340 −3.233 0.000 −2.1750.021 −0.743 0.551 1.058 0.263 2.491 0.004 1.433 0.110mmu_miR_425_001516 1.711 0.488 −4.554 0.029 4.197 0.066 −6.265 0.0022.486 0.203 8.752 0.000 mmu_miR_429_001077 2.568 0.378 0.664 0.882 2.8910.370 −1.904 0.502 0.324 0.907 2.227 0.412 mmu_miR_431_001979 2.2230.028 −1.743 0.117 −4.616 0.000 −3.966 0.000 −6.840 0.000 −2.873 0.006mmu_miR_432_241135_mat −1.407 0.833 −3.461 0.384 −2.469 0.628 −2.0550.627 −1.063 0.789 0.992 0.839 mmu_miR_433_001028 5.030 0.000 1.3300.009 0.137 0.875 −3.700 0.000 −4.893 0.000 −1.193 0.013mmu_miR_433_5p_001078 2.017 0.649 −3.246 0.354 0.657 0.912 −5.263 0.086−1.360 0.689 3.903 0.214 mmu_miR_434_3p_002604 5.044 0.000 0.998 0.048−0.060 0.943 −4.046 0.000 −5.104 0.000 −1.058 0.027mmu_miR_434_5p_002581 7.306 0.000 2.398 0.048 −0.342 0.874 −4.908 0.000−7.648 0.000 −2.741 0.019 mmu_miR_448_001029 8.071 0.000 2.194 0.218−0.588 0.836 −5.876 0.000 −8.659 0.000 −2.782 0.086 mmu_miR_449a_0010302.903 0.036 −2.008 0.190 0.927 0.650 −4.911 0.001 −1.976 0.144 2.9350.036 mmu_miR_449b_001667 4.277 0.020 −0.925 0.754 2.201 0.364 −5.2020.006 −2.077 0.271 3.125 0.099 mmu_miR_449b_002539 0.172 0.719 −0.1080.841 −1.130 0.001 −0.280 0.406 −1.302 0.000 −1.022 0.002mmu_miR_450B_3P_002632 −2.905 0.394 −5.323 0.084 −2.193 0.603 −2.4180.452 0.712 0.823 3.130 0.306 mmu_miR_450a_3p_002525 0.175 0.690 −0.1410.754 −1.201 0.000 −0.316 0.314 −1.377 0.000 −1.061 0.001mmu_miR_450a_5p_002303 −2.769 0.048 −1.540 0.334 −2.984 0.065 1.2280.429 −0.215 0.892 −1.443 0.330 mmu_miR_450b_5p_001962 0.145 0.918−0.036 0.972 −0.936 0.151 −0.181 0.817 −1.081 0.042 −0.900 0.105mmu_miR_451_001141 −4.842 0.154 −6.224 0.073 0.824 0.896 −1.382 0.7585.665 0.070 7.048 0.031 mmu_miR_452_001032 0.723 0.943 1.195 0.841 3.8860.380 0.471 0.935 3.163 0.365 2.691 0.480 mmu_miR_453_002484 0.112 0.9910.344 0.882 0.113 0.963 0.233 0.912 0.002 0.999 −0.231 0.898mmu_miR_455_002455 −7.521 0.000 −4.167 0.004 −4.250 0.005 3.355 0.0133.271 0.013 −0.084 0.964 mmu_miR_463_002582 0.046 0.996 −3.437 0.0145.163 0.001 −3.483 0.008 5.117 0.000 8.600 0.000 mmu_miR_463_002662−3.425 0.185 −7.865 0.003 −1.331 0.729 −4.440 0.070 2.094 0.407 6.5340.009 mmu_miR_464_001081 0.202 0.939 0.044 0.979 −1.603 0.112 −0.1580.912 −1.805 0.031 −1.646 0.059 mmu_miR_465C_5P_002654 1.929 0.369−4.658 0.018 5.129 0.012 −6.587 0.001 3.200 0.070 9.787 0.000mmu_miR_465a_3p_002040 1.660 0.652 −0.350 0.948 −0.217 0.963 −2.0100.482 −1.877 0.475 0.133 0.971 mmu_miR_465a_5p_001082 −8.260 0.194−2.654 0.784 −3.303 0.727 5.606 0.398 4.957 0.426 −0.649 0.938mmu_miR_465b_5p_002485 4.942 0.256 4.345 0.339 1.846 0.771 −0.597 0.932−3.097 0.454 −2.500 0.575 mmu_miR_466E_5P_002718 −2.304 0.729 −5.5560.230 0.951 0.906 −3.252 0.492 3.255 0.452 6.507 0.124mmu_miR_466J_002817 −6.904 0.000 −2.722 0.067 −3.240 0.039 4.182 0.0033.665 0.007 −0.518 0.773 mmu_miR_466a_3p_002586 −4.030 0.000 −0.0530.972 −0.566 0.599 3.977 0.000 3.464 0.000 −0.513 0.532mmu_miR_466b_3_3p_002500 −4.068 0.000 −1.190 0.354 −0.678 0.686 2.8780.010 3.389 0.002 0.511 0.711 mmu_miR_466d_5p_002534 3.616 0.540 −2.4880.706 4.514 0.458 −6.104 0.195 0.898 0.859 7.002 0.125mmu_miR_466g_241015_mat −2.278 0.379 3.276 0.184 4.018 0.124 5.554 0.0126.296 0.004 0.742 0.806 mmu_miR_466h_002516 −1.391 0.599 0.223 0.9531.368 0.629 1.614 0.452 2.760 0.143 1.145 0.603 mmu_miR_466k_240990_mat−4.461 0.090 −1.100 0.791 1.124 0.795 3.361 0.216 5.585 0.027 2.2250.434 mmu_miR_467F_002886 −5.922 0.051 −7.574 0.019 −0.696 0.906 −1.6530.665 5.226 0.073 6.878 0.025 mmu_miR_467H_002809 −4.066 0.000 0.9750.470 −0.059 0.978 5.041 0.000 4.007 0.001 −1.034 0.398mmu_miR_467a_001826 −5.209 0.000 −4.692 0.001 −0.616 0.768 0.517 0.7804.593 0.001 4.076 0.003 mmu_miR_467a_002587 −3.725 0.001 1.339 0.278−1.333 0.346 5.064 0.000 2.392 0.024 −2.671 0.016 mmu_miR_467b_001671−5.130 0.000 −1.642 0.184 −2.771 0.027 3.488 0.002 2.360 0.029 −1.1280.339 mmu_miR_467b_001684 −4.205 0.037 −8.053 0.000 2.608 0.309 −3.8480.057 6.813 0.001 10.661 0.000 mmu_miR_467c_002517 −6.425 0.000 −2.0090.317 −1.495 0.548 4.416 0.012 4.929 0.005 0.514 0.838mmu_miR_467d_002518 −2.833 0.022 −0.957 0.539 0.219 0.920 1.876 0.1453.052 0.012 1.176 0.379 mmu_miR_467e_002568 −3.548 0.062 −3.650 0.070−0.023 0.993 −0.102 0.968 3.525 0.054 3.627 0.056 mmu_miR_467e_002569−1.516 0.565 0.270 0.948 −3.108 0.186 1.785 0.409 −1.592 0.433 −3.3770.087 mmu_miR_468_001085 0.262 0.961 −0.119 0.972 −3.341 0.067 −0.3810.885 −3.603 0.019 −3.222 0.043 mmu_miR_469_001086 0.418 0.979 −0.1810.978 −2.397 0.628 −0.600 0.912 −2.816 0.419 −2.216 0.555mmu_miR_470_002588 −0.488 0.828 0.519 0.784 0.672 0.712 1.007 0.4411.160 0.337 0.153 0.928 mmu_miR_470_002589 −2.865 0.721 −8.182 0.1446.303 0.339 −5.318 0.334 9.168 0.063 14.485 0.006 mmu_miR_471_0026050.180 0.852 0.033 0.972 −0.746 0.203 −0.147 0.840 −0.926 0.051 −0.7790.115 mmu_miR_483_001291 −2.270 0.547 −2.959 0.363 1.505 0.738 −0.6890.885 3.775 0.177 4.464 0.123 mmu_miR_483_002560 −0.254 0.941 0.3680.855 2.606 0.046 0.622 0.667 2.860 0.010 2.238 0.052 mmu_miR_484_001821−2.187 0.000 −1.011 0.029 −1.115 0.024 1.175 0.008 1.071 0.012 −0.1040.868 mmu_miR_485_3p_001943 4.239 0.000 1.700 0.003 1.155 0.064 −2.5390.000 −3.085 0.000 −0.545 0.339 mmu_miR_486_001278 −6.407 0.000 −1.6000.318 −7.399 0.000 4.807 0.001 −0.992 0.501 −5.799 0.000mmu_miR_487b_001285 5.104 0.000 1.309 0.022 0.802 0.220 −3.795 0.000−4.302 0.000 −0.507 0.380 mmu_miR_487b_001306 7.099 0.000 3.152 0.0000.276 0.741 −3.946 0.000 −6.822 0.000 −2.876 0.000 mmu_miR_488_001659−0.642 0.757 1.127 0.445 0.364 0.875 1.769 0.172 1.006 0.439 −0.7620.590 mmu_miR_488_002014 2.542 0.371 4.774 0.067 4.604 0.107 2.232 0.4072.063 0.411 −0.169 0.960 mmu_miR_489_001302 6.276 0.001 0.907 0.765−1.437 0.611 −5.370 0.006 −7.714 0.000 −2.344 0.248 mmu_miR_490_0010374.692 0.000 −1.430 0.277 −1.670 0.236 −6.122 0.000 −6.363 0.000 −0.2400.891 mmu_miR_491_001630 4.656 0.000 3.961 0.000 0.528 0.728 −0.6950.534 −4.128 0.000 −3.433 0.001 mmu_miR_493_002519 1.745 0.558 −1.5070.606 −1.494 0.650 −3.252 0.156 −3.239 0.136 0.013 0.995mmu_miR_494_001293 1.835 0.285 1.500 0.401 −1.173 0.603 −0.336 0.904−3.009 0.045 −2.673 0.086 mmu_miR_494_002365 0.339 0.908 −1.252 0.364−1.713 0.246 −1.591 0.211 −2.051 0.079 −0.460 0.769 mmu_miR_495_0016635.096 0.000 1.903 0.000 0.043 0.950 −3.194 0.000 −5.053 0.000 −1.8600.000 mmu_miR_496_001953 1.569 0.649 −2.101 0.452 −3.603 0.205 −3.6700.128 −5.172 0.024 −1.502 0.572 mmu_miR_497_001346 −5.540 0.000 0.4900.784 −1.905 0.151 6.029 0.000 3.634 0.001 −2.395 0.032mmu_miR_499_001352 1.750 0.468 0.405 0.918 1.157 0.698 −1.345 0.553−0.593 0.790 0.752 0.766 mmu_miR_500_002606 0.203 0.948 0.238 0.908−1.089 0.439 0.035 0.976 −1.291 0.208 −1.327 0.214 mmu_miR_501_0013560.000 1.000 0.400 0.918 0.687 0.847 0.400 0.911 0.687 0.758 0.287 0.923mmu_miR_501_3p_001651 −0.323 0.771 1.220 0.084 −1.672 0.024 1.543 0.018−1.349 0.034 −2.892 0.000 mmu_miR_503_002456 −0.366 0.924 −0.259 0.927−0.617 0.800 0.107 0.962 −0.251 0.879 −0.358 0.861 mmu_miR_503_002536−3.864 0.000 −1.686 0.111 −1.499 0.203 2.178 0.026 2.365 0.013 0.1870.898 mmu_miR_504_002084 1.244 0.261 −0.500 0.754 −2.447 0.031 −1.7440.086 −3.691 0.000 −1.947 0.056 mmu_miR_505_001655 1.006 0.484 1.6240.199 2.213 0.102 0.618 0.669 1.207 0.303 0.589 0.667mmu_miR_509_3p_002521 0.714 0.967 −2.740 0.706 −0.278 0.978 −3.454 0.553−0.992 0.859 2.462 0.679 mmu_miR_509_5p_002520 4.369 0.370 4.125 0.3902.736 0.657 −0.243 0.968 −1.633 0.727 −1.389 0.806 mmu_miR_511_0025490.837 0.764 1.551 0.423 2.651 0.182 0.714 0.754 1.815 0.280 1.101 0.551mmu_miR_532_3p_002355 −0.882 0.179 −1.851 0.005 −0.459 0.611 −0.9690.125 0.424 0.512 1.392 0.026 mmu_miR_532_5p_001518 −1.886 0.000 −1.1230.023 −0.781 0.162 0.763 0.105 1.106 0.015 0.342 0.510mmu_miR_539_001286 4.967 0.000 4.133 0.000 0.623 0.669 −0.834 0.437−4.345 0.000 −3.511 0.001 mmu_miR_540_3p_001310 3.160 0.003 0.555 0.7330.597 0.721 −2.606 0.014 −2.563 0.013 0.043 0.977 mmu_miR_540_5p_0025615.694 0.000 2.693 0.023 1.405 0.330 −3.001 0.008 −4.289 0.000 −1.2880.275 mmu_miR_541_002562 5.280 0.000 −0.673 0.302 −0.718 0.338 −5.9530.000 −5.998 0.000 −0.045 0.956 mmu_miR_542_3p_001284 −2.679 0.039−0.440 0.849 −1.702 0.301 2.238 0.087 0.977 0.474 −1.262 0.366mmu_miR_542_5p_002563 1.648 0.721 1.062 0.835 −2.600 0.529 −0.586 0.911−4.248 0.137 −3.662 0.228 mmu_miR_543_001298 5.130 0.000 1.455 0.0220.119 0.914 −3.676 0.000 −5.012 0.000 −1.336 0.027 mmu_miR_543_0023765.450 0.000 1.949 0.000 0.298 0.677 −3.501 0.000 −5.152 0.000 −1.6510.001 mmu_miR_544_002550 6.701 0.000 4.842 0.000 1.939 0.062 −1.8590.038 −4.762 0.000 −2.903 0.002 mmu_miR_546_001312 2.258 0.882 −4.1910.664 4.317 0.677 −6.449 0.397 2.059 0.793 8.508 0.235mmu_miR_547_002564 1.049 0.835 1.958 0.558 −0.621 0.906 0.909 0.813−1.670 0.554 −2.579 0.366 mmu_miR_551b_001535 0.347 0.889 −2.149 0.0730.399 0.839 −2.496 0.025 0.052 0.970 2.548 0.025 mmu_miR_574_3p_002349−5.848 0.000 −4.339 0.000 −4.573 0.000 1.510 0.040 1.275 0.073 −0.2340.817 mmu_miR_582_3p_002567 −1.142 0.646 1.703 0.384 0.997 0.702 2.8450.098 2.139 0.205 −0.706 0.745 mmu_miR_582_5p_002566 0.369 0.820 1.2160.192 −0.264 0.868 0.846 0.359 −0.634 0.474 −1.480 0.082mmu_miR_590_5p_001984 0.306 0.972 0.221 0.966 −0.630 0.880 −0.085 0.976−0.936 0.711 −0.851 0.771 mmu_miR_592_002017 3.212 0.000 1.015 0.2120.378 0.742 −2.197 0.003 −2.834 0.000 −0.637 0.429 mmu_miR_598_0024762.922 0.011 2.336 0.061 −0.127 0.951 −0.586 0.697 −3.049 0.007 −2.4630.036 mmu_miR_599_241117_mat −2.471 0.410 0.313 0.953 −1.775 0.630 2.7840.307 0.696 0.807 −2.088 0.454 mmu_miR_615_3p_001960 0.676 0.618 4.2580.000 −0.483 0.748 3.582 0.000 −1.158 0.229 −4.740 0.000mmu_miR_615_5p_002353 0.131 0.918 0.517 0.363 0.104 0.913 0.386 0.494−0.027 0.965 −0.413 0.454 mmu_miR_652_002352 −3.416 0.001 0.485 0.772−2.667 0.025 3.901 0.000 0.749 0.500 −3.152 0.004 mmu_miR_654_3p_0022390.144 0.957 0.104 0.948 −0.927 0.367 −0.040 0.969 −1.072 0.166 −1.0310.206 mmu_miR_654_5p_002522 0.170 0.957 0.034 0.979 −0.682 0.619 −0.1370.933 −0.852 0.375 −0.716 0.493 mmu_miR_665_002607 1.792 0.110 0.8500.530 −1.109 0.456 −0.942 0.437 −2.901 0.007 −1.959 0.076mmu_miR_666_3p_002448 0.615 0.889 0.042 0.986 3.364 0.162 −0.573 0.8562.749 0.162 3.323 0.105 mmu_miR_666_5p_001952 5.556 0.000 2.544 0.0011.453 0.092 −3.012 0.000 −4.103 0.000 −1.091 0.141 mmu_miR_667_0019494.972 0.000 2.518 0.000 0.166 0.868 −2.454 0.000 −4.807 0.000 −2.3520.000 mmu_miR_668_001947 3.404 0.073 1.630 0.466 −0.235 0.943 −1.7730.392 −3.639 0.046 −1.866 0.353 mmu_miR_669C_002646 −5.195 0.000 −1.9520.174 −1.793 0.258 3.244 0.012 3.402 0.007 0.158 0.932mmu_miR_669D_002808 −4.143 0.001 −0.247 0.920 −0.503 0.827 3.896 0.0033.640 0.004 −0.256 0.896 mmu_miR_669E_002774 −2.975 0.052 0.405 0.8821.039 0.646 3.380 0.026 4.015 0.007 0.634 0.745 mmu_miR_669G_0028130.164 0.870 0.022 0.979 −0.814 0.156 −0.142 0.845 −0.978 0.035 −0.8360.083 mmu_miR_669H_5P_002906 0.857 0.822 1.855 0.423 0.388 0.914 0.9980.696 −0.469 0.832 −1.467 0.505 mmu_miR_669a_001683 −0.992 0.649 1.0210.605 1.139 0.603 2.013 0.199 2.131 0.145 0.118 0.956mmu_miR_669M_21149_mat −4.415 0.000 −0.053 0.979 −0.386 0.868 4.3620.001 4.030 0.001 −0.332 0.848 mmu_miR_669m_121190_mat −1.542 0.570−1.911 0.415 2.051 0.455 −0.369 0.912 3.593 0.065 3.961 0.051mmu_miR_669n_197143_mat −4.025 0.000 −1.000 0.413 −0.795 0.603 3.0250.004 3.230 0.002 0.205 0.898 mmu_miR_669o_121176_mat −2.992 0.030 0.7560.712 0.527 0.833 3.748 0.007 3.520 0.010 −0.229 0.910mmu_miR_670_002020 −4.339 0.368 −6.021 0.186 −1.516 0.836 −1.683 0.7742.822 0.512 4.505 0.298 mmu_miR_671_3p_002322 −1.629 0.071 −0.780 0.4610.295 0.861 0.848 0.389 1.923 0.027 1.075 0.249 mmu_miR_672_002327 9.1440.000 5.512 0.002 −0.872 0.738 −3.632 0.027 −10.016 0.000 −6.384 0.000mmu_miR_673_001954 0.873 0.874 −3.674 0.196 4.634 0.129 −4.546 0.0793.761 0.135 8.307 0.002 mmu_miR_673_3p_002449 9.016 0.001 −2.277 0.4692.706 0.451 −11.293 0.000 −6.309 0.014 4.984 0.060 mmu_miR_674_001956−3.054 0.000 −0.279 0.823 −0.461 0.677 2.775 0.000 2.593 0.001 −0.1820.861 mmu_miR_674_002021 −6.963 0.000 −7.330 0.000 −2.865 0.112 −0.3670.886 4.098 0.007 4.465 0.005 mmu_miR_675_3p_001941 −3.023 0.764 −7.2360.288 0.097 0.993 −4.213 0.550 3.120 0.634 7.333 0.243mmu_miR_675_5p_001940 −1.956 0.658 −3.782 0.264 −0.719 0.903 −1.8270.618 1.237 0.712 3.064 0.336 mmu_miR_676_001958 −0.224 0.941 1.0060.380 1.088 0.417 1.230 0.244 1.311 0.182 0.082 0.955 mmu_miR_676_001959−3.531 0.006 1.638 0.260 −1.621 0.329 5.169 0.000 1.911 0.130 −3.2580.013 mmu_miR_677_001660 0.099 0.994 0.333 0.882 −2.155 0.151 0.2350.912 −2.254 0.064 −2.488 0.049 mmu_miR_679_001662 −2.695 0.707 −1.4910.855 1.782 0.830 1.203 0.874 4.477 0.349 3.273 0.529 mmu_miR_680_001664−4.295 0.513 −4.935 0.408 −3.539 0.643 −0.640 0.936 0.756 0.893 1.3960.848 mmu_miR_682_001666 2.340 0.737 −0.929 0.917 5.144 0.360 −3.2690.508 2.804 0.541 6.073 0.170 mmu_miR_683_001668 −1.149 0.889 0.2270.973 −1.009 0.884 1.375 0.795 0.140 0.979 −1.235 0.807mmu_miR_684_001669 0.175 0.690 −0.141 0.754 −1.201 0.000 −0.316 0.314−1.377 0.000 −1.061 0.001 mmu_miR_685_001670 2.592 0.582 2.127 0.6608.034 0.041 −0.465 0.936 5.443 0.108 5.908 0.092 mmu_miR_686_001672−2.552 0.098 −0.127 0.970 −1.303 0.539 2.425 0.113 1.249 0.425 −1.1760.486 mmu_miR_687_001674 −0.709 0.484 0.205 0.887 −0.421 0.742 0.9140.299 0.288 0.754 −0.625 0.491 mmu_miR_688_001675 2.220 0.374 −1.9080.449 1.189 0.721 −4.128 0.054 −1.031 0.660 3.097 0.152mmu_miR_690_001677 −0.108 0.994 0.500 0.823 1.159 0.531 0.607 0.7341.267 0.349 0.660 0.676 mmu_miR_691_001678 2.138 0.774 −5.171 0.2981.659 0.834 −7.309 0.100 −0.479 0.926 6.831 0.127 mmu_miR_692_001679−0.413 0.950 −4.656 0.039 −3.581 0.160 −4.243 0.047 −3.168 0.129 1.0750.673 mmu_miR_693_001680 −0.603 0.967 −5.401 0.223 0.038 0.994 −4.7980.260 0.642 0.887 5.439 0.183 mmu_miR_693_3p_002036 −0.728 0.961 −5.6300.260 −0.840 0.916 −4.902 0.308 −0.112 0.986 4.790 0.307mmu_miR_694_001681 −0.801 0.941 −5.374 0.182 5.587 0.200 −4.573 0.2296.388 0.067 10.961 0.004 mmu_miR_695_001627 1.525 0.830 −2.582 0.5920.412 0.950 −4.107 0.306 −1.113 0.793 2.994 0.470 mmu_miR_696_001628−4.505 0.477 −9.029 0.099 0.944 0.916 −4.524 0.420 5.448 0.290 9.9730.051 mmu_miR_697_001631 −0.277 0.988 3.846 0.225 1.803 0.677 4.1240.163 2.080 0.485 −2.044 0.523 mmu_miR_698_001632 0.038 0.996 0.0350.979 −0.685 0.595 −0.002 0.997 −0.723 0.430 −0.720 0.464mmu_miR_700_001634 −0.410 0.882 2.356 0.082 −0.672 0.737 2.766 0.027−0.262 0.855 −3.028 0.018 mmu_miR_701_001635 −1.908 0.581 1.048 0.7981.845 0.620 2.956 0.280 3.753 0.130 0.798 0.817 mmu_miR_702_001636 4.1540.050 0.314 0.943 1.794 0.548 −3.840 0.070 −2.360 0.269 1.480 0.531mmu_miR_704_001639 1.441 0.386 1.877 0.236 −0.059 0.983 0.435 0.840−1.500 0.300 −1.935 0.183 mmu_miR_706_001641 1.707 0.855 −0.016 0.9988.215 0.146 −1.724 0.796 6.507 0.156 8.231 0.083 mmu_miR_707_0016420.143 0.918 0.066 0.953 −0.762 0.243 −0.077 0.933 −0.906 0.080 −0.8280.128 mmu_miR_708_002341 −1.282 0.023 0.155 0.882 −0.679 0.360 1.4370.012 0.603 0.302 −0.834 0.150 mmu_miR_710_001645 1.401 0.941 2.4960.811 5.146 0.563 1.095 0.914 3.745 0.577 2.650 0.744 mmu_miR_711_001646−0.507 0.994 −2.830 0.778 1.038 0.924 −2.322 0.795 1.545 0.823 3.8670.584 mmu_miR_712_001961 0.298 0.936 0.270 0.917 −1.892 0.211 −0.0280.983 −2.190 0.071 −2.162 0.087 mmu_miR_712_002636 −0.988 0.908 −7.5370.047 1.537 0.797 −6.550 0.067 2.525 0.499 9.074 0.013mmu_miR_713_001648 −0.266 0.996 −0.769 0.953 0.666 0.958 −0.503 0.9620.932 0.900 1.435 0.884 mmu_miR_715_001649 −1.448 0.824 0.406 0.9531.189 0.849 1.855 0.669 2.638 0.465 0.783 0.874 mmu_miR_717_001652−6.698 0.245 −6.378 0.285 −1.314 0.900 0.320 0.968 5.384 0.320 5.0640.368 mmu_miR_718_001656 3.915 0.252 4.870 0.157 5.369 0.151 0.955 0.8401.455 0.675 0.499 0.913 mmu_miR_719_001673 −0.059 0.996 0.157 0.968−2.407 0.246 0.217 0.936 −2.348 0.158 −2.564 0.138 mmu_miR_720_0016290.466 0.764 −3.574 0.001 4.610 0.000 −4.040 0.000 4.144 0.000 8.1840.000 mmu_miR_721_001657 −2.053 0.889 −5.555 0.488 4.723 0.629 −3.5020.679 6.777 0.321 10.279 0.128 mmu_miR_741_002457 −0.113 0.996 −5.3510.097 0.344 0.949 −5.238 0.082 0.456 0.892 5.694 0.059mmu_miR_742_002038 −1.682 0.419 0.587 0.849 0.924 0.737 2.269 0.2152.606 0.126 0.337 0.898 mmu_miR_742_002458 3.383 0.582 −1.550 0.8451.085 0.903 −4.933 0.313 −2.298 0.640 2.635 0.608 mmu_miR_743a_0024693.127 0.157 0.482 0.909 1.307 0.679 −2.645 0.235 −1.820 0.405 0.8260.766 mmu_miR_743b_3p_002471 0.120 0.983 0.277 0.882 −0.320 0.871 0.1580.932 −0.440 0.709 −0.598 0.616 mmu_miR_743b_5p_002470 −4.433 0.184−4.635 0.184 0.059 0.992 −0.202 0.968 4.492 0.144 4.694 0.141mmu_miR_744_002324 1.357 0.105 0.159 0.920 0.172 0.912 −1.198 0.155−1.185 0.137 0.013 0.994 mmu_miR_758_002025 0.249 0.918 −0.015 0.990−3.243 0.002 −0.264 0.861 −3.493 0.000 −3.228 0.001 mmu_miR_759_002034−0.123 0.996 2.529 0.579 1.014 0.875 2.651 0.515 1.137 0.783 −1.5140.739 mmu_miR_761_002030 −0.359 0.994 −3.694 0.558 1.098 0.912 −3.3350.573 1.456 0.797 4.791 0.370 mmu_miR_762_002028 0.393 0.983 2.806 0.5242.959 0.559 2.414 0.564 2.566 0.492 0.153 0.976 mmu_miR_763_002033−1.298 0.889 −4.887 0.306 −0.181 0.983 −3.589 0.445 1.117 0.816 4.7060.289 mmu_miR_764_3p_002032 1.515 0.771 0.161 0.979 −1.179 0.830 −1.3550.748 −2.694 0.399 −1.339 0.731 mmu_miR_764_5p_002031 2.071 0.306 1.3630.542 −1.542 0.544 −0.708 0.780 −3.612 0.039 −2.904 0.111mmu_miR_767_241081_mat 0.175 0.690 −0.140 0.754 −1.197 0.000 −0.3150.312 −1.373 0.000 −1.057 0.001 mmu_miR_770_3p_002027 5.398 0.000 1.3040.271 0.707 0.650 −4.093 0.000 −4.691 0.000 −0.598 0.616mmu_miR_770_5p_002608 3.184 0.000 1.746 0.063 0.200 0.906 −1.438 0.105−2.983 0.001 −1.545 0.082 mmu_miR_7a_000268 3.819 0.110 −3.096 0.232−1.574 0.650 −6.915 0.003 −5.393 0.017 1.522 0.558 mmu_miR_7b_0025555.443 0.002 −2.396 0.208 −0.369 0.912 −7.838 0.000 −5.811 0.001 2.0270.262 mmu_miR_802_002029 −1.461 0.455 −0.774 0.754 0.133 0.963 0.6870.752 1.595 0.324 0.907 0.614 mmu_miR_804_002044 −7.713 0.201 −6.9050.280 −2.508 0.790 0.808 0.933 5.205 0.373 4.397 0.489mmu_miR_805_002045 −3.266 0.456 −1.863 0.728 4.631 0.304 1.403 0.7807.896 0.022 6.493 0.070 mmu_miR_871_002354 0.093 0.996 0.335 0.918−0.401 0.903 0.242 0.933 −0.494 0.794 −0.737 0.729 mmu_miR_872_002264−1.123 0.041 2.227 0.000 0.170 0.870 3.351 0.000 1.294 0.015 −2.0570.001 mmu_miR_872_002542 −2.193 0.000 1.300 0.020 −0.568 0.418 3.4940.000 1.625 0.002 −1.869 0.001 mmu_miR_873_002356 3.300 0.003 0.9810.461 −0.849 0.603 −2.319 0.039 −4.150 0.000 −1.830 0.108mmu_miR_874_002268 −0.207 0.984 0.530 0.882 1.581 0.561 0.738 0.7881.789 0.368 1.051 0.636 mmu_miR_875_3p_002547 0.919 0.941 −2.582 0.6542.843 0.645 −3.501 0.449 1.924 0.676 5.425 0.205 mmu_miR_876_3p_0024642.146 0.481 0.838 0.845 2.195 0.521 −1.308 0.669 0.050 0.988 1.357 0.625mmu_miR_876_5p_002463 2.253 0.098 2.320 0.107 0.359 0.884 0.067 0.969−1.894 0.145 −1.961 0.146 mmu_miR_877_002548 −3.597 0.184 −6.876 0.0120.149 0.978 −3.279 0.220 3.745 0.134 7.025 0.007 mmu_miR_878_3p_002541−1.435 0.835 −3.968 0.336 6.293 0.148 −2.533 0.550 7.727 0.028 10.2610.006 mmu_miR_878_5p_002540 0.095 0.996 −5.379 0.140 −0.396 0.946 −5.4740.102 −0.491 0.893 4.983 0.138 mmu_miR_879_002472 0.040 0.996 0.8120.749 0.328 0.914 0.771 0.722 0.287 0.877 −0.484 0.830mmu_miR_879_002473 −0.039 0.996 −1.282 0.426 −1.435 0.444 −1.243 0.414−1.396 0.322 −0.152 0.937 mmu_miR_880_002665 −6.619 0.261 −2.302 0.7882.901 0.732 4.317 0.476 9.520 0.067 5.203 0.366 mmu_miR_881_002475 0.0450.997 −5.358 0.203 0.712 0.916 −5.403 0.173 0.667 0.879 6.070 0.118mmu_miR_881_002609 2.386 0.599 0.380 0.953 5.202 0.190 −2.006 0.6192.817 0.411 4.823 0.150 mmu_miR_882_002610 0.175 0.690 −0.141 0.754−1.201 0.000 −0.316 0.314 −1.377 0.000 −1.061 0.001mmu_miR_883B_5P_002669 0.625 0.961 −2.469 0.607 3.361 0.512 −3.095 0.4472.736 0.474 5.830 0.116 mmu_miR_883a_3p_002461 1.691 0.479 2.062 0.3491.204 0.677 0.371 0.912 −0.488 0.822 −0.858 0.718 mmu_miR_883a_5p_0026110.160 0.823 −0.070 0.923 −1.047 0.013 −0.231 0.616 −1.208 0.001 −0.9770.012 mmu_miR_883b_3p_002565 4.279 0.150 3.529 0.270 −0.869 0.871 −0.7510.873 −5.148 0.061 −4.397 0.127 mmu_miR_92a_000430 0.177 0.822 −2.7320.000 2.316 0.000 −2.909 0.000 2.139 0.000 5.048 0.000mmu_miR_92a_002496 0.142 0.983 −0.033 0.985 −0.812 0.677 −0.175 0.936−0.954 0.482 −0.779 0.599 mmu_miR_93_001090 −1.806 0.013 1.295 0.105−0.470 0.674 3.100 0.000 1.336 0.062 −1.764 0.019 mmu_miR_96_0001865.054 0.004 −3.573 0.063 1.819 0.456 −8.627 0.000 −3.235 0.062 5.3920.004 mmu_miR_98_000577 2.930 0.062 −0.682 0.784 −2.405 0.200 −3.6130.020 −5.336 0.001 −1.723 0.292 mmu_miR_99a_000435 −2.472 0.001 −1.7680.022 −0.306 0.807 0.704 0.381 2.165 0.003 1.461 0.046mmu_miR_99b_000436 −1.966 0.035 0.548 0.681 0.283 0.871 2.514 0.0072.248 0.013 −0.266 0.840 mmu_miR_9_000583 −2.772 0.000 −0.573 0.169−0.998 0.017 2.198 0.000 1.773 0.000 −0.425 0.281

TABLE 4 Brain Stem miRNA data. mean_ mean_ mean_ mean_ detect_ detect_detect_ detect_ bs.ChAT bs.GFAP bs.Lyz2 bs.Syn pSI_BS.ChAT pSI_BS.GFAPpSI_BS.Lyz2 pSI_BS.Syn BS.ChAT BS.GFAP BS.Lyz2 BS.Syn hsa_let_7b_00240430.434 30.568 32.311 34.174 0.263 0.220 0.784 0.973 TRUE TRUE TRUE TRUEhsa_let_7e_002407 29.845 30.485 29.490 30.383 0.495 0.708 0.518 0.638TRUE TRUE TRUE TRUE hsa_let_7f_1_002417 38.091 34.575 38.321 37.593 NA0.033 NA NA FALSE TRUE FALSE FALSE hsa_let_7i_002172 35.202 31.68333.850 34.880 NA 0.054 NA 0.739 FALSE TRUE FALSE TRUEhsa_miR_106b_002380 31.761 28.527 31.863 27.336 0.879 0.273 NA 0.057TRUE TRUE FALSE TRUE hsa_miR_10a_002288 37.788 38.584 38.553 39.428 NANA NA NA FALSE FALSE FALSE FALSE hsa_miR_1197_002810 31.437 35.56333.740 32.817 0.125 NA NA 0.450 TRUE FALSE FALSE TRUE hsa_miR_124_00219733.367 35.516 35.026 35.695 NA NA NA 0.743 FALSE FALSE FALSE TRUEhsa_miR_127_5p_002229 33.808 34.690 33.263 33.401 NA 0.786 NA 0.395FALSE TRUE FALSE TRUE hsa_miR_136_000592 28.841 32.218 27.819 29.1450.442 0.971 0.305 0.497 TRUE TRUE TRUE TRUE hsa_miR_136_002100 21.42124.050 24.092 21.782 0.261 0.779 0.909 0.289 TRUE TRUE TRUE TRUEhsa_miR_140_3p_002234 29.226 27.686 28.505 27.789 0.821 0.431 0.7310.326 TRUE TRUE TRUE TRUE hsa_miR_143_000466 27.198 26.694 26.214 29.2460.509 0.396 0.399 0.969 TRUE TRUE TRUE TRUE hsa_miR_144_002676 37.70037.852 38.215 39.548 NA NA NA NA FALSE FALSE FALSE FALSEhsa_miR_148a_002134 38.518 38.580 38.824 37.837 NA NA NA NA FALSE FALSEFALSE TRUE hsa_miR_149_002255 19.540 21.538 21.293 19.270 0.416 0.7930.837 0.222 TRUE TRUE TRUE TRUE hsa_miR_151_5P_002642 33.956 28.97030.520 29.653 0.991 0.173 0.654 0.308 TRUE TRUE TRUE TRUEhsa_miR_154_000478 26.477 27.881 27.338 26.423 0.459 0.772 0.724 0.359TRUE TRUE TRUE TRUE hsa_miR_15b_002173 34.070 35.301 26.617 37.222 NA NA0.003 NA FALSE FALSE TRUE FALSE hsa_miR_183_002270 25.794 32.436 25.21426.665 0.252 1.000 0.266 0.514 TRUE TRUE TRUE TRUE hsa_miR_189_00048828.951 28.688 25.020 31.972 0.604 0.504 0.073 0.994 TRUE TRUE TRUE TRUEhsa_miR_190b_002263 27.724 27.463 27.813 30.158 0.408 0.330 0.594 0.961TRUE TRUE TRUE TRUE hsa_miR_196a_241070_mat 32.372 37.264 33.308 30.1220.441 NA NA 0.019 TRUE FALSE FALSE TRUE hsa_miR_200a_001011 39.48536.945 39.735 39.687 NA NA NA NA FALSE TRUE FALSE FALSEhsa_miR_200b_001800 28.278 33.939 27.140 33.967 0.196 0.942 0.112 0.897TRUE TRUE TRUE TRUE hsa_miR_200b_002274 35.926 39.292 40.372 40.499 NANA NA NA FALSE FALSE FALSE FALSE hsa_miR_200c_000505 31.975 30.25525.288 31.441 0.915 0.555 0.036 0.733 TRUE TRUE TRUE TRUEhsa_miR_200c_002286 38.694 39.262 39.873 39.630 NA NA NA NA FALSE FALSEFALSE FALSE hsa_miR_206_000510 28.359 27.407 27.323 26.978 0.818 0.5640.635 0.315 TRUE TRUE TRUE TRUE hsa_miR_213_000516 28.920 26.020 26.93126.933 0.939 0.256 0.626 0.446 TRUE TRUE TRUE TRUE hsa_miR_214_00051728.917 31.861 25.809 32.003 0.424 0.882 0.063 0.880 TRUE TRUE TRUE TRUEhsa_miR_214_002293 36.550 35.972 36.817 38.637 NA NA NA NA FALSE FALSEFALSE FALSE hsa_miR_218_2_002294 26.211 31.344 30.326 29.884 0.029 0.905NA 0.584 TRUE TRUE FALSE TRUE hsa_miR_223_000526 27.468 28.773 15.22034.785 0.495 0.597 0.000 NA TRUE TRUE TRUE FALSE hsa_miR_22_00039827.805 24.403 30.737 25.335 0.724 0.097 0.994 0.202 TRUE TRUE TRUE TRUEhsa_miR_22_002301 29.328 29.533 29.132 30.107 0.482 0.575 0.570 0.729TRUE TRUE TRUE TRUE hsa_miR_23a_002439 38.796 39.294 28.613 41.955 NA NA0.001 NA FALSE FALSE TRUE FALSE hsa_miR_26b_002444 33.572 32.024 31.23633.868 NA 0.404 0.311 0.838 FALSE TRUE TRUE TRUE hsa_miR_27a_00244533.991 35.349 35.233 37.296 NA NA NA NA FALSE FALSE FALSE TRUEhsa_miR_27b_002174 34.186 33.247 33.389 34.129 NA 0.429 NA 0.643 FALSETRUE FALSE TRUE hsa_miR_28_3p_002446 37.121 37.725 37.345 37.774 NA NANA NA FALSE FALSE FALSE TRUE hsa_miR_299_5p_000600 29.902 37.773 32.23836.179 0.028 NA NA 0.798 TRUE FALSE FALSE TRUE hsa_miR_29a_002447 26.05227.242 24.052 26.836 0.559 0.819 0.222 0.719 TRUE TRUE TRUE TRUEhsa_miR_29b_2_002166 25.519 29.022 27.905 29.466 0.096 0.778 0.622 0.844TRUE TRUE TRUE TRUE hsa_miR_30a_3p_000416 20.644 20.331 20.356 20.7760.588 0.511 0.658 0.614 TRUE TRUE TRUE TRUE hsa_miR_30c_1_002108 37.94435.826 39.076 38.526 NA NA NA NA FALSE FALSE FALSE FALSEhsa_miR_30c_2_002110 28.241 38.668 37.794 34.723 0.001 NA NA 0.362 TRUEFALSE FALSE TRUE hsa_miR_30d_002305 30.742 28.457 29.160 30.321 0.8490.240 0.554 0.677 TRUE TRUE TRUE TRUE hsa_miR_30e_3p_000422 20.19020.373 18.882 20.676 0.599 0.659 0.373 0.719 TRUE TRUE TRUE TRUEhsa_miR_324_3p_000579 28.368 25.541 25.449 25.655 0.966 0.412 0.4800.362 TRUE TRUE TRUE TRUE hsa_miR_338_000548 27.266 22.604 25.289 23.5370.971 0.118 0.789 0.274 TRUE TRUE TRUE TRUE hsa_miR_338_5P_002658 24.02922.551 24.232 23.233 0.723 0.302 0.851 0.409 TRUE TRUE TRUE TRUEhsa_miR_33a_002136 35.133 29.937 30.568 29.366 NA 0.355 0.564 0.163FALSE TRUE TRUE TRUE hsa_miR_340_000550 23.506 23.449 24.239 23.6470.511 0.506 0.804 0.505 TRUE TRUE TRUE TRUE hsa_miR_363_001283 40.09533.199 37.805 37.736 NA 0.004 NA NA FALSE TRUE TRUE FALSEhsa_miR_376a_001287 24.347 28.975 25.870 25.621 0.149 0.976 0.610 0.471TRUE TRUE TRUE TRUE hsa_miR_378_000567 23.620 25.178 21.652 27.299 0.4350.645 0.158 0.982 TRUE TRUE TRUE TRUE hsa_miR_411_002238 24.657 28.97029.827 25.309 0.100 0.827 0.973 0.215 TRUE TRUE TRUE TRUEhsa_miR_412_001023 30.780 35.319 24.951 31.354 0.504 0.997 0.014 0.600TRUE TRUE TRUE TRUE hsa_miR_421_002700 22.200 22.945 23.999 23.005 0.3290.531 0.884 0.538 TRUE TRUE TRUE TRUE hsa_miR_423_3P_002626 29.56827.930 27.157 28.221 0.901 0.528 0.375 0.488 TRUE TRUE TRUE TRUEhsa_miR_425_001104 32.387 31.046 26.712 29.362 0.955 0.767 0.097 0.372TRUE TRUE TRUE TRUE hsa_miR_431_002312 32.157 37.151 32.333 34.027 0.184NA 0.362 0.622 TRUE FALSE TRUE TRUE hsa_miR_455_001280 31.707 27.39026.382 28.677 0.993 0.335 0.214 0.564 TRUE TRUE TRUE TRUEhsa_miR_485_5p_001036 35.747 36.568 34.541 35.670 NA 0.790 0.399 0.526FALSE TRUE TRUE TRUE hsa_miR_493_3p_001282 33.823 39.803 35.837 40.4030.037 NA 0.398 NA TRUE FALSE TRUE FALSE hsa_miR_590_3P_002677 40.55339.781 40.129 39.642 NA NA NA NA FALSE FALSE FALSE FALSEhsa_miR_653_002292 35.570 38.640 35.155 37.152 0.298 NA 0.346 NA TRUEFALSE TRUE TRUE hsa_miR_671_5p_197646_mat 29.677 32.567 29.854 38.2210.172 0.586 0.278 NA TRUE TRUE TRUE TRUE hsa_miR_708_002342 40.43640.199 36.808 39.872 NA NA NA NA FALSE FALSE TRUE FALSEhsa_miR_744_002325 29.906 32.132 29.147 31.138 0.398 0.869 0.342 0.703TRUE TRUE TRUE TRUE hsa_miR_875_5p_002203 29.170 31.613 23.935 37.1910.414 0.639 0.007 NA TRUE TRUE TRUE TRUE hsa_miR_935_002178 35.68935.255 35.413 35.777 NA 0.486 NA 0.617 FALSE TRUE FALSE TRUEhsa_miR_93_002139 26.818 24.833 25.487 25.510 0.875 0.352 0.635 0.460TRUE TRUE TRUE TRUE hsa_miR_99b_002196 32.682 29.792 31.883 31.331 0.8780.138 NA 0.468 TRUE TRUE FALSE TRUE hsa_miR_9_002231 20.922 17.33919.345 19.660 0.921 0.082 0.682 0.595 TRUE TRUE TRUE TRUEmmu_let_7a_000377 25.121 22.205 26.424 22.828 0.794 0.152 0.961 0.200TRUE TRUE TRUE TRUE mmu_let_7a_002478 27.040 24.472 25.460 26.910 0.8200.165 0.569 0.768 TRUE TRUE TRUE TRUE mmu_let_7b_000378 21.087 19.33620.589 21.251 0.671 0.211 0.708 0.746 TRUE TRUE TRUE TRUEmmu_let_7c_000379 20.610 18.852 20.133 20.102 0.763 0.252 0.756 0.553TRUE TRUE TRUE TRUE mmu_let_7c_1_002479 35.061 33.804 33.692 35.897 NA0.353 NA 0.895 FALSE TRUE FALSE TRUE mmu_let_7d_001178 34.147 31.55432.490 31.230 NA 0.382 NA 0.201 FALSE TRUE FALSE TRUE mmu_let_7d_00228321.499 20.703 21.447 21.426 0.618 0.414 0.740 0.579 TRUE TRUE TRUE TRUEmmu_let_7e_002406 19.033 19.032 18.704 19.049 0.591 0.618 0.608 0.549TRUE TRUE TRUE TRUE mmu_let_7f_000382 28.381 23.278 26.668 24.450 0.9690.081 0.829 0.266 TRUE TRUE TRUE TRUE mmu_let_7g_002282 20.687 20.74822.080 21.362 0.409 0.415 0.864 0.600 TRUE TRUE TRUE TRUEmmu_let_7g_002492 31.538 33.480 30.996 33.693 0.361 0.781 0.357 0.829TRUE TRUE TRUE TRUE mmu_let_7i_002221 22.310 20.755 22.444 22.311 0.6420.226 0.810 0.631 TRUE TRUE TRUE TRUE mmu_miR_100_000437 21.320 18.57520.961 20.198 0.835 0.128 0.825 0.473 TRUE TRUE TRUE TRUEmmu_miR_101a_002253 22.611 22.120 22.059 22.232 0.693 0.544 0.641 0.487TRUE TRUE TRUE TRUE mmu_miR_101a_002507 34.319 32.954 34.658 33.1520.727 0.366 NA 0.294 TRUE TRUE FALSE TRUE mmu_miR_101b_002531 23.13223.051 24.168 23.343 0.488 0.456 0.848 0.510 TRUE TRUE TRUE TRUEmmu_miR_103_000439 23.062 23.983 23.456 23.342 0.468 0.721 0.665 0.498TRUE TRUE TRUE TRUE mmu_miR_105_002465 35.643 36.454 28.902 34.276 NA NA0.024 0.459 FALSE FALSE TRUE TRUE mmu_miR_106a_002459 26.615 21.44121.190 21.951 0.998 0.335 0.341 0.413 TRUE TRUE TRUE TRUEmmu_miR_106b_000442 24.983 23.018 23.966 23.903 0.840 0.306 0.699 0.478TRUE TRUE TRUE TRUE mmu_miR_107_000443 25.300 25.893 27.235 25.745 0.3730.516 0.918 0.445 TRUE TRUE TRUE TRUE mmu_miR_10a_000387 23.708 26.10224.476 24.291 0.346 0.866 0.628 0.477 TRUE TRUE TRUE TRUEmmu_miR_10b_001181 29.264 32.944 32.007 28.448 0.336 0.934 NA 0.062 TRUETRUE FALSE TRUE mmu_miR_10b_002218 26.421 35.293 31.249 22.367 0.2770.997 0.826 0.001 TRUE TRUE TRUE TRUE mmu_miR_10b_002572 34.529 37.26334.417 35.584 NA NA NA 0.627 FALSE FALSE FALSE TRUE mmu_miR_1186_00282532.523 35.271 35.084 37.786 NA 0.521 0.657 NA FALSE TRUE TRUE FALSEmmu_miR_1188_002866 33.122 33.621 36.405 36.582 0.189 0.216 0.917 0.899TRUE TRUE TRUE TRUE mmu_miR_1191_002892 28.902 30.073 28.750 33.7730.308 0.492 0.375 0.996 TRUE TRUE TRUE TRUE mmu_miR_1192_002806 39.44639.327 39.732 37.831 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_1193_002794 28.907 32.400 31.853 32.430 0.084 0.782 NA 0.742TRUE TRUE FALSE TRUE mmu_miR_1194_002793 38.645 38.769 39.026 37.065 NANA NA NA FALSE FALSE FALSE TRUE mmu_miR_1195_002839 32.959 37.286 36.96638.911 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_1198_002780 28.23226.900 31.296 26.120 0.611 0.347 0.993 0.095 TRUE TRUE TRUE TRUEmmu_miR_1199_240984_mat 40.779 40.407 40.776 39.620 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_1224_240985_mat 40.569 40.300 40.616 39.214 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_122_002245 36.227 37.637 32.10638.209 NA NA 0.052 NA FALSE FALSE TRUE TRUE mmu_miR_124_001182 23.16423.414 24.104 22.933 0.541 0.576 0.826 0.360 TRUE TRUE TRUE TRUEmmu_miR_125a_3p_002199 26.699 26.213 26.085 26.534 0.664 0.532 0.6000.566 TRUE TRUE TRUE TRUE mmu_miR_125a_5p_002198 19.648 19.951 20.88519.731 0.473 0.539 0.857 0.426 TRUE TRUE TRUE TRUE mmu_miR_125b_00250827.982 28.087 29.434 29.015 0.367 0.384 0.860 0.685 TRUE TRUE TRUE TRUEmmu_miR_125b_3p_002378 31.114 30.269 29.950 32.016 0.591 0.415 0.4450.882 TRUE TRUE TRUE TRUE mmu_miR_125b_5p_000449 18.605 18.192 19.06218.646 0.559 0.449 0.797 0.534 TRUE TRUE TRUE TRUE mmu_miR_126_3p_00222821.279 24.181 20.259 22.698 0.367 0.925 0.271 0.708 TRUE TRUE TRUE TRUEmmu_miR_126_5p_000451 23.120 26.318 22.505 24.685 0.313 NA 0.309 NA TRUEFALSE TRUE FALSE mmu_miR_1274a_121150_mat 31.992 32.495 24.705 33.454 NANA 0.006 NA FALSE FALSE TRUE FALSE mmu_miR_127_000452 17.757 20.81819.687 17.827 0.298 0.913 0.794 0.245 TRUE TRUE TRUE TRUEmmu_miR_128a_002216 21.223 21.008 20.910 20.653 0.677 0.599 0.686 0.387TRUE TRUE TRUE TRUE mmu_miR_129_3p_001184 19.707 21.808 20.868 19.5850.430 0.839 0.734 0.287 TRUE TRUE TRUE TRUE mmu_miR_129_5p_000590 27.01028.204 30.022 27.169 0.325 0.559 0.971 0.298 TRUE TRUE TRUE TRUEmmu_miR_1306_121155_mat 35.808 35.958 35.514 35.068 NA NA NA 0.327 FALSEFALSE FALSE TRUE mmu_miR_130a_000454 28.741 22.626 28.602 24.793 0.9130.022 0.940 0.272 TRUE TRUE TRUE TRUE mmu_miR_130b_000456 29.944 27.09326.578 29.185 0.937 0.296 0.290 0.714 TRUE TRUE TRUE TRUEmmu_miR_130b_002460 28.591 31.823 29.783 28.383 0.371 0.939 0.705 0.221TRUE TRUE TRUE TRUE mmu_miR_132_000457 18.035 19.896 19.396 17.703 0.4540.804 0.787 0.237 TRUE TRUE TRUE TRUE mmu_miR_133a_001637 39.021 39.12639.251 38.610 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_133a_00224618.976 26.628 23.107 19.978 0.050 0.995 0.813 0.238 TRUE TRUE TRUE TRUEmmu_miR_133b_002247 23.603 27.595 26.324 24.681 0.123 0.932 0.809 0.378TRUE TRUE TRUE TRUE mmu_miR_134_001186 24.953 28.914 28.803 24.447 0.2560.891 0.937 0.072 TRUE TRUE TRUE TRUE mmu_miR_135a_000460 22.296 21.72022.947 21.224 0.670 0.481 0.875 0.242 TRUE TRUE TRUE TRUEmmu_miR_135b_002261 22.920 23.363 25.387 22.631 0.446 0.503 0.964 0.250TRUE TRUE TRUE TRUE mmu_miR_136_002511 24.804 25.342 28.027 23.107 0.5020.535 NA 0.067 TRUE TRUE FALSE TRUE mmu_miR_136_002512 27.928 33.35426.670 33.230 0.209 0.946 0.117 0.881 TRUE TRUE TRUE TRUEmmu_miR_137_001129 21.307 24.504 24.442 23.077 0.115 0.786 0.879 0.492TRUE TRUE TRUE TRUE mmu_miR_138_002284 16.359 20.181 19.959 17.325 0.1120.874 0.909 0.317 TRUE TRUE TRUE TRUE mmu_miR_138_002554 24.236 27.89825.725 25.031 0.220 0.941 0.669 0.417 TRUE TRUE TRUE TRUEmmu_miR_139_3p_002546 33.359 36.004 31.195 29.851 NA NA NA 0.050 FALSEFALSE FALSE TRUE mmu_miR_139_5p_002289 20.048 21.609 19.632 20.161 0.5120.834 0.498 0.500 TRUE TRUE TRUE TRUE mmu_miR_140_001187 23.036 22.72522.684 22.970 0.621 0.541 0.647 0.559 TRUE TRUE TRUE TRUEmmu_miR_141_000463 33.803 33.932 28.985 37.568 0.576 0.532 0.034 NA TRUETRUE TRUE TRUE mmu_miR_141_002513 28.188 32.907 24.416 35.162 0.296 NA0.017 NA TRUE FALSE TRUE FALSE mmu_miR_142_3p_000464 29.811 28.71119.522 32.652 NA NA 0.001 NA FALSE FALSE TRUE FALSEmmu_miR_142_5p_002248 32.005 32.756 25.253 38.885 0.511 0.568 0.004 NATRUE TRUE TRUE FALSE mmu_miR_143_002249 28.060 28.450 25.414 30.7500.535 0.568 0.152 NA TRUE TRUE TRUE FALSE mmu_miR_145_002278 27.75627.402 23.963 29.597 NA NA 0.103 NA FALSE FALSE TRUE FALSEmmu_miR_145_002514 37.933 39.523 40.040 39.638 NA NA NA NA FALSE FALSEFALSE FALSE mmu_miR_146a_000468 20.639 22.626 17.434 23.710 0.479 0.7560.071 0.945 TRUE TRUE TRUE TRUE mmu_miR_146b_001097 22.695 22.216 21.83922.482 0.687 0.567 0.545 0.563 TRUE TRUE TRUE TRUE mmu_miR_146b_00245331.794 31.415 31.443 33.050 0.481 0.401 NA 0.878 TRUE TRUE FALSE TRUEmmu_miR_147_002262 36.016 33.798 33.587 38.816 NA NA NA NA FALSE FALSEFALSE FALSE mmu_miR_148a_000470 26.811 25.080 30.850 26.539 0.497 0.136NA 0.390 TRUE TRUE FALSE TRUE mmu_miR_148b_000471 27.647 25.405 30.95426.787 0.600 0.121 0.994 0.323 TRUE TRUE TRUE TRUE mmu_miR_150_00047323.174 25.591 21.132 27.950 0.385 NA 0.109 NA TRUE FALSE TRUE FALSEmmu_miR_150_002570 36.223 39.715 36.964 39.714 0.180 NA NA NA TRUE FALSEFALSE FALSE mmu_miR_151_3p_001190 30.840 24.438 31.063 26.117 0.9070.032 0.954 0.222 TRUE TRUE TRUE TRUE mmu_miR_152_000475 26.857 22.88823.571 27.870 0.800 0.100 0.350 0.970 TRUE TRUE TRUE TRUEmmu_miR_153_001191 29.396 30.050 29.135 29.692 0.512 0.720 0.555 0.576TRUE TRUE TRUE TRUE mmu_miR_154_000477 31.574 35.290 32.145 29.713 0.494NA NA 0.040 TRUE FALSE FALSE TRUE mmu_miR_155_002571 28.988 26.56425.019 33.436 0.679 0.277 0.115 1.000 TRUE TRUE TRUE TRUEmmu_miR_15a_000389 27.748 23.050 23.786 25.578 0.984 0.126 0.409 0.641TRUE TRUE TRUE TRUE mmu_miR_15a_002488 32.231 31.428 32.252 32.864 0.5290.349 0.713 0.760 TRUE TRUE TRUE TRUE mmu_miR_15b_000390 25.296 22.56422.469 24.117 0.937 0.289 0.398 0.627 TRUE TRUE TRUE TRUEmmu_miR_16_000391 20.727 18.380 17.503 18.919 0.946 0.467 0.322 0.507TRUE TRUE TRUE TRUE mmu_miR_16_002489 35.351 29.781 26.776 33.488 NA0.261 0.053 0.763 FALSE TRUE TRUE TRUE mmu_miR_17_002308 25.016 21.09220.348 21.549 0.990 0.401 0.299 0.445 TRUE TRUE TRUE TRUEmmu_miR_17_002543 30.979 37.822 27.821 34.399 0.301 NA 0.039 0.727 TRUEFALSE TRUE TRUE mmu_miR_181A_2_002687 40.599 40.161 40.674 39.605 NA NANA NA FALSE FALSE FALSE FALSE mmu_miR_181a_000480 24.582 21.252 23.71022.198 0.912 0.152 0.833 0.308 TRUE TRUE TRUE TRUE mmu_miR_181c_00048228.994 27.339 28.014 27.754 0.831 0.403 0.690 0.402 TRUE TRUE TRUE TRUEmmu_miR_182_002599 22.728 26.575 23.162 23.594 0.255 0.969 0.494 0.513TRUE TRUE TRUE TRUE mmu_miR_1839_3p_121203_mat 24.447 24.082 25.14124.832 0.503 0.397 0.814 0.610 TRUE TRUE TRUE TRUEmmu_miR_1839_5p_121135_mat 24.912 24.707 28.820 25.164 0.353 0.322 0.9920.395 TRUE TRUE TRUE TRUE mmu_miR_183_002269 28.202 33.198 29.383 29.5200.152 0.988 0.535 0.497 TRUE TRUE TRUE TRUE mmu_miR_184_000485 28.73133.046 25.242 30.157 0.402 NA 0.059 0.691 TRUE FALSE TRUE TRUEmmu_miR_185_002271 26.081 26.282 32.052 25.770 0.382 0.406 0.999 0.208TRUE TRUE TRUE TRUE mmu_miR_186_002285 23.564 21.590 22.348 23.100 0.8200.276 0.606 0.630 TRUE TRUE TRUE TRUE mmu_miR_186_002574 28.670 30.83826.330 30.285 0.474 0.880 0.141 0.793 TRUE TRUE TRUE TRUEmmu_miR_187_001193 33.055 25.462 31.176 27.396 0.982 0.026 0.866 0.247TRUE TRUE TRUE TRUE mmu_miR_188_3p_002106 39.121 38.941 39.540 39.323 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_188_5p_002320 25.401 26.06422.115 27.573 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_1893_121170_mat 39.304 40.600 36.900 40.075 NA NA NA NA FALSEFALSE TRUE FALSE mmu_miR_1894_3p_241002_mat 27.801 30.706 25.968 33.3320.335 NA 0.109 NA TRUE FALSE TRUE FALSE mmu_miR_1894_5p_121144_mat38.271 36.354 38.706 39.612 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_1896_121128_mat 22.791 25.156 19.203 30.938 0.393 0.620 0.028 NATRUE TRUE TRUE FALSE mmu_miR_1897_3p_121126_mat 40.712 40.345 40.73339.619 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_1897_5p_121199_mat17.358 20.450 17.629 22.211 NA NA 0.349 NA FALSE FALSE TRUE FALSEmmu_miR_1898_121195_mat 40.754 40.130 40.752 39.621 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_1899_121198_mat 40.114 39.769 40.350 39.621 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_18a_002422 31.352 27.187 25.28327.985 0.994 0.407 0.166 0.540 TRUE TRUE TRUE TRUE mmu_miR_18a_00249033.913 32.190 29.459 33.745 0.865 0.482 0.136 0.792 TRUE TRUE TRUE TRUEmmu_miR_18b_002466 40.650 38.742 40.323 39.953 NA NA NA NA FALSE FALSEFALSE FALSE mmu_miR_1900_121143_mat 40.382 40.016 40.523 39.626 NA NA NANA FALSE FALSE FALSE FALSE mmu_miR_1901_121183_mat 33.367 34.836 38.44836.561 0.127 0.304 NA 0.702 TRUE TRUE FALSE TRUE mmu_miR_1902_121197_mat40.597 40.228 40.662 39.611 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_1903_121153_mat 40.379 36.811 35.263 40.133 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_1904_121162_mat 15.010 18.703 14.060 20.519 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_1905_121196_mat 25.376 28.00124.687 31.218 0.273 0.631 0.216 NA TRUE TRUE TRUE FALSEmmu_miR_1906_121169_mat 40.168 38.123 40.252 38.085 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_190_000489 26.239 24.859 25.449 25.666 0.7700.387 0.647 0.542 TRUE TRUE TRUE TRUE mmu_miR_191_002299 20.075 19.63219.418 19.673 0.705 0.575 0.594 0.484 TRUE TRUE TRUE TRUEmmu_miR_191_002576 31.390 30.572 30.354 31.978 0.618 0.434 0.486 0.810TRUE TRUE TRUE TRUE mmu_miR_1927_121193_mat 37.418 34.176 37.493 36.762NA 0.051 NA NA FALSE TRUE FALSE TRUE mmu_miR_1928_121164_mat 18.30923.066 19.404 28.506 0.065 0.675 0.263 NA TRUE TRUE TRUE FALSEmmu_miR_192_000491 25.904 23.854 25.070 25.323 0.809 0.230 0.702 0.588TRUE TRUE TRUE TRUE mmu_miR_1930_121201_mat 29.247 29.979 27.194 28.9800.710 0.816 0.275 0.527 TRUE TRUE TRUE TRUE mmu_miR_1931_121168_mat40.109 38.542 40.241 38.119 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_1932_121172_mat 32.634 29.164 34.172 35.153 NA 0.012 0.845 0.944FALSE TRUE TRUE TRUE mmu_miR_1933_3p_121145_mat 40.509 40.133 40.60539.601 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_1933_5p_121133_mat31.267 36.124 31.827 35.135 0.130 NA 0.326 0.800 TRUE FALSE TRUE TRUEmmu_miR_1934_121185_mat 38.764 30.581 38.675 39.556 NA 0.000 NA NA FALSETRUE FALSE FALSE mmu_miR_1935_121192_mat 37.587 39.820 40.427 38.135 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_1936_121158_mat 37.623 38.92539.390 38.950 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_1937b_241023_mat 19.684 21.650 18.534 24.192 0.359 NA 0.210 NATRUE FALSE TRUE FALSE mmu_miR_1937c_241011_mat 20.764 22.957 19.74825.354 0.335 NA 0.223 NA TRUE FALSE TRUE FALSE mmu_miR_1938_121194_mat38.858 38.707 39.286 39.541 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_1939_121180_mat 38.426 38.695 38.538 37.256 NA NA NA NA FALSEFALSE FALSE TRUE mmu_miR_193_002250 35.294 32.650 35.316 35.961 NA NA NANA FALSE FALSE FALSE FALSE mmu_miR_193_002577 30.351 30.720 31.80931.789 0.322 0.411 NA 0.756 TRUE TRUE FALSE TRUE mmu_miR_193b_00246722.479 21.410 24.489 22.163 0.549 0.266 0.960 0.389 TRUE TRUE TRUE TRUEmmu_miR_1940_121187_mat 38.067 39.190 32.253 39.388 NA NA 0.017 NA FALSEFALSE TRUE TRUE mmu_miR_1941_3p_121130_mat 38.834 38.716 39.340 39.579NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_1941_5p_121140_mat 32.25730.942 29.886 33.774 0.638 0.385 0.251 0.973 TRUE TRUE TRUE TRUEmmu_miR_1942_121136_mat 34.626 32.903 27.591 37.286 0.712 0.425 0.013 NATRUE TRUE TRUE TRUE mmu_miR_1943_121174_mat 34.816 31.883 32.801 32.777NA 0.253 NA 0.436 FALSE TRUE FALSE TRUE mmu_miR_1944_121189_mat 39.85838.519 40.370 38.606 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_1945_121166_mat 38.586 38.632 39.052 38.188 NA NA NA NA FALSEFALSE FALSE TRUE mmu_miR_1946a_121178_mat 41.116 41.011 29.608 38.214 NANA 0.002 NA FALSE FALSE TRUE FALSE mmu_miR_1947_121156_mat 38.479 35.56838.700 37.990 NA NA NA NA FALSE FALSE FALSE TRUE mmu_miR_1948_121171_mat34.678 37.569 36.859 36.217 0.175 NA NA 0.542 TRUE FALSE FALSE TRUEmmu_miR_1949_121182_mat 40.209 39.917 40.385 38.679 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_194_000493 26.451 23.960 23.957 25.288 0.9230.309 0.438 0.602 TRUE TRUE TRUE TRUE mmu_miR_1950_121146_mat 40.56140.166 40.607 39.643 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_1951_121165_mat 33.211 37.796 26.261 40.596 0.331 NA 0.001 NATRUE FALSE TRUE FALSE mmu_miR_1952_121167_mat 40.666 40.303 40.70939.621 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_1953_121159_mat39.568 39.198 39.936 39.588 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_1954_121137_mat 30.339 32.215 26.346 38.985 0.419 0.593 0.022 NATRUE TRUE TRUE FALSE mmu_miR_1956_121129_mat 37.850 36.225 37.633 35.738NA NA NA 0.181 FALSE FALSE FALSE TRUE mmu_miR_1957_121163_mat 40.77940.407 40.776 39.620 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_1958_121181_mat 38.999 39.003 39.333 37.052 NA NA NA NA FALSEFALSE FALSE TRUE mmu_miR_1959_121132_mat 27.990 31.239 25.584 33.6860.337 0.721 0.065 0.996 TRUE TRUE TRUE TRUE mmu_miR_195_000494 23.62819.832 20.314 22.240 0.966 0.158 0.403 0.678 TRUE TRUE TRUE TRUEmmu_miR_1960_121148_mat 36.936 33.980 36.872 36.795 NA 0.056 NA NA FALSETRUE FALSE TRUE mmu_miR_1961_197391_mat 23.108 29.697 27.375 37.5450.002 NA 0.439 NA TRUE FALSE TRUE FALSE mmu_miR_1962_121173_mat 38.82439.910 39.220 39.780 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_1963_121191_mat 40.779 40.407 40.776 39.620 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_1964_121138_mat 37.575 37.060 38.006 39.532 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_1965_121186_mat 40.795 40.41040.366 39.649 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_1966_121134_mat40.660 40.345 40.680 39.620 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_1967_121151_mat 40.021 40.401 40.778 39.673 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_1968_121179_mat 30.248 36.761 36.635 37.6430.002 NA 0.788 NA TRUE FALSE TRUE TRUE mmu_miR_1969_121131_mat 21.27425.058 18.341 26.745 0.336 0.792 0.043 0.985 TRUE TRUE TRUE TRUEmmu_miR_196a_002477 21.777 25.204 20.904 27.980 NA NA NA NA FALSE FALSEFALSE FALSE mmu_miR_196b_002215 34.768 38.244 31.439 33.210 NA NA 0.1300.280 FALSE FALSE TRUE TRUE mmu_miR_1970_121202_mat 32.780 40.987 31.26641.111 0.166 NA 0.058 NA TRUE FALSE TRUE FALSE mmu_miR_1971_121161_mat29.699 38.627 31.814 35.040 0.035 NA 0.354 0.702 TRUE FALSE TRUE TRUEmmu_miR_197_000497 32.912 34.297 26.123 35.535 NA 0.743 0.005 NA FALSETRUE TRUE FALSE mmu_miR_1981_121200_mat 28.065 29.920 29.937 28.0930.375 0.741 0.867 0.289 TRUE TRUE TRUE TRUE mmu_miR_1982.1_121157_mat30.826 31.427 30.776 30.341 0.607 0.731 0.655 0.343 TRUE TRUE TRUE TRUEmmu_miR_1982.2_121154_mat 27.576 31.319 26.539 29.548 0.312 0.956 0.2200.729 TRUE TRUE TRUE TRUE mmu_miR_199a_3p_002304 29.777 28.047 26.52329.533 0.858 0.452 0.221 0.757 TRUE TRUE TRUE TRUEmmu_miR_199a_5p_000498 34.724 34.590 36.359 34.891 NA 0.410 NA 0.464FALSE TRUE FALSE TRUE mmu_miR_199b_001131 35.176 37.688 36.650 36.005 NANA NA 0.475 FALSE FALSE FALSE TRUE mmu_miR_19a_000395 27.188 23.58623.321 25.452 0.972 0.255 0.312 0.638 TRUE TRUE TRUE TRUEmmu_miR_19a_002544 40.034 39.695 40.309 39.617 NA NA NA NA FALSE FALSEFALSE FALSE mmu_miR_19b_000396 23.294 20.144 19.669 20.797 0.975 0.3860.351 0.477 TRUE TRUE TRUE TRUE mmu_miR_1_002222 21.871 27.594 20.56323.178 0.288 0.998 0.181 0.605 TRUE TRUE TRUE TRUE mmu_miR_1_2_AS_00288235.345 28.481 26.118 34.981 0.967 0.209 0.051 0.877 TRUE TRUE TRUE TRUEmmu_miR_200a_000502 31.719 37.663 36.941 39.953 0.003 NA NA NA TRUEFALSE FALSE FALSE mmu_miR_200b_002251 31.231 31.741 30.026 34.919 NA0.494 NA NA FALSE TRUE FALSE FALSE mmu_miR_200c_002300 31.716 36.23032.300 37.303 NA NA 0.309 NA FALSE FALSE TRUE FALSE mmu_miR_201_00257836.148 38.928 39.538 39.763 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_202_3p_001195 36.927 36.113 33.539 38.039 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_202_5p_002579 33.390 31.430 36.135 37.191 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_203_000507 25.969 24.325 24.24727.330 0.632 0.271 0.397 0.965 TRUE TRUE TRUE TRUE mmu_miR_203_00258035.108 36.643 37.195 39.914 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_204_000508 21.447 17.333 19.260 21.373 0.882 0.039 0.545 0.838TRUE TRUE TRUE TRUE mmu_miR_205_000509 34.048 37.286 34.959 34.082 NA NANA 0.296 FALSE FALSE FALSE TRUE mmu_miR_207_001198 39.726 39.574 40.01338.300 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_208_000511 39.61634.309 38.909 39.531 NA 0.006 NA NA FALSE TRUE FALSE FALSEmmu_miR_208b_002290 32.923 39.937 34.748 39.077 0.039 NA 0.353 NA TRUEFALSE TRUE FALSE mmu_miR_20a_000580 23.656 20.751 19.671 21.382 0.9740.439 0.268 0.509 TRUE TRUE TRUE TRUE mmu_miR_20a_002491 34.777 30.02729.243 32.265 NA 0.253 0.197 0.654 FALSE TRUE TRUE TRUEmmu_miR_20b_001014 28.488 23.612 22.946 24.275 0.996 0.359 0.271 0.465TRUE TRUE TRUE TRUE mmu_miR_20b_002524 39.840 39.637 39.999 38.737 NA NANA NA FALSE FALSE FALSE FALSE mmu_miR_210_000512 35.629 29.576 31.13230.080 NA 0.181 NA 0.261 FALSE TRUE FALSE TRUE mmu_miR_211_001199 24.14522.814 22.479 24.265 0.734 0.416 0.422 0.765 TRUE TRUE TRUE TRUEmmu_miR_212_002551 20.874 22.679 22.638 20.192 0.475 0.768 0.876 0.141TRUE TRUE TRUE TRUE mmu_miR_2134_241120_mat 24.834 28.789 24.542 31.1200.173 NA 0.216 NA TRUE FALSE TRUE FALSE mmu_miR_2135_241140_mat 33.80638.244 37.114 39.303 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_2136_241133_mat 37.318 39.436 35.632 37.052 NA NA NA NA FALSEFALSE FALSE TRUE mmu_miR_2138_241080_mat 30.888 30.392 24.701 38.6420.567 0.473 0.009 NA TRUE TRUE TRUE TRUE mmu_miR_2139_241130_mat 36.92738.347 38.463 37.743 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_2146_241082_mat 25.772 30.577 26.557 34.080 0.078 NA 0.257 NATRUE FALSE TRUE FALSE mmu_miR_214_002306 34.389 35.010 32.191 36.076 NA0.660 0.199 0.912 FALSE TRUE TRUE TRUE mmu_miR_215_001200 35.445 31.87731.067 33.831 NA 0.292 NA 0.669 FALSE TRUE FALSE TRUEmmu_miR_216a_002220 30.048 37.348 31.795 29.662 0.270 NA 0.645 0.111TRUE FALSE TRUE TRUE mmu_miR_216b_002326 26.065 32.405 28.652 25.9020.203 0.996 0.761 0.125 TRUE TRUE TRUE TRUE mmu_miR_217_001133 31.55435.319 29.570 32.348 0.427 NA 0.157 0.608 TRUE FALSE TRUE TRUEmmu_miR_217_002556 31.155 32.594 29.283 30.120 0.732 0.900 0.315 0.345TRUE TRUE TRUE TRUE mmu_miR_2182_241119_mat 31.778 35.018 35.966 36.2660.055 NA NA NA TRUE FALSE FALSE FALSE mmu_miR_2183_241095_mat 27.25029.961 25.247 34.319 0.337 NA 0.086 NA TRUE FALSE TRUE FALSEmmu_miR_218_000521 15.816 20.069 20.109 18.091 0.053 0.825 0.920 0.437TRUE TRUE TRUE TRUE mmu_miR_218_1_002552 27.788 31.808 30.423 28.2790.177 0.945 0.822 0.263 TRUE TRUE TRUE TRUE mmu_miR_219_000522 30.74822.905 27.038 23.221 NA 0.117 0.801 0.125 FALSE TRUE TRUE TRUEmmu_miR_21_000397 22.751 20.844 18.683 21.333 0.942 0.544 0.195 0.565TRUE TRUE TRUE TRUE mmu_miR_21_002493 36.705 35.839 36.208 35.769 NA NANA 0.368 FALSE FALSE FALSE TRUE mmu_miR_220_002468 40.660 40.316 40.69139.348 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_221_000524 24.00121.593 22.265 23.310 0.881 0.245 0.543 0.638 TRUE TRUE TRUE TRUEmmu_miR_222_002276 21.201 20.667 20.026 20.960 0.723 0.579 0.475 0.579TRUE TRUE TRUE TRUE mmu_miR_223_002295 29.089 31.997 17.947 35.498 0.428NA 0.000 NA TRUE FALSE TRUE FALSE mmu_miR_224_002553 32.228 29.99132.008 31.560 0.779 0.169 NA 0.524 TRUE TRUE FALSE TRUEmmu_miR_23a_000399 38.256 37.681 38.710 39.541 NA NA NA NA FALSE FALSEFALSE FALSE mmu_miR_23b_000400 24.939 23.136 23.435 24.304 0.843 0.3360.547 0.601 TRUE TRUE TRUE TRUE mmu_miR_24_000402 18.998 19.268 18.38419.273 0.571 0.671 0.502 0.614 TRUE TRUE TRUE TRUE mmu_miR_24_2_00249427.423 26.213 25.855 28.226 0.639 0.386 0.406 0.889 TRUE TRUE TRUE TRUEmmu_miR_25_000403 26.882 23.960 23.313 26.221 0.937 0.285 0.259 0.749TRUE TRUE TRUE TRUE mmu_miR_26a_000405 19.177 17.911 17.801 18.582 0.8050.454 0.526 0.562 TRUE TRUE TRUE TRUE mmu_miR_26b_000407 21.789 19.68919.536 21.076 0.892 0.345 0.421 0.640 TRUE TRUE TRUE TRUEmmu_miR_27a_000408 23.456 21.793 22.832 24.680 0.573 0.190 0.614 0.931TRUE TRUE TRUE TRUE mmu_miR_27b_000409 22.422 21.502 22.410 21.611 0.7090.457 0.796 0.361 TRUE TRUE TRUE TRUE mmu_miR_28_000411 24.637 23.16423.167 26.535 0.590 0.265 0.415 0.978 TRUE TRUE TRUE TRUEmmu_miR_28_002545 26.622 29.680 28.827 30.317 0.124 0.726 0.637 0.856TRUE TRUE TRUE TRUE mmu_miR_290_000187 39.287 39.601 24.958 41.533 NA NA0.000 NA FALSE FALSE TRUE FALSE mmu_miR_290_3p_002591 40.705 40.33440.729 39.619 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_290_5p_00259037.325 36.079 33.962 38.083 NA 0.468 NA NA FALSE TRUE FALSE TRUEmmu_miR_291_3p_001135 40.674 40.359 40.671 38.800 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_291_5p_001202 40.658 40.344 40.686 39.613 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_291a_3p_002592 40.712 40.34340.735 39.620 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_291b_3p_00253840.268 39.913 40.449 39.616 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_291b_5p_002537 40.802 40.420 40.795 39.653 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_292_3p_001054 39.757 40.471 40.569 39.822 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_292_3p_002593 37.329 35.76833.538 36.540 NA 0.539 0.190 NA FALSE TRUE TRUE FALSEmmu_miR_292_5p_001055 38.946 34.584 38.600 39.977 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_293_001794 35.456 36.244 30.953 36.610 NA NA0.055 0.854 FALSE FALSE TRUE TRUE mmu_miR_293_002594 39.272 38.55339.580 37.980 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_294_00105638.715 36.370 34.327 40.025 NA NA 0.128 NA FALSE FALSE TRUE FALSEmmu_miR_294_002595 40.779 40.407 40.776 39.620 NA NA NA NA FALSE FALSEFALSE FALSE mmu_miR_295_000189 38.981 38.889 37.797 39.785 NA NA NA NAFALSE FALSE FALSE FALSE mmu_miR_295_002596 41.119 40.867 34.183 40.117NA NA 0.023 NA FALSE FALSE TRUE FALSE mmu_miR_296_3p_002101 36.26235.884 36.232 39.131 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_296_5p_000527 24.300 24.992 28.026 25.671 0.210 0.369 NA 0.566TRUE TRUE FALSE TRUE mmu_miR_297a_002454 31.680 29.002 31.750 31.6910.698 0.076 0.827 0.696 TRUE TRUE TRUE TRUE mmu_miR_297b_5p_00162638.154 36.702 38.584 39.546 NA NA NA NA FALSE TRUE FALSE FALSEmmu_miR_297c_002480 35.366 34.247 35.620 36.814 NA 0.210 NA NA FALSETRUE FALSE TRUE mmu_miR_298_002598 31.634 34.349 31.848 28.722 0.5980.953 NA 0.016 TRUE TRUE FALSE TRUE mmu_miR_299_002612 40.779 40.40740.776 39.620 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_29a_00211219.161 19.807 20.212 18.938 0.508 0.637 0.821 0.334 TRUE TRUE TRUE TRUEmmu_miR_29b_000413 21.629 24.117 23.945 23.070 0.190 0.763 0.822 0.529TRUE TRUE TRUE TRUE mmu_miR_29b_002497 25.614 26.667 22.986 29.804 0.474NA 0.103 NA TRUE FALSE TRUE FALSE mmu_miR_29c_000587 21.034 22.10422.771 21.397 0.379 0.631 0.864 0.412 TRUE TRUE TRUE TRUEmmu_miR_300_000191 27.480 30.709 30.748 27.987 0.184 0.823 NA 0.271 TRUETRUE FALSE TRUE mmu_miR_300_002613 29.809 35.221 32.721 32.235 0.057 NANA 0.494 TRUE FALSE FALSE TRUE mmu_miR_301a_000528 24.920 23.709 24.17824.297 0.762 0.428 0.660 0.502 TRUE TRUE TRUE TRUE mmu_miR_301b_00260023.624 22.973 24.039 23.249 0.634 0.430 0.824 0.423 TRUE TRUE TRUE TRUEmmu_miR_302a_000529 26.977 31.723 25.356 28.214 0.334 0.993 0.163 0.631TRUE TRUE TRUE TRUE mmu_miR_302a_002615 34.844 37.421 37.131 37.606 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_302b_000531 33.904 33.17435.800 34.292 NA 0.267 NA NA FALSE TRUE FALSE FALSE mmu_miR_302b_00130739.725 39.648 34.500 40.069 NA NA 0.053 NA FALSE FALSE TRUE FALSEmmu_miR_302c_002557 38.167 36.546 40.449 39.965 NA 0.082 NA NA FALSETRUE FALSE FALSE mmu_miR_302c_002558 37.423 36.512 33.955 38.827 NA NA0.157 NA FALSE FALSE TRUE FALSE mmu_miR_302d_000535 35.291 36.049 36.79236.616 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_30a_000417 21.69820.137 20.265 21.016 0.832 0.393 0.554 0.562 TRUE TRUE TRUE TRUEmmu_miR_30b_000602 17.475 17.380 17.142 17.355 0.614 0.606 0.624 0.519TRUE TRUE TRUE TRUE mmu_miR_30b_002498 36.132 34.886 36.121 35.905 NA0.321 NA 0.558 FALSE TRUE FALSE TRUE mmu_miR_30c_000419 17.116 16.96616.927 16.891 0.621 0.575 0.689 0.474 TRUE TRUE TRUE TRUEmmu_miR_30d_000420 23.825 22.193 23.057 23.532 0.747 0.299 0.665 0.628TRUE TRUE TRUE TRUE mmu_miR_30e_002223 21.736 20.479 21.089 21.616 0.6940.366 0.642 0.644 TRUE TRUE TRUE TRUE mmu_miR_31_000185 25.626 27.06926.014 26.001 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_31_00249528.358 29.511 27.044 27.678 0.700 0.847 0.402 0.377 TRUE TRUE TRUE TRUEmmu_miR_320_002277 21.156 19.411 20.620 20.927 0.727 0.245 0.720 0.642TRUE TRUE TRUE TRUE mmu_miR_322_001059 31.125 30.989 27.236 30.603 0.8360.770 0.123 0.569 TRUE TRUE TRUE TRUE mmu_miR_322_001076 35.284 27.16926.585 26.663 NA 0.430 0.324 0.261 FALSE TRUE TRUE TRUEmmu_miR_322_002506 33.990 30.829 28.704 28.871 0.992 0.614 0.290 0.214TRUE TRUE TRUE TRUE mmu_miR_323_3p_002227 25.537 28.141 28.960 25.1950.313 0.758 0.961 0.127 TRUE TRUE TRUE TRUE mmu_miR_324_3p_002509 27.42025.593 28.723 25.850 0.725 0.262 0.951 0.216 TRUE TRUE TRUE TRUEmmu_miR_324_5p_000539 25.924 24.992 25.826 24.829 0.732 0.483 0.8000.301 TRUE TRUE TRUE TRUE mmu_miR_325_001060 32.862 30.823 25.244 30.8590.967 0.653 0.031 0.537 TRUE TRUE TRUE TRUE mmu_miR_325_002510 26.74527.111 32.150 26.365 0.389 0.430 NA 0.187 TRUE TRUE FALSE TRUEmmu_miR_326_001061 36.948 38.300 20.219 34.048 NA NA 0.000 0.351 FALSEFALSE TRUE TRUE mmu_miR_327_002481 39.744 39.792 40.626 39.733 NA NA NANA FALSE FALSE FALSE FALSE mmu_miR_328_000543 19.530 20.759 20.60620.132 0.377 0.695 0.750 0.510 TRUE TRUE TRUE TRUE mmu_miR_329_00019225.707 28.477 29.202 26.116 0.214 0.755 0.951 0.264 TRUE TRUE TRUE TRUEmmu_miR_32_002109 35.828 28.818 29.159 30.486 NA 0.174 0.349 0.526 FALSETRUE TRUE TRUE mmu_miR_330_001062 31.613 37.408 33.542 34.761 NA NA0.511 0.641 FALSE FALSE TRUE TRUE mmu_miR_330_002230 33.887 35.39831.767 33.041 0.739 0.903 0.264 0.381 TRUE TRUE TRUE TRUEmmu_miR_331_3p_000545 21.656 22.319 23.293 22.730 0.320 0.504 0.8520.627 TRUE TRUE TRUE TRUE mmu_miR_331_5p_002233 27.229 27.501 25.15931.110 0.496 0.484 0.184 0.997 TRUE TRUE TRUE TRUE mmu_miR_335_3p_00218525.593 29.003 31.297 24.093 0.318 0.738 NA 0.021 TRUE TRUE FALSE TRUEmmu_miR_335_5p_000546 20.861 24.311 23.122 21.683 0.189 0.914 0.7860.375 TRUE TRUE TRUE TRUE mmu_miR_337_000193 25.962 27.401 28.392 26.6760.281 0.613 0.919 0.434 TRUE TRUE TRUE TRUE mmu_miR_337_3p_002532 25.48127.726 28.505 26.162 0.224 0.697 0.938 0.358 TRUE TRUE TRUE TRUEmmu_miR_337_5p_002515 21.915 24.957 25.898 25.164 0.081 0.625 0.9130.650 TRUE TRUE TRUE TRUE mmu_miR_338_3p_002252 28.573 23.817 28.41624.306 0.909 0.121 0.936 0.152 TRUE TRUE TRUE TRUE mmu_miR_339_3p_00253332.270 28.192 27.526 30.403 0.982 0.259 0.222 0.673 TRUE TRUE TRUE TRUEmmu_miR_339_5p_002257 33.696 27.922 28.878 29.064 0.997 0.167 0.5050.432 TRUE TRUE TRUE TRUE mmu_miR_340_3p_002259 23.516 23.383 23.77723.630 0.544 0.525 0.740 0.542 TRUE TRUE TRUE TRUE mmu_miR_340_5p_00225822.685 21.831 23.300 22.327 0.624 0.368 0.858 0.439 TRUE TRUE TRUE TRUEmmu_miR_342_3p_002260 21.459 22.717 21.021 21.081 0.597 0.822 0.5410.380 TRUE TRUE TRUE TRUE mmu_miR_342_5p_002527 32.442 32.170 31.71129.804 0.801 0.715 NA 0.088 TRUE TRUE FALSE TRUE mmu_miR_343_00248340.770 40.406 40.771 39.668 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_344_001063 26.914 26.244 29.304 25.831 0.582 0.392 0.975 0.176TRUE TRUE TRUE TRUE mmu_miR_345_001137 26.300 24.825 26.214 26.402 0.6310.243 0.770 0.687 TRUE TRUE TRUE TRUE mmu_miR_345_3p_002529 32.92930.769 32.058 31.965 NA 0.234 NA 0.509 FALSE TRUE FALSE TRUEmmu_miR_345_5p_002528 30.664 26.774 31.071 27.911 0.862 0.087 0.9400.244 TRUE TRUE TRUE TRUE mmu_miR_346_001064 35.876 37.331 36.678 36.125NA NA NA 0.439 FALSE FALSE FALSE TRUE mmu_miR_34a_000426 18.770 23.40021.626 19.254 0.153 0.965 0.829 0.233 TRUE TRUE TRUE TRUEmmu_miR_34b_001065 32.898 31.491 31.978 33.863 0.596 0.273 0.546 0.908TRUE TRUE TRUE TRUE mmu_miR_34b_3p_002618 22.661 21.800 24.385 23.6440.403 0.211 0.901 0.715 TRUE TRUE TRUE TRUE mmu_miR_34b_5p_002617 29.58729.940 30.812 32.273 0.311 0.341 NA 0.933 TRUE TRUE FALSE TRUEmmu_miR_34c_000428 24.984 24.061 30.994 26.306 0.257 0.132 0.999 0.610TRUE TRUE TRUE TRUE mmu_miR_34c_002584 25.127 24.564 26.480 26.516 0.3830.241 0.850 0.816 TRUE TRUE TRUE TRUE mmu_miR_350_002530 28.443 24.74225.919 25.830 0.970 0.189 0.622 0.420 TRUE TRUE TRUE TRUEmmu_miR_351_001067 36.990 36.649 37.191 36.818 NA NA NA NA FALSE FALSEFALSE TRUE mmu_miR_361_000554 23.226 23.218 23.997 23.240 0.526 0.5260.810 0.454 TRUE TRUE TRUE TRUE mmu_miR_362_3p_002616 29.143 26.04624.541 27.146 0.974 0.407 0.206 0.589 TRUE TRUE TRUE TRUEmmu_miR_362_5p_002614 27.218 26.025 25.038 26.850 0.815 0.522 0.3360.653 TRUE TRUE TRUE TRUE mmu_miR_363_001271 34.901 35.817 35.924 35.922NA NA NA 0.641 FALSE FALSE FALSE TRUE mmu_miR_365_001020 28.515 22.80128.738 26.247 0.875 0.008 0.933 0.383 TRUE TRUE TRUE TRUEmmu_miR_367_000555 23.509 20.741 22.536 22.063 0.884 0.168 0.769 0.453TRUE TRUE TRUE TRUE mmu_miR_369_3p_000557 25.317 27.740 27.202 25.4590.329 0.833 0.814 0.297 TRUE TRUE TRUE TRUE mmu_miR_369_5p_001021 28.65733.050 30.290 29.089 0.219 0.976 0.683 0.302 TRUE TRUE TRUE TRUEmmu_miR_370_001068 36.861 36.610 37.089 36.043 NA NA NA 0.288 FALSEFALSE FALSE TRUE mmu_miR_370_002275 26.763 29.245 31.622 25.539 0.3610.675 0.993 0.041 TRUE TRUE TRUE TRUE mmu_miR_374_002043 35.132 35.76436.212 40.845 0.253 0.329 NA NA TRUE TRUE FALSE FALSEmmu_miR_374_5p_001319 34.579 25.126 28.482 25.368 1.000 0.135 0.7260.131 TRUE TRUE TRUE TRUE mmu_miR_375_000564 27.321 24.201 28.854 27.4830.607 0.028 0.932 0.639 TRUE TRUE TRUE TRUE mmu_miR_376a_001069 20.80523.784 23.358 21.174 0.245 0.859 0.862 0.281 TRUE TRUE TRUE TRUEmmu_miR_376a_002482 26.076 30.398 27.854 26.617 0.197 0.971 0.706 0.317TRUE TRUE TRUE TRUE mmu_miR_376b_002451 21.874 24.907 24.508 22.3720.221 0.858 0.865 0.305 TRUE TRUE TRUE TRUE mmu_miR_376b_002452 25.52028.888 29.909 25.773 0.177 0.773 0.976 0.193 TRUE TRUE TRUE TRUEmmu_miR_376c_002450 21.766 23.756 23.879 22.471 0.280 0.715 0.866 0.423TRUE TRUE TRUE TRUE mmu_miR_376c_002523 38.055 39.234 40.519 40.097 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_377_000566 32.446 32.807 33.19633.281 0.407 0.527 NA 0.672 TRUE TRUE FALSE TRUE mmu_miR_379_00113822.106 25.162 25.346 23.238 0.139 0.784 0.913 0.398 TRUE TRUE TRUE TRUEmmu_miR_380_3p_001071 30.486 36.926 32.914 32.247 0.073 NA NA 0.427 TRUEFALSE FALSE TRUE mmu_miR_380_5p_002601 24.184 28.762 27.336 25.226 0.0940.953 0.833 0.324 TRUE TRUE TRUE TRUE mmu_miR_381_000571 27.886 29.66828.167 28.382 0.410 0.821 0.581 0.536 TRUE TRUE TRUE TRUEmmu_miR_382_000572 20.778 24.724 28.808 20.142 0.237 0.700 0.998 0.051TRUE TRUE TRUE TRUE mmu_miR_383_001767 23.437 28.223 27.018 23.664 0.1460.961 0.876 0.172 TRUE TRUE TRUE TRUE mmu_miR_384_3p_002603 23.61925.238 25.061 23.639 0.411 0.750 0.811 0.322 TRUE TRUE TRUE TRUEmmu_miR_384_5p_002602 18.345 20.403 19.959 18.148 0.410 0.809 0.8090.249 TRUE TRUE TRUE TRUE mmu_miR_409_3p_002332 22.085 25.320 24.97222.624 0.194 NA NA 0.294 TRUE FALSE FALSE TRUE mmu_miR_409_5p_00233129.518 34.225 31.925 29.316 0.246 0.977 NA 0.132 TRUE TRUE FALSE TRUEmmu_miR_410_001274 20.161 23.158 23.569 20.333 0.223 0.798 0.943 0.217TRUE TRUE TRUE TRUE mmu_miR_411_001610 20.584 22.914 23.126 21.221 0.2490.741 0.895 0.366 TRUE TRUE TRUE TRUE mmu_miR_412_002575 25.140 30.51830.482 25.782 0.078 0.906 0.952 0.189 TRUE TRUE TRUE TRUEmmu_miR_423_5p_002340 30.466 27.801 29.204 28.226 0.909 0.276 0.7620.302 TRUE TRUE TRUE TRUE mmu_miR_425_001516 18.851 21.662 16.661 25.6340.346 0.647 0.075 1.000 TRUE TRUE TRUE TRUE mmu_miR_429_001077 34.93037.298 34.723 38.088 NA NA 0.351 NA FALSE FALSE TRUE TRUEmmu_miR_431_001979 33.814 32.845 31.658 27.380 0.921 0.782 NA 0.003 TRUETRUE FALSE TRUE mmu_miR_432_241135_mat 35.801 36.966 38.337 37.508 NA NANA NA FALSE FALSE FALSE TRUE mmu_miR_433_001028 20.179 23.825 23.43920.606 0.178 0.888 0.898 0.237 TRUE TRUE TRUE TRUE mmu_miR_433_5p_00107830.375 35.965 29.787 31.137 0.286 NA 0.291 0.502 TRUE FALSE TRUE TRUEmmu_miR_434_3p_002604 18.234 21.249 19.807 18.237 0.340 0.917 0.7500.246 TRUE TRUE TRUE TRUE mmu_miR_434_5p_002581 24.507 28.480 27.47525.019 0.160 0.934 0.853 0.255 TRUE TRUE TRUE TRUE mmu_miR_448_00102928.304 33.346 30.590 28.353 0.212 0.986 0.771 0.173 TRUE TRUE TRUE TRUEmmu_miR_449a_001030 27.725 28.761 25.362 29.015 0.541 0.769 0.176 0.831TRUE TRUE TRUE TRUE mmu_miR_449b_001667 29.951 32.432 29.427 32.2410.327 0.844 0.330 0.805 TRUE TRUE TRUE TRUE mmu_miR_449b_002539 40.71140.345 40.736 39.620 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_450B_3P_002632 34.541 34.539 28.340 33.043 NA 0.845 0.042 0.468FALSE TRUE TRUE TRUE mmu_miR_450a_3p_002525 40.779 40.407 40.776 39.620NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_450a_5p_002303 33.816 31.46832.812 32.601 NA 0.230 NA 0.477 FALSE TRUE FALSE TRUEmmu_miR_450b_5p_001962 40.528 40.169 40.614 39.617 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_451_001141 34.722 32.232 29.234 39.399 NA NA0.049 NA FALSE FALSE TRUE FALSE mmu_miR_452_001032 36.669 35.070 32.30134.894 NA NA 0.172 0.479 FALSE FALSE TRUE TRUE mmu_miR_453_002484 39.56239.369 39.948 38.935 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_455_002455 34.544 27.947 29.791 28.553 NA 0.154 0.646 0.256FALSE TRUE TRUE TRUE mmu_miR_463_002582 27.834 30.557 26.058 34.1860.332 NA 0.108 NA TRUE FALSE TRUE FALSE mmu_miR_463_002662 32.696 35.61530.031 37.548 NA NA 0.063 NA FALSE FALSE TRUE FALSE mmu_miR_464_00108140.260 39.976 40.420 39.610 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_465C_5P_002654 27.488 34.074 26.941 35.262 0.121 NA 0.126 NATRUE FALSE TRUE FALSE mmu_miR_465a_3p_002040 32.197 35.521 35.325 33.2230.140 0.840 NA 0.376 TRUE TRUE FALSE TRUE mmu_miR_465a_5p_001082 38.07831.114 37.052 39.259 NA 0.001 NA NA FALSE TRUE TRUE FALSEmmu_miR_465b_5p_002485 33.795 36.924 30.696 33.397 NA NA NA 0.433 FALSEFALSE FALSE TRUE mmu_miR_466E_5P_002718 34.009 32.512 25.828 34.7850.783 0.516 0.009 0.948 TRUE TRUE TRUE TRUE mmu_miR_466J_002817 32.15830.298 31.384 32.447 0.690 0.207 NA 0.793 TRUE TRUE FALSE TRUEmmu_miR_466a_3p_002586 31.405 27.770 32.036 30.440 0.792 0.032 NA 0.482TRUE TRUE FALSE TRUE mmu_miR_466b_3_3p_002500 32.011 28.743 31.91230.742 0.839 0.074 NA 0.458 TRUE TRUE FALSE TRUE mmu_miR_466d_5p_00253434.250 37.227 35.285 35.714 NA NA 0.586 0.617 FALSE TRUE TRUE TRUEmmu_miR_466g_241015_mat 35.780 32.194 37.048 36.680 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_466h_002516 36.720 35.351 36.680 34.987 NA0.428 NA 0.210 FALSE TRUE FALSE TRUE mmu_miR_466k_240990_mat 31.86936.174 29.194 35.851 0.322 0.942 0.055 0.871 TRUE TRUE TRUE TRUEmmu_miR_467F_002886 30.823 28.068 25.607 30.661 NA NA 0.118 NA FALSEFALSE TRUE FALSE mmu_miR_467H_002809 35.688 31.163 34.289 33.569 NA0.041 NA 0.472 FALSE TRUE FALSE TRUE mmu_miR_467a_001826 28.224 25.53529.254 29.010 0.553 0.044 0.873 0.791 TRUE TRUE TRUE TRUEmmu_miR_467a_002587 27.427 24.764 30.760 27.354 0.526 0.047 0.993 0.503TRUE TRUE TRUE TRUE mmu_miR_467b_001671 33.237 28.109 31.912 29.9320.956 0.047 NA 0.329 TRUE TRUE FALSE TRUE mmu_miR_467b_001684 29.22030.182 27.116 32.731 0.478 0.580 0.165 0.988 TRUE TRUE TRUE TRUEmmu_miR_467c_002517 32.292 27.982 31.406 33.290 0.698 0.015 NA 0.937TRUE TRUE FALSE TRUE mmu_miR_467d_002518 32.683 30.286 31.325 33.3920.705 0.146 NA 0.909 TRUE TRUE FALSE TRUE mmu_miR_467e_002568 29.54027.406 25.368 29.772 0.839 0.382 0.161 0.888 TRUE TRUE TRUE TRUEmmu_miR_467e_002569 39.520 39.678 38.066 37.865 NA NA NA NA FALSE FALSEFALSE FALSE mmu_miR_468_001085 40.237 40.133 40.332 39.662 NA NA NA NAFALSE FALSE FALSE FALSE mmu_miR_469_001086 39.130 39.516 39.226 35.650NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_470_002588 39.083 38.98439.534 39.024 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_470_00258934.099 30.637 26.014 36.689 0.784 0.312 0.015 NA TRUE TRUE TRUE TRUEmmu_miR_471_002605 40.363 40.038 40.509 39.206 NA NA NA NA FALSE FALSEFALSE FALSE mmu_miR_483_001291 35.848 37.737 30.555 38.260 NA NA 0.017NA FALSE FALSE TRUE FALSE mmu_miR_483_002560 36.720 37.308 37.096 39.545NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_484_001821 21.593 19.82119.846 20.566 0.870 0.391 0.527 0.536 TRUE TRUE TRUE TRUEmmu_miR_485_3p_001943 21.271 23.481 23.929 22.164 0.222 0.707 0.9020.424 TRUE TRUE TRUE TRUE mmu_miR_486_001278 30.587 24.633 32.254 24.3160.849 0.149 NA 0.070 TRUE TRUE FALSE TRUE mmu_miR_487b_001285 21.55323.904 23.491 22.514 0.245 0.788 0.797 0.474 TRUE TRUE TRUE TRUEmmu_miR_487b_001306 23.472 24.851 25.981 23.208 0.398 0.632 0.950 0.215TRUE TRUE TRUE TRUE mmu_miR_488_001659 30.015 29.381 31.520 29.927 0.5320.339 NA 0.441 TRUE TRUE FALSE TRUE mmu_miR_488_002014 36.722 37.58636.788 38.553 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_489_00130224.782 30.644 26.602 26.022 0.115 0.994 0.609 0.411 TRUE TRUE TRUE TRUEmmu_miR_490_001037 34.460 37.250 31.550 29.778 0.797 NA 0.344 0.026 TRUEFALSE TRUE TRUE mmu_miR_491_001630 25.556 28.057 29.451 26.264 0.1860.661 0.975 0.315 TRUE TRUE TRUE TRUE mmu_miR_493_002519 32.532 35.27634.029 35.663 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_494_00129336.178 34.718 35.857 35.363 NA 0.343 NA 0.440 FALSE TRUE FALSE TRUEmmu_miR_494_002365 30.331 32.000 31.697 31.179 0.314 0.739 NA 0.522 TRUETRUE FALSE TRUE mmu_miR_495_001663 18.735 21.612 21.168 18.746 0.3020.862 0.863 0.214 TRUE TRUE TRUE TRUE mmu_miR_496_001953 32.882 30.91431.855 28.407 0.905 0.503 NA 0.034 TRUE TRUE FALSE TRUEmmu_miR_497_001346 29.645 23.883 26.612 27.522 0.979 0.019 0.587 0.625TRUE TRUE TRUE TRUE mmu_miR_499_001352 33.524 35.272 30.975 31.824 0.7850.939 0.239 0.265 TRUE TRUE TRUE TRUE mmu_miR_500_002606 31.136 27.44926.448 27.684 0.989 0.449 0.276 0.422 TRUE TRUE TRUE TRUEmmu_miR_501_001356 35.848 37.612 37.167 37.116 NA NA NA NA FALSE FALSEFALSE TRUE mmu_miR_501_3p_001651 28.632 26.429 25.461 26.115 0.954 0.5520.360 0.362 TRUE TRUE TRUE TRUE mmu_miR_503_002456 35.490 33.449 34.92633.837 NA 0.306 NA 0.316 FALSE TRUE FALSE TRUE mmu_miR_503_002536 34.90932.622 30.234 33.746 NA 0.475 0.148 0.657 FALSE TRUE TRUE TRUEmmu_miR_504_002084 33.539 35.757 33.286 33.431 0.499 0.895 NA 0.402 TRUETRUE FALSE TRUE mmu_miR_505_001655 38.563 38.523 39.008 39.606 NA NA NANA FALSE FALSE FALSE FALSE mmu_miR_509_3p_002521 34.418 38.474 36.15541.171 NA NA 0.438 NA FALSE FALSE TRUE FALSE mmu_miR_509_5p_00252035.148 39.872 40.214 40.015 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_511_002549 38.873 38.235 36.445 39.701 NA NA 0.235 NA FALSEFALSE TRUE FALSE mmu_miR_532_3p_002355 24.706 23.419 22.585 24.339 0.8170.495 0.357 0.654 TRUE TRUE TRUE TRUE mmu_miR_532_5p_001518 23.87121.515 21.110 22.417 0.935 0.400 0.378 0.545 TRUE TRUE TRUE TRUEmmu_miR_539_001286 22.369 24.949 24.761 22.838 0.267 0.801 0.865 0.332TRUE TRUE TRUE TRUE mmu_miR_540_3p_001310 31.949 35.794 32.473 32.5400.280 NA NA 0.445 TRUE FALSE FALSE TRUE mmu_miR_540_5p_002561 32.08634.072 32.194 32.494 0.424 0.846 NA 0.515 TRUE TRUE FALSE TRUEmmu_miR_541_002562 26.472 30.871 28.929 26.056 0.282 0.969 0.825 0.094TRUE TRUE TRUE TRUE mmu_miR_542_3p_001284 35.450 32.698 34.516 33.763 NA0.190 NA 0.400 FALSE TRUE FALSE TRUE mmu_miR_542_5p_002563 36.846 36.48336.662 36.574 NA NA NA 0.474 FALSE FALSE FALSE TRUE mmu_miR_543_00129821.415 24.412 24.195 21.712 0.240 0.843 0.893 0.257 TRUE TRUE TRUE TRUEmmu_miR_543_002376 20.547 23.579 23.312 21.084 0.212 0.847 0.880 0.304TRUE TRUE TRUE TRUE mmu_miR_544_002550 22.636 25.456 25.326 24.434 NA NANA NA FALSE FALSE FALSE FALSE mmu_miR_546_001312 33.281 33.170 27.37624.877 NA NA NA 0.008 FALSE FALSE FALSE TRUE mmu_miR_547_002564 25.86126.191 23.097 25.264 0.797 0.800 0.211 0.502 TRUE TRUE TRUE TRUEmmu_miR_551b_001535 26.284 27.273 24.939 27.453 0.498 0.745 0.312 0.786TRUE TRUE TRUE TRUE mmu_miR_574_3p_002349 29.981 25.061 24.414 26.1910.996 0.316 0.253 0.524 TRUE TRUE TRUE TRUE mmu_miR_582_3p_002567 32.52933.030 32.153 33.626 0.448 0.622 0.490 0.792 TRUE TRUE TRUE TRUEmmu_miR_582_5p_002566 28.511 29.854 31.850 28.927 0.277 0.555 NA 0.328TRUE TRUE FALSE TRUE mmu_miR_590_5p_001984 37.609 35.633 37.682 35.544NA 0.326 NA 0.192 FALSE TRUE FALSE TRUE mmu_miR_592_002017 26.939 29.65330.067 26.555 0.332 0.794 0.941 0.117 TRUE TRUE TRUE TRUEmmu_miR_598_002476 25.089 25.609 26.502 25.281 0.436 0.565 0.864 0.427TRUE TRUE TRUE TRUE mmu_miR_599_241117_mat 36.290 33.531 36.113 38.5450.551 0.048 0.692 NA TRUE TRUE TRUE FALSE mmu_miR_615_3p_001960 35.00137.236 33.634 35.001 NA NA NA 0.494 FALSE FALSE FALSE TRUEmmu_miR_615_5p_002353 38.986 38.890 39.371 39.557 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_652_002352 25.804 22.996 24.210 24.716 0.9030.173 0.636 0.585 TRUE TRUE TRUE TRUE mmu_miR_654_3p_002239 40.17339.881 40.391 39.630 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_654_5p_002522 39.725 40.059 40.519 39.661 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_665_002607 35.224 35.286 34.309 33.107 NA NANA 0.154 FALSE FALSE FALSE TRUE mmu_miR_666_3p_002448 36.724 38.19037.855 39.859 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_666_5p_00195232.047 36.100 32.384 32.174 0.333 0.982 NA 0.342 TRUE TRUE FALSE TRUEmmu_miR_667_001949 22.019 25.572 24.829 22.213 0.220 0.909 0.867 0.217TRUE TRUE TRUE TRUE mmu_miR_668_001947 29.405 29.162 29.431 27.281 0.7270.632 0.817 0.107 TRUE TRUE TRUE TRUE mmu_miR_669C_002646 33.789 30.71432.462 33.516 NA 0.088 NA 0.740 FALSE TRUE FALSE TRUEmmu_miR_669D_002808 33.465 30.754 33.550 33.545 NA 0.071 NA 0.721 FALSETRUE FALSE TRUE mmu_miR_669E_002774 36.634 34.066 36.607 36.517 NA 0.094NA 0.672 FALSE TRUE FALSE TRUE mmu_miR_669G_002813 40.449 40.093 40.55539.607 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_669H_5P_002906 36.08636.354 33.693 35.622 NA NA 0.253 0.519 FALSE FALSE TRUE TRUEmmu_miR_669a_001683 30.472 27.744 31.263 29.861 0.734 0.082 0.908 0.490TRUE TRUE TRUE TRUE mmu_miR_669l_121149_mat 33.168 30.704 33.709 33.6750.595 0.073 NA 0.775 TRUE TRUE FALSE TRUE mmu_miR_669m_121190_mat 30.82528.346 31.895 31.620 0.539 0.056 NA 0.783 TRUE TRUE FALSE TRUEmmu_miR_669n_197143_mat 34.946 30.901 33.100 33.241 NA 0.067 NA 0.558FALSE TRUE FALSE TRUE mmu_miR_669o_121176_mat 30.009 30.380 32.86933.757 0.202 0.210 NA 0.944 TRUE TRUE FALSE TRUE mmu_miR_670_00202032.275 31.355 25.955 31.268 NA 0.733 0.042 0.577 FALSE TRUE TRUE TRUEmmu_miR_671_3p_002322 28.882 28.298 31.958 28.483 0.492 0.336 NA 0.270TRUE TRUE FALSE TRUE mmu_miR_672_002327 26.448 28.627 30.095 24.1580.438 0.711 NA 0.014 TRUE TRUE FALSE TRUE mmu_miR_673_001954 19.80024.039 20.825 27.536 0.094 0.674 0.304 NA TRUE TRUE TRUE FALSEmmu_miR_673_3p_002449 29.443 33.136 30.424 29.464 0.336 0.962 0.6400.273 TRUE TRUE TRUE TRUE mmu_miR_674_001956 27.953 24.617 26.055 26.8670.924 0.112 0.615 0.632 TRUE TRUE TRUE TRUE mmu_miR_674_002021 32.30728.218 29.997 28.652 0.975 0.205 0.728 0.253 TRUE TRUE TRUE TRUEmmu_miR_675_3p_001941 34.169 34.934 24.982 34.614 0.707 0.851 0.0030.752 TRUE TRUE TRUE TRUE mmu_miR_675_5p_001940 37.109 33.765 36.84836.845 NA 0.042 NA NA FALSE TRUE FALSE TRUE mmu_miR_676_001958 28.81129.942 30.601 29.697 0.309 0.609 0.849 0.532 TRUE TRUE TRUE TRUEmmu_miR_676_001959 28.905 25.575 27.909 27.668 0.890 0.091 0.763 0.531TRUE TRUE TRUE TRUE mmu_miR_677_001660 36.510 36.727 37.552 38.085 NA NANA NA FALSE FALSE FALSE FALSE mmu_miR_679_001662 35.212 35.308 31.86231.518 NA NA NA 0.119 FALSE FALSE FALSE TRUE mmu_miR_680_001664 38.34834.243 29.115 35.970 NA NA 0.020 0.677 FALSE FALSE TRUE TRUEmmu_miR_682_001666 37.348 34.625 36.994 39.107 NA 0.058 NA NA FALSE TRUEFALSE FALSE mmu_miR_683_001668 39.278 34.231 34.118 40.413 NA 0.1180.198 NA FALSE TRUE TRUE FALSE mmu_miR_684_001669 40.779 40.407 40.77639.620 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_685_001670 33.61337.065 31.979 40.667 0.277 NA 0.099 NA TRUE FALSE TRUE FALSEmmu_miR_686_001672 40.864 40.480 40.588 39.596 NA NA NA NA FALSE FALSETRUE FALSE mmu_miR_687_001674 40.104 39.787 40.335 39.226 NA NA NA NAFALSE FALSE FALSE FALSE mmu_miR_688_001675 36.601 40.473 40.485 40.2920.052 NA NA NA TRUE FALSE FALSE FALSE mmu_miR_690_001677 38.672 38.61736.851 39.331 NA NA NA NA FALSE FALSE TRUE FALSE mmu_miR_691_00167832.428 36.683 32.718 38.078 0.138 NA 0.287 NA TRUE FALSE TRUE TRUEmmu_miR_692_001679 39.842 40.402 37.586 40.218 NA NA NA NA FALSE FALSETRUE FALSE mmu_miR_693_001680 39.142 30.660 34.813 39.756 NA 0.001 0.425NA FALSE TRUE TRUE FALSE mmu_miR_693_3p_002036 40.503 34.490 33.49137.948 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_694_001681 28.76232.464 27.378 37.905 0.234 0.670 0.095 NA TRUE TRUE TRUE TRUEmmu_miR_695_001627 33.397 38.315 39.404 38.315 0.013 NA NA NA TRUE FALSEFALSE FALSE mmu_miR_696_001628 32.814 39.178 28.941 37.917 0.293 NA0.017 NA TRUE FALSE TRUE TRUE mmu_miR_697_001631 34.315 40.466 38.64238.706 0.015 NA NA NA TRUE FALSE TRUE TRUE mmu_miR_698_001632 40.36639.987 39.633 39.688 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_700_001634 25.572 25.661 27.463 25.630 0.447 0.454 0.933 0.389TRUE TRUE TRUE TRUE mmu_miR_701_001635 31.511 31.838 28.773 33.711 0.5580.585 0.157 0.962 TRUE TRUE TRUE TRUE mmu_miR_702_001636 30.189 32.80429.595 30.244 0.486 0.932 0.418 0.448 TRUE TRUE TRUE TRUEmmu_miR_704_001639 36.886 35.390 37.248 37.178 NA 0.204 NA NA FALSE TRUEFALSE TRUE mmu_miR_706_001641 26.138 35.476 33.207 38.592 0.000 0.6850.537 NA TRUE TRUE TRUE TRUE mmu_miR_707_001642 40.405 40.031 40.54239.608 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_708_002341 23.71923.636 25.849 23.687 0.458 0.419 0.951 0.363 TRUE TRUE TRUE TRUEmmu_miR_710_001645 32.320 36.476 38.806 40.606 0.009 NA NA NA TRUE FALSEFALSE FALSE mmu_miR_711_001646 31.956 37.169 37.270 40.300 0.004 NA NANA TRUE FALSE TRUE FALSE mmu_miR_712_001961 39.482 38.272 40.076 39.598NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_712_002636 33.036 34.11332.822 36.288 0.347 0.551 NA 0.971 TRUE TRUE FALSE TRUEmmu_miR_713_001648 33.397 39.304 38.922 40.154 0.005 NA NA NA TRUE FALSEFALSE FALSE mmu_miR_715_001649 33.695 38.619 39.129 39.784 NA NA NA NAFALSE FALSE FALSE FALSE mmu_miR_717_001652 36.026 38.260 31.203 40.8480.464 NA 0.013 NA TRUE FALSE TRUE FALSE mmu_miR_718_001656 34.117 40.25939.777 37.247 0.019 NA NA NA TRUE FALSE FALSE FALSE mmu_miR_719_00167338.115 39.504 38.847 39.594 NA NA NA NA FALSE FALSE TRUE FALSEmmu_miR_720_001629 24.232 25.498 21.867 27.961 NA NA 0.128 NA FALSEFALSE TRUE FALSE mmu_miR_721_001657 21.681 24.545 25.636 29.432 0.0490.363 0.769 0.996 TRUE TRUE TRUE TRUE mmu_miR_741_002457 37.816 38.43237.835 36.176 NA NA NA 0.141 FALSE FALSE FALSE TRUE mmu_miR_742_00203838.716 38.645 39.214 39.112 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_742_002458 34.365 36.092 35.923 36.772 0.241 NA NA NA TRUE FALSEFALSE TRUE mmu_miR_743a_002469 28.031 30.747 26.683 31.826 0.346 0.7750.177 0.947 TRUE TRUE TRUE TRUE mmu_miR_743b_3p_002471 39.893 39.57540.160 39.607 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_743b_5p_00247032.283 32.691 30.261 34.276 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_744_002324 24.223 25.567 25.414 25.042 0.340 0.698 0.751 0.544TRUE TRUE TRUE TRUE mmu_miR_758_002025 35.766 37.048 35.681 36.230 NA NANA 0.566 FALSE FALSE FALSE TRUE mmu_miR_759_002034 33.250 34.639 35.26139.970 0.161 0.353 0.649 NA TRUE TRUE TRUE FALSE mmu_miR_761_00203036.196 33.800 25.101 37.298 NA 0.422 0.001 NA FALSE TRUE TRUE TRUEmmu_miR_762_002028 34.208 38.322 37.861 39.880 NA NA NA NA FALSE FALSEFALSE FALSE mmu_miR_763_002033 37.647 37.969 38.912 39.345 NA NA NA NAFALSE FALSE FALSE FALSE mmu_miR_764_3p_002032 31.727 37.035 34.67533.315 NA NA NA 0.392 FALSE FALSE FALSE TRUE mmu_miR_764_5p_00203131.117 37.576 30.762 33.600 0.183 NA 0.232 0.650 TRUE FALSE TRUE TRUEmmu_miR_767_241081_mat 40.729 40.407 40.776 39.623 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_770_3p_002027 31.720 36.098 32.238 31.2020.399 0.990 NA 0.165 TRUE TRUE FALSE TRUE mmu_miR_770_5p_002608 31.86135.790 33.555 32.904 0.175 NA NA 0.444 TRUE FALSE FALSE TRUEmmu_miR_7a_000268 26.427 24.507 25.351 26.830 0.705 0.218 NA 0.833 TRUETRUE FALSE TRUE mmu_miR_7b_002555 26.818 27.811 27.476 26.899 0.473 NANA 0.424 TRUE FALSE FALSE TRUE mmu_miR_802_002029 34.040 32.331 34.07032.861 NA 0.302 NA 0.354 FALSE TRUE FALSE TRUE mmu_miR_804_002044 31.81427.826 30.680 35.732 0.621 0.016 0.559 0.997 TRUE TRUE TRUE TRUEmmu_miR_805_002045 27.298 30.778 25.563 33.185 0.293 NA 0.099 NA TRUEFALSE TRUE FALSE mmu_miR_871_002354 39.458 37.370 39.742 39.615 NA NA NANA FALSE FALSE FALSE FALSE mmu_miR_872_002264 25.578 23.421 26.03725.108 0.717 0.146 0.875 0.512 TRUE TRUE TRUE TRUE mmu_miR_872_00254224.241 22.853 25.342 23.868 0.627 0.245 0.909 0.442 TRUE TRUE TRUE TRUEmmu_miR_873_002356 32.523 34.776 32.446 32.401 0.485 0.896 NA 0.371 TRUETRUE FALSE TRUE mmu_miR_874_002268 36.393 38.081 38.527 39.642 NA NA NANA FALSE FALSE FALSE FALSE mmu_miR_875_3p_002547 40.325 37.253 35.97838.715 NA NA 0.211 NA FALSE TRUE TRUE FALSE mmu_miR_876_3p_002464 39.26739.203 39.445 39.858 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_876_5p_002463 38.519 37.965 38.792 38.611 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_877_002548 21.133 24.956 18.274 24.164 0.3740.948 0.069 0.818 TRUE TRUE TRUE TRUE mmu_miR_878_3p_002541 32.96935.576 29.154 39.116 NA NA NA NA FALSE FALSE FALSE FALSEmmu_miR_878_5p_002540 37.798 38.550 37.891 37.103 NA NA NA NA FALSEFALSE FALSE TRUE mmu_miR_879_002472 34.099 33.900 34.127 33.819 NA 0.556NA 0.438 FALSE TRUE FALSE TRUE mmu_miR_879_002473 27.117 28.411 30.02226.658 0.412 0.599 NA 0.164 TRUE TRUE FALSE TRUE mmu_miR_880_00266535.299 38.314 33.252 39.143 NA NA 0.113 NA FALSE FALSE TRUE FALSEmmu_miR_881_002475 35.896 39.013 38.933 39.810 NA NA NA NA FALSE FALSEFALSE FALSE mmu_miR_881_002609 32.441 36.609 36.666 38.051 0.027 NA NANA TRUE FALSE FALSE TRUE mmu_miR_882_002610 40.779 40.407 40.776 39.620NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_883B_5P_002669 34.585 38.20938.887 39.543 0.041 NA NA NA TRUE FALSE FALSE TRUEmmu_miR_883a_3p_002461 38.076 38.365 38.467 39.719 NA NA NA NA FALSEFALSE FALSE FALSE mmu_miR_883a_5p_002611 40.644 40.273 40.692 39.621 NANA NA NA FALSE FALSE FALSE FALSE mmu_miR_883b_3p_002565 38.081 40.02539.666 39.791 NA NA NA NA FALSE FALSE FALSE FALSE mmu_miR_92a_00043019.360 20.369 17.520 21.330 0.491 0.683 0.220 0.912 TRUE TRUE TRUE TRUEmmu_miR_92a_002496 38.278 40.167 40.521 39.742 NA NA NA NA FALSE FALSEFALSE FALSE mmu_miR_93_001090 23.794 21.212 22.453 22.527 0.892 0.2120.686 0.511 TRUE TRUE TRUE TRUE mmu_miR_96_000186 28.897 34.078 31.39531.599 0.066 0.962 NA 0.586 TRUE TRUE FALSE TRUE mmu_miR_98_00057730.069 29.061 31.357 27.704 0.706 0.436 0.947 0.082 TRUE TRUE TRUE TRUEmmu_miR_99a_000435 21.605 19.498 20.893 20.744 0.822 0.226 0.753 0.508TRUE TRUE TRUE TRUE mmu_miR_99b_000436 22.549 21.380 23.717 22.913 0.5130.230 0.883 0.624 TRUE TRUE TRUE TRUE mmu_miR_9_000583 19.265 16.68418.258 18.223 0.858 0.177 0.734 0.533 TRUE TRUE TRUE TRUE log2FC_adj.p.value_ log2FC_ adj.p.value_ log2FC_ adj.p.value_ log2FC_adj.p.value_ log2FC_ adj.p.value_ log2FC_ adj.p.value_ ChATvs ChATvsChATvs ChATvs ChATvs ChATvs GFAPvs GFAPvs GFAPvs GFAPvs Lyz2vs Lyz2vsGFAP_bs GFAP_bs Lyz2_bs Lyz2_bs Syn_bs Syn_bs Lyz2_bs Lyz2_bs Syn_bsSyn_bs Syn_bs Syn_bs hsa_let_7b_002404 0.134 0.980 1.877 0.730 3.7400.410 1.743 0.711 3.606 0.383 1.863 0.671 hsa_let_7e_002407 0.641 0.670−0.354 0.911 0.538 0.782 −0.995 0.473 −0.103 0.965 0.892 0.512hsa_let_7f_1_002417 −3.516 0.135 0.230 0.996 −0.498 0.907 3.746 0.1283.018 0.237 −0.728 0.817 hsa_let_7i_002172 −3.519 0.001 −1.352 0.236−0.322 0.858 2.167 0.042 3.197 0.003 1.030 0.348 hsa_miR_106b_002380−3.233 0.009 0.102 0.996 −4.424 0.001 3.336 0.011 −1.191 0.417 −4.5270.001 hsa_miR_10a_002288 0.796 0.770 0.765 0.858 1.640 0.558 −0.0310.991 0.845 0.771 0.875 0.753 hsa_miR_1197_002810 4.126 0.011 2.3030.207 1.380 0.528 −1.823 0.315 −2.746 0.112 −0.923 0.638hsa_miR_124_002197 2.149 0.297 1.658 0.504 2.327 0.343 −0.491 0.8750.179 0.963 0.669 0.810 hsa_miR_127_5p_002229 0.882 0.447 −0.545 0.739−0.408 0.813 −1.427 0.208 −1.289 0.278 0.138 0.937 hsa_miR_136_0005923.378 0.000 −1.021 0.307 0.305 0.834 −4.399 0.000 −3.073 0.001 1.3260.134 hsa_miR_136_002100 2.629 0.179 2.671 0.203 0.361 0.924 0.042 0.990−2.268 0.285 −2.310 0.238 hsa_miR_140_3p_002234 −1.540 0.047 −0.7210.452 −1.437 0.103 0.818 0.355 0.103 0.938 −0.715 0.402hsa_miR_143_000466 −0.504 0.925 −0.985 0.905 2.048 0.672 −0.480 0.9392.552 0.513 3.033 0.388 hsa_miR_144_002676 0.152 0.883 0.515 0.577 1.8490.016 0.363 0.691 1.697 0.021 1.334 0.055 hsa_miR_148a_002134 0.0620.984 0.306 0.982 −0.681 0.858 0.243 0.952 −0.743 0.819 −0.986 0.735hsa_miR_149_002255 1.998 0.002 1.753 0.006 −0.269 0.792 −0.245 0.784−2.267 0.001 −2.023 0.001 hsa_miR_151_5P_002642 −4.985 0.000 −3.4360.002 −4.303 0.000 1.549 0.172 0.682 0.611 −0.867 0.459hsa_miR_154_000478 1.404 0.233 0.861 0.552 −0.054 0.983 −0.543 0.715−1.458 0.247 −0.915 0.466 hsa_miR_15b_002173 1.231 0.816 −7.453 0.0763.153 0.558 −8.683 0.038 1.922 0.732 10.605 0.007 hsa_miR_183_0022706.642 0.002 −0.580 0.917 0.871 0.801 −7.222 0.001 −5.771 0.009 1.4510.542 hsa_miR_189_000488 −0.264 0.961 −3.932 0.369 3.020 0.544 −3.6680.378 3.284 0.455 6.952 0.056 hsa_miR_190b_002263 −0.261 0.906 0.0890.996 2.434 0.136 0.350 0.880 2.694 0.072 2.345 0.102hsa_miR_196a_241070_mat 4.892 0.000 0.935 0.518 −2.251 0.078 −3.9560.001 −7.143 0.000 −3.186 0.005 hsa_miR_200a_001011 −2.540 0.089 0.2500.967 0.202 0.944 2.790 0.075 2.742 0.077 −0.048 0.983hsa_miR_200b_001800 5.661 0.040 −1.138 0.830 5.689 0.066 −6.799 0.0180.028 0.995 6.827 0.013 hsa_miR_200b_002274 3.366 0.478 4.446 0.3784.573 0.395 1.080 0.873 1.207 0.849 0.127 0.983 hsa_miR_200c_000505−1.721 0.304 −6.687 0.000 −0.535 0.846 −4.967 0.003 1.186 0.543 6.1520.000 hsa_miR_200c_002286 0.568 0.751 1.179 0.477 0.937 0.617 0.6110.735 0.369 0.852 −0.242 0.911 hsa_miR_206_000510 −0.952 0.677 −1.0360.710 −1.381 0.581 −0.083 0.980 −0.429 0.874 −0.345 0.911hsa_miR_213_000516 −2.900 0.006 −1.988 0.074 −1.986 0.093 0.912 0.4540.914 0.471 0.002 0.999 hsa_miR_214_000517 2.943 0.034 −3.108 0.0313.086 0.045 −6.051 0.000 0.142 0.955 6.194 0.000 hsa_miR_214_002293−0.578 0.739 0.267 0.956 2.087 0.158 0.845 0.592 2.665 0.050 1.820 0.171hsa_miR_218_2_002294 5.133 0.000 4.114 0.001 3.673 0.005 −1.019 0.468−1.460 0.287 −0.441 0.796 hsa_miR_223_000526 1.305 0.727 −12.248 0.0007.317 0.017 13.552 0.000 6.012 0.040 19.565 0.000 hsa_miR_22_000398−3.402 0.118 2.931 0.222 −2.470 0.357 6.334 0.005 0.932 0.761 −5.4020.011 hsa_miR_22_002301 0.205 0.869 −0.196 0.949 0.779 0.491 −0.4010.727 0.574 0.601 0.976 0.279 hsa_miR_23a_002439 0.498 0.931 −10.1830.011 3.159 0.545 10.681 0.009 2.661 0.589 13.342 0.001hsa_miR_26b_002444 −1.548 0.571 −2.336 0.414 0.296 0.951 −0.788 0.8201.845 0.523 2.633 0.295 hsa_miR_27a_002445 1.358 0.571 1.242 0.682 3.3050.154 −0.116 0.977 1.947 0.417 2.063 0.351 hsa_miR_27b_002174 −0.9390.293 −0.797 0.443 −0.057 0.976 0.142 0.926 0.882 0.375 0.740 0.429hsa_miR_28_3p_002446 0.604 0.813 0.223 0.995 0.653 0.841 −0.380 0.9100.049 0.991 0.429 0.891 hsa_miR_299_5p_000600 7.871 0.003 2.336 0.4586.276 0.024 −5.535 0.040 −1.594 0.631 3.941 0.129 hsa_miR_29a_0024471.189 0.659 −2.001 0.453 0.783 0.830 −3.190 0.172 −0.406 0.910 2.7840.217 hsa_miR_29b_2_002166 3.504 0.193 2.386 0.448 3.947 0.181 −1.1180.758 0.444 0.916 1.561 0.608 hsa_miR_30a_3p_000416 −0.313 0.539 −0.2880.637 0.133 0.866 0.025 0.977 0.445 0.383 0.420 0.376hsa_miR_30c_1_002108 −2.117 0.571 1.133 0.869 0.583 0.930 3.250 0.3632.700 0.477 −0.550 0.918 hsa_miR_30c_2_002110 10.427 0.008 9.553 0.0206.481 0.151 −0.874 0.895 −3.946 0.389 −3.072 0.490 hsa_miR_30d_002305−2.285 0.473 −1.582 0.712 −0.421 0.941 0.702 0.879 1.863 0.610 1.1610.766 hsa_miR_30e_3p_000422 0.183 0.766 −1.308 0.006 0.486 0.408 −1.4910.002 0.303 0.607 1.794 0.000 hsa_miR_324_3p_000579 −2.827 0.195 −2.9180.211 −2.712 0.279 −0.091 0.980 0.114 0.980 0.206 0.958hsa_miR_338_000548 −4.662 0.011 −1.977 0.362 −3.728 0.068 2.685 0.1720.934 0.722 −1.752 0.378 hsa_miR_338_5P_002658 −1.478 0.103 0.203 0.950−0.796 0.506 1.681 0.076 0.682 0.533 −0.999 0.293 hsa_miR_33a_002136−5.196 0.001 −4.565 0.004 −5.767 0.001 0.631 0.772 −0.571 0.803 −1.2020.484 hsa_miR_340_000550 −0.057 0.963 0.733 0.479 0.141 0.932 0.7900.404 0.198 0.874 −0.592 0.533 hsa_miR_363_001283 −6.896 0.016 −2.2910.537 −2.359 0.545 4.606 0.138 4.537 0.141 −0.069 0.983hsa_miR_376a_001287 4.627 0.000 1.522 0.243 1.273 0.387 −3.105 0.011−3.354 0.006 −0.249 0.899 hsa_miR_378_000567 1.558 0.421 −1.968 0.3383.679 0.061 −3.526 0.056 2.121 0.286 5.647 0.002 hsa_miR_411_0022384.313 0.002 5.170 0.000 0.652 0.764 0.857 0.611 −3.662 0.010 −4.5180.001 hsa_miR_412_001023 4.539 0.009 −5.829 0.001 0.574 0.848 10.3680.000 −3.965 0.028 6.402 0.000 hsa_miR_421_002700 0.745 0.224 1.7990.003 0.805 0.243 1.055 0.089 0.060 0.955 −0.994 0.086hsa_miR_423_3P_002626 −1.638 0.224 −2.411 0.076 −1.348 0.415 −0.7730.629 0.291 0.878 1.063 0.459 hsa_miR_425_001104 −1.341 0.550 −5.6750.004 −3.025 0.169 −4.334 0.032 −1.684 0.465 2.650 0.179hsa_miR_431_002312 4.994 0.003 0.176 0.996 1.871 0.364 −4.818 0.005−3.124 0.068 1.695 0.337 hsa_miR_455_001280 −4.316 0.007 −5.324 0.001−3.030 0.089 −1.008 0.603 1.286 0.501 2.294 0.157 hsa_miR_485_5p_0010360.820 0.586 −1.207 0.448 −0.077 0.979 −2.027 0.144 −0.898 0.587 1.1290.429 hsa_miR_493_3p_001282 5.980 0.207 2.014 0.800 6.580 0.211 −3.9660.446 0.600 0.938 4.566 0.351 hsa_miR_590_3P_002677 −0.772 0.221 −0.4240.594 −0.911 0.185 0.347 0.642 −0.139 0.876 −0.486 0.466hsa_miR_653_002292 3.070 0.350 −0.415 0.985 1.582 0.757 −3.485 0.304−1.488 0.732 1.998 0.575 hsa_miR_671_5p_197646_mat 2.890 0.518 0.1770.996 8.544 0.046 −2.712 0.557 5.655 0.177 8.367 0.028hsa_miR_708_002342 −0.236 0.938 −3.628 0.109 −0.564 0.886 −3.391 0.134−0.328 0.926 3.064 0.155 hsa_miR_744_002325 2.226 0.022 −0.760 0.5461.231 0.301 −2.986 0.004 −0.995 0.383 1.991 0.038 hsa_miR_875_5p_0022032.443 0.770 −5.235 0.518 8.021 0.303 −7.678 0.272 5.578 0.465 13.2570.034 hsa_miR_935_002178 −0.434 0.875 −0.276 0.981 0.088 0.983 0.1590.967 0.522 0.852 0.363 0.911 hsa_miR_93_002139 −1.984 0.040 −1.3310.222 −1.307 0.260 0.653 0.578 0.677 0.585 0.024 0.983hsa_miR_99b_002196 −2.889 0.042 −0.798 0.710 −1.351 0.472 2.091 0.1721.538 0.355 −0.552 0.785 hsa_miR_9_002231 −3.583 0.000 −1.576 0.001−1.261 0.007 2.006 0.000 2.321 0.000 0.315 0.518 mmu_let_7a_000377−2.915 0.046 1.303 0.477 −2.293 0.175 4.218 0.006 0.623 0.767 −3.5950.013 mmu_let_7a_002478 −2.568 0.696 −1.580 0.904 −0.130 0.992 0.9880.912 2.438 0.733 1.450 0.838 mmu_let_7b_000378 −1.751 0.000 −0.4990.307 0.163 0.816 1.252 0.005 1.914 0.000 0.662 0.124 mmu_let_7c_000379−1.758 0.000 −0.477 0.321 −0.508 0.325 1.281 0.004 1.250 0.004 −0.0310.967 mmu_let_7c_1_002479 −1.257 0.754 −1.369 0.789 0.836 0.880 −0.1120.980 2.093 0.582 2.205 0.513 mmu_let_7d_001178 −2.594 0.003 −1.6580.063 −2.918 0.002 0.936 0.322 −0.324 0.798 −1.260 0.146mmu_let_7d_002283 −0.795 0.156 −0.051 0.996 −0.073 0.946 0.744 0.2040.723 0.229 −0.021 0.979 mmu_let_7e_002406 −0.001 0.999 −0.329 0.8690.016 0.993 −0.328 0.806 0.017 0.991 0.345 0.793 mmu_let_7f_000382−5.103 0.077 −1.713 0.694 −3.931 0.249 3.390 0.284 1.172 0.771 −2.2180.492 mmu_let_7g_002282 0.061 0.953 1.393 0.063 0.675 0.472 1.332 0.0780.613 0.472 −0.718 0.352 mmu_let_7g_002492 1.942 0.221 −0.542 0.8682.155 0.219 −2.484 0.123 0.213 0.934 2.697 0.070 mmu_let_7i_002221−1.555 0.003 0.134 0.934 0.002 0.998 1.689 0.002 1.557 0.005 −0.1320.869 mmu_miR_100_000437 −2.745 0.000 −0.358 0.722 −1.122 0.137 2.3870.001 1.623 0.019 −0.764 0.274 mmu_miR_101a_002253 −0.491 0.349 −0.5520.333 −0.379 0.575 −0.062 0.948 0.112 0.878 0.173 0.800mmu_miR_101a_002507 −1.365 0.079 0.338 0.803 −1.168 0.190 1.703 0.0360.197 0.863 −1.506 0.048 mmu_miR_101b_002531 −0.082 0.931 1.036 0.1070.211 0.833 1.118 0.078 0.292 0.732 −0.825 0.179 mmu_miR_103_0004390.921 0.266 0.394 0.760 0.280 0.832 −0.527 0.579 −0.641 0.501 −0.1140.933 mmu_miR_105_002465 0.811 0.925 −6.741 0.243 −1.367 0.886 −7.5520.172 −2.178 0.767 5.374 0.329 mmu_miR_106a_002459 −5.175 0.022 −5.4250.021 −4.665 0.066 −0.250 0.953 0.510 0.878 0.760 0.814mmu_miR_106b_000442 −1.965 0.004 −1.017 0.173 −1.080 0.162 0.948 0.1930.885 0.242 −0.062 0.960 mmu_miR_107_000443 0.593 0.770 1.935 0.2670.445 0.869 1.342 0.447 −0.148 0.959 −1.490 0.371 mmu_miR_10a_0003872.394 0.055 0.768 0.678 0.582 0.772 −1.626 0.231 −1.811 0.180 −0.1860.933 mmu_miR_10b_001181 3.680 0.004 2.743 0.039 −0.816 0.672 −0.9360.534 −4.495 0.001 −3.559 0.005 mmu_miR_10b_002218 8.872 0.000 4.8280.004 −4.054 0.020 −4.043 0.016 −12.925 0.000 −8.882 0.000mmu_miR_10b_002572 2.734 0.237 −0.112 0.996 1.055 0.764 −2.846 0.237−1.679 0.535 1.167 0.671 mmu_miR_1186_002825 2.749 0.421 2.562 0.5165.263 0.136 −0.187 0.977 2.514 0.501 2.701 0.429 mmu_miR_1188_0028660.498 0.898 3.283 0.267 3.460 0.265 2.785 0.341 2.961 0.318 0.176 0.972mmu_miR_1191_002892 1.171 0.805 −0.152 0.996 4.871 0.253 −1.323 0.8013.700 0.376 5.023 0.171 mmu_miR_1192_002806 −0.119 0.959 0.286 0.961−1.615 0.428 0.405 0.873 −1.496 0.418 −1.900 0.248 mmu_miR_1193_0027943.492 0.000 2.945 0.000 3.523 0.000 −0.547 0.501 0.030 0.983 0.577 0.459mmu_miR_1194_002793 0.124 0.931 0.381 0.849 −1.580 0.154 0.257 0.869−1.704 0.099 −1.961 0.042 mmu_miR_1195_002839 4.326 0.129 4.007 0.1985.952 0.055 −0.319 0.952 1.625 0.656 1.945 0.542 mmu_miR_1198_002780−1.332 0.102 3.064 0.000 −2.112 0.016 4.396 0.000 −0.781 0.406 −5.1770.000 mmu_miR_1199_240984_mat −0.372 0.224 −0.003 0.996 −1.160 0.0000.369 0.246 −0.788 0.010 −1.156 0.000 mmu_miR_1224_240985_mat −0.2690.720 0.047 0.996 −1.355 0.028 0.316 0.655 −1.086 0.067 −1.402 0.012mmu_miR_122_002245 1.410 0.798 −4.121 0.408 1.982 0.763 −5.532 0.2170.572 0.936 6.103 0.147 mmu_miR_124_001182 0.249 0.858 0.940 0.435−0.231 0.903 0.690 0.557 −0.481 0.732 −1.171 0.258mmu_miR_125a_3p_002199 −0.486 0.786 −0.614 0.798 −0.165 0.953 −0.1280.964 0.321 0.875 0.449 0.814 mmu_miR_125a_5p_002198 0.303 0.577 1.2370.011 0.083 0.932 0.934 0.059 −0.220 0.742 −1.154 0.013mmu_miR_125b_002508 0.106 0.936 1.453 0.144 1.033 0.365 1.347 0.1720.927 0.383 −0.420 0.731 mmu_miR_125b_3p_002378 −0.845 0.404 −1.1640.267 0.902 0.455 −0.319 0.814 1.747 0.071 2.066 0.023mmu_miR_125b_5p_000449 −0.413 0.434 0.458 0.434 0.042 0.967 0.871 0.0890.455 0.418 −0.416 0.430 mmu_miR_126_3p_002228 2.902 0.000 −1.020 0.0381.419 0.006 −3.922 0.000 −1.483 0.004 2.439 0.000 mmu_miR_126_5p_0004513.198 0.000 −0.615 0.316 1.565 0.007 −3.813 0.000 −1.633 0.004 2.1800.000 mmu_miR_1274a_121150_mat 0.502 0.881 −7.287 0.002 1.461 0.672−7.790 0.001 0.959 0.767 8.749 0.000 mmu_miR_127_000452 3.061 0.0001.931 0.000 0.070 0.933 −1.130 0.013 −2.991 0.000 −1.860 0.000mmu_miR_128a_002216 −0.215 0.768 −0.313 0.710 −0.570 0.422 −0.098 0.921−0.355 0.613 −0.257 0.727 mmu_miR_129_3p_001184 2.100 0.000 1.160 0.050−0.123 0.907 −0.940 0.123 −2.223 0.000 −1.283 0.022mmu_miR_129_5p_000590 1.194 0.312 3.012 0.009 0.160 0.942 1.818 0.129−1.034 0.436 −2.853 0.010 mmu_miR_1306_121155_mat 0.151 0.938 −0.2940.956 −0.740 0.744 −0.445 0.821 −0.890 0.610 −0.446 0.814mmu_miR_130a_000454 −6.115 0.000 −0.138 0.996 −3.947 0.016 5.977 0.0002.168 0.182 −3.809 0.011 mmu_miR_130b_000456 −2.850 0.002 −3.366 0.000−0.758 0.527 −0.516 0.642 2.092 0.023 2.608 0.004 mmu_miR_130b_0024603.232 0.062 1.192 0.615 −0.208 0.953 −2.040 0.285 −3.440 0.057 −1.4000.467 mmu_miR_132_000457 1.861 0.000 1.361 0.003 −0.332 0.577 −0.5000.295 −2.193 0.000 −1.693 0.000 mmu_miR_133a_001637 0.106 0.964 0.2310.983 −0.411 0.896 0.125 0.973 −0.517 0.832 −0.641 0.785mmu_miR_133a_002246 7.652 0.000 4.131 0.000 1.002 0.062 −3.522 0.000−6.650 0.000 −3.129 0.000 mmu_miR_133b_002247 3.992 0.001 2.721 0.0321.078 0.513 −1.271 0.360 −2.914 0.022 −1.643 0.190 mmu_miR_134_0011863.961 0.000 3.851 0.000 −0.506 0.701 −0.110 0.948 −4.467 0.000 −4.3570.000 mmu_miR_135a_000460 −0.576 0.311 0.651 0.289 −1.072 0.076 1.2270.030 −0.496 0.438 −1.723 0.002 mmu_miR_135b_002261 0.443 0.739 2.4670.016 −0.290 0.869 2.024 0.053 −0.733 0.553 −2.756 0.005mmu_miR_136_002511 0.538 0.825 3.223 0.100 −1.697 0.486 2.685 0.172−2.235 0.282 −4.920 0.007 mmu_miR_136_002512 5.426 0.014 −1.258 0.7105.303 0.028 −6.684 0.004 −0.124 0.980 6.560 0.003 mmu_miR_137_0011293.197 0.032 3.135 0.044 1.769 0.345 −0.062 0.980 −1.427 0.417 −1.3650.404 mmu_miR_138_002284 3.822 0.000 3.600 0.000 0.966 0.144 −0.2220.791 −2.857 0.000 −2.635 0.000 mmu_miR_138_002554 3.662 0.001 1.4900.208 0.795 0.581 −2.173 0.051 −2.867 0.010 −0.694 0.573mmu_miR_139_3p_002546 2.645 0.429 −2.164 0.592 −3.508 0.356 −4.809 0.139−6.153 0.052 −1.344 0.746 mmu_miR_139_5p_002289 1.561 0.044 −0.416 0.7300.114 0.942 −1.977 0.015 −1.448 0.077 0.530 0.556 mmu_miR_140_001187−0.310 0.758 −0.352 0.786 −0.066 0.967 −0.042 0.977 0.245 0.827 0.2870.791 mmu_miR_141_000463 0.129 0.980 −4.818 0.214 3.765 0.394 −4.9470.184 3.636 0.373 8.583 0.012 mmu_miR_141_002513 4.718 0.152 −3.7720.303 6.974 0.048 −8.490 0.011 2.256 0.578 10.746 0.001mmu_miR_142_3p_000464 −1.100 0.613 −10.290 0.000 2.841 0.179 −9.1900.000 3.941 0.039 13.130 0.000 mmu_miR_142_5p_002248 0.751 0.889 −6.7510.076 6.880 0.089 −7.502 0.047 6.129 0.108 13.631 0.000mmu_miR_143_002249 0.390 0.803 −2.646 0.030 2.690 0.036 −3.036 0.0132.300 0.061 5.336 0.000 mmu_miR_145_002278 −0.353 0.840 −3.792 0.0041.842 0.210 −3.439 0.009 2.195 0.100 5.634 0.000 mmu_miR_145_0025141.590 0.571 2.107 0.477 1.706 0.610 0.517 0.898 0.116 0.982 −0.401 0.919mmu_miR_146a_000468 1.987 0.000 −3.204 0.000 3.071 0.000 −5.192 0.0001.084 0.022 6.276 0.000 mmu_miR_146b_001097 −0.479 0.319 −0.856 0.074−0.213 0.769 −0.376 0.471 0.266 0.655 0.642 0.165 mmu_miR_146b_002453−0.378 0.931 −0.351 0.986 1.257 0.779 0.027 0.995 1.635 0.655 1.6080.628 mmu_miR_147_002262 −2.217 0.524 −2.429 0.531 2.800 0.486 −0.2120.975 5.018 0.117 5.229 0.081 mmu_miR_148a_000470 −1.732 0.169 4.0390.001 −0.272 0.906 5.770 0.000 1.459 0.286 −4.311 0.001mmu_miR_148b_000471 −2.242 0.022 3.307 0.001 −0.860 0.515 5.548 0.0001.382 0.194 −4.166 0.000 mmu_miR_150_000473 2.416 0.007 −2.042 0.0284.776 0.000 −4.458 0.000 2.360 0.012 6.818 0.000 mmu_miR_150_0025703.493 0.205 0.741 0.916 3.491 0.265 −2.752 0.355 −0.002 1.000 2.7500.329 mmu_miR_151_3p_001190 −6.402 0.000 0.223 0.926 −4.723 0.000 6.6250.000 1.679 0.053 −4.946 0.000 mmu_miR_152_000475 −3.970 0.000 −3.2860.000 1.013 0.215 0.683 0.392 4.983 0.000 4.300 0.000 mmu_miR_153_0011910.654 0.687 −0.260 0.956 0.297 0.903 −0.915 0.543 −0.358 0.850 0.5570.746 mmu_miR_154_000477 3.716 0.004 0.571 0.803 −1.860 0.220 −3.1450.020 −5.577 0.000 −2.432 0.058 mmu_miR_155_002571 −2.424 0.008 −3.9690.000 4.448 0.000 −1.545 0.117 6.872 0.000 8.417 0.000mmu_miR_15a_000389 −4.698 0.000 −3.961 0.002 −2.170 0.120 0.737 0.6292.528 0.048 1.792 0.152 mmu_miR_15a_002488 −0.803 0.347 0.022 0.9960.633 0.558 0.825 0.360 1.436 0.087 0.612 0.493 mmu_miR_15b_000390−2.732 0.000 −2.828 0.000 −1.180 0.020 −0.096 0.907 1.552 0.002 1.6480.001 mmu_miR_16_000391 −2.347 0.000 −3.224 0.000 −1.808 0.000 −0.8760.053 0.539 0.265 1.415 0.001 mmu_miR_16_002489 −5.569 0.000 −8.5740.000 −1.863 0.185 −3.005 0.018 3.707 0.004 6.712 0.000mmu_miR_17_002308 −3.924 0.000 −4.668 0.000 −3.467 0.000 −0.743 0.3990.457 0.655 1.201 0.125 mmu_miR_17_002543 6.842 0.043 −3.158 0.448 3.4200.436 10.000 0.005 −3.422 0.387 6.578 0.049 mmu_miR_181A_2_002687 −0.4380.798 0.075 0.996 −0.994 0.577 0.513 0.783 −0.555 0.767 −1.069 0.459mmu_miR_181a_000480 −3.329 0.000 −0.872 0.169 −2.383 0.000 2.458 0.0000.946 0.121 −1.512 0.008 mmu_miR_181c_000482 −1.654 0.020 −0.979 0.223−1.240 0.130 0.675 0.409 0.414 0.661 −0.261 0.796 mmu_miR_182_0025993.846 0.107 0.434 0.961 0.865 0.828 −3.412 0.177 −2.981 0.262 0.4310.911 mmu_miR_1839_3p_121203_mat −0.365 0.770 0.693 0.576 0.385 0.8051.059 0.313 0.751 0.512 −0.308 0.814 mmu_miR_1839_5p_121135_mat −0.2050.931 3.908 0.017 0.252 0.934 4.113 0.013 0.457 0.849 −3.656 0.020mmu_miR_183_002269 4.997 0.004 1.181 0.622 1.318 0.581 −3.816 0.038−3.679 0.042 0.137 0.966 mmu_miR_184_000485 4.315 0.033 −3.489 0.1101.426 0.618 −7.804 0.001 −2.889 0.190 4.915 0.014 mmu_miR_185_0022710.201 0.898 5.971 0.000 −0.311 0.866 5.770 0.000 −0.512 0.732 −6.2820.000 mmu_miR_186_002285 −1.973 0.061 −1.216 0.318 −0.463 0.789 0.7580.543 1.510 0.186 0.752 0.532 mmu_miR_186_002574 2.168 0.070 −2.3400.062 1.616 0.254 −4.508 0.001 −0.553 0.746 3.956 0.001mmu_miR_187_001193 −7.593 0.000 −1.878 0.039 −5.659 0.000 5.714 0.0001.934 0.033 −3.780 0.000 mmu_miR_188_3p_002106 −0.180 0.894 0.419 0.7880.202 0.906 0.599 0.585 0.382 0.767 −0.217 0.883 mmu_miR_188_5p_0023200.663 0.754 −3.285 0.045 2.172 0.244 −3.948 0.016 1.509 0.416 5.4580.001 mmu_miR_1893_121170_mat 1.297 0.655 −2.403 0.388 0.771 0.849−3.700 0.141 −0.526 0.878 3.174 0.188 mmu_miR_1894_3p_241002_mat 2.9050.398 −1.833 0.703 5.531 0.122 −4.738 0.164 2.626 0.492 7.364 0.017mmu_miR_1894_5p_121144_mat −1.917 0.185 0.435 0.901 1.341 0.457 2.3520.112 3.258 0.023 0.906 0.573 mmu_miR_1896_121128_mat 2.365 0.589 −3.5880.435 8.147 0.051 −5.953 0.140 5.782 0.151 11.735 0.002mmu_miR_1897_3p_121126_mat −0.368 0.280 0.021 0.996 −1.093 0.002 0.3880.274 −0.726 0.031 −1.114 0.001 mmu_miR_1897_5p_121199_mat 3.092 0.1450.271 0.986 4.853 0.031 −2.821 0.205 1.760 0.476 4.581 0.024mmu_miR_1898_121195_mat −0.624 0.077 −0.002 0.997 −1.132 0.003 0.6220.095 −0.509 0.179 −1.131 0.002 mmu_miR_1899_121198_mat −0.346 0.7560.235 0.916 −0.493 0.707 0.581 0.557 −0.147 0.914 −0.729 0.429mmu_miR_18a_002422 −4.165 0.001 −6.068 0.000 −3.367 0.014 −1.903 0.1610.798 0.617 2.701 0.028 mmu_miR_18a_002490 −1.723 0.293 −4.454 0.006−0.168 0.957 −2.731 0.099 1.555 0.389 4.286 0.006 mmu_miR_18b_002466−1.908 0.518 −0.327 0.986 −0.697 0.885 1.581 0.614 1.211 0.735 −0.3700.933 mmu_miR_1900_121143_mat −0.366 0.724 0.141 0.961 −0.756 0.4570.507 0.592 −0.390 0.729 −0.897 0.276 mmu_miR_1901_121183_mat 1.4690.737 5.081 0.154 3.194 0.452 3.612 0.318 1.725 0.703 −1.887 0.628mmu_miR_1902_121197_mat −0.369 0.349 0.064 0.963 −0.986 0.014 0.4340.284 −0.617 0.113 −1.050 0.004 mmu_miR_1903_121153_mat −3.568 0.430−5.116 0.275 −0.246 0.979 −1.548 0.796 3.322 0.501 4.870 0.259mmu_miR_1904_121162_mat 3.692 0.000 −0.950 0.227 5.508 0.000 −4.6430.000 1.816 0.013 6.458 0.000 mmu_miR_1905_121196_mat 2.626 0.472 −0.6890.956 5.843 0.117 −3.315 0.369 3.217 0.398 6.531 0.043mmu_miR_1906_121169_mat −2.045 0.275 0.084 0.996 −2.083 0.352 2.1290.277 −0.038 0.991 −2.167 0.244 mmu_miR_190_000489 −1.380 0.248 −0.7910.612 −0.574 0.762 0.589 0.691 0.806 0.578 0.217 0.911mmu_miR_191_002299 −0.443 0.259 −0.657 0.101 −0.402 0.398 −0.214 0.6480.041 0.953 0.255 0.556 mmu_miR_191_002576 −0.818 0.416 −1.036 0.3300.587 0.672 −0.218 0.885 1.405 0.151 1.624 0.073 mmu_miR_1927_121193_mat−3.242 0.103 0.075 0.996 −0.656 0.847 3.317 0.115 2.586 0.237 −0.7310.793 mmu_miR_1928_121164_mat 4.757 0.039 1.095 0.782 10.197 0.000−3.662 0.139 5.441 0.023 9.102 0.000 mmu_miR_192_000491 −2.050 0.012−0.834 0.388 −0.581 0.612 1.216 0.169 1.469 0.088 0.252 0.821mmu_miR_1930_121201_mat 0.732 0.720 −2.053 0.236 −0.267 0.932 −2.7850.090 −0.999 0.612 1.786 0.272 mmu_miR_1931_121168_mat −1.566 0.2520.132 0.996 −1.990 0.185 1.699 0.231 −0.424 0.827 −2.122 0.105mmu_miR_1932_121172_mat −3.469 0.345 1.538 0.798 2.520 0.595 5.007 0.1725.989 0.099 0.982 0.838 mmu_miR_1933_3p_121145_mat −0.376 0.544 0.0960.961 −0.908 0.136 0.472 0.441 −0.532 0.389 −1.004 0.056mmu_miR_1933_5p_121133_mat 4.857 0.429 0.560 0.996 3.868 0.623 −4.2970.509 −0.989 0.914 3.308 0.619 mmu_miR_1934_121185_mat −8.183 0.006−0.089 0.996 0.792 0.886 8.094 0.009 8.975 0.004 0.881 0.829mmu_miR_1935_121192_mat 2.233 0.246 2.840 0.158 0.548 0.866 0.607 0.821−1.685 0.439 −2.292 0.231 mmu_miR_1936_121158_mat 1.302 0.366 1.7670.241 1.327 0.447 0.465 0.814 0.025 0.991 −0.440 0.814mmu_miR_1937b_241023_mat 1.965 0.849 −1.150 0.976 4.508 0.699 −3.1160.766 2.543 0.819 5.658 0.498 mmu_miR_1937c_241011_mat 2.194 0.000−1.016 0.109 4.590 0.000 −3.210 0.000 2.396 0.000 5.606 0.000mmu_miR_1938_121194_mat −0.151 0.952 0.429 0.934 0.683 0.808 0.579 0.8160.834 0.732 0.254 0.933 mmu_miR_1939_121180_mat 0.269 0.951 0.112 0.996−1.169 0.808 −0.157 0.977 −1.439 0.732 −1.281 0.746 mmu_miR_193_002250−2.644 0.412 0.022 0.997 0.667 0.905 2.666 0.430 3.311 0.322 0.645 0.896mmu_miR_193_002577 0.370 0.705 1.458 0.063 1.439 0.087 1.088 0.175 1.0690.187 −0.019 0.983 mmu_miR_193b_002467 −1.069 0.106 2.010 0.003 −0.3170.762 3.080 0.000 0.753 0.313 −2.327 0.001 mmu_miR_1940_121187_mat 1.1230.734 −5.814 0.023 1.321 0.749 −6.937 0.007 0.198 0.967 7.135 0.004mmu_miR_1941_3p_121130_mat −0.118 0.889 0.505 0.475 0.745 0.273 0.6230.323 0.862 0.154 0.239 0.753 mmu_miR_1941_5p_121140_mat −1.315 0.524−2.371 0.239 1.517 0.528 −1.056 0.636 2.832 0.138 3.888 0.027mmu_miR_1942_121136_mat −1.723 0.805 −7.035 0.236 2.660 0.762 −5.3110.373 4.383 0.494 9.695 0.063 mmu_miR_1943_121174_mat −2.933 0.003−2.015 0.050 −2.039 0.064 0.918 0.416 0.894 0.445 −0.025 0.983mmu_miR_1944_121189_mat −1.339 0.603 0.512 0.947 −1.252 0.720 1.8510.463 0.087 0.985 −1.764 0.467 mmu_miR_1945_121166_mat 0.046 0.966 0.4660.694 −0.398 0.762 0.420 0.672 −0.444 0.672 −0.864 0.299mmu_miR_1946a_121178_mat −0.105 0.982 −11.509 0.001 −2.903 0.515 11.4040.001 −2.798 0.482 8.606 0.009 mmu_miR_1947_121156_mat −2.911 0.1540.221 0.996 −0.490 0.896 3.132 0.139 2.422 0.280 −0.710 0.797mmu_miR_1948_121171_mat 2.891 0.169 2.181 0.362 1.539 0.581 −0.710 0.811−1.352 0.603 −0.643 0.817 mmu_miR_1949_121182_mat −0.291 0.766 0.1770.942 −1.530 0.061 0.468 0.598 −1.238 0.109 −1.706 0.018mmu_miR_194_000493 −2.491 0.021 −2.494 0.027 −1.163 0.399 −0.003 0.9981.328 0.281 1.331 0.240 mmu_miR_1950_121146_mat −0.395 0.872 0.046 0.996−0.918 0.742 0.441 0.869 −0.523 0.832 −0.964 0.632mmu_miR_1951_121165_mat 4.585 0.558 −6.950 0.382 7.385 0.381 11.5350.105 2.800 0.767 14.335 0.028 mmu_miR_1952_121167_mat −0.363 0.3070.043 0.986 −1.045 0.004 0.406 0.271 −0.682 0.052 −1.088 0.002mmu_miR_1953_121159_mat −0.371 0.768 0.368 0.849 0.020 0.992 0.739 0.5020.391 0.771 −0.348 0.796 mmu_miR_1954_121137_mat 1.876 0.455 −3.9930.099 8.646 0.001 −5.869 0.013 6.770 0.005 12.639 0.000mmu_miR_1956_121129_mat −1.624 0.768 −0.217 0.996 −2.111 0.757 1.4080.815 −0.487 0.948 −1.894 0.731 mmu_miR_1957_121163_mat −0.372 0.224−0.003 0.996 −1.160 0.000 0.369 0.246 −0.788 0.010 −1.156 0.000mmu_miR_1958_121181_mat 0.004 0.999 0.334 0.976 −1.947 0.491 0.330 0.935−1.951 0.439 −2.281 0.318 mmu_miR_1959_121132_mat 3.249 0.032 −2.4060.147 5.696 0.001 −5.655 0.001 2.447 0.128 8.102 0.000mmu_miR_195_000494 −3.796 0.000 −3.314 0.000 −1.388 0.038 0.482 0.4982.408 0.000 1.926 0.002 mmu_miR_1960_121148_mat −2.957 0.091 −0.0640.996 −0.141 0.971 2.893 0.118 2.816 0.125 −0.077 0.977mmu_miR_1961_197391_mat 6.588 0.104 4.267 0.369 14.437 0.001 −2.3210.642 7.848 0.061 10.170 0.010 mmu_miR_1962_121173_mat 1.085 0.387 0.3960.878 0.956 0.543 −0.690 0.633 −0.130 0.952 0.560 0.712mmu_miR_1963_121191_mat −0.372 0.224 −0.003 0.996 −1.160 0.000 0.3690.246 −0.788 0.010 −1.156 0.000 mmu_miR_1964_121138_mat −0.515 0.7100.431 0.831 1.957 0.100 0.946 0.435 2.472 0.024 1.526 0.156mmu_miR_1965_121186_mat −0.385 0.285 −0.429 0.271 −1.146 0.002 −0.0440.948 −0.761 0.032 −0.718 0.033 mmu_miR_1966_121134_mat −0.315 0.5710.020 0.996 −1.040 0.047 0.336 0.552 −0.725 0.152 −1.061 0.023mmu_miR_1967_121151_mat 0.380 0.445 0.757 0.118 −0.348 0.577 0.377 0.468−0.728 0.127 −1.105 0.013 mmu_miR_1968_121179_mat 6.513 0.033 6.3870.045 7.395 0.027 −0.126 0.980 0.882 0.849 1.008 0.814mmu_miR_1969_121131_mat 3.784 0.042 −2.933 0.152 5.471 0.007 −6.7170.001 1.687 0.449 8.404 0.000 mmu_miR_196a_002477 3.428 0.616 −0.8730.978 6.203 0.396 −4.300 0.524 2.776 0.732 7.076 0.239mmu_miR_196b_002215 3.477 0.060 −3.329 0.091 −1.558 0.529 −6.805 0.001−5.035 0.010 1.771 0.377 mmu_miR_1970_121202_mat 8.207 0.003 −1.5140.714 8.331 0.005 −9.720 0.001 0.124 0.983 9.844 0.001mmu_miR_1971_121161_mat 8.928 0.006 2.115 0.637 5.341 0.144 −6.813 0.043−3.587 0.330 3.226 0.353 mmu_miR_197_000497 1.385 0.798 −6.789 0.1212.623 0.672 −8.174 0.056 1.238 0.836 9.412 0.019 mmu_miR_1981_121200_mat1.855 0.030 1.872 0.035 0.028 0.991 0.017 0.990 −1.826 0.040 −1.8440.028 mmu_miR_1982.1_121157_mat 0.601 0.739 −0.050 0.996 −0.485 0.829−0.651 0.715 −1.086 0.501 −0.435 0.815 mmu_miR_1982.2_121154_mat 3.7430.083 −1.038 0.771 1.971 0.490 −4.781 0.034 −1.772 0.494 3.009 0.170mmu_miR_199a_3p_002304 −1.730 0.248 −3.254 0.028 −0.244 0.932 −1.5240.342 1.486 0.375 3.010 0.032 mmu_miR_199a_5p_000498 −0.135 0.964 1.6350.537 0.166 0.971 1.770 0.458 0.301 0.930 −1.469 0.533mmu_miR_199b_001131 2.512 0.207 1.475 0.546 0.829 0.791 −1.038 0.664−1.683 0.457 −0.646 0.812 mmu_miR_19a_000395 −3.602 0.000 −3.866 0.000−1.736 0.007 −0.265 0.751 1.866 0.004 2.131 0.001 mmu_miR_19a_002544−0.339 0.571 0.276 0.717 −0.416 0.543 0.614 0.268 −0.078 0.926 −0.6920.181 mmu_miR_19b_000396 −3.150 0.000 −3.625 0.000 −2.497 0.002 −0.4750.585 0.653 0.443 1.128 0.120 mmu_miR_1_002222 5.722 0.001 −1.308 0.5511.307 0.577 −7.030 0.000 −4.415 0.013 2.615 0.130 mmu_miR_1_2_AS_002882−6.864 0.051 −9.227 0.011 −0.364 0.959 −2.363 0.579 6.500 0.079 8.8630.011 mmu_miR_200a_000502 5.944 0.020 5.222 0.050 8.234 0.003 −0.7220.858 2.290 0.454 3.012 0.262 mmu_miR_200b_002251 0.510 0.931 −1.2050.904 3.688 0.472 −1.715 0.753 3.178 0.501 4.893 0.227mmu_miR_200c_002300 4.514 0.116 0.584 0.956 5.586 0.078 −3.930 0.1971.073 0.798 5.002 0.074 mmu_miR_201_002578 2.780 0.193 3.390 0.121 3.6160.119 0.610 0.842 0.836 0.771 0.226 0.955 mmu_miR_202_3p_001195 −0.8140.845 −3.387 0.333 1.112 0.828 −2.574 0.459 1.926 0.615 4.500 0.141mmu_miR_202_5p_002579 −1.959 0.255 2.746 0.121 3.802 0.034 4.705 0.0075.761 0.001 1.056 0.582 mmu_miR_203_000507 −1.644 0.540 −1.722 0.5671.361 0.708 −0.078 0.983 3.005 0.243 3.084 0.192 mmu_miR_203_0025801.534 0.655 2.087 0.565 4.806 0.130 0.553 0.910 3.271 0.299 2.719 0.369mmu_miR_204_000508 −4.113 0.000 −2.187 0.000 −0.074 0.944 1.927 0.0014.040 0.000 2.113 0.000 mmu_miR_205_000509 3.238 0.267 0.911 0.890 0.0340.995 −2.327 0.468 −3.204 0.313 −0.877 0.817 mmu_miR_207_001198 −0.1520.931 0.287 0.934 −1.426 0.304 0.439 0.789 −1.274 0.326 −1.713 0.138mmu_miR_208_000511 −5.307 0.268 −0.707 0.976 −0.085 0.993 4.600 0.3735.222 0.316 0.622 0.937 mmu_miR_208b_002290 7.014 0.072 1.825 0.7826.154 0.164 −5.190 0.217 −0.860 0.880 4.329 0.294 mmu_miR_20a_000580−2.905 0.000 −3.985 0.000 −2.274 0.001 −1.080 0.096 0.631 0.376 1.7110.005 mmu_miR_20a_002491 −4.750 0.011 −5.535 0.004 −2.513 0.261 −0.7850.766 2.237 0.289 3.022 0.109 mmu_miR_20b_001014 −4.875 0.002 −5.5410.001 −4.212 0.014 −0.666 0.766 0.663 0.767 1.329 0.450mmu_miR_20b_002524 −0.203 0.945 0.159 0.996 −1.103 0.742 0.362 0.921−0.900 0.759 −1.262 0.592 mmu_miR_210_000512 −6.053 0.000 −4.498 0.002−5.549 0.000 1.555 0.318 0.504 0.809 −1.052 0.503 mmu_miR_211_001199−1.331 0.860 −1.666 0.904 0.119 0.992 −0.335 0.977 1.450 0.852 1.7860.814 mmu_miR_212_002551 1.805 0.103 1.763 0.140 −0.682 0.681 −0.0410.980 −2.487 0.028 −2.446 0.023 mmu_miR_2134_241120_mat 3.955 0.013−0.292 0.961 6.286 0.000 −4.248 0.011 2.331 0.179 6.578 0.000mmu_miR_2135_241140_mat 4.438 0.571 3.308 0.768 5.498 0.547 −1.130 0.9261.059 0.926 2.190 0.815 mmu_miR_2136_241133_mat 2.118 0.822 −1.686 0.943−0.266 0.989 −3.803 0.670 −2.384 0.819 1.420 0.908mmu_miR_2138_241080_mat −0.496 0.926 −6.187 0.066 7.754 0.026 −5.6910.095 8.250 0.013 13.941 0.000 mmu_miR_2139_241130_mat 1.420 0.442 1.5360.453 0.816 0.762 0.116 0.975 −0.604 0.809 −0.720 0.750mmu_miR_2146_241082_mat 4.805 0.169 0.785 0.947 8.308 0.023 −4.020 0.2743.504 0.375 7.523 0.023 mmu_miR_214_002306 0.621 0.758 −2.198 0.1941.687 0.379 −2.819 0.079 1.066 0.581 3.885 0.010 mmu_miR_215_001200−3.568 0.067 −4.378 0.030 −1.614 0.541 −0.809 0.768 1.954 0.389 2.7630.165 mmu_miR_216a_002220 7.300 0.000 1.747 0.297 −0.386 0.886 −5.5530.001 −7.686 0.000 −2.133 0.152 mmu_miR_216b_002326 6.340 0.000 2.5870.116 −0.163 0.957 −3.753 0.018 −6.503 0.000 −2.750 0.070mmu_miR_217_001133 3.765 0.022 −1.984 0.296 0.794 0.763 −5.749 0.001−2.971 0.090 2.778 0.093 mmu_miR_217_002556 1.439 0.296 −1.872 0.199−1.035 0.558 −3.312 0.015 −2.474 0.070 0.837 0.582mmu_miR_2182_241119_mat 3.240 0.272 4.188 0.177 4.488 0.161 0.948 0.8161.247 0.760 0.300 0.956 mmu_miR_2183_241095_mat 2.712 0.233 −2.002 0.4537.070 0.003 −4.714 0.039 4.358 0.055 9.072 0.000 mmu_miR_218_0005214.253 0.000 4.294 0.000 2.276 0.000 0.041 0.966 −1.978 0.000 −2.0180.000 mmu_miR_218_1_002552 4.020 0.001 2.634 0.026 0.490 0.795 −1.3860.270 −3.529 0.004 −2.144 0.057 mmu_miR_219_000522 −7.843 0.000 −3.7100.001 −7.528 0.000 4.133 0.001 0.316 0.847 −3.817 0.001mmu_miR_21_000397 −1.907 0.017 −4.068 0.000 −1.418 0.122 −2.161 0.0100.489 0.640 2.650 0.001 mmu_miR_21_002493 −0.866 0.571 −0.497 0.854−0.936 0.613 0.370 0.859 −0.070 0.980 −0.440 0.814 mmu_miR_220_002468−0.345 0.358 0.031 0.996 −1.312 0.001 0.376 0.339 −0.968 0.009 −1.3430.000 mmu_miR_221_000524 −2.408 0.000 −1.736 0.000 −0.691 0.154 0.6720.141 1.717 0.000 1.045 0.013 mmu_miR_222_002276 −0.534 0.099 −1.1750.001 −0.241 0.581 −0.641 0.056 0.292 0.439 0.934 0.004mmu_miR_223_002295 2.907 0.001 −11.143 0.000 6.409 0.000 14.050 0.0003.501 0.000 17.551 0.000 mmu_miR_224_002553 −2.237 0.034 −0.220 0.956−0.667 0.676 2.017 0.073 1.570 0.168 −0.448 0.753 mmu_miR_23a_000399−0.576 0.771 0.453 0.908 1.284 0.528 1.029 0.572 1.860 0.278 0.831 0.648mmu_miR_23b_000400 −1.804 0.062 −1.505 0.155 −0.635 0.660 0.299 0.8361.169 0.285 0.870 0.411 mmu_miR_24_000402 0.270 0.352 −0.614 0.028 0.2750.434 −0.884 0.002 0.005 0.991 0.889 0.001 mmu_miR_24_2_002494 −1.2100.158 −1.568 0.074 0.803 0.457 −0.357 0.760 2.013 0.020 2.371 0.004mmu_miR_25_000403 −2.922 0.013 −3.569 0.004 −0.661 0.735 −0.647 0.6642.262 0.068 2.908 0.013 mmu_miR_26a_000405 −1.266 0.001 −1.376 0.000−0.595 0.144 −0.110 0.836 0.671 0.075 0.781 0.027 mmu_miR_26b_000407−2.100 0.000 −2.253 0.000 −0.712 0.144 −0.153 0.806 1.388 0.003 1.5400.001 mmu_miR_27a_000408 −1.662 0.144 −0.624 0.710 1.224 0.380 1.0380.409 2.887 0.012 1.848 0.093 mmu_miR_27b_000409 −0.919 0.093 −0.0120.996 −0.811 0.194 0.907 0.117 0.108 0.899 −0.799 0.147mmu_miR_28_000411 −1.473 0.436 −1.469 0.500 1.899 0.382 0.004 0.9983.372 0.061 3.368 0.047 mmu_miR_28_002545 3.058 0.084 2.205 0.270 3.6950.060 −0.854 0.715 0.637 0.809 1.490 0.446 mmu_miR_290_000187 0.3140.951 −14.329 0.000 2.246 0.668 14.643 0.000 1.932 0.678 16.575 0.000mmu_miR_290_3p_002591 −0.370 0.261 0.024 0.996 −1.085 0.002 0.394 0.247−0.715 0.028 −1.109 0.001 mmu_miR_290_5p_002590 −1.247 0.782 −3.3630.414 0.758 0.906 −2.117 0.614 2.004 0.655 4.121 0.247mmu_miR_291_3p_001135 −0.315 0.750 −0.003 0.997 −1.874 0.018 0.312 0.763−1.559 0.040 −1.871 0.010 mmu_miR_291_5p_001202 −0.315 0.546 0.028 0.996−1.045 0.032 0.342 0.510 −0.730 0.124 −1.072 0.015mmu_miR_291a_3p_002592 −0.369 0.248 0.023 0.996 −1.092 0.001 0.392 0.237−0.723 0.023 −1.115 0.001 mmu_miR_291b_3p_002538 −0.356 0.586 0.1810.895 −0.653 0.353 0.536 0.400 −0.297 0.703 −0.833 0.145mmu_miR_291b_5p_002537 −0.382 0.430 −0.007 0.996 −1.149 0.016 0.3750.462 −0.767 0.100 −1.142 0.009 mmu_miR_292_3p_001054 0.714 0.822 0.8110.878 0.065 0.992 0.098 0.980 −0.649 0.852 −0.746 0.817mmu_miR_292_3p_002593 −1.561 0.798 −3.792 0.518 −0.789 0.932 −2.2300.715 0.772 0.921 3.003 0.575 mmu_miR_292_5p_001055 −4.363 0.358 −0.3460.996 1.031 0.903 4.017 0.431 5.394 0.282 1.377 0.820 mmu_miR_293_0017940.789 0.916 −4.503 0.427 1.154 0.896 −5.292 0.304 0.366 0.968 5.6580.244 mmu_miR_293_002594 −0.719 0.750 0.308 0.961 −1.291 0.575 1.0270.615 −0.573 0.819 −1.600 0.376 mmu_miR_294_001056 −2.344 0.571 −4.3870.284 1.310 0.828 −2.043 0.648 3.654 0.383 5.697 0.114mmu_miR_294_002595 −0.372 0.224 −0.003 0.996 −1.160 0.000 0.369 0.246−0.788 0.010 −1.156 0.000 mmu_miR_295_000189 −0.091 0.965 −1.183 0.5320.804 0.742 −1.092 0.527 0.895 0.640 1.988 0.188 mmu_miR_295_002596−0.251 0.931 −6.936 0.001 −1.002 0.762 −6.685 0.002 −0.751 0.803 5.9340.003 mmu_miR_296_3p_002101 −0.379 0.876 −0.031 0.996 2.868 0.136 0.3480.907 3.247 0.066 2.899 0.084 mmu_miR_296_5p_000527 0.693 0.611 3.7260.002 1.371 0.343 3.034 0.011 0.678 0.655 −2.355 0.037mmu_miR_297a_002454 −2.677 0.004 0.070 0.996 0.011 0.995 2.748 0.0052.689 0.006 −0.059 0.972 mmu_miR_297b_5p_001626 −1.452 0.278 0.430 0.8811.392 0.389 1.882 0.172 2.844 0.031 0.962 0.501 mmu_miR_297c_002480−1.118 0.571 0.254 0.978 1.448 0.524 1.372 0.478 2.566 0.154 1.194 0.535mmu_miR_298_002598 2.715 0.077 0.214 0.982 −2.912 0.089 −2.500 0.127−5.626 0.001 −3.126 0.038 mmu_miR_299_002612 −0.372 0.224 −0.003 0.996−1.160 0.000 0.369 0.246 −0.788 0.010 −1.156 0.000 mmu_miR_29a_0021120.647 0.172 1.052 0.026 −0.223 0.762 0.405 0.439 −0.869 0.068 −1.2750.005 mmu_miR_29b_000413 2.488 0.013 2.316 0.026 1.441 0.219 −0.1720.924 −1.047 0.375 −0.875 0.429 mmu_miR_29b_002497 1.053 0.339 −2.6280.013 4.191 0.000 −3.681 0.001 3.138 0.004 6.818 0.000mmu_miR_29c_000587 1.071 0.007 1.737 0.000 0.364 0.491 0.666 0.117−0.707 0.092 −1.373 0.001 mmu_miR_300_000191 3.228 0.202 3.268 0.2270.507 0.909 0.040 0.991 −2.722 0.323 −2.761 0.277 mmu_miR_300_0026135.413 0.000 2.912 0.025 2.426 0.084 −2.501 0.056 −2.986 0.022 −0.4860.784 mmu_miR_301a_000528 −1.211 0.018 −0.743 0.196 −0.623 0.333 0.4680.431 0.588 0.316 0.120 0.886 mmu_miR_301b_002600 −0.651 0.339 0.4150.641 −0.375 0.708 1.066 0.117 0.277 0.761 −0.789 0.234mmu_miR_302a_000529 4.747 0.330 −1.620 0.869 1.237 0.885 −6.367 0.194−3.510 0.531 2.857 0.592 mmu_miR_302a_002615 2.577 0.348 2.287 0.4732.762 0.395 −0.290 0.952 0.185 0.971 0.475 0.911 mmu_miR_302b_000531−0.729 0.815 1.897 0.520 0.389 0.932 2.626 0.306 1.118 0.732 −1.5080.575 mmu_miR_302b_001307 −0.076 0.986 −5.224 0.116 0.345 0.957 −5.1480.120 0.421 0.938 5.569 0.069 mmu_miR_302c_002557 −1.620 0.532 2.2830.388 1.799 0.552 3.903 0.102 3.419 0.152 −0.484 0.899mmu_miR_302c_002558 −0.911 0.859 −3.469 0.434 1.404 0.813 −2.557 0.5542.316 0.615 4.873 0.190 mmu_miR_302d_000535 0.758 0.847 1.501 0.7301.325 0.771 0.743 0.869 0.567 0.899 −0.176 0.972 mmu_miR_30a_000417−1.562 0.000 −1.434 0.000 −0.682 0.114 0.128 0.816 0.879 0.025 0.7510.044 mmu_miR_30b_000602 −0.095 0.840 −0.334 0.422 −0.120 0.833 −0.2380.558 −0.025 0.971 0.213 0.594 mmu_miR_30b_002498 −1.245 0.509 −0.0110.997 −0.226 0.944 1.235 0.520 1.019 0.632 −0.216 0.937mmu_miR_30c_000419 −0.149 0.696 −0.188 0.658 −0.225 0.581 −0.039 0.948−0.075 0.864 −0.037 0.944 mmu_miR_30d_000420 −1.632 0.007 −0.767 0.267−0.293 0.763 0.864 0.186 1.338 0.034 0.474 0.488 mmu_miR_30e_002223−1.257 0.000 −0.647 0.027 −0.121 0.796 0.610 0.040 1.137 0.000 0.5270.059 mmu_miR_31_000185 1.443 0.037 0.389 0.710 0.375 0.747 −1.055 0.161−1.068 0.151 −0.013 0.986 mmu_miR_31_002495 1.153 0.612 −1.314 0.615−0.680 0.832 −2.466 0.237 −1.833 0.416 0.634 0.814 mmu_miR_320_002277−1.744 0.000 −0.535 0.214 −0.229 0.707 1.209 0.003 1.516 0.000 0.3070.475 mmu_miR_322_001059 −0.136 0.980 −3.889 0.362 −0.522 0.942 −3.7530.360 −0.386 0.954 3.367 0.393 mmu_miR_322_001076 −8.114 0.000 −8.6990.000 −8.621 0.000 −0.584 0.801 −0.507 0.829 0.078 0.977mmu_miR_322_002506 −3.161 0.050 −5.285 0.002 −5.118 0.004 −2.125 0.227−1.958 0.285 0.167 0.956 mmu_miR_323_3p_002227 2.604 0.002 3.423 0.000−0.342 0.803 0.819 0.378 −2.946 0.001 −3.765 0.000 mmu_miR_324_3p_002509−1.827 0.061 1.304 0.235 −1.570 0.157 3.130 0.002 0.257 0.856 −2.8730.004 mmu_miR_324_5p_000539 −0.933 0.436 −0.098 0.996 −1.095 0.436 0.8350.510 −0.162 0.928 −0.997 0.402 mmu_miR_325_001060 −2.040 0.617 −7.6180.032 −2.003 0.713 −5.578 0.131 0.036 0.995 5.615 0.104mmu_miR_325_002510 0.367 0.762 5.406 0.000 −0.380 0.801 5.039 0.000−0.746 0.498 −5.785 0.000 mmu_miR_326_001061 1.352 0.844 −16.729 0.001−2.900 0.709 18.082 0.001 −4.252 0.472 13.829 0.005 mmu_miR_327_0024810.048 0.980 0.882 0.537 −0.010 0.995 0.834 0.520 −0.059 0.980 −0.8920.468 mmu_miR_328_000543 1.228 0.003 1.075 0.010 0.602 0.195 −0.1530.792 −0.627 0.145 −0.473 0.262 mmu_miR_329_000192 2.770 0.006 3.4950.001 0.409 0.805 0.725 0.538 −2.362 0.023 −3.087 0.002mmu_miR_32_002109 −7.009 0.004 −6.669 0.008 −5.342 0.047 0.341 0.9431.667 0.590 1.327 0.652 mmu_miR_330_001062 5.796 0.144 1.929 0.759 3.1490.544 −3.867 0.373 −2.647 0.589 1.219 0.817 mmu_miR_330_002230 1.5100.229 −2.120 0.099 −0.846 0.616 −3.631 0.004 −2.357 0.061 1.274 0.322mmu_miR_331_3p_000545 0.663 0.244 1.637 0.004 1.074 0.077 0.974 0.0920.412 0.535 −0.562 0.336 mmu_miR_331_5p_002233 0.272 0.936 −2.070 0.4883.882 0.152 −2.341 0.385 3.610 0.155 5.951 0.011 mmu_miR_335_3p_0021853.410 0.006 5.704 0.000 −1.500 0.327 2.294 0.078 −4.909 0.000 −7.2040.000 mmu_miR_335_5p_000546 3.450 0.000 2.261 0.000 0.822 0.200 −1.1890.041 −2.628 0.000 −1.439 0.009 mmu_miR_337_000193 1.439 0.270 2.4300.063 0.714 0.720 0.991 0.493 −0.725 0.656 −1.716 0.179mmu_miR_337_3p_002532 2.244 0.039 3.024 0.007 0.680 0.681 0.780 0.547−1.564 0.187 −2.344 0.029 mmu_miR_337_5p_002515 3.042 0.109 3.983 0.0413.249 0.130 0.941 0.703 0.207 0.953 −0.734 0.784 mmu_miR_338_3p_002252−4.756 0.000 −0.157 0.981 −4.267 0.000 4.599 0.000 0.489 0.756 −4.1100.000 mmu_miR_339_3p_002533 −4.077 0.027 −4.743 0.013 −1.867 0.434−0.666 0.804 2.210 0.287 2.876 0.123 mmu_miR_339_5p_002257 −5.774 0.000−4.818 0.000 −4.632 0.000 0.956 0.468 1.142 0.389 0.187 0.921mmu_miR_340_3p_002259 −0.132 0.795 0.262 0.615 0.114 0.866 0.394 0.3630.247 0.613 −0.147 0.785 mmu_miR_340_5p_002258 −0.854 0.029 0.615 0.152−0.358 0.491 1.469 0.001 0.496 0.262 −0.973 0.012 mmu_miR_342_3p_0022601.258 0.001 −0.439 0.321 −0.378 0.447 −1.697 0.000 −1.636 0.000 0.0610.925 mmu_miR_342_5p_002527 −0.272 0.890 −0.731 0.715 −2.638 0.077−0.459 0.814 −2.366 0.092 −1.907 0.160 mmu_miR_343_002483 −0.364 0.5820.001 0.999 −1.103 0.085 0.365 0.598 −0.738 0.246 −1.103 0.049mmu_miR_344_001063 −0.670 0.577 2.390 0.026 −1.083 0.416 3.060 0.005−0.413 0.780 −3.473 0.001 mmu_miR_345_001137 −1.475 0.120 −0.086 0.9960.102 0.957 1.389 0.169 1.577 0.109 0.188 0.908 mmu_miR_345_3p_002529−2.160 0.053 −0.871 0.546 −0.965 0.524 1.289 0.298 1.195 0.362 −0.0940.963 mmu_miR_345_5p_002528 −3.890 0.000 0.407 0.704 −2.754 0.000 4.2970.000 1.137 0.127 −3.161 0.000 mmu_miR_346_001064 1.455 0.309 0.8020.694 0.250 0.930 −0.653 0.715 −1.205 0.455 −0.552 0.766mmu_miR_34a_000426 4.629 0.000 2.856 0.000 0.483 0.528 −1.773 0.003−4.146 0.000 −2.373 0.000 mmu_miR_34b_001065 −1.407 0.333 −0.921 0.6220.965 0.614 0.486 0.806 2.372 0.100 1.885 0.177 mmu_miR_34b_3p_002618−0.861 0.066 1.723 0.001 0.983 0.060 2.585 0.000 1.844 0.000 −0.7410.116 mmu_miR_34b_5p_002617 0.352 0.844 1.225 0.435 2.686 0.061 0.8720.575 2.333 0.086 1.461 0.282 mmu_miR_34c_000428 −0.923 0.265 6.0100.000 1.322 0.142 6.933 0.000 2.245 0.007 −4.688 0.000mmu_miR_34c_002584 −0.563 0.372 1.353 0.026 1.390 0.029 1.916 0.0021.952 0.002 0.037 0.972 mmu_miR_350_002530 −3.701 0.000 −2.524 0.000−2.613 0.000 1.177 0.033 1.088 0.048 −0.089 0.919 mmu_miR_351_001067−0.341 0.811 0.201 0.961 −0.172 0.933 0.542 0.698 0.169 0.926 −0.3730.804 mmu_miR_361_000554 −0.007 0.999 0.771 0.710 0.014 0.995 0.7780.642 0.021 0.992 −0.757 0.639 mmu_miR_362_3p_002616 −3.097 0.001 −4.6020.000 −1.997 0.054 −1.504 0.134 1.101 0.297 2.605 0.005mmu_miR_362_5p_002614 −1.194 0.154 −2.181 0.009 −0.368 0.779 −0.9870.268 0.825 0.383 1.812 0.023 mmu_miR_363_001271 0.916 0.771 1.024 0.8151.021 0.799 0.107 0.980 0.105 0.983 −0.002 0.999 mmu_miR_365_001020−5.714 0.000 0.223 0.922 −2.269 0.011 5.937 0.000 3.445 0.000 −2.4920.003 mmu_miR_367_000555 −2.768 0.612 −0.973 0.956 −1.447 0.858 1.7950.787 1.322 0.849 −0.474 0.956 mmu_miR_369_3p_000557 2.423 0.010 1.8840.056 0.142 0.940 −0.539 0.648 −2.281 0.020 −1.742 0.061mmu_miR_369_5p_001021 4.393 0.000 1.633 0.125 0.432 0.791 −2.760 0.008−3.961 0.000 −1.201 0.244 mmu_miR_370_001068 −0.252 0.931 0.228 0.986−0.818 0.778 0.480 0.869 −0.566 0.829 −1.046 0.627 mmu_miR_370_0022752.481 0.000 4.859 0.000 −1.225 0.112 2.378 0.001 −3.706 0.000 −6.0840.000 mmu_miR_374_002043 0.632 0.931 1.079 0.952 5.713 0.345 0.447 0.9645.081 0.370 4.634 0.376 mmu_miR_374_5p_001319 −9.452 0.006 −6.096 0.094−9.210 0.014 3.356 0.386 0.242 0.971 −3.114 0.404 mmu_miR_375_000564−3.119 0.007 1.534 0.241 0.162 0.944 4.653 0.000 3.281 0.008 −1.3720.261 mmu_miR_376a_001069 2.979 0.000 2.553 0.000 0.368 0.585 −0.4260.454 −2.610 0.000 −2.184 0.000 mmu_miR_376a_002482 4.322 0.019 1.7780.432 0.541 0.869 −2.544 0.203 −3.781 0.050 −1.237 0.565mmu_miR_376b_002451 3.033 0.479 2.634 0.615 0.498 0.948 −0.399 0.957−2.535 0.606 −2.135 0.643 mmu_miR_376b_002452 3.368 0.001 4.389 0.0000.253 0.893 1.021 0.363 −3.115 0.004 −4.135 0.000 mmu_miR_376c_0024501.990 0.000 2.113 0.000 0.705 0.152 0.123 0.856 −1.285 0.005 −1.4080.001 mmu_miR_376c_002523 1.179 0.646 2.464 0.305 2.042 0.455 1.2850.618 0.863 0.771 −0.422 0.908 mmu_miR_377_000566 0.361 0.888 0.7500.803 0.835 0.762 0.389 0.893 0.475 0.852 0.086 0.977 mmu_miR_379_0011383.055 0.005 3.240 0.004 1.132 0.414 0.184 0.924 −1.924 0.091 −2.1080.047 mmu_miR_380_3p_001071 6.440 0.000 2.428 0.013 1.761 0.101 −4.0130.000 −4.679 0.000 −0.667 0.541 mmu_miR_380_5p_002601 4.578 0.000 3.1520.000 1.042 0.152 −1.426 0.034 −3.536 0.000 −2.110 0.001mmu_miR_381_000571 1.783 0.253 0.281 0.961 0.496 0.847 −1.501 0.373−1.287 0.472 0.214 0.933 mmu_miR_382_000572 3.946 0.003 8.030 0.000−0.636 0.762 4.084 0.003 −4.582 0.001 −8.666 0.000 mmu_miR_383_0017674.785 0.000 3.581 0.000 0.227 0.830 −1.204 0.071 −4.559 0.000 −3.3550.000 mmu_miR_384_3p_002603 1.619 0.004 1.442 0.013 0.019 0.991 −0.1770.833 −1.600 0.007 −1.423 0.011 mmu_miR_384_5p_002602 2.058 0.000 1.6140.000 −0.196 0.751 −0.444 0.274 −2.254 0.000 −1.811 0.000mmu_miR_409_3p_002332 3.235 0.002 2.887 0.006 0.540 0.753 −0.348 0.816−2.696 0.012 −2.348 0.020 mmu_miR_409_5p_002331 4.707 0.000 2.407 0.013−0.202 0.907 −2.300 0.018 −4.909 0.000 −2.609 0.005 mmu_miR_410_0012742.997 0.000 3.408 0.000 0.172 0.813 0.411 0.413 −2.825 0.000 −3.2360.000 mmu_miR_411_001610 2.330 0.001 2.541 0.000 0.636 0.457 0.212 0.825−1.693 0.013 −1.905 0.004 mmu_miR_412_002575 5.379 0.000 5.343 0.0000.642 0.628 −0.036 0.980 −4.737 0.000 −4.700 0.000 mmu_miR_423_5p_002340−2.665 0.003 −1.262 0.202 −2.240 0.020 1.403 0.139 0.424 0.733 −0.9780.298 mmu_miR_425_001516 2.811 0.170 −2.190 0.342 6.783 0.002 −5.0010.015 3.972 0.053 8.973 0.000 mmu_miR_429_001077 2.368 0.379 −0.2070.996 3.158 0.299 −2.575 0.362 0.790 0.829 3.365 0.188mmu_miR_431_001979 −0.969 0.381 −2.156 0.042 −6.434 0.000 −1.187 0.294−5.465 0.000 −4.278 0.000 mmu_miR_432_241135_mat 1.165 0.798 2.536 0.5761.706 0.762 1.371 0.783 0.542 0.926 −0.829 0.883 mmu_miR_433_0010283.646 0.000 3.261 0.000 0.427 0.496 −0.385 0.478 −3.219 0.000 −2.8340.000 mmu_miR_433_5p_001078 5.590 0.067 −0.587 0.961 0.762 0.896 −6.1770.053 −4.828 0.136 1.350 0.746 mmu_miR_434_3p_002604 3.014 0.000 1.5730.002 0.003 0.997 −1.441 0.004 −3.012 0.000 −1.570 0.001mmu_miR_434_5p_002581 3.972 0.001 2.968 0.012 0.512 0.782 −1.005 0.446−3.460 0.004 −2.456 0.029 mmu_miR_448_001029 5.042 0.002 2.286 0.2030.049 0.992 −2.756 0.109 −4.992 0.004 −2.237 0.174 mmu_miR_449a_0010301.036 0.518 −2.363 0.112 1.290 0.485 −3.399 0.018 0.254 0.910 3.6530.008 mmu_miR_449b_001667 2.481 0.205 −0.524 0.916 2.290 0.324 −3.0050.134 −0.191 0.955 2.814 0.138 mmu_miR_449b_002539 −0.367 0.249 0.0250.996 −1.091 0.001 0.391 0.237 −0.725 0.022 −1.116 0.000mmu_miR_450B_3P_002632 −0.001 0.999 −6.200 0.039 −1.498 0.757 −6.1990.041 −1.497 0.716 4.702 0.105 mmu_miR_450a_3p_002525 −0.372 0.224−0.003 0.996 −1.160 0.000 0.369 0.246 −0.788 0.010 −1.156 0.000mmu_miR_450a_5p_002303 −2.349 0.097 −1.004 0.588 −1.216 0.519 1.3450.397 1.133 0.501 −0.212 0.932 mmu_miR_450b_5p_001962 −0.359 0.571 0.0860.976 −0.912 0.144 0.445 0.478 −0.552 0.386 −0.997 0.065mmu_miR_451_001141 −2.489 0.500 −5.487 0.115 4.678 0.215 −2.998 0.4197.167 0.033 10.165 0.002 mmu_miR_452_001032 −1.599 0.722 −4.368 0.254−1.775 0.754 −2.770 0.478 −0.177 0.980 2.593 0.494 mmu_miR_453_002484−0.193 0.925 0.386 0.896 −0.626 0.755 0.579 0.715 −0.434 0.809 −1.0120.450 mmu_miR_455_002455 −6.597 0.000 −4.753 0.001 −5.991 0.000 1.8440.207 0.606 0.759 −1.238 0.402 mmu_miR_463_002582 2.723 0.037 −1.7760.227 6.352 0.000 −4.499 0.001 3.630 0.009 8.129 0.000mmu_miR_463_002662 2.919 0.253 −2.665 0.356 4.853 0.077 −5.584 0.0301.934 0.513 7.518 0.002 mmu_miR_464_001081 −0.284 0.804 0.160 0.961−0.651 0.581 0.444 0.691 −0.367 0.767 −0.811 0.389mmu_miR_465C_5P_002654 6.586 0.001 −0.547 0.908 7.774 0.000 −7.133 0.0001.188 0.611 8.321 0.000 mmu_miR_465a_3p_002040 3.324 0.209 3.128 0.2771.026 0.805 −0.197 0.971 −2.298 0.443 −2.101 0.457mmu_miR_465a_5p_001082 −6.964 0.270 −1.026 0.967 1.181 0.921 5.938 0.3848.145 0.218 2.207 0.796 mmu_miR_465b_5p_002485 3.129 0.483 −3.099 0.546−0.399 0.960 −6.227 0.143 −3.527 0.457 2.700 0.556mmu_miR_466E_5P_002718 −1.496 0.785 −8.180 0.062 0.777 0.929 −6.6840.134 2.273 0.690 8.957 0.028 mmu_miR_466J_002817 −1.861 0.200 −0.7740.710 0.289 0.909 1.086 0.501 2.150 0.146 1.063 0.493mmu_miR_466a_3p_002586 −3.636 0.000 0.631 0.498 −0.966 0.273 4.266 0.0002.670 0.001 −1.596 0.027 mmu_miR_466b_3_3p_002500 −3.268 0.004 −0.0990.996 −1.269 0.365 3.169 0.007 1.999 0.090 −1.170 0.329mmu_miR_466d_5p_002534 2.978 0.571 1.035 0.949 1.464 0.850 −1.943 0.760−1.513 0.819 0.430 0.958 mmu_miR_466g_241015_mat −3.586 0.109 1.2680.710 0.901 0.805 4.854 0.037 4.487 0.052 −0.368 0.920mmu_miR_466h_002516 −1.368 0.542 −0.039 0.996 −1.733 0.500 1.329 0.564−0.365 0.909 −1.694 0.428 mmu_miR_466k_240990_mat 4.305 0.101 −2.6760.386 3.981 0.181 −6.981 0.010 −0.324 0.942 6.657 0.010mmu_miR_467F_002886 −2.755 0.404 −5.216 0.107 −0.162 0.981 −2.461 0.4782.593 0.472 5.054 0.093 mmu_miR_467H_002809 −4.526 0.000 −1.399 0.278−2.119 0.096 3.127 0.009 2.407 0.040 −0.720 0.585 mmu_miR_467a_001826−2.689 0.039 1.030 0.541 0.786 0.701 3.718 0.007 3.475 0.011 −0.2430.911 mmu_miR_467a_002587 −2.663 0.014 3.334 0.003 −0.073 0.976 5.9960.000 2.590 0.023 −3.407 0.002 mmu_miR_467b_001671 −5.128 0.000 −1.3250.298 −3.306 0.006 3.803 0.001 1.822 0.123 −1.981 0.072mmu_miR_467b_001684 0.962 0.720 −2.105 0.383 3.511 0.130 −3.066 0.1612.549 0.263 5.615 0.005 mmu_miR_467c_002517 −4.310 0.014 −0.887 0.7590.998 0.727 3.423 0.067 5.308 0.005 1.884 0.320 mmu_miR_467d_002518−2.397 0.055 −1.358 0.359 0.709 0.727 1.039 0.471 3.106 0.018 2.0670.100 mmu_miR_467e_002568 −2.134 0.280 −4.172 0.032 0.232 0.952 −2.0380.332 2.366 0.263 4.404 0.017 mmu_miR_467e_002569 0.159 0.956 −1.4540.570 −1.655 0.528 −1.612 0.475 −1.814 0.436 −0.201 0.956mmu_miR_468_001085 −0.104 0.964 0.095 0.996 −0.576 0.828 0.199 0.948−0.472 0.841 −0.671 0.753 mmu_miR_469_001086 0.386 0.936 0.096 0.996−3.480 0.423 −0.289 0.966 −3.866 0.314 −3.576 0.322 mmu_miR_470_002588−0.099 0.954 0.452 0.850 −0.059 0.983 0.550 0.727 0.040 0.988 −0.5100.748 mmu_miR_470_002589 −3.462 0.565 −8.085 0.147 2.591 0.762 −4.6230.431 6.052 0.293 10.676 0.033 mmu_miR_471_002605 −0.325 0.571 0.1450.908 −1.157 0.029 0.471 0.396 −0.832 0.106 −1.303 0.007mmu_miR_483_001291 1.889 0.571 −5.292 0.079 2.412 0.528 −7.182 0.0160.523 0.910 7.704 0.007 mmu_miR_483_002560 0.587 0.687 0.376 0.890 2.8250.023 −0.211 0.917 2.238 0.061 2.449 0.029 mmu_miR_484_001821 −1.7720.000 −1.747 0.000 −1.027 0.032 0.025 0.977 0.745 0.109 0.720 0.102mmu_miR_485_3p_001943 2.210 0.000 2.658 0.000 0.893 0.144 0.448 0.470−1.317 0.019 −1.765 0.001 mmu_miR_486_001278 −5.954 0.000 1.667 0.303−6.271 0.000 7.621 0.000 −0.317 0.878 −7.938 0.000 mmu_miR_487b_0012852.351 0.000 1.938 0.001 0.961 0.119 −0.413 0.511 −1.390 0.013 −0.9770.069 mmu_miR_487b_001306 1.379 0.009 2.508 0.000 −0.265 0.762 1.1300.042 −1.643 0.004 −2.773 0.000 mmu_miR_488_001659 −0.634 0.693 1.5050.292 −0.088 0.976 2.139 0.110 0.546 0.761 −1.593 0.218mmu_miR_488_002014 0.863 0.786 0.065 0.996 1.830 0.581 −0.798 0.8210.967 0.780 1.765 0.521 mmu_miR_489_001302 5.862 0.003 1.820 0.444 1.2400.672 −4.043 0.047 −4.622 0.022 −0.579 0.829 mmu_miR_490_001037 2.7900.016 −2.910 0.015 −4.682 0.000 −5.700 0.000 −7.472 0.000 −1.772 0.133mmu_miR_491_001630 2.501 0.009 3.895 0.000 0.707 0.597 1.394 0.177−1.794 0.077 −3.187 0.001 mmu_miR_493_002519 2.745 0.237 1.497 0.6243.131 0.231 −1.247 0.654 0.386 0.916 1.634 0.515 mmu_miR_494_001293−1.460 0.381 −0.322 0.956 −0.816 0.752 1.139 0.529 0.645 0.767 −0.4940.817 mmu_miR_494_002365 1.669 0.189 1.365 0.333 0.848 0.618 −0.3040.875 −0.821 0.596 −0.517 0.753 mmu_miR_495_001663 2.878 0.000 2.4330.000 0.012 0.992 −0.444 0.295 −2.866 0.000 −2.422 0.000mmu_miR_496_001953 −1.968 0.454 −1.027 0.805 −4.476 0.092 0.941 0.783−2.507 0.366 −3.449 0.152 mmu_miR_497_001346 −5.762 0.000 −3.032 0.008−2.123 0.088 2.729 0.018 3.639 0.002 0.910 0.461 mmu_miR_499_0013521.748 0.415 −2.549 0.243 −1.700 0.516 −4.297 0.036 −3.448 0.092 0.8490.747 mmu_miR_500_002606 −3.686 0.001 −4.688 0.000 −3.452 0.002 −1.0020.395 0.234 0.878 1.236 0.253 mmu_miR_501_001356 1.764 0.418 1.319 0.6271.268 0.672 −0.445 0.893 −0.496 0.864 −0.051 0.983 mmu_miR_501_3p_001651−2.203 0.001 −3.171 0.000 −2.517 0.001 −0.968 0.172 −0.313 0.733 0.6540.356 mmu_miR_503_002456 −2.041 0.174 −0.564 0.849 −1.653 0.362 1.4770.363 0.388 0.852 −1.089 0.501 mmu_miR_503_002536 −2.287 0.019 −4.6750.000 −1.163 0.343 −2.388 0.018 1.124 0.313 3.512 0.001mmu_miR_504_002084 2.219 0.028 −0.252 0.934 −0.108 0.957 −2.471 0.018−2.326 0.026 0.145 0.933 mmu_miR_505_001655 −0.039 0.981 0.445 0.8491.044 0.494 0.485 0.766 1.083 0.424 0.598 0.675 mmu_miR_509_3p_0025214.056 0.463 1.737 0.875 6.753 0.253 −2.319 0.727 2.697 0.693 5.016 0.351mmu_miR_509_5p_002520 4.724 0.279 5.066 0.288 4.867 0.351 0.342 0.9680.142 0.988 −0.199 0.977 mmu_miR_511_002549 −0.638 0.770 −2.427 0.1870.828 0.762 −1.790 0.334 1.466 0.457 3.256 0.046 mmu_miR_532_3p_002355−1.287 0.037 −2.121 0.001 −0.367 0.707 −0.835 0.214 0.919 0.167 1.7540.005 mmu_miR_532_5p_001518 −2.357 0.000 −2.762 0.000 −1.454 0.004−0.405 0.452 0.902 0.065 1.307 0.005 mmu_miR_539_001286 2.580 0.0082.392 0.016 0.469 0.762 −0.188 0.912 −2.111 0.035 −1.923 0.043mmu_miR_540_3p_001310 3.846 0.001 0.524 0.767 0.591 0.738 −3.321 0.003−3.254 0.004 0.067 0.972 mmu_miR_540_5p_002561 1.986 0.078 0.109 0.9960.409 0.828 −1.877 0.118 −1.578 0.195 0.300 0.856 mmu_miR_541_0025624.400 0.000 2.458 0.000 −0.416 0.610 −1.942 0.002 −4.816 0.000 −2.8740.000 mmu_miR_542_3p_001284 −2.752 0.034 −0.934 0.588 −1.687 0.280 1.8190.193 1.065 0.500 −0.753 0.628 mmu_miR_542_5p_002563 −0.364 0.931 −0.1840.996 −0.272 0.964 0.179 0.977 0.092 0.989 −0.087 0.983mmu_miR_543_001298 2.996 0.000 2.779 0.000 0.297 0.762 −0.217 0.804−2.700 0.000 −2.483 0.000 mmu_miR_543_002376 3.032 0.000 2.765 0.0000.537 0.367 −0.267 0.654 −2.495 0.000 −2.228 0.000 mmu_miR_544_0025502.819 0.002 2.689 0.004 1.798 0.072 −0.130 0.941 −1.021 0.316 −0.8910.356 mmu_miR_546_001312 −0.111 0.991 −5.906 0.500 −8.405 0.327 −5.7940.468 −8.293 0.286 −2.499 0.796 mmu_miR_547_002564 0.329 0.931 −2.7640.384 −0.597 0.906 −3.094 0.294 −0.926 0.819 2.167 0.466mmu_miR_551b_001535 0.990 0.421 −1.345 0.292 1.169 0.415 −2.334 0.0470.180 0.926 2.514 0.022 mmu_miR_574_3p_002349 −4.920 0.000 −5.567 0.000−3.790 0.000 −0.647 0.445 1.130 0.151 1.777 0.014 mmu_miR_582_3p_0025670.502 0.825 −0.375 0.952 1.098 0.672 −0.877 0.691 0.596 0.818 1.4730.432 mmu_miR_582_5p_002566 1.343 0.117 3.338 0.000 0.415 0.762 1.9960.023 −0.928 0.341 −2.923 0.001 mmu_miR_590_5p_001984 −1.976 0.429 0.0730.996 −2.065 0.491 2.049 0.431 −0.089 0.985 −2.138 0.386mmu_miR_592_002017 2.714 0.000 3.129 0.000 −0.384 0.755 0.415 0.654−3.098 0.000 −3.512 0.000 mmu_miR_598_002476 0.519 0.739 1.412 0.2890.192 0.932 0.893 0.510 −0.328 0.850 −1.221 0.329 mmu_miR_599_241117_mat−2.759 0.298 −0.177 0.996 2.255 0.501 2.582 0.363 5.015 0.056 2.4330.374 mmu_miR_615_3p_001960 2.235 0.020 −1.367 0.204 0.000 1.000 −3.6020.001 −2.235 0.025 1.367 0.165 mmu_miR_615_5p_002353 −0.096 0.898 0.3850.548 0.571 0.361 0.480 0.396 0.667 0.226 0.186 0.793 mmu_miR_652_002352−2.808 0.008 −1.594 0.173 −1.088 0.427 1.214 0.300 1.720 0.127 0.5070.717 mmu_miR_654_3p_002239 −0.292 0.781 0.218 0.919 −0.543 0.630 0.5100.597 −0.250 0.829 −0.761 0.376 mmu_miR_654_5p_002522 0.334 0.786 0.7930.504 −0.064 0.976 0.460 0.711 −0.398 0.767 −0.858 0.402mmu_miR_665_002607 0.063 0.967 −0.915 0.514 −2.116 0.085 −0.978 0.437−2.179 0.056 −1.201 0.301 mmu_miR_666_3p_002448 1.465 0.530 1.131 0.7103.135 0.176 −0.334 0.926 1.669 0.494 2.004 0.358 mmu_miR_666_5p_0019524.053 0.000 0.336 0.788 0.127 0.932 −3.717 0.000 −3.926 0.000 −0.2090.838 mmu_miR_667_001949 3.553 0.000 2.811 0.000 0.194 0.828 −0.7420.193 −3.359 0.000 −2.617 0.000 mmu_miR_668_001947 −0.243 0.931 0.0260.996 −2.123 0.367 0.269 0.942 −1.880 0.389 −2.149 0.277mmu_miR_669C_002646 −3.075 0.017 −1.327 0.387 −0.273 0.909 1.748 0.2122.802 0.037 1.054 0.466 mmu_miR_669D_002808 −2.712 0.034 0.084 0.9960.080 0.979 2.796 0.038 2.791 0.036 −0.005 0.999 mmu_miR_669E_002774−2.568 0.096 −0.027 0.996 −0.117 0.974 2.541 0.119 2.451 0.128 −0.0900.973 mmu_miR_669G_002813 −0.356 0.518 0.106 0.952 −0.842 0.122 0.4620.396 −0.486 0.383 −0.948 0.044 mmu_miR_669H_5P_002906 0.268 0.931−2.394 0.289 −0.464 0.903 −2.661 0.214 −0.732 0.804 1.930 0.369mmu_miR_669a_001683 −2.727 0.069 0.792 0.730 −0.611 0.805 3.519 0.0252.117 0.193 −1.402 0.390 mmu_miR_669l_121149_mat −2.464 0.043 0.5410.802 0.507 0.804 3.005 0.018 2.971 0.020 −0.034 0.983mmu_miR_669m_121190_mat −2.479 0.238 1.069 0.730 0.794 0.812 3.548 0.0973.273 0.125 −0.275 0.937 mmu_miR_669n_197143_mat −4.045 0.000 −1.8450.100 −1.705 0.152 2.199 0.046 2.340 0.031 0.140 0.937mmu_miR_669o_121176_mat 0.371 0.847 2.860 0.048 3.747 0.014 2.489 0.0933.376 0.020 0.888 0.584 mmu_miR_670_002020 −0.920 0.876 −6.319 0.161−1.006 0.896 −5.399 0.226 −0.086 0.991 5.313 0.210 mmu_miR_671_3p_002322−0.584 0.571 3.076 0.001 −0.399 0.782 3.660 0.000 0.184 0.894 −3.4760.000 mmu_miR_672_002327 2.179 0.207 3.647 0.032 −2.290 0.241 1.4680.438 −4.469 0.010 −5.937 0.001 mmu_miR_673_001954 4.239 0.103 1.0250.843 7.736 0.006 −3.214 0.250 3.497 0.217 6.711 0.009mmu_miR_673_3p_002449 3.693 0.179 0.981 0.857 0.021 0.996 −2.712 0.363−3.672 0.201 −0.960 0.796 mmu_miR_674_001956 −3.335 0.000 −1.897 0.012−1.086 0.200 1.438 0.063 2.249 0.004 0.812 0.298 mmu_miR_674_002021−4.089 0.008 −2.310 0.174 −3.655 0.029 1.780 0.295 0.434 0.850 −1.3450.429 mmu_miR_675_3p_001941 0.765 0.931 −9.187 0.166 0.445 0.976 −9.9520.123 −0.320 0.980 9.632 0.112 mmu_miR_675_5p_001940 −3.345 0.290 −0.2610.996 −0.264 0.967 3.084 0.363 3.081 0.381 −0.003 0.999mmu_miR_676_001958 1.132 0.280 1.790 0.093 0.886 0.507 0.659 0.585−0.245 0.866 −0.904 0.408 mmu_miR_676_001959 −3.330 0.010 −0.996 0.548−1.237 0.463 2.334 0.090 2.093 0.127 −0.241 0.911 mmu_miR_677_0016600.217 0.914 1.042 0.516 1.575 0.305 0.825 0.587 1.358 0.353 0.533 0.753mmu_miR_679_001662 0.095 0.988 −3.350 0.587 −3.695 0.558 −3.445 0.527−3.790 0.501 −0.345 0.967 mmu_miR_680_001664 −4.104 0.474 −9.232 0.092−2.377 0.774 −5.128 0.377 1.727 0.819 6.855 0.192 mmu_miR_682_001666−2.723 0.589 −0.354 0.996 1.759 0.805 2.369 0.664 4.482 0.376 2.1130.710 mmu_miR_683_001668 −5.047 0.195 −5.160 0.214 1.136 0.864 −0.1130.984 6.183 0.116 6.296 0.089 mmu_miR_684_001669 −0.372 0.224 −0.0030.996 −1.160 0.000 0.369 0.246 −0.788 0.010 −1.156 0.000mmu_miR_685_001670 3.451 0.352 −1.634 0.782 7.053 0.068 −5.085 0.1723.602 0.375 8.687 0.011 mmu_miR_686_001672 −0.384 0.858 −0.277 0.961−1.269 0.530 0.107 0.975 −0.885 0.655 −0.992 0.573 mmu_miR_687_001674−0.317 0.768 0.230 0.916 −0.879 0.394 0.548 0.576 −0.561 0.587 −1.1090.182 mmu_miR_688_001675 3.872 0.070 3.884 0.088 3.691 0.130 0.012 0.998−0.181 0.965 −0.193 0.960 mmu_miR_690_001677 −0.055 0.980 −1.821 0.2170.659 0.762 −1.766 0.217 0.714 0.693 2.480 0.057 mmu_miR_691_0016784.255 0.369 0.290 0.996 5.650 0.288 −3.965 0.432 1.395 0.829 5.360 0.244mmu_miR_692_001679 0.559 0.850 −2.257 0.373 0.375 0.932 −2.816 0.224−0.184 0.965 2.632 0.238 mmu_miR_693_001680 −8.481 0.033 −4.329 0.3590.614 0.938 4.152 0.360 9.096 0.028 4.943 0.235 mmu_miR_693_3p_002036−6.014 0.195 −7.012 0.149 −2.555 0.720 −0.999 0.893 3.458 0.523 4.4570.353 mmu_miR_694_001681 3.703 0.338 −1.383 0.850 9.143 0.020 −5.0860.191 5.440 0.158 10.526 0.004 mmu_miR_695_001627 4.918 0.205 6.0080.135 4.918 0.265 1.089 0.846 0.000 1.000 −1.089 0.833mmu_miR_696_001628 6.364 0.231 −3.873 0.552 5.103 0.436 10.237 0.055−1.261 0.864 8.976 0.074 mmu_miR_697_001631 6.151 0.031 4.328 0.1704.392 0.181 −1.824 0.600 −1.760 0.636 0.064 0.983 mmu_miR_698_001632−0.379 0.750 −0.732 0.516 −0.678 0.577 −0.353 0.782 −0.299 0.819 0.0550.972 mmu_miR_700_001634 0.089 0.961 1.892 0.173 0.058 0.983 1.802 0.180−0.031 0.991 −1.834 0.152 mmu_miR_701_001635 0.327 0.931 −2.738 0.3622.200 0.520 −3.065 0.271 1.873 0.553 4.938 0.048 mmu_miR_702_0016362.615 0.237 −0.594 0.916 0.055 0.992 −3.209 0.161 −2.560 0.285 0.6490.822 mmu_miR_704_001639 −1.496 0.322 0.361 0.934 0.292 0.912 1.8570.229 1.788 0.263 −0.069 0.977 mmu_miR_706_001641 9.338 0.046 7.0690.173 12.454 0.015 −2.269 0.715 3.116 0.606 5.385 0.277mmu_miR_707_001642 −0.374 0.550 0.137 0.934 −0.798 0.199 0.511 0.403−0.423 0.515 −0.934 0.080 mmu_miR_708_002341 −0.083 0.931 2.130 0.001−0.032 0.980 2.213 0.000 0.051 0.964 −2.162 0.000 mmu_miR_710_0016454.157 0.571 6.486 0.387 8.286 0.273 2.329 0.801 4.129 0.610 1.800 0.838mmu_miR_711_001646 5.212 0.454 5.314 0.504 8.344 0.265 0.101 0.991 3.1320.729 3.030 0.712 mmu_miR_712_001961 −1.209 0.370 0.594 0.782 0.1160.964 1.804 0.179 1.326 0.368 −0.478 0.789 mmu_miR_712_002636 1.0770.822 −0.215 0.996 3.251 0.491 −1.292 0.804 2.175 0.640 3.466 0.371mmu_miR_713_001648 5.907 0.421 5.525 0.516 6.757 0.434 −0.382 0.9770.850 0.940 1.232 0.911 mmu_miR_715_001649 4.925 0.169 5.434 0.150 6.0900.121 0.510 0.939 1.165 0.819 0.655 0.911 mmu_miR_717_001652 2.233 0.754−4.823 0.458 4.822 0.491 −7.056 0.217 2.589 0.732 9.645 0.065mmu_miR_718_001656 6.142 0.048 5.660 0.089 3.130 0.437 −0.482 0.935−3.012 0.411 −2.530 0.466 mmu_miR_719_001673 1.389 0.463 0.733 0.8091.479 0.520 −0.657 0.789 0.090 0.980 0.747 0.746 mmu_miR_720_0016291.266 0.192 −2.365 0.013 3.729 0.000 −3.631 0.000 2.464 0.010 6.0950.000 mmu_miR_721_001657 2.863 0.750 3.955 0.694 7.751 0.354 1.092 0.9274.888 0.556 3.796 0.636 mmu_miR_741_002457 0.616 0.889 0.019 0.997−1.640 0.742 −0.597 0.910 −2.256 0.539 −1.658 0.646 mmu_miR_742_002038−0.071 0.980 0.499 0.916 0.396 0.905 0.570 0.821 0.467 0.852 −0.1020.973 mmu_miR_742_002458 1.727 0.770 1.558 0.877 2.407 0.749 −0.1690.980 0.680 0.928 0.849 0.911 mmu_miR_743a_002469 2.716 0.223 −1.3480.654 3.795 0.115 −4.064 0.069 1.079 0.722 5.143 0.013mmu_miR_743b_3p_002471 −0.318 0.822 0.267 0.934 −0.286 0.885 0.585 0.6590.032 0.989 −0.553 0.672 mmu_miR_743b_5p_002470 0.408 0.931 −2.022 0.6501.994 0.673 −2.430 0.509 1.586 0.727 4.016 0.218 mmu_miR_744_0023241.344 0.103 1.190 0.190 0.819 0.437 −0.153 0.917 −0.525 0.614 −0.3710.735 mmu_miR_758_002025 1.283 0.195 −0.085 0.996 0.464 0.762 −1.3680.177 −0.819 0.471 0.549 0.628 mmu_miR_759_002034 1.390 0.768 2.0110.710 6.720 0.092 0.622 0.924 5.330 0.161 4.709 0.197 mmu_miR_761_002030−2.396 0.720 −11.095 0.032 1.101 0.907 −8.699 0.105 3.498 0.585 12.1970.014 mmu_miR_762_002028 4.114 0.272 3.653 0.388 5.672 0.164 −0.4610.948 1.558 0.761 2.018 0.638 mmu_miR_763_002033 0.322 0.959 1.265 0.9081.697 0.808 0.943 0.894 1.375 0.827 0.433 0.956 mmu_miR_764_3p_0020325.308 0.088 2.948 0.434 1.588 0.757 −2.360 0.510 −3.720 0.285 −1.3600.746 mmu_miR_764_5p_002031 6.460 0.001 −0.355 0.961 2.484 0.243 −6.8140.001 −3.976 0.033 2.839 0.117 mmu_miR_767_241081_mat −0.323 0.285 0.0470.973 −1.106 0.001 0.370 0.237 −0.783 0.010 −1.153 0.000mmu_miR_770_3p_002027 4.378 0.000 0.519 0.766 −0.518 0.762 −3.859 0.001−4.896 0.000 −1.036 0.363 mmu_miR_770_5p_002608 3.929 0.000 1.694 0.0661.043 0.343 −2.235 0.015 −2.885 0.002 −0.650 0.512 mmu_miR_7a_000268−1.920 0.457 −1.076 0.788 0.403 0.932 0.844 0.804 2.323 0.389 1.4790.585 mmu_miR_7b_002555 0.993 0.635 0.658 0.850 0.081 0.983 −0.335 0.912−0.912 0.704 −0.577 0.814 mmu_miR_802_002029 −1.709 0.307 0.030 0.996−1.179 0.585 1.739 0.322 0.530 0.820 −1.209 0.494 mmu_miR_804_002044−3.987 0.547 −1.133 0.960 3.919 0.627 2.854 0.703 7.906 0.201 5.0520.419 mmu_miR_805_002045 3.480 0.360 −1.735 0.768 5.887 0.144 −5.2150.172 2.407 0.596 7.622 0.029 mmu_miR_871_002354 −2.088 0.237 0.2830.967 0.156 0.964 2.372 0.191 2.245 0.229 −0.127 0.967mmu_miR_872_002264 −2.157 0.000 0.458 0.516 −0.470 0.527 2.615 0.0001.687 0.004 −0.928 0.091 mmu_miR_872_002542 −1.388 0.008 1.101 0.043−0.373 0.612 2.489 0.000 1.015 0.064 −1.474 0.005 mmu_miR_873_0023562.253 0.043 −0.076 0.996 −0.122 0.957 −2.329 0.048 −2.375 0.041 −0.0450.979 mmu_miR_874_002268 1.688 0.429 2.134 0.345 3.249 0.139 0.446 0.8901.560 0.501 1.115 0.628 mmu_miR_875_3p_002547 −3.071 0.521 −4.347 0.379−1.610 0.813 −1.275 0.836 1.461 0.818 2.737 0.573 mmu_miR_876_3p_002464−0.065 0.985 0.178 0.996 0.590 0.898 0.243 0.961 0.655 0.852 0.412 0.919mmu_miR_876_5p_002463 −0.554 0.756 0.273 0.956 0.092 0.976 0.826 0.6140.646 0.732 −0.180 0.937 mmu_miR_877_002548 3.823 0.146 −2.859 0.3373.031 0.343 −6.682 0.012 −0.792 0.832 5.890 0.019 mmu_miR_878_3p_0025412.607 0.534 −3.815 0.375 6.147 0.136 −6.422 0.095 3.540 0.401 9.9620.006 mmu_miR_878_5p_002540 0.752 0.876 0.093 0.996 −0.695 0.909 −0.6580.910 −1.447 0.761 −0.789 0.883 mmu_miR_879_002472 −0.199 0.931 0.0280.996 −0.280 0.932 0.227 0.943 −0.081 0.981 −0.308 0.911mmu_miR_879_002473 1.294 0.387 2.905 0.042 −0.459 0.847 1.612 0.289−1.753 0.258 −3.365 0.013 mmu_miR_880_002665 3.015 0.646 −2.046 0.8503.845 0.610 −5.061 0.409 0.830 0.926 5.891 0.301 mmu_miR_881_0024753.117 0.463 3.037 0.537 3.914 0.428 −0.080 0.990 0.797 0.893 0.877 0.888mmu_miR_881_002609 4.168 0.229 4.225 0.260 5.610 0.137 0.056 0.991 1.4410.761 1.385 0.755 mmu_miR_882_002610 −0.372 0.224 −0.003 0.996 −1.1600.000 0.369 0.246 −0.788 0.010 −1.156 0.000 mmu_miR_883B_5P_002669 3.6240.355 4.302 0.305 4.957 0.254 0.678 0.917 1.334 0.809 0.655 0.913mmu_miR_883a_3p_002461 0.289 0.929 0.391 0.956 1.643 0.524 0.103 0.9771.354 0.578 1.251 0.574 mmu_miR_883a_5p_002611 −0.371 0.358 0.048 0.986−1.023 0.013 0.419 0.318 −0.652 0.102 −1.071 0.005mmu_miR_883b_3p_002565 1.944 0.559 1.585 0.710 1.710 0.701 −0.360 0.948−0.235 0.966 0.125 0.977 mmu_miR_92a_000430 1.009 0.013 −1.840 0.0001.970 0.000 −2.849 0.000 0.961 0.023 3.809 0.000 mmu_miR_92a_0024961.889 0.159 2.243 0.107 1.463 0.368 0.354 0.866 −0.426 0.826 −0.7800.613 mmu_miR_93_001090 −2.582 0.001 −1.341 0.089 −1.267 0.134 1.2410.117 1.315 0.092 0.074 0.958 mmu_miR_96_000186 5.180 0.004 2.498 0.2132.701 0.190 −2.682 0.166 −2.479 0.204 0.204 0.953 mmu_miR_98_000577−1.009 0.575 1.288 0.516 −2.365 0.185 2.296 0.172 −1.357 0.466 −3.6530.017 mmu_miR_99a_000435 −2.108 0.004 −0.712 0.420 −0.862 0.345 1.3960.070 1.246 0.106 −0.150 0.907 mmu_miR_99b_000436 −1.169 0.231 1.1680.271 0.364 0.813 2.337 0.016 1.533 0.122 −0.804 0.435 mmu_miR_9_000583−2.581 0.000 −1.007 0.009 −1.042 0.011 1.574 0.000 1.539 0.000 −0.0350.960

REFERENCES FOR THE EXAMPLES

-   1. Sayed D & Abdellatif M (2011) MicroRNAs in development and    disease. Physiol Rev 91(3):827-887.-   2. Ardekani A M & Naeini M M (2010) The Role of MicroRNAs in Human    Diseases. Avicenna J Med Biotechnol 2(4):161-179.-   3. O'Connell R M, Rao D S, Chaudhuri A A, & Baltimore D (2010)    Physiological and pathological roles for microRNAs in the immune    system. Nat Rev Immunol 10(2):111-122.-   4. Koval E D, et al. (2013) Method for widespread microRNA-155    inhibition prolongs survival in ALS-model mice. Human Molecular    Genetics 22(20):4127-4135.-   5. Chen X, et al. (2008) Characterization of microRNAs in serum: a    novel class of biomarkers for diagnosis of cancer and other    diseases. Cell Res 18(10):997-1006.-   6. Butovsky O, et al. (2014) Targeting miR-155 restores abnormal    microglia and attenuates disease in SOD1 mice. Ann Neurol.-   7. Ilieva H, Polymenidou M, & Cleveland D W (2009) Non-cell    autonomous toxicity in neurodegenerative disorders: ALS and beyond.    The Journal of Cell Biology 187(6):761-772.-   8. Boillee S, et al. (2006) Onset and progression in inherited ALS    determined by motor neurons and microglia. Science    312(5778):1389-1392.-   9. Doyle J P, et al. (2008) Application of a Translational Profiling    Approach for the Comparative Analysis of CNS Cell Types. Cell    135(4):749-762.-   10. He M, et al. (2012) Cell-type-based analysis of microRNA    profiles in the mouse brain. Neuron 73(1):35-48.-   11. Dougherty J D, Schmidt E F, Nakajima M, & Heintz N (2010)    Analytical approaches to RNA profiling data for the identification    of genes enriched in specific cells. Nucleic Acids Research    38(13):4218-4230.-   12. Gaughwin P, Ciesla M, Yang H, Lim B, & Brundin P (2011)    Stage-specific modulation of cortical neuronal development by    Mmu-miR-134. Cereb Cortex 21(8):1857-1869.-   13. Kocerha J, et al. (2009) MicroRNA-219 modulates NMDA    receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci    USA 106(9):3507-3512.-   14. Ying Z, et al. (2013) Loss of miR-204 expression enhances glioma    migration and stem cell-like phenotype. Cancer Res 73(2):990-999.-   15. Lu X, et al. (2013) miR-142-3p regulates the formation and    differentiation of hematopoietic stem cells in vertebrates. Cell Res    23(12):1356-1368.-   16. Peltier H J & Latham G J (2008) Normalization of microRNA    expression levels in quantitative RT-PCR assays: identification of    suitable reference RNA targets in normal and cancerous human solid    tissues. RNA 14(5):844-852.-   17. Xu X, Wells Aft O'Brien D R, Nehorai A, & Dougherty J D (2014)    Cell Type-Specific Expression Analysis to Identify Putative Cellular    Mechanisms for Neurogenetic Disorders. Journal of Neuroscience    34(4):1420-1431.-   18. Wooley C M, et al. (2005) Gait analysis detects early changes in    transgenic SOD1(G93A) mice. Muscle Nerve 32(1):43-50.-   19. Howland D S, et al. (2002) Focal loss of the glutamate    transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated    amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci USA    99(3):1604-1609.-   20. Smith R A, et al. (2006) Antisense oligonucleotide therapy for    neurodegenerative disease. J Clin Invest 116(8):2290-2296.-   21. Thiebes K P, et al. (2015) miR-218 is essential to establish    motor neuron fate as a downstream effector of Isl1-Lhx3. Nat Commun    6:7718.-   22. Amin N D, et al. (2015) Loss of motoneuron-specific microRNA-218    causes systemic neuromuscular failure. Science 350(6267):1525-1529.-   23. Aluise C D, Sowell R A, & Butterfield D A (2008) Peptides and    proteins in plasma and cerebrospinal fluid as biomarkers for the    prediction, diagnosis, and monitoring of therapeutic efficacy of    Alzheimer's disease. Biochim Biophys Acta 1782(10):549-558.-   24. Su Z, et al. (2014) Discovery of a biomarker and lead small    molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.    Neuron 83(5):1043-1050.-   25. Mitchell P S, et al. (2008) Circulating microRNAs as stable    blood-based markers for cancer detection. Proc Natl Acad Sci USA    105(30):10513-10518.-   26. Arroyo J D, et al. (2011) Argonaute2 complexes carry a    population of circulating microRNAs independent of vesicles in human    plasma. Proc Natl Acad Sci USA 108(12):5003-5008.-   27. Valadi H, et al. (2007) Exosome-mediated transfer of mRNAs and    microRNAs is a novel mechanism of genetic exchange between cells.    Nat Cell Biol 9(6):654-659.-   28. Wang K, Zhang S, Weber J, Baxter D, & Galas D J (2010) Export of    microRNAs and microRNA-protective protein by mammalian cells.    Nucleic Acids Res 38(20):7248-7259.-   29. Risso D, Massa M S, Chiogna M, & Romualdi C (2009) A modified    LOESS normalization applied to microRNA arrays: a comparative    evaluation. Bioinformatics 25(20):2685-2691.-   30. Smyth G K (2004) Linear models and empirical bayes methods for    assessing differential expression in microarray experiments. Stat    Appl Genet Mol Biol 3:Article3.-   31. Klipper-Aurbach Y, et al. (1995) Mathematical formulae for the    prediction of the residual beta cell function during the first two    years of disease in children and adolescents with insulin-dependent    diabetes mellitus. Med Hypotheses 45(5):486-490.

What is claimed is:
 1. A method to detect motor neuron disease, themethod comprising: a) measuring the amount of miR-218 in a biologicalsample obtained from a subject, b) comparing the amount of miR-218 inthe biological sample to a reference value, wherein an increase in theamount of miR-218 relative to the reference value indicates motor neurondisease; and c) treating the motor neuron disease detected based on theamount of miR-218, wherein the treatment is one or more of riluzole,tizanidine, baclofen, quinine, hyoscine hydrobromide skin patch, NSAID,gabapentin, physical therapy, acupuncture, immunotherapy, gene transfertherapy, stem cell or progenitor cell based cellular replacementtherapy, an antisense oligonucleotide therapeutic, an antioxidanttherapeutic, an antibody therapeutic, an autophagy control therapeuticor a small-molecule inhibitor of kynurenine 3-monooxygenase.
 2. Themethod of claim 1, further comprising: measuring at least one additionalmiRNA selected from the group consisting of miR-138, miR-133a, miR-133b,miR-1193, miR-34b, miR-380, and miR-379 in a biological sample obtainedfrom a subject, and comparing the amount of miR-218 and the at least oneadditional miRNA to a reference value, wherein dysregulation of miR-218and the at least one additional miRNA relative to the reference valueindicates motor neuron disease.
 3. The method of claim 2, whereindysregulation of miR-218 and miR-138 relative to a reference value aredetected.
 4. The method of claim 3, wherein miR-138 is increasedrelative to a reference value.
 5. The method of claim 1, wherein theamount of miR-218 in the biological sample compared to the referencevalue is increased at least 5-fold.
 6. The method of claim 4, whereinthe amount of miR-138 in the biological sample compared to the referencevalue is increased at least 2-fold.
 7. A method to detect the efficacyof treatment for motor neuron disease in a subject, the methodcomprising: a. measuring the amount of miR-218 in a first biologicalsample obtained from a subject; b. treating the subject with one or moreof riluzole, tizanidine, baclofen, quinine, hyoscine hydrobromide skinpatch, NSAID, gabapentin, physical therapy, acupuncture, immunotherapy,gene transfer therapy, stem cell or progenitor cell based cellularreplacement therapy, an antisense oligonucleotide therapeutic, anantioxidant therapeutic, an antibody therapeutic, an autophagy controltherapeutic or a small-molecule inhibitor of kynurenine 3-monooxygenase;c. then at a time after treating in step b, measuring the amount ofmiR-218 in a second biological sample obtained from a subject; and d.comparing the amount of miR-218 in the first biological sample to theamount of miR-218 in the second biological sample, wherein a change inmiR-218 indicates effectiveness of treatment, wherein ineffectiveness oftreatment is indicated if miR-218 is unchanged or increased in thesecond biological sample relative to the first biological sample andwherein effectiveness of treatment is indicated if miR-218 is decreasedin the second biological sample relative to the first biological sample.8. The method of claim 7, further comprising: measuring an amount of atleast one additional miRNA selected from the group consisting ofmiR-138, miR-133a, miR-133b, miR-1193, miR-34b, miR-380, and miR-379 inthe first biological sample obtained from the subject in step (a),measuring an amount of the at least one additional miRNA in the secondbiological sample obtained from the subject in step (b), and comparingthe amount of miR-218 and amount of the at least one additional miRNA inthe first biological sample to the amount of miR-218 and amount of theat least one additional miRNA in the second biological sample, wherein achange in the amount of miR-218 and amount of the at least oneadditional miRNA indicates effectiveness of treatment or progression ofmotor neuron disease.
 9. The method of claim 8, wherein the amountmiR-218 and miR-138 is measured.
 10. The method of claim 9, whereinineffectiveness of treatment or progression of motor neuron disease isindicated if miR-138 is increased in the second biological samplerelative to the first biological sample.
 11. The method of claim 7,further comprising altering treatment modality if ineffectiveness oftreatment or progression of motor neuron disease is detected.
 12. Themethod of claim 7, wherein the amount of miRNA is normalized to anamount of a control nucleic acid, wherein the control nucleic acid isselected from the group consisting of miR-191, miR-24 and miR-30c. 13.The method of claim 7, wherein the first biological sample and thesecond biological sample are selected from the group consisting ofcerebrospinal fluid (CSF), serum and urine.